cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
43237,"1,1'-but-2-ynylenedipyrrolidinium dichloride",206-097-8,300-68-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H312:38;H302:38
43240,2-(N-ethylanilino)ethanol,202-160-9,92-50-2,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,163,H314:33;H318:117;H317:85;H302:130;H331:84;H319:45;H315:44;H335:43;H412:20;H332:1;H312:1
43246,"1,1-diethoxyisooctane",273-905-3,69178-43-4,Flam. Liq. 3,Notified C&L,115,H226:115;H335:2
43248,N-Methylmethanesulfonamide,601-529-5,1184-85-6,,Notified C&L,4,H226:4;H319:2;H315:2;H335:2
43252,"Disodium 7-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(4-methoxy-2-sulphonatophenyl)azo]naphthalene-2-sulphonate",247-026-0,25489-36-5,,Notified C&L,1,Not classified:1
43256,"Poly(oxy-1,2-ethanediyl), alpha-(2-methyl-1-oxo-2-propenyl)-omega-hydroxy-, C16-18-alkyl ethers",615-186-4,70879-51-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,449,H319:441;H315:443;H335:443;Not classified:6;H318:2;H317:2
43258,"1,2-dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridinium chloride",223-444-9,3895-92-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H332:40;H315:41;H312:40;H335:40;H302:41;H319:41
43260,Cibenzoline,258-453-7,53267-01-9,Acute Tox. 4;Skin Irrit. 2,Notified C&L,1,H302:1;H315:1
43262,"cis-1,2,3,6-tetrahydrophthalimide",215-999-0,1469-48-3,Acute Tox. 5;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H303:1;H319:1;H315:1;H335:1
43264,"Cymbopogon, ext., oxidized",282-487-1,84238-19-7,Not Classified,Notified C&L,88,Not classified:88
43267,(±)-2-amino-3-(p-chlorophenyl)propanol,252-533-5,35373-63-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
43269,"Poly(oxy-1,2-ethanediyl),α-hydro-ω-hydroxy- Ethane-1,2-diol, ethoxylated",500-038-2,25322-68-3,Not Classified,REACH registration C&L,3339,Not classified:2978;H335:281;H319:114;H336:35;H302:6;H314:1;H351:1;H315:1;H226:1
43272,"2,2'-butyliminodiethanol",203-055-0,102-79-4,Eye Dam. 1,REACH registration C&L,331,H318:233;Not classified:55;H314:64
43273,2-ethylhexyl 4-(dimethylamino)benzoate,244-289-3,21245-02-3,Repr. 1B;Repr. 1B,REACH registration C&L,388,H360:12;Not classified:156;H319:220;H315:134;H335:127
43281,Dimethyl (3-amino-3-oxopropyl)phosphonate,219-765-9,2526-69-4,Not Classified,Notified C&L,7,Not classified:7
43282,"1-methyltrimethylene diacrylate;1,3-butylene glycol diacrylate",243-105-9,19485-03-1,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Harmonised C&L,0,H317:0;H312:0;H314:0
43284,"Benzenesulfonic acid, hydroxy-, reaction products with formaldehyde and urea, ammonium salts",296-371-3,92623-43-3,Not Classified,Notified C&L,3,Not classified:2;H319:1
43287,κ-Carrageenan,234-350-2,11114-20-8,,Notified C&L,44,Not classified:44
43290,"ETHYL (2R,3AR,10Z,11AS,12AR,14AR)-2-({7-METHOXY-8-METHYL-2-[4-(PROPAN-2-YL)-1,3-THIAZOL-2-YL]QUINOLIN-4-YL}OXY)-5-METHYL-4,14-DIOXO-2,3,3A,4,5,6,7,8,9,11A,12,13,14,14A-TETRADECAHYDROCYCLOPENTA[C]CYCLOPROPA[G][1,6]DIAZACYCLOTETRADECINE-12A(1H)-CARBOXYLATE",618-843-3,923604-57-3,Acute Tox. 4,REACH registration C&L,1,H302:1
43293,Pentamethylphenol,220-580-0,2819-86-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
43295,"Inula graveolens, ext.",295-773-6,92128-75-1,Not Classified,Notified C&L,187,Not classified:184;H317:2;H315:2;H411:2;H304:3;H412:1
43298,"Fatty acids, palm-oil, hydrogenated",282-486-6,84238-17-5,Not Classified,REACH registration C&L,13,Not classified:13
43299,Diammonium iron bis(sulphate),233-151-8,10045-89-3,Not Classified,REACH registration C&L,69,Not classified:67;H319:2;H315:2;H335:2
43301,Naturally occurring substances,310-127-6,999999-99-4,Not Classified,Notified C&L,511,Not classified:316;H372:49;H315:46;H360:107;H351:62;H373:91;H411:43;H410:40;H317:42;H350:41;H400:29;H226:22;H304:21;H332:7;H302:19;H412:18;H335:2;H319:3;H314:1;H371:1;H312:1;H318:1
43308,methyl 4-bromomethyl-3-methoxybenzoate,410-310-1,70264-94-7,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H317:0;H400:0;H318:0
43313,p-(chloromethyl)anisole,212-540-6,824-94-2,Skin Corr. 1B,Notified C&L,47,H314:47;H290:2;H318:2;H335:1
43319,Cobalt disodium ethylenediaminetetraacetate,239-198-0,15137-09-4,Acute Tox. 4;Skin Sens. 1,REACH registration C&L,112,H317:20;H302:20;H351:86;Not classified:6
43320,"1,5-Naphthalenedisulfonic acid, 2-[2-[6-[[4-chloro-6-[[3-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3-sulfo-2-naphthalenyl]diazenyl]-",604-676-3,149124-59-4,Not Classified,Notified C&L,13,Not classified:13
43321,"Poly(oxy-1,2-ethanediyl), alpha-(2-methyl-1-oxo-2-propenyl)-omega hydroxy-, C22-alkyl ether",603-068-5,125441-87-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Resp. Sens. 1,Notified C&L,45,H314:38;H302:38;H334:38;H312:38;H318:39;Not classified:6;H317:1;H315:1;H335:1
43323,"1-Chloro-2,4-difluorobenzene",604-365-2,1435-44-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:46;H315:46;H226:46;H335:45;Not classified:3
43324,Benzyl [5-(hydroxyimino)pentyl]carbamate,603-896-7,135124-61-7,Not Classified,Notified C&L,2,Not classified:1;H341:1
43325,"Amides, C10-16, N-(hydroxyethyl)",272-736-2,68910-39-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
43326,"naled (ISO);1,2-dibromo-2,2-dichloroethyl dimethyl phosphate",206-098-3,300-76-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Harmonised C&L,0,H315:0;H312:0;H400:0;H302:0;H319:0
43327,"2,3,4-trifluoroaniline",407-170-9,3862-73-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H315:0;H302:0;H411:0;H312:0;H318:0;H373:0
43328,O-p-tolyl chlorothioformate,213-333-3,937-63-3,Skin Corr. 1B;Acute Tox. 3,Notified C&L,42,H314:42;H331:38
43329,"Cyclohexane, Oxidized, aq. ext., Me ester, C5-6 fraction, distn. residues, di-Me ester fraction, hydrogenated, distn. residues",610-911-0,528857-25-2,Aquatic Chronic 3,Notified C&L,83,H412:83
43330,"1,5-diaminobromo-4,8-dihydroxyanthraquinone",250-817-3,31810-89-6,Not Classified,Notified C&L,84,Not classified:42;H319:39;H315:39;H335:39;H317:3
43331,N-[4-(aminocarbonyl)phenyl]-4-nitrobenzamide,298-791-2,93839-21-5,Not Classified,REACH registration C&L,37,Not classified:36;H341:1
43341,"tridemorph (ISO);2,6-dimethyl-4-tridecylmorpholine",246-347-3,24602-86-6,Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H410:0;H332:0;H315:0;H360:0;H400:0;H302:0
43342,"Paraformaldehyde, oligomeric reaction products with 4-tert-butylphenol and m-phenylenebis(methylamine)",925-847-1,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,2,H412:2;H312:2;H302:2;H314:2
43344,"2-Propenoic acid, 2-hydroxyethyl ester, polymer with 1,6-diisocyanatohexane",616-633-6,78567-28-9,Not Classified,Notified C&L,5,Not classified:5
43345,"Fatty acids, C5-9, mixed esters with dipentaerythritol and pentaerythritol",287-517-7,85536-35-2,Not Classified,Notified C&L,21,Not classified:21
43348,1-(1-oxododecyl)-L-proline,261-407-9,58725-39-6,Eye Dam. 1,Notified C&L,1,H318:1
43350,"2,2'-bipyrimidine",252-137-2,34671-83-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:38
43351,Diisopropylnaphthalenesulphonic acid,249-201-7,28757-00-8,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1,Notified C&L,24,H317:20;H314:23;H302:22;H290:2;H318:4;H336:1
43356,"1-Propanone, 3-(dimethylamino)-1-(3-methoxyphenyl)-, hydrochloride (1:1)",610-988-0,53342-08-8,Not Classified,Notified C&L,1,Not classified:1
43357,Sodium 1-methyl-1H-tetrazole-5-thiolate,257-006-3,51138-06-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
43360,Diiron arsenide,234-474-7,12005-88-8,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:42;H400:38;H331:42;H301:42;H373:4
43367,"2,3-didehydro-D-erythro-hexono-1,4-lactone",201-928-0,89-65-6,Not Classified,REACH registration C&L,498,Not classified:204;H319:279;H315:277;H335:275;H412:15
43368,"3,9-dichloro-7-methoxyacridine",201-666-7,86-38-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,43,H315:43;H317:39;H335:43;H334:39;H319:43
43371,"2,6-dimethylhept-5-en-2-ol",228-029-6,6090-15-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,259,H318:259;H315:259
43372,"Proteinase, Bacillus subtilis metallo-",232-991-2,9080-56-2,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,80,H334:79;H319:32;H315:32;H335:32;Not classified:1
43374,"2,3-diphenylcycloprop-2-en-1-one",212-948-4,886-38-4,Skin Irrit. 2;Skin Sens. 1,Notified C&L,46,H317:45;H315:41;H319:1;H335:1
43383,"3,4-dihydroxybenzonitrile",241-367-9,17345-61-8,Acute Tox. 3;Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,46,H317:1;H318:1;H411:1;H301:2;H332:43;H312:44;H302:44;H315:7;H335:6;H319:7
43385,"Oils, vegetable, brominated",232-416-5,8016-94-2,Not Classified,Notified C&L,88,Not classified:88
43404,"Calcium (±)-N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-β-alaninate",228-972-3,6381-63-1,Not Classified,Notified C&L,1,Not classified:1
43405,"Phenols, C",293-435-2,91079-47-9,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
43409,"2-methyl-1H,5H-pyrimidine-4,5-dione",254-941-9,40497-30-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:46;H315:46;H335:44;Not classified:1
43412,diazomethane,206-382-7,334-88-3,Carc. 1B,Harmonised C&L,0,H350:0
43415,"5,6-dimethoxyindoline",927-137-7,15937-07-2,Not Classified,REACH registration C&L,1,Not classified:1
43416,Chlorotetrafluoroethane,264-567-8,63938-10-3,Press. Gas (Liq.),Notified C&L,22,H280:22
43417,3-chlorobut-1-yne,244-151-2,21020-24-6,Flam. Liq. 2,Notified C&L,1,H225:1
43418,Bromothymol blue,200-971-2,76-59-5,Not Classified,Notified C&L,8,Not classified:6;H319:1;H315:1;H302:1
43419,Trimethyloxosulphonium chloride,225-724-6,5034-06-0,Not Classified,REACH registration C&L,48,Not classified:5;H319:43;H315:43;H335:42;H302:3;H332:1;H312:1
43422,"1-{[(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridinium chloride hydrochloride (1:1:1)",615-984-2,73547-70-3,Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;Aquatic Chronic 3,REACH registration C&L,5,H319:3;H412:3;H317:5;H334:5;H400:2
43429,"2,5-dichloroanilinium chloride",251-620-5,33663-41-1,Acute Tox. 3;Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H301:1;H331:1;H311:1;H400:1;H318:1;H373:1
43430,2-phenylpropionaldehyde oxime,261-839-8,59647-78-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
43431,"Glycerides, C8-10 di-",293-200-4,91052-40-3,Not Classified,Notified C&L,2,Not classified:2
43432,"4-hydroxybenzene-1,3-disulphonic acid",202-533-6,96-77-5,,Notified C&L,50,Not classified:33;H314:17
43435,Methyl 2-thienyl ketone,201-804-6,88-15-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1473,H332:1288;H312:1288;H302:1295;H311:167;H330:134;H301:121;H300:58;H331:50;H310:11;Not classified:1;H412:1
43438,"reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid;triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid",430-410-9,186148-38-9,Aquatic Chronic 3,Harmonised C&L,0,H412:0
43440,butyl formate,209-772-5,592-84-7,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H225:0;H319:0;H335:0
43452,Succinyl dichloride,208-838-0,543-20-4,Skin Corr. 1B,Notified C&L,45,H314:45;H290:1;H318:1;H332:1;H227:1;H302:1;H312:1
43453,"(E,E)-[5-(4-methoxy-2,3,6-trimethylphenyl)-3-methyl-2,4-pentadienyl]triphenylphosphonium chloride",273-975-5,69365-97-5,Acute Tox. 4;Repr. 2,REACH registration C&L,2,H361:2;H302:2
43458,Manganese dibromide,236-591-9,13446-03-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,115,H332:111;H312:111;H302:115
43459,Lithium triethylhydroborate,245-076-8,22560-16-3,Pyr. Sol. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,153,H314:153;H250:27;H260:153;H335:83;H225:4
43461,Lithium sulphate,233-820-4,10377-48-7,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,172,H319:4;H302:168;Not classified:4;H362:3;H412:3;H361:3
43462,Reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride,406-620-1,129217-90-9,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
43467,"Cytidine 5'-(trihydrogen diphosphate), mono[2-(trimethylammonio)ethyl] ester, hydroxide, inner salt, monosodium salt",251-689-1,33818-15-4,Not Classified,Notified C&L,6,Not classified:5;H302:1
43470,2-amino-2-ethylpropanediol,204-101-2,115-70-8,Eye Dam. 1,REACH registration C&L,554,H318:10;H319:539;H315:98;H302:38;H335:38;Not classified:5
43471,2-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazole,440-240-7,,Not Classified,Notified C&L,3,Not classified:2;H410:1;H400:1;H373:1
43474,"Bis(2-chloroethyl) ether-1,3-bis[3-(dimethylamino)propyl]urea copolymer",614-612-6,68555-36-2,Aquatic Chronic 2,Notified C&L,104,H411:85;H410:15;H400:11;Not classified:2;H412:2
43475,2-[(dimethylamino)methyl]pyridin-3-ol,218-510-9,2168-13-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
43479,"Amines, C12-14-tert-alkyl, reaction products with isooctanol and phosphorus oxide (P2O5)",292-558-9,90640-40-7,Not Classified,Notified C&L,47,Not classified:47
43481,"3,5-dimethyltricyclo[3.3.1.13,7]decan-1-amine hydrochloride",255-219-6,41100-52-1,Acute Tox. 4,Notified C&L,20,H302:15;H332:3;H312:3;H336:3;Not classified:1;H315:5;H335:2;H319:4;H301:2;H331:1;H413:2;H317:1;H361:1
43482,Neomycin B sulphate,248-770-9,28002-70-2,Not Classified,Notified C&L,53,Not classified:52;H332:1;H361:1;H312:1
43483,"Fatty acids, soya, reaction products with diethylenetriamine, propoxylated, chloromethane-quaternized",614-646-1,68605-26-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,22,H319:22;H315:22
43485,Bumadizone,222-710-1,3583-64-0,,Notified C&L,1,H302:1
43486,"tert-butyl (3S,5S)-3-isopropyl-5-((2S,4S)-tetrahydro-4-isopropyl-5-oxo-furan-2-yl)-2-oxo-pyrrolidine-carboxylate",472-680-0,,,Notified C&L,1,Not classified:1
43487,"1,5,9-trimethyl-13-oxabicyclo[10.1.0]trideca-4,8-diene",237-443-6,13786-79-3,Not Classified,Notified C&L,233,Not classified:233
43489,"2,2-dimethylpropane-1,3-diyl dibenzoate",224-081-9,4196-89-8,Not Classified,REACH registration C&L,53,Not classified:53
43493,Tetrachlorocyclobut-2-enone,221-704-6,3200-96-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
43497,Rubidium chloride,232-240-9,7791-11-9,Not Classified,Notified C&L,153,Not classified:152;H319:1
43499,"Trisodium 4-amino-5-hydroxy-3-[[4-[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo]phenyl]azo]-6-[(4-sulphonato-1-naphthyl)azo]naphthalene-2,7-disulphonate",279-093-7,79135-92-5,Not Classified,REACH registration C&L,85,Not classified:83;H319:2;H317:2;H334:2
43500,3-(indol-3-yl)acrylic acid,214-872-7,1204-06-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
43506,"2,5,6-trimethylcyclohex-2-en-1-one",243-473-0,20030-30-2,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,342,H412:342;H302:342;H315:342;H226:233
43508,2-amino-4-chlorophenol,202-458-9,95-85-2,Acute Tox. 4;Skin Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 4,REACH registration C&L,188,H315:139;H341:5;H351:93;H302:173;H413:3;H317:89;H335:135;H319:137;H411:31;Not classified:15;H332:1;H312:1
43509,"Iron, 4-[[5-(3,5-dinitrophenyl)azo]-2,4-dihydroxy-3-[(4-nitrophenyl)azo]]-5-hydroxy-2,7-naphthalenedisulfonic acid complex",232-363-8,8007-63-4,Aquatic Chronic 3,Notified C&L,37,H412:33;Not classified:2;H319:1;H411:1;H315:1
43510,Hexadecyldimethyl(3-sulphonatopropyl)ammonium,218-918-7,2281-11-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:42
43511,"1,2:5,6-diepoxyhexane",217-564-0,1888-89-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H332:1;H315:1;H312:1;H302:1;H319:1;H226:1
43512,"Citrus hystrix, ext.",294-942-1,91771-50-5,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1593,H317:1398;H412:1288;Not classified:195;H315:111;H411:109;H319:27;H410:1;H400:1;H226:1;H304:1
43513,"3,7-bis(dimethylamino)-1,9-dimethylphenothiazin-5-ium chloride",245-683-8,23481-50-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
43514,Potassium perfluoropentane-1-sulphonate,223-394-8,3872-25-1,Acute Tox. 3;Eye Irrit. 2;STOT SE 3,Notified C&L,69,H319:69;H335:69;H301:69;H412:14
43516,1-[4-(2-CHLOROETHOXY)PHENYL]-2-PHENYL-1-BUTANONE,600-461-3,103628-22-4,Not Classified,REACH registration C&L,3,Not classified:3
43517,"symclosene;trichloroisocyanuric acid;trichloro-1,3,5-triazinetrion",201-782-8,87-90-1,Ox. Sol. 2;Acute Tox. 4;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H335:0;H272:0;H400:0;H302:0;H319:0
43519,Diterbium trisulphate,237-213-5,13692-99-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H315:39;H335:39;Not classified:1
43523,(E)-o-methoxycinnamic acid,213-785-1,1011-54-7,,Notified C&L,5,H319:5;H315:5;H335:4
43530,"4-methyl-m-phenylene diisocyanate;toluene-2,6-di-isocyanate;toluene-2,4-di-isocyanate",209-544-5,584-84-9,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 2;STOT SE 3;Resp. Sens. 1;Carc. 2;Aquatic Chronic 3,Harmonised C&L,0,H315:0;H317:0;H335:0;H330:0;H351:0;H412:0;H334:0;H319:0
43532,4-acetoxybenzoic acid,219-066-9,2345-34-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
43537,"3,5-dibromo-p-cresol",237-763-6,13979-81-2,,Notified C&L,5,H319:5;H315:5;H335:4
43538,Dimethyl bromomalonate,212-775-4,868-26-8,Skin Corr. 1B,Notified C&L,40,H314:40;H318:2;H290:1
43540,Cyclopentadec-4-en-1-one,252-692-0,35720-57-1,Not Classified,Notified C&L,113,Not classified:113
43542,4-[2-[4-[benzyl(ethyl)amino]phenyl]vinyl]-1-(2-hydroxyethyl)pyridinium chloride,278-763-6,77769-98-3,,Notified C&L,42,Not classified:33;H412:9;H318:9;H302:9;H315:9
43548,"diphenylmethyl (6R,7S)-7-[(bromoacetyl)amino]-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",615-054-6,70035-75-5,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,2,H334:1;H317:1;Not classified:1
43549,"2',3'-dimethoxycinnamic acid",231-249-5,7461-60-1,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H317:38;H302:38
43552,"Icosahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin",240-216-4,16069-36-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,47,H315:39;H335:39;H311:43;H319:44;H331:39;H301:47;Not classified:2;H314:1;H290:1;H302:1;H250:1;H318:1
43554,"1,2-Ethanediamine, N-(2-aminoethyl)-, polymer with (chloromethyl)oxirane and N-methylmethanamine",610-056-3,42751-78-0,Not Classified,Notified C&L,31,Not classified:31
43557,"5,7-diazaspiro[3.4]octane-6,8-dione",618-291-3,89691-88-3,Flam. Sol. 2;Self-heat. 2,REACH registration C&L,3,H228:2;H252:2;H319:1;H302:1;H315:1
43558,"(S)-(4,5-dihydro-5-thioxo-1,3,4-thiadiazol-2-yl) benzenecarbothioate",257-581-0,51988-14-8,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,6,H317:6;H411:2;H318:4
43560,"2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride",407-010-8,118208-02-9,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H318:0;H411:0
43561,2-methoxy-5-methyl-4-[(4-methyl-2-nitrophenyl)azo]benzenediazonium tetrachlorozincate (2:1),263-357-3,61966-14-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 1B,Notified C&L,38,H332:38;H350:38;H312:38;H302:38
43562,"1H-Pyrazole-1-carboxamide, N,N',N''-[(2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tri-6,1-hexanediyl]tris[3,5-dimethyl-",604-937-1,154031-76-2,Not Classified,Notified C&L,83,Not classified:83
43564,"Tannins, sodium salts",297-654-4,93686-05-6,Not Classified,Notified C&L,62,Not classified:62
43566,3-benzoylphenylacetonitrile,244-315-3,21288-34-6,,Notified C&L,1,H302:1
43569,Cadmium silicate,236-765-4,13477-19-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H332:1;H400:1;H302:1;H312:1
43579,"Fatty acids, C8-18 and C18-unsatd., strontium salts",283-973-6,84776-46-5,Skin Irrit. 2,Notified C&L,1,H315:1
43580,Dipotassium hexachlororuthenate,245-381-6,23013-82-3,,Notified C&L,4,H319:4;H315:4;H335:4
43581,α-3-dimethylbenzyl alcohol,230-715-5,7287-81-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
43584,2-(trifluoromethoxy)-benzenesulphonamide,448-450-0,37526-59-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
43586,"Matte, copper",266-967-8,67711-91-5,Not Classified,REACH registration C&L,42,Not classified:21;H362:21;H360:21;H372:21;H412:21;H350:21
43590,"3,3-dimethylglutaric acid",225-425-0,4839-46-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:43
43595,Dihydrogen telluride,231-981-5,7783-09-7,Flam. Gas 1;Press. Gas (Liq.);Acute Tox. 1,Notified C&L,111,H330:111;H220:111;H280:111
43598,p-benzoquinone bis(O-benzoyloxime),204-403-4,120-52-5,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H332:1;H315:1;H335:1;H319:1;H302:1;H228:1;H312:1
43599,9-anthracenemethanol,215-998-5,1468-95-7,Not Classified,REACH registration C&L,3,Not classified:2;H341:1
43600,Ethyl 7-bromoheptanoate,249-883-6,29823-18-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,44,H319:43;H317:1;H315:43;H335:43;H332:1;H312:1;H302:1
43605,"2,4-dinitromesitylene",210-164-7,608-50-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H319:1;H315:1;H335:1
43606,"3,5,6-trichlorosalicylic acid",255-144-9,40932-60-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
43608,4''-pentyl-p-terphenyl-4-carbonitrile,259-028-9,54211-46-0,,Notified C&L,6,H332:5;H312:5;H302:5;Not classified:1;H413:1;H315:1;H319:1
43610,N-[2-(tetradecyloxy)phenyl]acetamide,268-034-0,67990-10-7,Eye Irrit. 2,Notified C&L,38,H319:38
43613,"Clove, ext., acetylated",294-944-2,91771-52-7,,Notified C&L,1557,H317:1557;H411:13
43614,"9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-, homopolymer",608-152-5,27925-02-6,Not Classified,Notified C&L,470,Not classified:470
43615,"Propane-1,2-diol, propoxylated",500-039-8,25322-69-4,Not Classified,REACH registration C&L,2130,Not classified:892;H302:665;H301:441;H319:116;H315:15;H332:2;H318:1;H317:1
43616,"4-amino-3,5-dichlorobenzonitrile",278-914-6,78473-00-4,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,Notified C&L,44,H317:39;H332:42;H312:42;H302:42;H315:5;H335:5;H319:5;H311:2;H331:2;H301:2
43618,"Disodium 5-[(3-carboxylato-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidene)(2,6-dichlorophenyl)methyl]-3-methylsalicylate",217-279-1,1796-92-5,Eye Irrit. 2,Notified C&L,22,H319:13;Not classified:9
43619,"9-methylacridin-10-ium-3,6-diamine; chloride",617-132-5,8063-24-9,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,50,H302:49;H318:49;H411:44;H410:2;H315:5;H335:4;H400:2;H319:1
43620,"4,4,4-trichlorobutyric acid",219-065-3,2345-32-6,,Notified C&L,4,H314:4
43623,Ethyl 4-methylimidazole-5-carboxylate,257-315-3,51605-32-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
43625,"Pentyl 2,5-bis[(4-[[6-(acryloyloxy)hexyl]oxy]benzoyl)oxy]benzoate",438-650-6,,Aquatic Chronic 4,REACH registration C&L,4,H413:4
43628,2-benzylaminoethyldimethylamine,203-122-4,103-55-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H315:38;H335:38;H314:4
43629,Potassium 2-ethylhexanoate,221-625-7,3164-85-0,Skin Irrit. 2;Eye Dam. 1;Repr. 2,REACH registration C&L,1254,H318:125;H361:140;H315:992;H319:924;Not classified:150;H412:18;H226:4;H373:4;H413:2
43630,"7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2H-benzo-1,4-diazepin-2-one monohydrochloride",252-867-1,36105-20-1,Acute Tox. 4;STOT RE 2,Notified C&L,26,H302:26;H373:24;H362:1;H361:2;H336:2
43631,1-chloro-4-phenoxybenzene,230-281-7,7005-72-3,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,5,H410:3;H400:3;H302:3;H318:3;H319:1;H315:1;H335:1;Not classified:1;H317:1
43632,Ethyl perfluorobenzoate,224-854-0,4522-93-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
43633,2-(4-amino-3-sulphophenyl)-6-methylbenzothiazole-7-sulphonic acid,227-471-7,5855-98-1,,Notified C&L,1,H319:1;H315:1
43634,2-fluoro-4-hydroxybenzonitrile,422-810-7,82380-18-5,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H318:0;H411:0
43635,(4-propoxyphenyl)formaldehyde,611-515-0,5736-85-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H332:40;H315:43;H312:40;H335:39;H302:45;H319:44
43638,2-(N-methylanilino)ethanol,202-285-9,93-90-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
43643,Lithium iodide,233-822-5,10377-51-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,120,H319:55;H315:55;Not classified:39;H302:30;H335:11
43645,"1-Butanone, 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-, (2E)-2-butenedioate (1:1)",619-301-9,97928-20-6,Not Classified,REACH registration C&L,1,Not classified:1
43651,(S)-4-Chloro-3-hydroxybutyric acid ethyl ester,617-912-5,86728-85-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,45,H302:43;H318:44;H332:4;H315:5;H312:4;H319:1
43652,"2,3-dibromothiophene",221-542-6,3140-93-0,Flam. Liq. 3;Acute Tox. 3;Eye Irrit. 2,Notified C&L,47,H319:46;H226:43;H301:40;H315:8;H314:1;H318:1;H335:4;H332:1;H312:1;H302:1
43654,magnesium sodium fluoride silicate,442-650-1,56450-90-9,STOT RE 2,Harmonised C&L,0,H373:0
43657,Oxyclozanide,218-904-0,2277-92-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,82,H410:79;H400:76;H302:46;H361:35;H371:35;H373:35;Not classified:1;H413:1;H411:1
43659,6-deoxy-6-formamido-L-sorbose,601-350-2,115241-16-2,Not Classified,Notified C&L,1,Not classified:1
43661,"and isobutane ;isobutane (containing ≥ 0,1 % butadiene (203-450-8))",200-857-2,75-28-5,,,0,H220:0;Not classified:0
43663,"2-chloro-4,5-difluorobenzoic acid",405-380-5,110877-64-0,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H312:0;H302:0;H318:0
43665,5-amino-3-sulphosalicylic acid,228-262-3,6201-87-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38;H301:38
43668,2-(3-bromophenyl)-2-methylpropanoic acid,617-247-0,81606-47-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
43669,4-piperidinobutyronitrile,225-119-7,4672-18-8,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H312:38;H301:38
43670,2-ethylidenehexanal,246-950-1,25409-08-9,Not Classified,Notified C&L,88,Not classified:88
43674,"Reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate",406-460-2,125139-08-4,Aquatic Chronic 3,Harmonised C&L,0,H412:0
43675,4-(4-methoxyphenyl)-3-methylbutan-2-one,267-240-8,67828-19-7,Not Classified,Notified C&L,113,Not classified:113
43678,"Trisodium bis[6-amino-5-[(2-hydroxy-3,5-dinitrophenyl)azo]naphthalene-1-sulphonato(3-)]cobaltate(3-)",281-891-5,84057-73-8,Not Classified,Notified C&L,2,Not classified:2
43682,"Molasses, blackstrap",232-487-2,8052-35-5,Not Classified,Notified C&L,97,Not classified:97
43686,2-decyltetradecanoic acid,298-190-5,93778-52-0,Not Classified,REACH registration C&L,2,Not classified:2
43687,"1-Dodecene, polymer with 1-decene and 1-octene, hydrogenated",605-315-2,163149-28-8,Asp. Tox. 1,Notified C&L,9,H304:8;Not classified:1;H413:1
43688,1H-Imidazole-1-propanenitrile,607-301-1,23996-53-4,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,89,H319:88;H302:88;H315:3;H360:1;H317:1;H331:1;H311:1;H412:1;H350:1;H318:1;H301:1;H332:2;H312:2;H335:2
43690,1-fluorodecane,206-380-6,334-56-5,Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:38;H400:38;H300:39
43695,"Tris[3-bromo-2,2-bis(bromomethyl)propyl] phosphate",606-254-4,19186-97-1,Not Classified,Notified C&L,87,Not classified:87
43696,"4-amino-3,6-bis[[5-[[4-chloro-6-[(3-sulphophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulphophenyl]azo]-5-hydroxynaphthalene-2,7-disulphonic acid",279-756-0,81417-94-9,Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,3,H334:2;H319:2;H335:2;Not classified:1
43699,"Trimethyl-13-oxabicyclo[10.1.0]trideca-4,8-diene",275-967-7,71735-79-0,Not Classified,Notified C&L,165,Not classified:139;H315:25;H411:24;H412:1;H410:1;H319:1;H335:1
43700,(5-fluoro-2-methoxyphenyl)methanol,610-053-7,426831-32-5,Eye Irrit. 2,Notified C&L,84,H319:83;H318:1
43701,"N-[(1,1-dimethylethoxy)carbonyl]-L-alanine",239-847-8,15761-38-3,Not Classified,Notified C&L,7,Not classified:5;H319:2;H315:2;H335:2
43706,"1,1,1,2,2-pentafluoro-3-iodopropane",206-568-8,354-69-8,,Notified C&L,5,H319:5;H315:5;H335:5
43711,Pentyl lactate,228-974-4,6382-06-5,Not Classified,Notified C&L,1,Not classified:1
43717,Sodium bis(2-ethylhexyl) phosphate,205-493-8,141-65-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,59,H319:40;H315:44;H318:14;Not classified:5
43720,(2-chloroethyl)(3-hydroxypropyl)ammonium chloride,429-740-6,40722-80-3,Skin Sens. 1;Muta. 1B;Carc. 1B;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H340:0;H412:0;H350:0;H373:0
43721,hydrogenated cetyl olive oil esters,921-980-4,,Acute Tox. 3;Eye Irrit. 2B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H400:2;H319:2;H301:2
43722,Silver thiocyanate,216-934-9,1701-93-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:42;H332:42;H400:42;H302:42;H312:42
43726,Dodecyl acrylate,218-463-4,2156-97-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,938,H319:908;H315:908;H411:900;H335:906;H317:110;Not classified:30
43730,4-fluoro-α-methylbenzyl alcohol,206-959-3,403-41-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H302:1
43731,Thioridazine hydrochloride,204-992-8,130-61-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,47,H410:42;H315:46;H335:46;H400:42;H302:46;H319:47;H332:4;H312:4;H341:1;H317:1;H413:1;H331:1;H301:1
43736,"4-Methoxy-2,2,6,6-tetramethylpiperidin-N-oxyl",619-125-2,95407-69-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
43737,Chrome niobium titanium buff rutile,271-891-3,68611-42-7,Not Classified,Notified C&L,5,Not classified:5
43738,"Carbonic dichloride, polymer with 4,4'-(1-methylethylidene)bis[2,6-dibromophenol] and phenol",619-012-8,94334-64-2,,Notified C&L,65,Not classified:65
43739,Ammonium perrhenate,237-075-6,13598-65-7,Not Classified,REACH registration C&L,169,Not classified:33;H332:83;H319:141;H302:83;H315:141;H335:49;H272:58
43741,"2,6-di-tert-butyl-4-ethylphenol",223-945-2,4130-42-1,Aquatic Chronic 2,Notified C&L,18,H411:5;H319:11;H315:11;H335:10;H410:6;H400:6;Not classified:1
43747,"Fatty acids, tallow, hydrogenated, zinc salts",273-204-2,68953-40-2,Aquatic Chronic 2,Notified C&L,44,H411:25;Not classified:19
43748,Calcium hexafluorosilicate,240-991-9,16925-39-6,Not Classified,Notified C&L,1,Not classified:1
43750,5-chloroindole-2-carboxylic acid,234-050-1,10517-21-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H302:45;H315:44;H335:43
43751,"Carbamic acid, N-10H-phenothiazin-2-yl-, ethyl ester",609-471-2,37711-29-8,,Notified C&L,1,H319:1;H315:1;H335:1
43752,Padimate,244-288-8,21245-01-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39;H332:1;H312:1;H302:1;H226:1
43753,N-tert-butylglycyl chloride hydrochloride (1:1),618-771-2,915725-52-9,Skin Corr. 1B,REACH registration C&L,2,H314:2
43755,6-methylergoline-8β-carboxylic acid,227-551-1,5878-43-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,4,H332:2;H302:4;H362:1
43758,N-tert-butoxycarbonylamino-3-hydroxypropionic acid,444-670-6,,Not Classified,Notified C&L,2,Not classified:1;H318:1
43759,"Formic acid, compound with 2-aminoethanol (1:1)",258-440-6,53226-35-0,Not Classified,Notified C&L,2,Not classified:2
43761,Zirconium dinitrate oxide,237-529-3,13826-66-9,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,173,H302:115;H318:116;H290:9;H314:62;H272:70;H335:1;H319:1;H315:1;H412:1
43766,"2,3,6-trichlorophenol",213-271-7,933-75-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,43,H319:42;H302:41;H315:42;Not classified:1;H411:1;H301:1
43767,Ergometrine,200-485-0,60-79-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H311:38;H331:38;H301:38
43768,o-cymene,208-426-0,527-84-4,Flam. Liq. 3,Notified C&L,132,H226:132;H302:4;H319:1;H315:1
43770,"4,4'-difluorobenzhydryl alcohol",206-671-8,365-24-2,Eye Irrit. 2,Notified C&L,40,H319:39;H315:1;H335:1;Not classified:1
43774,Oct-1-ene,203-893-7,111-66-0,Flam. Liq. 2;Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2099,H410:207;H400:207;H225:1949;H304:1947;H315:353;H411:353;Not classified:104;H312:48;H319:75;H335:22;H310:1
43775,"2-[4-[(hexahydro-2,4,6-trioxo-5-pyrimidyl)azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid, compound with 2,2',2''-nitrilotris[ethanol] (1:1)",265-314-4,65036-46-6,Not Classified,REACH registration C&L,135,Not classified:135
43776,"Distillates (petroleum), acid-treated heavy paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C",265-119-4,64742-20-7,Carc. 1A,Harmonised C&L,0,H350:0
43777,Proflavine hydrochloride,213-459-9,952-23-8,Eye Irrit. 2,Notified C&L,41,H319:41;H315:3;H335:3
43780,reaction mass of: disodium hexyldiphenyl ether disulphonate;disodium dihexyldiphenyl ether disulphonate,429-650-7,147732-60-3,Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H411:0
43781,"4-((4-Ethyl-2,6-difluorphenyl)-ethinyl)-4'-propylbiphenyl",606-940-3,221526-72-3,Aquatic Chronic 4,Notified C&L,2,H413:2;Not classified:1
43782,Diphenyl diselenide,216-780-2,1666-13-3,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46,H410:46;H301:45;H400:46;H331:45;H373:45;H330:1;H300:1
43783,2-phenyl-2-piperidinoacetamide,230-673-8,7253-67-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H315:38;H335:38
43785,"Pyrazole-3,5-dicarboxylic acid monohydrate",221-474-7,3112-31-0,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
43786,"3,5-diiodosalicylic acid",205-124-0,133-91-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,61,H332:44;H315:54;H312:44;H302:61;H319:54;H335:47
43787,"2,2-dibromo-2-nitroethanol",412-380-9,69094-18-4,Expl. 1.1;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H201:0;H314:0;H400:0;H351:0;H302:0;H373:0
43788,"Alcohols C12-14, ethoxylated (>2-5EO)",931-014-3,68439-50-9,Eye Dam. 1;Aquatic Acute 1,Notified C&L,2,H400:2;H318:2
43789,Ethyldiisopropylammonium p-toluenesulphonate,263-523-5,62359-01-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
43791,2-hexylfuran,223-235-2,3777-70-6,,Notified C&L,5,H302:5;H226:5
43792,Sodium hydrogen-5-sulphoisophthalate,228-845-2,6362-79-4,Eye Dam. 1;Repr. 2,REACH registration C&L,243,H361:66;H318:93;H319:111;H315:113;Not classified:39;H335:60;H412:4
43794,Bicyclohexyl,202-161-4,92-51-3,Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,155,H410:155;H400:155;H304:85;H319:32;H315:32
43795,Chlorodimethyl(2-phenylethyl)silane,241-207-8,17146-08-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H318:38
43802,Cyclohexylphenylacetic acid,223-443-3,3894-09-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
43804,"2-Propyn-1-amine, N,N-diethyl-, hydrochloride (9CI)",607-199-9,23123-80-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,2,H332:2;H412:2;H312:2;H302:2
43806,[No public or meaningful name is available],458-980-4,,Not Classified,Notified C&L,24,Not classified:24
43807,"BAYGENAL GRAU L-NG-R ""F",406-780-2,,Not Classified,Notified C&L,1,Not classified:1
43813,"4-(trans-5-Ethyl-1,3-dioxan-2-yl)-2,6-difluorbenzonitril",610-366-9,475644-15-6,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
43818,"D-Glucopyranose, oligomers, cetyl glycosides",500-524-4,161074-89-1,Not Classified,Notified C&L,1,Not classified:1
43819,"2-Ethylhexan-1-ol, ethoxylated, esters with acrylic acid",500-156-4,62722-22-9,Acute Tox. 5;Skin Sens. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H303:2;H410:2;H317:2;H335:2;H400:2;Not classified:2;H315:2
43821,benquinox (ISO);p-benzoquinone 1-benzoylhydrazone 4-oxime,207-807-9,495-73-8,Acute Tox. 3;Acute Tox. 4,Harmonised C&L,0,H312:0;H301:0
43822,"(S)-2-Amino-6-propionylamino-4,5,6,7-tetrahydrobenzothiazole",600-709-0,106006-84-2,Acute Tox. 4,Notified C&L,1,H302:1
43825,"reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate",400-580-9,85099-50-9,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H315:0;H411:0
43826,3-(tridecyloxy)propylamine,238-717-8,14676-61-0,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,441,H410:441;H314:441;H400:441;H302:441;H226:441
43829,Propyloxirane,213-701-3,1003-14-1,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Carc. 2,REACH registration C&L,126,H332:123;H312:123;H351:123;H302:123;H225:125;H319:124;H315:1;Not classified:1
43832,NYLON 6/66,607-478-5,24993-04-2,,Notified C&L,53,Not classified:33;H319:20
43833,propionic anhydride,204-638-2,123-62-6,Skin Corr. 1B,Harmonised C&L,0,H314:0
43835,3-(trimethoxysilyl)propiononitrile,219-764-3,2526-62-7,Not Classified,REACH registration C&L,28,Not classified:1;H315:23;H319:5;H332:1;H312:1;H335:1;H302:1
43836,Quinoxaline-2-carbonyl chloride,259-315-9,54745-92-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H314:39;H318:39
43839,"2,4,6-trimethyl-1,3,5-trioxane;paraldehyde",204-639-8,123-63-7,Flam. Liq. 3,Harmonised C&L,0,H226:0
43840,"3,4-dihydro-7-nitronaphthalen-1(2H)-one",254-887-6,40353-34-2,Acute Tox. 4,Notified C&L,40,H302:38;H319:2;H315:2;H335:1
43850,"Benzenesulfonic acid, hydroxy-, reaction products with formaldehyde and urea, sodium salts",296-372-9,92623-44-4,Not Classified,Notified C&L,5,Not classified:2;H319:3;H315:2;H335:1
43856,Lithium hexafluoroarsenate,249-963-0,29935-35-1,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,45,H410:42;H400:39;H331:43;H301:44;H373:4;Not classified:1;H311:1
43857,warfarin (ISO);4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,201-377-6,81-81-2,Acute Tox. 2;Acute Tox. 1;Acute Tox. 1;STOT RE 1;Aquatic Chronic 2;Repr. 1A,Harmonised C&L,0,H310:0;H360:0;H330:0;H372:0;H411:0;H300:0
43861,Piperonyl alcohol,207-808-4,495-76-1,Not Classified,Notified C&L,92,Not classified:90;H319:2;H315:2;H335:2
43866,"Oils, animal, Me esters, sulfurized",273-638-2,68991-18-4,Not Classified,Notified C&L,74,Not classified:74
43869,Sodium 3-[(ethylanilino)methyl]benzenesulphonate,255-842-3,42480-72-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
43876,"Butan-2-one O,O'-(methylvinylsilylene)dioxime",276-784-5,72721-10-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H226:1;H335:1
43877,"Formic acid, compound with 2-(dimethylamino)ethanol (1:1)",261-603-4,59101-30-3,Not Classified,Notified C&L,5,Not classified:5
43878,"Octadecan-1-ol, ethoxylated, phosphates",500-155-9,62362-49-6,Aquatic Chronic 4,REACH registration C&L,80,H413:4;H318:66;H302:50;H315:67;H360:17;H317:17;H335:17;H371:17;H319:18;H336:17;Not classified:8;H314:1
43881,Trisodium 5-[(7-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]-8-[[4-(phenylazo)-6-sulphonatonaphthyl]azo]naphthalene-2-sulphonate,233-981-0,10482-42-5,Not Classified,Notified C&L,2,Not classified:2
43883,"(1S,2R,4S,5S,7R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate",603-953-6,136310-64-0,Acute Tox. 3;Acute Tox. 3,Notified C&L,13,H311:9;H331:9;H361:3;H319:3;H315:4;H373:2;H300:2;H372:1;H318:1;H310:1;H335:1;H330:1
43885,DRIMARENE BRILLIANT RED X-2BN,400-190-9,,Not Classified,Notified C&L,31,Not classified:31
43888,3-bromo-4-fluorobenzaldehyde,278-764-1,77771-02-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:47;H302:40;H315:47;H335:45;H311:1;H331:1;H301:1
43889,"cis-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolane-4-ylmethyl methanesulphonate monohydrochloride",282-252-3,84145-27-7,Acute Tox. 4;Eye Dam. 1;Repr. 2;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,1,H410:1;H361:1;H302:1;H318:1;H373:1
43891,"2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium trichlorozincate",274-478-6,70236-45-2,Not Classified,Notified C&L,2,Not classified:2
43893,3-hydroxybutyric acid,206-099-9,300-85-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:43
43894,Isododecane,250-816-8,31807-55-3,Asp. Tox. 1,Notified C&L,1755,H304:1712;H226:389;H413:36;H319:32;H315:32;H332:1;Not classified:1
43897,Ethoxypyrazine,253-750-8,38028-67-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,43,H318:38;H302:38;H315:42;H319:5;H335:4;H226:1
43899,"Biphenyl-4,4'-diol",202-200-5,92-88-6,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,184,H317:96;H412:95;H319:54;H312:88;H315:54;H335:53;H411:34;Not classified:2;H252:1
43905,3-(decyloxy)propylamine,231-530-2,7617-78-9,,Notified C&L,1,Not classified:1
43912,2-[7-(diethylamino)-2-oxo-2H-1-benzopyran-3-yl]quinazolin-4(1H)-one,249-200-1,28754-28-1,Not Classified,REACH registration C&L,6,Not classified:6
43915,"Poly(oxy-1,2-ethanediyl), α,α'-[(9-octadecen-1-ylimino)di-2,1-ethanediyl]bis[ω-hydroxy-",611-637-4,58253-49-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H302:1;H315:1;H400:1
43919,"1,3-Naphthalenedisulfonic acid, 7-[2-[4-[2-[1-hydroxy-3-sulfo-7-[(2-sulfoethyl)amino]-2-naphthalenyl]diazenyl]-3-methoxyphenyl]diazenyl]-, sodium salt (1:4)",607-837-6,259685-51-3,Not Classified,Notified C&L,2037,Not classified:2037
43922,Fructose 1-(barium phosphate),258-811-2,53823-70-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H302:38;H331:1;H301:1
43923,5-methyl-2-phenylhex-2-enal,244-602-3,21834-92-4,Skin Sens. 1,Notified C&L,1486,H317:1442;H319:45;H315:45;H335:4;H413:1
43925,MTBA,462-670-4,,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1
43926,Ethotoin,201-665-1,86-35-1,Acute Tox. 4,Notified C&L,43,H302:43
43928,Acid black 2,616-852-7,8005-03-6,Not Classified,Notified C&L,292,Not classified:261;H373:31
43931,"Sulfonic acids, C13-18-alkane",293-713-3,91082-04-1,Skin Corr. 1C,Notified C&L,1,H314:1
43933,dimethyl carbonate,210-478-4,616-38-6,Flam. Liq. 2,Harmonised C&L,0,H225:0
43935,"Reaction mass of (4aR,8R,9bS)-7,7,8,9,9-pentamethyl-4,4a,5,6,7,8,9,9b-octahydroindeno[4,5-d][1,3]dioxine and (4aR,8S,9bS)-7,7,8,9,9-pentamethyl-4,4a,5,6,7,8,9,9b-octahydroindeno[4,5-d][1,3]dioxine",446-220-4,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,2,H317:2;H411:2
43936,"Zeolites, 5A",615-031-0,69912-79-4,,Notified C&L,38,Not classified:38
43937,"Fatty acids, tallow, sulfonated, sodium salts",270-600-7,68457-12-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,9,H319:9;H315:9
43938,"2,6,10-trimethylundeca-5,9-dienol",246-000-6,24048-14-4,Not Classified,Notified C&L,113,Not classified:113
43941,1-methylpyrrole-2-carbaldehyde,214-755-0,1192-58-1,Not Classified,Notified C&L,132,Not classified:89;H319:43;H315:43;H335:42
43943,"N2-[(1,1-dimethylethoxy)carbonyl]-N5-[imino(nitroamino)methyl]-L-ornithine",218-580-0,2188-18-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
43944,"5(or 6)-carboxy-4-hexylcyclohex-2-ene-1-octanoic acid, compound with 2,2',2''-nitrilotriethanol",282-473-5,84235-46-1,Not Classified,Notified C&L,12,Not classified:11;H319:1;H315:1
43945,3-[(2-hydroxyethyl)[4-[(4-nitrophenyl)azo]phenyl]amino]propiononitrile,229-690-3,6657-32-5,Not Classified,Notified C&L,2,Not classified:2
43946,Cyclotetradecan-1-one,222-758-3,3603-99-4,Not Classified,Notified C&L,88,Not classified:88
43948,Dodecamethylpentasiloxane,205-492-2,141-63-9,Not Classified,REACH registration C&L,234,Not classified:195;H319:39;H315:39;H335:39
43952,"O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]",421-870-1,156145-66-3,Acute Tox. 4;STOT RE 2;Repr. 2,Harmonised C&L,0,H361:0;H302:0;H373:0
43953,sec-butylcyclohexane,230-342-8,7058-01-7,Not Classified,Notified C&L,3,Not classified:3
43954,O-p-chlorophenyl chlorothioformate,213-334-9,937-64-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,43,H315:38;H335:38;H302:38;H413:38;H318:39;H314:5;H290:1
43959,3-Hydroxypyridine methylbromide,608-573-4,31034-86-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
43961,Ergotamine tartrate,206-835-9,379-79-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Repr. 2,Notified C&L,49,H311:42;H361:45;H331:41;H301:42;H362:4;H360:4;H372:4;H302:7;H413:4;H332:3;H312:3;H330:2
43962,"2-Propenoic acid, 2-methyl-, polymer with methyl 2-methyl-2-propenoate and 2-propenoic acid",609-651-0,39332-53-1,Aquatic Chronic 3,Notified C&L,83,H412:83
43964,1-chloro-3-methylbut-2-ene,207-972-7,503-60-6,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,57,H225:56;H319:57;H315:57;H335:56;H226:1
43966,"2,3-didehydro-3-O-sodio-D-erythro-hexono-1,4-lactone",228-973-9,6381-77-7,Not Classified,REACH registration C&L,276,Not classified:260;H319:16;H315:16;H335:1
43967,"Glycerides, C16-18 and C18-unsatd. mono-",294-571-5,91744-09-1,Not Classified,REACH registration C&L,39,Not classified:39
43970,"Peptones, soybean",293-434-7,91079-46-8,Not Classified,REACH registration C&L,10,Not classified:10
43975,Octadecadienoic acid,601-763-8,121250-47-3,Not Classified,Notified C&L,11,Not classified:11
43976,1-fluorododecane,206-381-1,334-68-9,Acute Tox. 2;Aquatic Chronic 4,Notified C&L,38,H300:38;H413:38
43978,Potassium pentahydrogen bis(phosphate),238-961-5,14887-42-4,Eye Irrit. 2,REACH registration C&L,28,H319:27;H290:1;H314:1
43981,Reactive Red 23,603-230-5,12769-07-2,Skin Sens. 1,Notified C&L,3,H317:3
43982,"[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]zinc",238-262-5,14320-04-8,Not Classified,Notified C&L,103,Not classified:103
43983,Viomycin,251-323-0,32988-50-4,Acute Tox. 4,Notified C&L,1,H302:1
43990,Dithulium tricarbonate,227-887-9,6026-63-7,Not Classified,Notified C&L,6,Not classified:6
43995,Aluminium diboride,234-923-7,12041-50-8,Not Classified,Notified C&L,1,Not classified:1
43996,Bromocresol green,200-972-8,76-60-8,Not Classified,Notified C&L,15,Not classified:15
43997,Dichlorotris(triphenylphosphine)ruthenium,239-569-7,15529-49-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H332:41;H312:41;H302:41;Not classified:1
44000,Thallium chloride,232-241-4,7791-12-0,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,43,H330:43;H300:43;H411:43;H373:43
44004,"3,3,7,7-tetraethyl-4,6-dioxa-5-thia-3,7-distannanonane 5,5-dioxide",200-335-4,57-52-3,,Notified C&L,4,H410:4;H310:4;H330:4;H400:4;H300:4
44009,"2-chloro-α,α,α-trifluorotoluene",201-805-1,88-16-4,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,264,H315:248;H335:247;H302:198;H319:248;H226:238
44015,"Proteinase, Aspergillus oryzae neutral",232-990-7,9080-55-1,Skin Irrit. 2;Eye Irrit. 2A;Resp. Sens. 1;STOT SE 3;STOT SE 3,Notified C&L,35,H334:35;H319:25;H315:25;H335:25
44018,"tetraboron disodium heptaoxide, hydrate",235-541-3,12267-73-1,Repr. 1B,Harmonised C&L,0,H360:0
44020,Myo-inositol,201-781-2,87-89-8,Not Classified,REACH registration C&L,132,Not classified:132
44021,Mercury dithiocyanate,209-773-0,592-85-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,76,H410:75;H310:72;H330:76;H400:73;H300:76;H373:76;H311:4;Not classified:1
44022,Dichloroisobutylaluminium,217-563-5,1888-87-5,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1A,REACH registration C&L,5,H314:5;H250:5;H260:5
44024,3-hydroxy-4-[(2-methoxyphenyl)azo]-N-phenylnaphthalene-2-carboxamide,242-621-1,18846-91-8,Aquatic Chronic 4,Notified C&L,38,H413:38
44025,Heptaminol hydrochloride,208-837-5,543-15-7,Acute Tox. 4,Notified C&L,4,H302:3;H319:1;H315:1;H335:1
44027,Potassium triethylhydroborate,245-077-3,22560-21-0,Water-react. 1;Skin Corr. 1B,Notified C&L,38,H314:38;H260:38
44028,Polyphosphoric acids,232-417-0,8017-16-1,Met. Corr. 1;Skin Corr. 1B,REACH registration C&L,1207,H290:171;H314:1207;H318:592;H302:85;H301:2;H335:1
44029,"5-(2,3-dimethyltricyclo[2.2.1.02,6]hept-3-yl)-2-methylpent-2-en-1-ol, stereoisomer",204-102-8,115-71-9,Not Classified,Notified C&L,113,Not classified:78;H317:35
44031,(2.xi)-D-gluco-heptono-γ-lactone,262-037-0,60046-25-5,Not Classified,Notified C&L,1,Not classified:1
44033,Strontium tartrate,212-774-9,868-19-9,Not Classified,REACH registration C&L,1,Not classified:1
44036,Ammonium benzenesulphonate,243-035-9,19402-64-3,Not Classified,Notified C&L,22,Not classified:22
44037,"(S)-6-(p-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole oxalate",263-487-0,62284-79-1,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H302:38
44046,Methylcellulose,618-391-7,9004-67-5,Not Classified,Notified C&L,320,Not classified:320
44048,"Formaldehyde, polymer with 1,3-benzenedimethanamine and 4-(1,1-dimethylethyl)phenol",603-750-2,133548-08-0,Not Classified,Notified C&L,80,Not classified:56;H412:24;H312:24;H302:24;H314:24
44054,"2-(1,1-dimethylethyl)-4-[[5-(1,1-dimethylethyl)-4-hydroxy-2-methylphenyl]thio]-5-methylphenyl 3-(dodecylthio)propionate",273-857-3,69075-62-3,Skin Sens. 1;STOT RE 1,Notified C&L,1,H372:1;H317:1
44057,"2,5-dihydroxy-N-(2-hydroxyethyl)benzamide",263-358-9,61969-53-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
44058,"5-chloro-α,α,α-trifluoro-2-nitrotoluene",204-280-7,118-83-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:46;H315:45;H335:41;H332:6;H312:6;H302:7;H311:1;H411:3;H331:1;H301:1;H317:2
44060,"2,3-dihydro-1,4-dihydroxyanthraquinone",254-942-4,40498-13-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2054,H410:2;H400:2;Not classified:2052
44062,α-methylcyclopentanemethanol,258-208-4,52829-98-8,Not Classified,Notified C&L,1,Not classified:1
44063,"2,4-di-tert-butylphenol",202-532-0,96-76-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1169,H410:755;H318:539;H315:1024;H400:661;H302:432;H319:485;H335:328;H373:127;H411:93;Not classified:53;H371:1
44065,"2,2-dichloro-1-(2,4,5-trichlorophenyl)ethan-1-one",214-871-1,1203-86-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H318:38
44067,"4-(4,6-Bis((biphenyl-4-yl)-1,3,5-triazine-2-yl)-1,3-benzodiole",485-420-6,,Not Classified,REACH registration C&L,84,Not classified:84
44068,"N,N''-naphthalene-1,5-diylbis[N'-[3-[(2-ethylhexyl)oxy]propyl]urea]",275-276-0,71216-01-8,Not Classified,REACH registration C&L,157,Not classified:134;H413:23
44069,Pleuromulin,204-747-5,125-65-5,Acute Tox. 4,Notified C&L,6,H302:4;H410:2;H400:3;Not classified:1;H317:1;H335:1;H334:1;H319:1
44070,Ammonium octadecyl hydrogen phosphate,231-393-9,7529-94-4,Not Classified,Notified C&L,1,Not classified:1
44074,Ammonium vanadium oxide,234-351-8,11115-67-6,Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Aquatic Chronic 2,Notified C&L,33,H331:33;H335:33;H411:33;H318:33;H301:33
44075,Iron trinitrate,233-899-5,10421-48-4,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,2252,H314:114;H318:16;H319:2132;H315:2130;H272:92;H373:22;Not classified:7;H332:5;H335:5;H317:1;H290:1;H302:2
44076,"7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt",424-850-0,,Eye Dam. 1,Harmonised C&L,0,H318:0
44079,"1,2-epoxycyclododecane",206-012-4,286-99-7,Not Classified,REACH registration C&L,120,Not classified:82;H315:38
44082,"Balsams, Canada",232-362-2,8007-47-4,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,275,H317:254;H315:116;H411:255;H304:100;Not classified:12;H226:10
44083,"1-chloro-1,2,2,2-tetrafluoroethane",220-629-6,2837-89-0,Press. Gas (Liq.),Notified C&L,123,H280:76;H420:49;H059:3
44084,4-chloro-4'-fluorobutyrophenone,223-395-3,3874-54-2,Flam. Liq. 4;Skin Sens. 1B;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,24,H317:10;H401:10;H227:10;H411:10;H341:5;H302:8;Not classified:3;H319:2;H315:2;H335:2;H412:1
44087,2-nitrophenyl acetate,210-233-1,610-69-5,Skin Sens. 1,REACH registration C&L,41,H317:40;H319:1;H315:1;H335:1
44090,"Sodium 2,4-dinitrophenoxide",213-786-7,1011-73-0,Expl. 1.3;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H311:1;H301:1;H331:1;H203:1
44091,"Benzenesulfonic acid, mono-C10-16-alkyl derivs., sodium salts",268-356-1,68081-81-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,559,H318:343;H302:400;H315:422;H335:46;Not classified:129;H312:46;H330:43;H319:79;H400:5;H412:5
44094,"Benzene, mono-C12-18-branched alkyl derivs.",302-197-1,94094-94-7,Asp. Tox. 1;Aquatic Chronic 4,Notified C&L,30,H413:30;H304:30
44101,"Triisotridecyl benzene-1,2,4-tricarboxylate",276-594-2,72361-35-4,Not Classified,REACH registration C&L,470,Not classified:469;H413:1
44102,"Sulfonic acids, petroleum, magnesium salts",263-094-4,61789-87-5,Not Classified,Notified C&L,328,Not classified:291;H413:20;H319:17
44103,"2-methyl-1,5-dioxaspiro[5.5]undecane",229-115-6,6413-26-9,Not Classified,Notified C&L,88,Not classified:88
44109,"Sunflower oil, dewaxed",283-107-7,84540-16-9,Not Classified,Notified C&L,1,Not classified:1
44110,"2,2,7,7-tetramethyl-3,6-dithia-2,7-disilaoctane",256-935-1,51048-29-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
44116,"Flue dust, copper-refining",266-966-2,67711-90-4,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Muta. 2;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,10,H410:10;H360:10;H317:10;H314:9;H331:9;H372:10;H341:10;H400:9;H350:10;H318:9;H301:10;H310:1;H330:1;H319:1
44122,Solsperse 20000,600-908-2,109265-72-7,Eye Irrit. 2,Notified C&L,82,H319:81;Not classified:1
44123,"L-lysine mono(1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate)",248-771-4,28003-86-3,Acute Tox. 4,Notified C&L,1,H302:1
44127,"Cellulose, triacetate",618-479-5,9012-09-3,Not Classified,Notified C&L,1,Not classified:1
44129,5-Ethenyl-2-pyrrolidinone,616-206-4,7529-16-0,Acute Tox. 3;Acute Tox. 3;Eye Dam. 1,Notified C&L,3,H311:2;H318:2;H301:2;H332:1;H319:1;H302:1;H315:1
44132,"1,2-Ethanediamine, polymer with (chloromethyl)oxirane and N- methylmethanamine",610-057-9,42751-79-1,Aquatic Chronic 3,Notified C&L,293,H412:198;H410:57;H319:59;H315:38;H335:38
44133,"(1-methylethylidene)bis(4,1-phenyleneoxy-3,1-propanediyl) bismethacrylate",248-607-1,27689-12-9,Aquatic Chronic 4,REACH registration C&L,1,H413:1
44134,5-Ethoxy-4-methyloxazole,610-500-6,5006-20-2,Flam. Liq. 3;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 2,Notified C&L,1,H315:1;H320:1;H411:1;Not classified:1;H319:1;H300:1;H226:1;H301:1
44135,"[N,N',N'',N'''-tetrakis[3-(dimethylamino)propyl]-29H,31H-phthalocyaninetetrasulphonamidato(2-)-N29,N30,N31,N32]copper tetraacetate",280-052-0,82864-55-9,Aquatic Chronic 3,Notified C&L,38,H412:37;Not classified:1
44137,"1,1-bis(cyclohexyloxy)trimethylamine",217-947-2,2016-05-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
44138,ASCOMYCIN,435-850-5,,Skin Irrit. 2;STOT RE 1;Aquatic Chronic 4,Notified C&L,1,H372:1;H315:1;H413:1
44139,Tropicamide,216-140-2,1508-75-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,60,H332:52;H315:43;H317:51;H335:43;H319:42;H302:59;H312:52;H334:12;H318:1
44141,5-MPCA,611-241-1,5521-55-1,Eye Dam. 1,Notified C&L,48,H318:42;H319:6;H315:6;H335:6;H411:1
44142,Methyl heptafluorobutyrate,206-600-0,356-24-1,Not Classified,REACH registration C&L,46,Not classified:2;H319:44;H315:44;H335:43;H225:1
44145,"Fatty acids, C8-10, esters with trimethylolpropane",287-516-1,85536-34-1,Not Classified,Notified C&L,3,Not classified:3
44147,Thiamazole,200-482-4,60-56-0,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Repr. 2,REACH registration C&L,57,H319:3;H361:46;H317:48;H302:10;H332:3;Not classified:1;H315:1;H335:1
44148,"(2-carbamimidamido-1,3-thiazol-4-yl)methyl carbamimidothioate dihydrochloride",618-106-6,88046-01-9,Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,7,H332:7;H317:6;H412:6;H302:7;H402:6;H315:1;H335:1;H319:1
44149,Bis(2-ethylhexyl) phenyl phosphite,221-624-1,3164-60-1,Not Classified,Notified C&L,18,Not classified:17;H315:1
44150,Mastic (resin),263-098-6,61789-92-2,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1418,H317:1383;H411:1371;H304:1393;H226:84;H315:26;H412:12
44153,"1-phenylbutane-1,3-dione",202-286-4,93-91-4,Not Classified,Notified C&L,4,Not classified:2;H319:2;H315:2;H335:2
44157,"Disodium 4,4'-bis[(4-ethoxyphenyl)azo]stilbene-2,2'-disulphonate",220-698-2,2870-32-8,Not Classified,Notified C&L,21,Not classified:18;H319:3;H315:1
44159,"Fatty acids, tall-oil, esters with dipentaerythritol",275-019-2,70913-98-3,Not Classified,REACH registration C&L,74,Not classified:72;H413:2
44160,"3,3,6-trimethylhepta-1,5-dien-4-one",208-903-3,546-49-6,Flam. Liq. 3,Notified C&L,126,H226:126
44164,1-(dimethylpropylsilyl)-1H-imidazole,263-526-1,62365-35-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
44169,"3,7-Dichloroquinoline-8-carboxylic acid",617-530-9,84087-01-4,Skin Sens. 1,Notified C&L,194,H317:194
44174,bis(2-ethylhexyl)octylphosphonate,417-170-0,52894-02-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
44175,"3,6-dichlorophthalic anhydride",224-733-2,4466-59-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
44176,Kerosine (petroleum);Straight run kerosine;[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C,232-366-4,8008-20-6,Asp. Tox. 1,Harmonised C&L,0,H304:0
44182,"2-Butenedioic acid (Z)-, di-C10-20-branched and linear alkyl esters, sulfonated, sodium salts",290-868-9,90268-65-8,Not Classified,Notified C&L,1,Not classified:1
44185,Emetine hydrochloride,206-259-8,316-42-7,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:40;H315:40;H300:41;H335:40;H301:1
44188,Methyl 5-chloro-2-methoxybenzoate,251-743-4,33924-48-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
44191,o-(trifluoromethyl)cinnamic acid,218-168-0,2062-25-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
44193,Tetradecylphosphonic acid,225-118-1,4671-75-4,,Notified C&L,6,H319:5;H315:5;H335:4;H332:1;H314:1;H302:1
44199,(R)-3-hydroxybutyric acid,210-909-6,625-72-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,80,H319:80;H315:80;H335:80
44200,"3-bromo-1,1,1-trifluoroacetone",207-071-9,431-35-6,Flam. Liq. 2;Skin Corr. 1B,REACH registration C&L,51,H225:51;H314:51;H319:1;H335:1;H318:1;H410:1;H272:1
44201,"Citric acid, chromium salt",260-543-6,57072-40-9,Eye Irrit. 2,Notified C&L,3,H319:2;Not classified:1;H332:1;H315:1;H312:1;H335:1;H302:1
44202,Hexasodium hexatriaconta-μ-oxooctadecaoxobis[μ9-[phosphato(3-)-O:O:O:O':O':O'':O'':O''':O''']]octadecamolybdate(6-),256-777-3,50811-90-0,Not Classified,Notified C&L,1,Not classified:1
44203,2-(tetrahydro-5-methyl-5-vinyl-2-furyl)propan-2-ol,262-038-6,60047-17-8,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,163,H319:33;H302:163;H315:114;H314:38;H318:1
44205,5-chloro-2-(trichloromethyl)-1H-benzimidazole,222-713-8,3584-66-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H315:38;H335:38;H311:38;H319:38;H331:38;H301:38
44206,"1,2-dichloro-1,1,2-trifluoro-2-iodoethane",206-565-1,354-61-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
44207,"Tetraethyl 2,2'-(1,4-phenylenedimethylidyne)bismalonate",228-726-5,6337-43-5,Skin Sens. 1,REACH registration C&L,52,H317:52
44213,Bromine chloride,237-601-4,13863-41-7,Skin Corr. 1A;Acute Tox. 4,Notified C&L,2,H332:1;H314:2;H272:1;H400:1;H290:1;H331:1
44215,"Benzenesulfonic acid, (tetrapropenyl)-, compd. with 2-propanamine (1:1)",605-119-7,157966-96-6,Not Classified,Notified C&L,176,Not classified:176
44221,"2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate",413-290-2,93672-52-7,Self-react. C;Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H242:0;H412:0;H302:0;H318:0
44225,"2-propenoic acid, ester with 2,2'-[oxybis(methylene)]bis[2-ethyl-1,3-propanediol]",609-563-2,385434-56-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
44227,(carboxymethyl)dimethyl-3-[(1-oxododecyl)amino]propylammonium hydroxide,224-292-6,4292-10-8,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,612,H412:8;H318:125;H319:482;H315:501;H400:20;Not classified:5
44230,Methyl 2-methylbutyrate,212-778-0,868-57-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1667,H225:1626;H319:1617;H315:1622;H226:39;H335:3;H411:1;Not classified:1
44234,Bis(2-ethylhexyl) peroxydicarbonate,240-282-4,16111-62-9,Org. Perox. C;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,539,H318:6;H317:538;H242:538;H315:455;H319:532;H302:83;H411:3;Not classified:1
44236,Trofosfamide,244-770-8,22089-22-1,Acute Tox. 3;Muta. 1B;Carc. 1B;Repr. 1B,Notified C&L,1,H360:1;H340:1;H372:1;H413:1;H350:1;H301:1
44238,3-amino-p-toluamide,243-039-0,19406-86-1,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,40,H302:34;H318:34;H411:1;H319:6;H315:6;H335:5
44239,4-bromo-6-chloro-o-cresol,231-394-4,7530-27-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
44243,"1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-[(1-oxododecyl)oxy]-, chloride (1:1)",610-973-9,53171-04-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,4,H318:4;H315:4
44244,Ethyl (Z)-oct-4-enoate,252-065-1,34495-71-1,,Notified C&L,1,Not classified:1
44247,"(R*,S*)-2,3-dimethylsuccinic acid",210-163-1,608-40-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
44249,1H-benzotriazol-4-amine,241-982-2,18076-61-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
44250,Purine Derivative,606-546-1,20419-68-5,Skin Irrit. 2;Skin Sens. 1,Notified C&L,35,H317:35;H315:35
44251,C.I. Disperse Yellow 126,612-901-1,61968-70-5,Not Classified,Notified C&L,2,Not classified:1;H319:1;H302:1;H315:1;H413:1
44255,"Hydrogen [4-[[4-(diethylamino)phenyl][4-[ethyl(3-sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt",223-942-6,4129-84-4,Aquatic Chronic 2,REACH registration C&L,92,H411:14;Not classified:70;H319:8
44256,"4(3H)-Quinazolinone, 6-chloro-2-(2-hydroxyphenyl)-",608-234-0,28683-81-0,Not Classified,Notified C&L,1,Not classified:1
44258,"Guar gum, 2-hydroxypropyl ether, depolymd.",270-497-9,68442-94-4,Not Classified,Notified C&L,3,Not classified:3
44259,"2,3-dihydro-2,2-dimethylbenzofuran-7-ol",216-350-4,1563-38-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
44262,1-ethoxy-2-(2-methoxyethoxy)ethane,213-690-5,1002-67-1,Not Classified,REACH registration C&L,264,Not classified:188;H319:75;H226:1
44263,2-CARBOXYETHYL-TRIPHENYLPHOSPHONIUM CHLORIDE,609-274-1,36626-29-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
44264,"Shellac, sapond.",293-666-9,91081-60-6,Not Classified,Notified C&L,1,Not classified:1
44267,2-bromovaleric acid,209-546-6,584-93-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,Notified C&L,41,H314:41;H331:38;H311:38;H318:39;H301:38;H290:1;H302:2;H332:1;H335:1;H312:1
44271,2-butoxyethyl 4-chloro-o-tolyloxyacetate,243-103-8,19480-43-4,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:39;H332:39;H312:39;H400:39;H302:39;H319:38
44272,2-dibutylaminoethanol,203-057-1,102-81-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT SE 3,REACH registration C&L,249,H314:229;H335:150;H302:215;H312:192;H318:169;H319:20;H315:20;H412:22;H371:4;H373:4
44273,"1-(4'-bromo[1,1'-biphenyl]-4-yl)ethan-1-one",227-236-9,5731-01-1,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,40,H319:40;H411:38;H315:2;H335:1
44275,Pentadecan-2-one,219-064-8,2345-28-0,Not Classified,Notified C&L,90,Not classified:90
44284,1-hexyl isocyanate,219-763-8,2525-62-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,40,H332:39;H317:38;H302:39;H334:40;H312:39;H226:40;H315:2;H335:1;H319:2;H310:1;H330:1;H300:1
44285,"quinomethionate;chinomethionat (ISO);6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one",219-455-3,2439-01-2,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H410:0;H332:0;H317:0;H312:0;H400:0;H361:0;H302:0;H319:0;H373:0
44286,Pyrrolidine-1-carbonyl chloride,214-758-7,1192-63-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42,H314:42;H318:38
44288,"Fatty acids, C16 and C18-unsatd., polymers with bisphenol A, Bu glycidyl ether, epichlorohydrin and triethylenetetramine",600-687-2,105839-18-7,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,10,H410:1;H315:1;H317:1;H400:1;H318:1;Not classified:9
44292,Lithium diethylamide,212-433-4,816-43-3,Pyr. Sol. 1;Water-react. 2;Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38;H250:38;H261:38
44301,7-methylindole,213-270-1,933-67-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H315:42;H335:41;Not classified:1
44302,N-(tert-butyl)benzylamine,222-179-6,3378-72-1,Acute Tox. 4;Skin Corr. 1,REACH registration C&L,24,H314:22;H302:22;H226:4;H225:1;H318:2;H301:1;Not classified:2;H312:1
44303,"Citric acid, manganese sodium salt",285-950-6,85169-06-8,Not Classified,Notified C&L,1,Not classified:1
44304,"1,1'-[isopropylidenebis(oxy)]dibutane",205-496-4,141-72-0,Flam. Liq. 3,Notified C&L,1,H226:1
44306,2-heptylfuran,223-236-8,3777-71-7,Not Classified,Notified C&L,92,Not classified:92
44307,"1,3-Propanediol, 2-ethyl-2-[(2-propen-1-yloxy)methyl]-, 1,3-diacetate",614-056-4,67385-16-4,Aquatic Chronic 3,Notified C&L,7,H412:7
44308,9H-fluoren-9-yltriphenylphosphonium bromide,230-672-2,7253-07-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
44310,Dihydrogen [4-hydroxy-3-[[2-hydroxy-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-1-sulphonato(4-)]cuprate(2-),267-592-2,67892-59-5,Not Classified,Notified C&L,2,Not classified:2
44313,Bis(piperidinothiocarbonyl) tetrasulphide,204-406-0,120-54-7,Aquatic Chronic 4,Notified C&L,149,H413:46;H411:38;H317:33;Not classified:24;H361:5;H302:7;H373:5;H319:1;H315:2;H332:1;H312:1
44315,Nickel niobium titanium yellow rutile,271-892-9,68611-43-8,Not Classified,Notified C&L,3,Not classified:3
44317,aminoguanidiniumoxalat,610-707-1,51601-65-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
44318,Tetraamminepalladium(2+) dinitrate,237-078-2,13601-08-6,Self-react. A;Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,52,H410:6;H240:6;H317:6;H400:6;H302:6;H319:52;H335:46;H315:46;H272:46;H200:4
44319,Ammonium thiosulphate,231-982-0,7783-18-8,Not Classified,REACH registration C&L,76,Not classified:72;H319:3;H302:1
44320,(2S-trans)-3-amino-2-methyl-4-oxoazetidine-1-sulphonic acid,279-393-8,80082-65-1,Skin Sens. 1,REACH registration C&L,5,H317:3;H319:2;H315:2;H335:2;H302:1
44336,"2,5-Difluorobenzenesulfonyl chloride",607-866-4,26120-86-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,45,H314:45;H318:38;H319:1;H335:1
44337,3-ethyl-2-hydroxycyclopent-2-en-1-one,244-606-5,21835-01-8,Not Classified,Notified C&L,1444,Not classified:1405;H317:38;H332:1;H302:1;H226:1
44339,"1,3-propanediamine dihydrochloride",234-051-7,10517-44-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,39,H315:38;H335:38;H311:38;H319:38;H331:38;H301:38;H332:1;H312:1;H302:1
44344,Amodiaquine,201-669-3,86-42-0,Acute Tox. 4,Notified C&L,2,H302:2
44348,Dipotassium aquapentachloroiridate(2-),248-921-9,28235-15-6,Skin Irrit. 2;Skin Sens. 1,Notified C&L,2,H317:2;H315:2
44350,octane;n-octane,203-892-1,111-65-9,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H304:0;H315:0;H400:0;H225:0;H336:0
44351,tert-butyl 2-ethylperoxyhexanoate,221-110-7,3006-82-4,Org. Perox. C;Skin Sens. 1;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,850,H360:31;H317:707;H242:778;H400:209;H411:88;H410:638;H220:52;H280:52;Not classified:51;H361:33;H319:20;H315:20
44356,Allyl 2-cyanoacrylate,230-796-7,7324-02-9,Not Classified,Notified C&L,1,Not classified:1
44359,Petroleum resins,265-116-8,64742-16-1,,REACH registration C&L,919,Not classified:880;H413:33;H315:5;H411:3;H410:1;H400:1;H317:1
44360,"2-(2-bromo-4,5-dimethoxyphenyl)ethan-1-amine hydrobromide",920-619-8,,Acute Tox. 4;Skin Corr. 1C,REACH registration C&L,2,H314:2;H302:2
44362,"Bulnesia sarmienti, ext., sapond.",290-792-6,90244-88-5,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H315:1;H411:1
44366,"(3aα,4α,6α,7α,7aα)-3a,4,5,6,7,7a-hexahydro-3-methyl-5-methylene-4,7-methano-1H-inden-6-yl acetate",279-836-5,81836-13-7,Not Classified,Notified C&L,88,Not classified:88
44369,"6-[methyl[(nitrophenyl)sulphonyl]amino]hexanoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",299-843-7,93905-09-0,Not Classified,Notified C&L,7,Not classified:7
44371,"2',4',6'-trimethylacetophenone",216-783-9,1667-01-2,Not Classified,Notified C&L,1,Not classified:1
44372,"1,2,3,4-tetrahydro-4-methylquinoline",242-977-8,19343-78-3,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,38,H317:38;H312:38;H302:38;H411:38
44375,"Benzoic acid, 4-[[6-(3-chloro-1-oxopropoxy)hexyl]oxy]-",605-984-0,182922-18-5,Not Classified,Notified C&L,1,Not classified:1
44376,"Pyrimidine-2,4-diyldiamine",205-862-3,156-81-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:42;H315:42;H335:41;H312:2;H302:3
44377,"2,7-Naphthalenedisulfonic acid, 4-amino-3,6-bis[2-[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]diazenyl]-5-hydroxy-, sodium salt (1:6)",606-088-2,186554-27-8,Not Classified,Notified C&L,3,Not classified:3
44381,4-nitrobiphenyl,202-204-7,92-93-3,Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H350:0;H411:0
44383,"Phosphonic acid, methyl-, bis[(5-ethyl-2-methyl-2,2-dioxido-1,3,2-dioxaphosphorinan-5-yl)methyl] ester, mixt. with (5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphorinan-5-yl)methyl methyl methylphosphonate",605-590-9,170836-68-7,Not Classified,Notified C&L,1,Not classified:1
44384,"Tetradecaamminedi-μ-oxotriruthenium(6+) hexachloride, stereoisomer",246-638-5,25125-46-6,Met. Corr. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H290:1;H315:1;H335:1
44385,"Benzenesulfonamide, 4-amino-N-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-",458-140-7,169280-56-2,Skin Sens. 1A;Eye Dam. 1;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,4,H317:4;H412:4;H318:4;H373:4
44388,Z-44,437-370-1,,Not Classified,REACH registration C&L,443,Not classified:443
44389,hydroxylammonium hydrogensulfate;hydroxylamine sulfate(1:1),233-154-4,10046-00-1,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Carc. 2;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H315:0;H201:0;H317:0;H312:0;H400:0;H351:0;H302:0;H319:0;H373:0
44390,2-chloropropane,200-858-8,75-29-6,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H332:0;H225:0;H312:0;H302:0
44393,4-fluoro-α-methylbenzylamine,206-958-8,403-40-7,Skin Corr. 1B,Notified C&L,44,H314:43;H302:1;H315:1
44399,"trans-4-Propyl-(trans,trans-4'-butyl-1,1'-bicyclohexyl)methoxy-cyclohexan",926-505-4,,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
44402,"(5α)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride",240-723-0,16676-29-2,Acute Tox. 4,Notified C&L,77,H302:76;H332:18;H317:29;H334:17;H312:17;H341:11;H318:2;H301:1;H361:3;H331:1;H336:1;H373:1;H362:2;H315:1;H372:1;H319:1;H314:1
44403,Calcium bis[(Z)-N-methyl-N-(1-oxo-9-octadecenyl)aminoacetate],240-166-3,16026-16-7,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,85,H319:1;H315:85;H411:1;H410:84;H318:84;H400:84
44404,"2,4'-dimethyl-3-piperidinopropiophenone hydrochloride",222-876-5,3644-61-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,95,H319:94;H302:95;H315:55;H335:55;H332:40;H312:39
44405,5-chloro-3-hydroxy-2-pyridone,258-441-1,53233-89-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
44406,"(2E,6Z)-nona-2,6-dienyl acetate",271-442-1,68555-65-7,Not Classified,Notified C&L,88,Not classified:88
44410,"4-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)benzene-1-sulphonyl azide",278-474-5,76464-67-0,Self-react. C;Skin Sens. 1,Notified C&L,1,H317:1;H242:1
44414,N-fluoren-2-ylacetamide,200-188-6,53-96-3,Acute Tox. 4;Carc. 1B,Notified C&L,105,H350:101;H302:102;H310:3;H330:3;H351:1
44416,"Fatty acids, tallow, magnesium salts",273-205-8,68953-41-3,Not Classified,Notified C&L,2,Not classified:2
44419,Insulib,448-620-4,,Not Classified,Notified C&L,1,Not classified:1
44421,2-(2-chlorophenoxy)acetamide,252-530-9,35368-68-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:42;H302:38;H315:4;H335:4
44423,"Dipotassium 4,4'-bis[6-anilino-4-[bis(2-hydroxyethyl)amino-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate",275-279-7,71230-67-6,Not Classified,REACH registration C&L,19,Not classified:19
44424,coumachlor (ISO);3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin,201-378-1,81-82-3,STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H373:0
44429,"3,5,7-trihydroxy-2-(4-hydroxyphenyl)benzopyrylium chloride",205-127-7,134-04-3,Not Classified,Notified C&L,2,Not classified:2
44432,"1,3-diamino-7-(diethylamino)-4-methylphenoxazin-5-ium tetrachlorozincate (2:1)",279-675-0,81029-05-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:41
44439,Phospholipase D,232-639-8,9001-87-0,Resp. Sens. 1,Notified C&L,7,H334:6;H302:1
44442,"Propane-1,2-diol",200-338-0,57-55-6,Not Classified,REACH registration C&L,6716,Not classified:6582;H410:57;H319:59;H302:21;H315:12;H335:9;H336:3;H411:2;H317:2;H301:1
44443,"α,α,α-trifluoro-o-toluidine",201-806-7,88-17-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,301,H315:256;H317:212;H302:256;H411:221;H319:251;H373:258;H226:130;H301:42;H311:42;H331:43;H332:37;H412:33;H335:5;H318:7;H312:3;Not classified:3;H371:1
44445,Butyl isothiocyanate,209-770-4,592-82-5,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2,Notified C&L,158,H311:113;H330:114;H314:156;H301:115;H332:43;H317:39;H302:43;H334:39;H312:43;H318:36;H335:2;H319:2;H315:2;H410:1;H310:1;H400:1;H227:1
44447,2-(2-oxoindolin-4-yl)ethyl 4-methylbenzenesulfonate,604-111-0,139122-20-6,Aquatic Chronic 4,Notified C&L,1,H413:1
44449,"2,3-dichloropropionyl chloride",231-541-2,7623-13-4,Skin Corr. 1A,Notified C&L,39,H314:39
44451,2-ethylbutylamine,210-530-6,617-79-8,,Notified C&L,5,H314:4;H302:5;H225:4;H312:4;H331:4;H319:1
44455,Neodymium trinitrate,233-153-9,10045-95-1,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,133,H410:125;H400:125;H318:88;H290:2;H315:90;H272:89;H314:38;H335:6;H319:6;H228:2;H411:1;Not classified:1
44458,"(tetrahydro-1H-1,4-diazepine-1,4(5H)-diyl)di(propane-1,3-diyl) bis(3,4,5-trimethoxybenzoate) dihydrochloride",243-548-8,20153-98-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
44461,5-mesyl-6-nitrobenzoxazol-2(3H)-one,250-795-5,31770-95-3,Not Classified,REACH registration C&L,84,Not classified:84
44463,"Phosphorous acid, mixed 2-(2-butoxyethoxy)ethyl and nonylphenyl esters",296-659-9,92908-31-1,Not Classified,Notified C&L,4,Not classified:1;H410:2;H317:2;H319:1;H315:1;H411:1;H400:1
44466,"Hexanedioic acid, polymer with 1,4-butanediol and 2,2-dimethyl-1,3-propanediol, isodecyl ester",601-110-7,111719-78-9,Not Classified,Notified C&L,1,Not classified:1
44467,"2,2-diethylpropanediol",204-103-3,115-76-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:38;H302:39
44470,"Alcohols, C12-14-branched and linear",284-855-7,84988-67-0,Not Classified,Notified C&L,1,Not classified:1
44474,"Benzofuro[3,2-c][1]benzoxepin-6(12H)-one",249-203-8,28763-77-1,Aquatic Chronic 3,REACH registration C&L,2,H412:2
44478,Iron dextran,618-390-1,9004-66-4,Skin Sens. 1;Carc. 1B,Notified C&L,91,H350:90;H317:91;H334:1;H351:1
44480,butocarboxim (ISO);3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime,252-139-3,34681-10-2,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H311:0;H400:0;H319:0;H331:0;H226:0;H301:0
44483,2'-deoxyuridine,213-455-7,951-78-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:1;H315:1;H335:1;Not classified:1;H332:1;H312:1;H302:1
44485,"Hexasodium 2,2'-[vinylenebis[(3-sulphonato-4,1-phenylene)imino[6-(diethylamino)-1,3,5-triazine-4,2-diyl]imino]]bis(benzene-1,4-disulphonate)",255-217-5,41098-56-0,Not Classified,REACH registration C&L,130,Not classified:130
44488,C.I. SOLVENT BLACK 7,616-851-1,8005-02-5,Not Classified,Notified C&L,292,Not classified:182;H373:100;H317:99;H331:99;H311:99;H372:101;H341:99;H351:102;H400:99;H318:99;H301:99;H332:4;H312:6;H302:6;H370:1;H252:1;H315:1;H319:1
44491,"Linseed oil, oxidized",272-038-8,68649-95-6,Not Classified,REACH registration C&L,37,Not classified:37
44495,2-(1H-pyrrol-1-yl)aniline,227-884-2,6025-60-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H332:43;H315:38;H312:43;H335:38;H302:43;H319:38
44498,4-chloroformylphthalic anhydride,214-874-8,1204-28-0,Acute Tox. 5;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1,REACH registration C&L,64,H303:3;H332:3;H314:48;H317:3;H334:3;H318:42;Not classified:16;H290:1
44500,"7-[(carbamoyl)amino]-4-hydroxy-3-[[4-[(4-sulphophenyl)azo]phenyl]azo]naphthalene-2-sulphonic acid, compound with 2,2',2''-nitrilotriethanol (1:2)",281-536-4,83968-56-3,Not Classified,Notified C&L,2,Not classified:2
44501,1-(p-tolyl)piperazine,254-534-6,39593-08-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:39;H315:39;H335:39;H314:2;H318:1;H312:1;H302:1
44503,"(2,5-Dimethylphenyl)acetyl chloride",611-253-7,55312-97-5,Skin Corr. 1A;Skin Sens. 1,Notified C&L,35,H317:34;H314:35;H290:3;H318:1
44508,Tetracaine hydrochloride,205-248-5,136-47-0,Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2,Notified C&L,146,H319:108;H317:134;H301:145;H370:35;H334:2;H361:1;H351:1;H335:1;H318:1;H302:1;H315:2;H411:1
44511,2-chloroethyl methacrylate,217-566-1,1888-94-4,Acute Tox. 3;Eye Dam. 1;Acute Tox. 3,Notified C&L,43,H318:38;H331:38;H301:43;H335:4;H319:4;H315:4;H330:1
44515,tert-butyloxirane,218-831-4,2245-30-9,,Notified C&L,5,H225:5;H319:5;H315:5;H335:5
44516,12H-phthaloperin-12-one,230-049-5,6925-69-5,Skin Sens. 1B,REACH registration C&L,2280,H317:12;Not classified:2240;H319:20;H312:20;H302:20;H315:20;H412:8;H411:1
44523,Tetrahydro-2-(2-propynyloxy)-2H-pyran,228-027-5,6089-04-9,Flam. Liq. 3,Notified C&L,41,H226:41;H319:3;H315:3;H335:2
44528,"Polyethylene glycol,ether with 4-hydroxy-2,2,6,6-tetramethyl-1-piperidineethanol (2:1)",611-848-1,59535-09-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
44531,Tetraammineplatinum (II) diacetate,457-310-8,,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1;H302:1
44532,Tetrabutylammonium hexafluorophosphate,221-472-6,3109-63-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H319:49;H315:49;H335:49;H302:8;H332:3;H312:3;H314:4;H318:1
44535,"2-Propenamide, N-[(diethylamino)methyl]-2-methyl-, hydrochloride (1:1)",610-599-6,51032-50-9,Skin Corr. 1A,Notified C&L,1,H314:1
44542,"1,1,2,2,3,3,4,4,4-nonafluoro-N,N-bis(2-hydroxyethyl)-1-butanesulfonamide",454-680-2,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,1,H302:1;H318:1;H413:1
44547,"Fatty acids, coco, reaction products with diethylenetriamine and soya fatty acids, ethoxylated, chloromethane-quaternized",614-644-0,68604-75-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,26,H412:24;H318:26;H302:26;H315:25;H314:1;H413:1;H226:2;H410:1
44549,DIPOTASSIUM MIDA (DIHYDRATE),411-630-4,,Eye Irrit. 2,Notified C&L,55,H319:55
44550,2-methoxybut-2-ene,228-970-2,6380-95-6,Flam. Liq. 2;Eye Irrit. 2A;Repr. 2;Aquatic Chronic 3,REACH registration C&L,2,H335:2;H361:2;H412:2;H225:2;H319:2
44553,"Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)-",618-263-0,89331-94-2,Aquatic Chronic 3,Notified C&L,9,H412:8;H413:1
44555,2-[[(butylamino)carbonyl]oxy]ethyl acrylate,264-036-0,63225-53-6,Skin Sens. 1A;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,165,H332:11;H317:29;H411:29;H331:18;H319:136;H315:136;H335:133
44556,"Glycerides, C14-18 and C16-22-unsatd. mono- and di-",294-574-1,91744-13-7,Not Classified,Notified C&L,1,Not classified:1
44557,DL-menthol,216-074-4,1490-04-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1659,H319:129;H315:1656;H318:39;H335:40;H302:3
44559,D-Galacto-d-mannan,234-299-6,11078-30-1,Skin Sens. 1,Notified C&L,128,H317:126;Not classified:2
44562,3-Chloro-4-fluoroiodobenzene,605-045-5,156150-67-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
44563,N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]-N-phenylpropionamide citrate,262-295-4,60561-17-3,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,42,H310:40;H330:42;H300:42;H336:2
44564,"(pentane-2,4-dionato-O,O')silver",239-568-1,15525-64-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,38,H332:38;H315:38;H312:38;H335:38;H351:38;H302:38;H319:38
44569,2-amino-5-nitrobenzenesulphonic acid,202-531-5,96-75-3,Eye Irrit. 2,REACH registration C&L,37,H319:37;H315:2;H335:2
44570,6-[(2-hydroxyethyl)sulphonyl]benzoxazol-2(3H)-one,225-722-5,5031-74-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
44573,Thymol blue,200-973-3,76-61-9,Acute Tox. 4,Notified C&L,162,H302:157;Not classified:5
44578,"Benzene, mono-C10-13-alkyl derivs., fractionation bottoms, heavy ends",302-196-6,94094-93-6,Asp. Tox. 1,Notified C&L,1287,H304:1286;H319:1;H315:1
44579,cyclohexyl salicylate,400-410-3,25485-88-5,Aquatic Chronic 2,REACH registration C&L,3150,H411:3149;H410:2;H315:1;H317:1;H319:1;H304:1
44582,2-[2-(dimethylammonio)ethyl]isothiouronium dichloride,240-281-9,16111-27-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,5,H315:4;H317:3;H335:1;H302:2;H334:1;H319:3;Not classified:1;H312:1;H318:1
44584,2-butyltetrahydro-6-methyl-4-methylene-2H-pyran,246-101-5,24237-02-3,Not Classified,Notified C&L,112,Not classified:112
44585,"N,N''-[(1,1,3,3-tetramethyldisiloxane-1,3-diyl)dipropane-3,1-diyl]bis(ethylenediamine)",241-817-4,17866-53-4,Not Classified,Notified C&L,1,Not classified:1
44586,"Lecithins, soybean",310-129-7,8030-76-0,Not Classified,Notified C&L,596,Not classified:575;H319:21
44587,"4,4'-(propane-1,3-diyl)bis(piperidine-1-ethanol)",241-981-7,18073-84-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
44588,Cyclopentylidenecyclopentan-2-one,212-542-7,825-25-2,Skin Irrit. 2,Notified C&L,39,H315:38;Not classified:1
44593,"N-((4R,5S,6R)-2-(((2S,3R,4R,5R,6R)-6-((R)-2-((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)-2-hydroxyethyl)-4,5-dihydroxy-3-((E)-13-methyl-2-oxotetradec-3-en-1-yl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide",601-012-4,11089-65-9,Acute Tox. 2,Notified C&L,43,H300:42;H310:2;H360:2;H330:2;H361:1;H301:1
44599,(-)-methyl(α-methylphenethyl)amine,251-687-0,33817-09-3,Acute Tox. 3;Aquatic Chronic 2,Notified C&L,122,H411:83;H301:122;H311:38;H361:38;H319:38;H331:38;H315:1
44602,"Ethyl 2-methyl-1,3-dioxolane-2-acetate",229-114-0,6413-10-1,Not Classified,REACH registration C&L,1664,Not classified:1623;H319:39;H315:40;H335:39;H317:1;H411:1
44604,2-[2-(2-hydroxyethoxy)ethoxy]ethyl benzoate,245-383-7,23022-51-7,Not Classified,Notified C&L,11,Not classified:11
44610,2-Butyl-4-chloro-5-(hydroxymethyl)imidazole,616-661-9,79047-41-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
44611,Choline salicylate,217-948-8,2016-36-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,95,H319:94;H302:95;H315:94
44612,Procyclidine hydrochloride,216-141-8,1508-76-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H302:3;H315:2
44613,Titanium complexes of ethanol and 2-dimethylaminoethanol,437-420-2,,Flam. Liq. 2;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H225:1;H314:1;H318:1
44614,"Fatty acids, C9-18, compds. with triethanolamine",273-560-9,68989-59-3,Not Classified,Notified C&L,1,Not classified:1
44624,Monalide,230-712-9,7287-36-7,Acute Tox. 3,Notified C&L,38,H311:38
44625,"2,2,2-trifluoro-1-methoxyethanol",207-072-4,431-46-9,,Notified C&L,9,H302:8;H226:9;H332:3;H312:3;H335:3;H319:3;H370:1;H315:2
44631,"Trisodium trihydrogen 5,5',5''-(1,3,5-triazine-2,4,6-triyltriimino)tris[5-sulphonatosalicylate]",279-091-6,79135-90-3,Not Classified,Notified C&L,1313,Not classified:1313
44634,"5,6-dimethylbenzothiazol-2-ylamine",249-960-4,29927-08-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
44636,"(Z,Z)-1-ethyl-2-(8-heptadecenyl)-4,5-dihydro-1-[2-[(1-oxo-9-octadecenyl)amino]ethyl]-1H-imidazolium ethyl sulphate",267-359-5,67846-14-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H318:1;H315:1;H400:1
44637,"2-tert-butyl-4,6-dinitrophenyl acetate",221-706-7,3204-27-1,Acute Tox. 2;Acute Tox. 3;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H360:38;H311:38;H400:38;H300:38
44641,(±)-α-(aminomethyl)-4-hydroxy-3-methoxybenzyl alcohol hydrochloride,213-787-2,1011-74-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
44651,Disamarium trisulphate,237-211-4,13692-98-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H315:39;H335:39;Not classified:1
44659,4-(2-methoxy-ethoxy)-3-oxo-butyric acid ethyl ester,603-429-7,130611-26-6,Flam. Liq. 3,Notified C&L,156,H226:156
44661,Wool wax,232-418-6,8020-84-6,Not Classified,Notified C&L,182,Not classified:182
44665,"N,N'-(1,6-hexanediyl)bismethacrylamide",240-214-3,16069-15-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
44666,"β,4-dimethyl-α-methylenecyclohex-3-ene-1-propan-1-al",278-761-5,77758-65-7,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,10,H319:10;H317:10;H411:10
44673,Isovaleric acid,207-975-3,503-74-2,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,1779,H314:1779;H318:1495;H332:16;H311:8;H302:6;H312:4;H290:1
44676,2-[[4-(4-aminophenyl)diazenyl-3-methyl-phenyl]-(2-hydroxyethyl)amino]ethanol,416-420-6,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,6,H317:6;H302:6;H411:6
44678,Pempidine hydrogen tartrate,208-902-8,546-48-5,Acute Tox. 3,Notified C&L,38,H301:38
44679,"Tallow, chlorinated",283-108-2,84540-17-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
44680,"(E)-2,3-dibromo-2-butene-1,4-diol",244-313-2,21285-46-1,Muta. 2,Notified C&L,2,H341:2
44681,tetrahydrofuran-2-carbonyl chloride,922-279-6,52449-98-6,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,3,H332:1;H314:3;H335:1;H290:1;H302:1;H318:1;H227:2
44682,Sodium 2-mercaptoethanolate,253-523-3,37482-11-4,Acute Tox. 3;Acute Tox. 2;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 3;Repr. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,131,H373:85;H310:85;H314:131;H317:89;H331:89;H361:85;H400:88;H411:85;H318:94;H301:98;H410:87;H311:4
44683,Luciferase (firefly luciferin),263-359-4,61970-00-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
44688,bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate,421-560-6,,Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0;H373:0
44693,2-amino-2-phenylbutyric acid,226-616-1,5438-07-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,39,H318:1;H319:39;H315:39;H335:39
44694,"methyl (2S)-1-(3,3-dimethyl-2-oxopentanoyl)pyrrolidine-2-carboxylate",606-076-7,186268-77-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
44695,Methyl 4-(acetylamino)salicylate,223-838-0,4093-28-1,Aquatic Chronic 3,REACH registration C&L,4,H412:2;H302:2;H332:1;H312:1
44697,"Oxydipropanol, oligomeric reaction products with 1-chloro-2,3-epoxypropane",500-690-8,162303-54-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,56,H319:56;H317:56;H412:56;H315:56
44700,"Silicic acid (H2Si2O5), barium salt (1:1), lead-doped",272-271-5,68784-75-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Chronic 4,REACH registration C&L,5,H332:5;H360:5;H302:5;H412:5;H413:4;H373:5
44704,Sodium diethyl phosphate,220-697-7,2870-30-6,Not Classified,Notified C&L,235,Not classified:235
44705,Octaphenylcyclotetrasiloxane,208-904-9,546-56-5,Not Classified,REACH registration C&L,34,Not classified:34
44712,2-(trichloromethyl)-1H-benzimidazole,222-712-2,3584-65-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
44713,"γ,4-dimethylcyclohex-3-ene-1-propan-1-ol",239-845-7,15760-18-6,Skin Irrit. 2;Skin Sens. 1,Notified C&L,1526,H317:1441;H315:1441;Not classified:85
44717,Octyl methacrylate,218-465-5,2157-01-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,25,H319:25;H315:19;H335:19;H410:1;H317:2;H412:1
44718,Ethyl 5-hydroxy-2-methyl-3-benzofurancarboxylate,230-713-4,7287-40-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
44720,2-butylfuran,224-732-7,4466-24-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,45,H302:38;H318:38;H226:7;H319:1;H315:1;H335:1
44723,"trans-tetrahydrofuran-3,4-diol",245-074-7,22554-74-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
44724,"Fatty acids, C16-18 and C18-unsatd., hexaesters with dipentaerythritol",271-689-5,68604-38-6,Not Classified,REACH registration C&L,24,Not classified:24
44727,"N,N,N',N',N'',N''-hexamethyl-1-phenylsilanetriamine",225-427-1,4840-75-9,,Notified C&L,1,H319:1;H315:1;H226:1;H335:1
44729,"4-chloro-2,6-diaminopyrimidine",205-863-9,156-83-2,Acute Tox. 4,REACH registration C&L,58,H302:51;H319:50;H315:50;H335:49;Not classified:1
44732,"1-Pyrrolidineacetic acid, α-ethyl-2-oxo-, (αS)-",600-362-5,102849-49-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
44735,Calcium sulphidoacetate,249-881-5,29820-13-1,Met. Corr. 1;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,6,H317:6;H335:6;H290:4;H302:6;H319:4;H315:1;H318:1
44736,"α-chloro-2,4-dinitrotoluene",210-230-5,610-57-1,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,42,H314:42;H318:38;H335:38
44737,"Aniba rosaeodora amazonica, ext.",297-586-5,93685-34-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H317:1;H412:1;H315:1
44738,"4,4'-Diaminobenzophenone",612-099-3,611-98-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
44740,"Leach of products of roasting of ""slags, steelmaking, vanadium",919-559-5,,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1B;Eye Irrit. 2;Resp. Sens. 1;Muta. 1B;Repr. 1B;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H373:1;H360:1;H317:1;H314:1;H340:1;H302:1;H412:1;H334:1;H350:1;H319:1;H331:1;H301:1
44741,Methyl 3-thienyl ketone,215-996-4,1468-83-3,,Notified C&L,6,H332:6;H312:6;H302:6
44742,C.I. Disperse Blue 284,615-648-5,71872-43-0,Not Classified,Notified C&L,3,Not classified:3
44744,3-Chloro-2-hydroxy-2-methylpropanoic acid,604-096-0,13881-41-9,Acute Tox. 4,Notified C&L,2,H302:1;H341:1;H314:1
44746,"Octahydro-3,6,6,7a-tetramethyl-2H-2a,7-methanoazuleno[5,6-b]oxirene",249-717-2,29597-36-2,Skin Irrit. 2,Notified C&L,39,H315:38;Not classified:1
44747,Berberine sulphate,206-258-2,316-41-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H311:1;H331:1;H301:1
44749,Cinnamyl propionate,203-124-5,103-56-0,Not Classified,REACH registration C&L,318,Not classified:294;H317:24
44750,"Glycerides, C18-36",293-165-5,91052-08-3,Not Classified,REACH registration C&L,59,Not classified:59
44751,"4'-trans-Propyl-[1,1'-bicyclohexyl]-4-trans-carbonicacid-(3,4,5-trifluorphenylester)",603-548-4,132123-45-6,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
44752,"Schiff bases, benzylidene C12-14-tert-alkyl",293-665-3,91081-59-3,Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:5;H335:5
44754,"Reaction mass of (2S,6S)-2,6-Dimethylmorpholine and (2R,6R)-2,6-Dimethylmorpholine",613-701-7,6485-45-6,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,142,H314:86;H302:86;H312:86;H318:2;H226:86;Not classified:56
44757,Desogestrel,258-929-4,54024-22-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,62,H410:56;H400:38;H360:23;H413:2;H302:2;H332:1;H312:1;H361:1;H351:3
44759,(±)-3-hydroxybutyric acid,210-908-0,625-71-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
44765,"Boronic acid, B-[2-[[(1,1-dimethylethyl)amino]sulfonyl]phenyl]-",604-746-3,150691-04-6,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1;H335:1
44766,N-(4-amino-m-tolyl)-N-ethylbenzamide,227-473-8,5856-00-8,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,157,H410:157;H317:157;H311:157;H400:157;H319:157;H331:157;H301:157
44770,S-methyl methanethiosulphonate,220-970-0,2949-92-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1417,H319:1417;H315:1368;H335:1367;H311:1;H331:1;H301:1;H332:1;H312:1;H302:1
44772,Allo-D-isoleucine,216-143-9,1509-35-9,Not Classified,Notified C&L,11,Not classified:11
44774,"2H-Pyran, 2-[trans-4-[difluoro(3,4,5-trifluorophenoxy)methyl]cyclohexyl]-5-ethyltetrahydro-, (2R,5S)-rel-",615-060-9,700863-39-4,Not Classified,Notified C&L,1,Not classified:1
44777,2-chloro-1-phenylethanol,216-816-7,1674-30-2,,Notified C&L,4,H332:4;H312:4;H302:4
44778,"2-Propenoic acid, δ-ω-perfluoro-C9-15-alkyl esters",614-030-2,671756-62-0,Not Classified,Notified C&L,37,Not classified:37
44779,Cyclopentanecarbonyl chloride,224-856-1,4524-93-0,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,46,H314:46;H226:46;H290:1;H318:1
44783,Ifosfamide,223-237-3,3778-73-2,Acute Tox. 3;Eye Irrit. 2,Notified C&L,92,H319:91;H301:91;H350:2;H360:2;H340:2;H372:1;H302:1;H413:1
44789,"Fatty acids, palm kernel-oil, sodium salts",263-097-0,61789-89-7,Not Classified,Notified C&L,121,Not classified:121
44790,Cesium perchlorate,236-643-0,13454-84-7,Ox. Sol. 2,Notified C&L,68,H272:42;H332:26;H271:26;H315:30;H335:30;H302:26;H319:30;H361:1
44792,"Dihydro-3-(2-octadecenyl)furan-2,5-dione",266-561-0,67066-88-0,Skin Irrit. 2;Skin Sens. 1B,Notified C&L,1,H317:1;H315:1
44793,"3-aminoprop-1-ene-1,1,3-tricarbonitrile",212-777-5,868-54-2,Acute Tox. 4,Notified C&L,41,H302:39;H315:1;H311:1;H319:1;H331:1;H301:1;Not classified:1
44795,biphenyl;diphenyl,202-163-5,92-52-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H335:0;H400:0;H319:0
44800,"Belladonna, ext.",232-365-9,8007-93-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,5,H319:3;H302:4;H332:1;H315:1;H301:1
44804,Bumetrizole,223-445-4,3896-11-5,Not Classified,REACH registration C&L,2117,Not classified:217;H413:1691;H412:129;H319:80;H315:79;H335:78;H332:1;H312:1;H400:1;H411:1
44808,"[[(phosphonomethyl)imino]bis[ethylenenitrilobis(methylene)]]tetrakisphosphonic acid, potassium salt",284-362-7,84852-49-3,Not Classified,REACH registration C&L,6,Not classified:2;H318:2;H290:3;H315:2;H314:1;H319:1
44809,"D-Glucopyranose, oligomers, stearyl glycosides",500-526-5,161074-90-4,Not Classified,Notified C&L,1,Not classified:1
44810,"2-methyl-4,5-diphenylthiazole",223-161-0,3755-83-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
44813,Allyltriphenylstannane,200-975-4,76-63-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H410:40;H311:40;H400:40;H331:40;H301:40;H315:1;H319:1
44814,"4-bromo-3,5-dihydroxybenzoic acid",240-606-4,16534-12-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H332:1;H312:1;H302:1
44817,"Methyl 3,4,5,6-tetrahydro-7H-azepin-2-yl ether",219-762-2,2525-16-8,Flam. Liq. 3,REACH registration C&L,153,H226:153
44822,"reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid",406-230-1,224635-63-6,Flam. Liq. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H332:0;H317:0;H314:0;H400:0;H351:0;H226:0
44824,8-benzyl-3-oxo-8-azoniabicyclo[3.2.1]octane chloride,617-458-8,83393-23-1,Not Classified,REACH registration C&L,4,Not classified:3;H412:1;H302:1
44825,Isoquinolin-5-ol,219-456-9,2439-04-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43;H312:1;H302:1
44829,2-methoxy-5-(2-oxopropyl)benzenesulfonamide,601-411-3,116091-63-5,Acute Tox. 4,REACH registration C&L,4,H302:3;H332:1;H315:1;H335:1;H319:1;Not classified:1
44830,"Solvent naphtha (petroleum), hydrotreated light naphthenic;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C",295-529-9,92062-15-2,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0;H304:0
44835,"Neodecanoic acid, compound with 2,2'-iminobis[ethanol] (1:1)",261-405-8,58722-91-1,Not Classified,Notified C&L,1,Not classified:1
44836,Pentafluoroiodoethane,206-566-7,354-64-3,Not Classified,REACH registration C&L,85,Not classified:38;H319:40;H280:40;H315:40;H335:47;H336:7
44842,"Sodium hydrogen 2-aminobenzene-1,4-disulphonate",246-349-4,24605-36-5,Not Classified,REACH registration C&L,30,Not classified:6;H318:18;H317:7;H331:7;H311:7;H372:7;H341:7;H351:7;H400:7;H301:7;H319:5;H315:6;H335:1
44844,"Bis(2-ethylhexyl) hydrogen phosphate, compound with 2,2'-iminodiethanol (1:1)",301-598-9,94023-03-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:2;H315:2
44852,Diethoxydivinylsilane,267-593-8,67892-60-8,Flam. Liq. 3,Notified C&L,1,H226:1
44853,"Artichoke, ext.",281-659-3,84012-14-6,Not Classified,Notified C&L,6,Not classified:4;H319:1;H317:1;H226:2
44854,(2S)-2-hydroxy-1-(1-pyrrolidinyl)-1-propanone,601-833-8,122151-38-6,Acute Tox. 4;Repr. 2,Notified C&L,1,H361:1;H302:1
44855,"2-(2,2-dimethylpropyl)-4,4-dimethylpent-1-ene",205-495-9,141-70-8,Flam. Liq. 3,Notified C&L,1,H226:1
44857,"Trisodium hydrogen 4-[[4-chloro-6-[[8-hydroxy-3,6-disulphonato-7-[(1-sulphonato-2-naphthyl)azo]-1-naphthyl]amino]-1,3,5-triazin-2-yl]amino]benzoate",274-867-0,70776-19-1,Not Classified,Notified C&L,9,Not classified:8;H411:1
44858,Trisodium hexanitritocobaltate,237-077-7,13600-98-1,Ox. Sol. 2;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3;Carc. 2,Notified C&L,54,H315:39;H317:41;H272:54;H335:39;H351:43;H334:39;H319:39;H350:1
44859,Boscalid (formerly Nicobifen),606-143-0,188425-85-6,Aquatic Chronic 2,Notified C&L,284,H411:281;Not classified:3
44862,6-ethoxy-2-mercaptobenzothiazole,204-405-5,120-53-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H315:38;H335:38
44865,"Silane, dichlorodimethyl-, reaction products with silica",271-893-4,68611-44-9,Not Classified,Notified C&L,1586,Not classified:1533;H330:43;H373:9;H319:4;H315:2;H335:2
44866,"2,3-dibromomaleic acid",210-162-6,608-37-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
44867,"Fatty acids, C14-18-unsatd., compds. with morpholine",272-196-8,68783-40-4,Not Classified,Notified C&L,3,Not classified:3
44869,Triacetoxyvinylsilane,223-943-1,4130-08-9,Skin Corr. 1B,REACH registration C&L,112,H314:112;H318:35
44870,"Vanadium, oxalate complexes",308-876-9,98903-75-4,Met. Corr. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Repr. 2;Aquatic Chronic 3,REACH registration C&L,46,H315:6;H361:6;H290:8;H302:42;H412:3;H318:6;H372:3;H411:41;H301:4;H332:38;H314:40;H312:1
44877,"7-(2-chloroethyl)-1,3-dimethyl-(1H,3H)-purine-2,6-dione",227-553-2,5878-61-5,Acute Tox. 4,Notified C&L,1,H302:1
44879,3-benzoylacrylic acid,209-496-5,583-06-2,,Notified C&L,4,H335:4;H319:4;H315:4;H301:4
44880,"3-[1-[difluoro[(trifluorovinyl)oxy]methyl]-1,2,2,2-tetrafluoroethoxy]-2,2,3,3-tetrafluoropropiononitrile",274-123-5,69804-19-9,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
44882,2-amino-α-methylbenzyl alcohol,234-052-2,10517-50-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
44883,"4-trans-Propyl-[1,1-bicyclohexyl]-4-trans-carbonic acid-(2-fluor-4-propylphenylester)",603-997-6,137019-97-7,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
44887,"(5α)-Androsta-2,16-dien-17-yl acetate",610-545-1,50588-42-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2;Carc. 2;Repr. 2,Notified C&L,2,H315:2;H335:2;H341:2;H351:2;H361:2;H319:2
44889,"3,6-dimethyloct-4-yne-3,6-diol",201-131-8,78-66-0,Acute Tox. 4,Notified C&L,65,H302:65;H319:27;H315:4;H335:4
44890,"2-Pentanol, 4-methyl-, phosphate",270-602-8,68457-68-1,,Notified C&L,1,Not classified:1
44891,2-furyl methyl ketone,214-757-1,1192-62-7,Acute Tox. 3;Acute Tox. 2;Eye Irrit. 2;Acute Tox. 2,Notified C&L,1536,H310:1485;H330:1490;H319:1418;H301:1490;H315:73;H311:47;H332:44;H318:41;H300:46;H312:4;H335:2;H331:1
44892,"Distillates (petroleum), acid-treated heavy naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-117-3,64742-18-3,Carc. 1A,Harmonised C&L,0,H350:0
44894,"Trimethylhexane-1,6-diol",248-481-8,27476-48-8,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1
44895,Pyridinium toluene-4-sulphonate,246-002-7,24057-28-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73,H319:71;H315:70;H335:59;Not classified:1;H332:2;H312:2;H302:2;H412:1;H373:1
44896,"1,3-bis(2,-dimethylphenoxy)propan-2-ol",287-775-0,85567-60-8,Aquatic Chronic 2,Notified C&L,83,H411:83
44897,"Amines, di-C12-18-alkylmethyl",270-418-8,68439-75-8,Skin Irrit. 2;Aquatic Acute 1,REACH registration C&L,33,H400:33;H315:2;H314:31
44898,Cyclohexylidenebis[tert-butyl] peroxide,221-111-2,3006-86-8,Org. Perox. C;Asp. Tox. 1;Aquatic Chronic 4,REACH registration C&L,65,H413:8;H242:23;H304:8;H319:39;H315:39;H335:38;Not classified:3;H332:1;H341:1;H351:1;H302:1;H312:1;H241:1
44906,Benzyl 4-Oxo-1-piperidinecarboxylate,606-227-7,19099-93-5,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,46,H412:38;H302:38;H319:8;H315:8;H335:7
44907,Octanoyl chloride,203-891-6,111-64-8,Met. Corr. 1;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2,REACH registration C&L,143,H315:136;H317:136;H330:136;H290:137;H318:137;H314:7;H302:5;H335:1
44910,"1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione",418-630-3,136465-99-1,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
44914,3-[(2-hydroxyethyl)amino]propanol,242-978-3,19344-29-7,Eye Dam. 1,REACH registration C&L,124,H318:124;H315:40;H335:40
44917,Biphenyl-4-carboxylic acid,202-203-1,92-92-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,52,H319:50;H315:10;H302:39;H335:7;Not classified:2;H332:1;H312:1;H228:1;H412:1
44919,"2,4-dimethyl-6-(1-methyl-pentadecyl)phenol",411-220-5,134701-20-5,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H317:0;H315:0
44923,1-(ethyldimethylsilyl)-1H-imidazole,263-525-6,62365-34-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
44926,Sodium ascorbate,205-126-1,134-03-2,Not Classified,REACH registration C&L,308,Not classified:306;H341:2
44927,"N-{4-[(4-methoxy-1,2,5-thiadiazol-3-yl)sulfamoyl]phenyl}acetamide",616-761-2,79962-97-3,Aquatic Chronic 3,Notified C&L,1,H412:1
44928,Heptyltetrahydrofuran,275-801-3,71662-35-6,Skin Irrit. 2,Notified C&L,1,H315:1
44932,"Xanthylium, 9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethyl-, molybdatetungstatesilicate",279-394-3,80083-40-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,29,H410:25;H400:24;H318:8;Not classified:4
44933,Quaternium-80 is the quaternary ammonium salt with the alkyl groups derived from coconut oil,620-271-4,134737-05-6,Skin Sens. 1,Notified C&L,85,H317:53;H318:31;H315:31;H412:1
44935,2-iodopropane,200-859-3,75-30-9,Flam. Liq. 3;Acute Tox. 4,Notified C&L,52,H302:42;H226:52;H319:10;H315:10;H335:9
44939,Ethyl 2-oxopyrrolidine-1-acetate,262-828-0,61516-73-2,Not Classified,Notified C&L,3,Not classified:2;H302:1
44947,N-[2-[4-(aminosulphonyl)phenyl]ethyl]-5-chloro-2-methoxybenzamide,240-722-5,16673-34-0,Not Classified,REACH registration C&L,8,Not classified:5;H319:2;H315:2;H335:2;H302:2
44952,"Hexanes, mixture",615-981-6,73513-42-5,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2;Aquatic Chronic 2,Notified C&L,2,H304:2;H315:2;H361:1;H411:2;H225:2;H319:1;H336:2
44953,2-methylanthraquinone,201-539-6,84-54-8,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H410:3;H400:3;H317:2
44958,Methyl 4-methylsalicylate,225-117-6,4670-56-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,3,H319:3;H315:3;H335:2
44960,Ethyltris(2-hydroxyethyl)ammonium ethyl sulphate,250-796-0,31774-90-0,Not Classified,REACH registration C&L,2,Not classified:2
44961,"stoddard solvent;Low boiling point naphtha - unspecified;[A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).]",232-489-3,8052-41-3,Asp. Tox. 1;Muta. 1B;Carc. 1B;STOT RE 1,Harmonised C&L,0,H372:0;H350:0;H340:0;H304:0
44964,"3,6,9,12,15,18-hexaoxaicosane",245-774-2,23601-39-0,Not Classified,Notified C&L,59,Not classified:59
44965,Magnesium bis(2-ethylbutanoate),421-140-2,,Skin Sens. 1B;Repr. 2;Aquatic Chronic 3,REACH registration C&L,1,H361:1;H317:1;H412:1
44967,"3,6-diamino-10-methylacridinium chloride",201-668-8,86-40-8,Aquatic Acute 1,Notified C&L,39,H400:39
44970,8-Methyl-N-vanillylnonanamide,606-308-7,19408-84-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H319:40;H315:40;H301:39;H300:1
44971,4-(methylsulphonyl)-3-nitrobenzoic acid,279-676-6,81029-08-5,Skin Irrit. 2,Notified C&L,38,H315:38
44973,"2-Iodo-1,3-dimethylbenzene",612-042-2,608-28-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:38;H315:45;H335:43;H319:7
44974,Bis(isopropylamino)dimethylsilane,227-885-8,6026-42-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,28,H319:22;H315:22;H335:22;Not classified:5;H314:1;H226:1
44977,"N-benzyl-N,N-dimethylanilinium chloride",221-707-2,3204-68-0,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,39,H400:38;H314:38;H302:39;H319:1;H315:1
44980,Phospholipase C,232-638-2,9001-86-9,Resp. Sens. 1,Notified C&L,1,H334:1
44983,"(3β)-9,19-cyclolanost-24-en-3-yl 4-hydroxy-3-methoxycinnamate",244-285-1,21238-33-5,Not Classified,Notified C&L,1,Not classified:1
44985,"Naphthalene-1,8-dicarboximide",201-379-7,81-83-4,Not Classified,Notified C&L,123,Not classified:84;H302:38;H319:1
44988,2-tert-butylphenol,201-807-2,88-18-6,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,769,H332:235;H314:318;H311:581;H302:764;H411:283;H318:140;H410:447;H315:451;H400:484;H319:451;H312:150;H330:75;H335:5
44992,BA 679 Tropenolester,603-954-1,136310-66-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H311:1;H331:1;H301:1
44994,2-chloropropionyl chloride,231-540-7,7623-09-8,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A,REACH registration C&L,58,H314:58;H302:17;H226:58;H335:9;H318:4
44995,Meprobamate,200-337-5,57-53-4,Acute Tox. 4,Notified C&L,41,H302:41
44996,"Bis(1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfonyl)imide",609-746-7,39847-39-7,Skin Corr. 1B,Notified C&L,1,H314:1
45000,"2-Propenoic acid, 2-methyl-, polymer with butyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate",608-181-3,28262-63-7,Not Classified,Notified C&L,41,Not classified:41
45001,"Amines, tallow alkyl, ethoxylated",500-153-8,61791-26-2,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1260,H410:651;H314:677;H400:763;H302:1225;H318:1012;H330:179;H411:290;H319:145;H315:177;H412:36;Not classified:12;H335:5;H312:3
45004,Mercury dinitrate,233-152-3,10045-94-0,Ox. Sol. 2;Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,74,H410:73;H310:73;H272:38;H330:73;H400:73;H300:73;H373:74;H370:4;Not classified:1;H362:1;H301:1;H311:1;H412:1;H331:1
45007,"2-Propenoic acid, homopolymer",618-347-7,9003-01-4,Acute Tox. 4;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1182,H335:242;H400:28;H302:25;H411:27;H318:26;Not classified:472;H319:368;H315:278;H314:200;H350:126;H340:126;H332:53;H412:26;H312:1;H226:1;H317:1;H290:1
45008,"Fir, Abies alba, ext.",289-870-2,90028-76-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1660,H315:359;H317:1634;H411:1343;H319:329;H226:1624;H304:345;H410:107;H400:101
45011,Pentaerythritol,204-104-9,115-77-5,Not Classified,REACH registration C&L,987,Not classified:981;H319:6;H315:1;H335:1
45016,4'-phenylacetophenone,202-202-6,92-91-1,,Notified C&L,5,H319:5;H315:5;H335:5
45017,Magnesium carbonate basic,609-673-0,39409-82-0,Not Classified,Notified C&L,1,Not classified:1
45018,"Cistus labdaniferus, ext., sapond.",290-793-1,90244-89-6,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,3,H317:3;H411:2;H410:1;H400:1;H304:1
45023,(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid,430-100-3,86978-24-7,Acute Tox. 4,Harmonised C&L,0,H302:0
45024,"2-Butenedioic acid (E)-, di-C18-22-alkyl esters",272-945-9,68921-53-9,Not Classified,REACH registration C&L,115,Not classified:115
45025,"3,4,5-trimethoxyphenylacetic acid",213-456-2,951-82-6,Skin Irrit. 2,Notified C&L,46,H315:46;H319:6;H335:6;H302:1
45029,Hydroxypropyl methylcellulose,618-389-6,9004-65-3,Not Classified,Notified C&L,297,Not classified:292;H372:4;H335:1
45031,p-fluorocumene,206-957-2,403-39-4,Acute Tox. 4,Notified C&L,39,H302:38;H315:1;H335:1;H411:1;H319:1;H226:1
45033,"(tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid",401-260-1,118800-27-4,Eye Irrit. 2,Harmonised C&L,0,H319:0
45037,Undecene,249-202-2,28761-27-5,Asp. Tox. 1,Notified C&L,1,H304:1
45039,"ethyl 6-[2-(4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)ethynyl]pyridine-3-carboxilate",601-516-4,118292-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2;Lact.,Notified C&L,1,H362:1;H315:1;H335:1;H361:1;H319:1
45040,"Slags, steelmaking, converter",294-409-3,91722-09-7,Not Classified,REACH registration C&L,30,Not classified:30
45043,3-nitropropanol,246-716-9,25182-84-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
45048,"Bromomethyl 2,5-dimethoxyphenyl ketone",214-873-2,1204-21-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,40,H400:39;H319:39;H315:39;H335:39;H311:1;H331:1;H301:1
45050,Dimethyl acetylsuccinate,233-897-4,10420-33-4,Not Classified,REACH registration C&L,3,Not classified:3
45052,"2,7-Naphthalenedisulfonic acid, 4-amino-6-[[5-[[4-chloro-6-[(3-chloro-4-methylphenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-3-[[2-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-, tetrasodium salt",279-444-4,80294-29-7,Not Classified,Notified C&L,1,Not classified:1
45053,N-(pyridin-3-ylcarbonyl)glycine,209-497-0,583-08-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
45055,"tris(η5-2,4-cyclopentadien-1-yl)praseodymium",234-298-0,11077-59-1,Water-react. 2,Notified C&L,42,H261:38;H228:4
45056,Isopropylcyclopentane,223-397-4,3875-51-2,Flam. Liq. 3;Acute Tox. 4;Eye Dam. 1,Notified C&L,43,H302:38;H318:38;H226:38;H225:5;H304:1
45057,nickel(II) neononanoate,300-094-6,93920-10-6,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H410:0;H360:0;H317:0;H372:0;H400:0;H341:0;H334:0;H350:0
45058,Dithiosalicylic acid,208-428-1,527-89-9,Not Classified,Notified C&L,1,Not classified:1
45059,5-(Methylthio)-1H-tetrazole,608-370-0,29515-99-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39;H228:1
45062,Pent-4-ynoic acid,228-028-0,6089-09-4,Skin Corr. 1B,Notified C&L,51,H314:51;H290:1;H302:2;H318:1;H332:1;H312:1
45063,m-(chloromethyl)anisole,212-541-1,824-98-6,Skin Corr. 1B,Notified C&L,47,H314:47;H341:1;H290:1;H318:1
45065,"2,6-dimethoxypyridine",228-334-4,6231-18-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:39;H302:40;H315:44;H335:42;H319:5;H332:1;H312:1;H226:1
45068,"Oxirane, mono[(C10-16-alkyloxy)methyl] derivs.",268-358-2,68081-84-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,398,H319:314;H317:398;H315:314;H411:398
45069,Calcium bis(2-ethylhexanoate),205-249-0,136-51-6,Eye Dam. 1;Repr. 2;Repr. 2,REACH registration C&L,403,H361:102;H318:46;H317:177;H302:177;H411:176;H334:176;H226:176;H319:101;H315:105;H335:100;Not classified:17;H413:2
45076,Bis[(1-methylhexyl)ammonium] sulphate,229-113-5,6411-75-2,,Notified C&L,5,H302:4;Not classified:1
45078,Fentin fluoride,206-833-8,379-52-2,,Notified C&L,4,H410:4;H311:4;H400:4;H331:4;H301:4
45083,p-tolyl chloroformate,213-332-8,937-62-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,38,H311:38;H314:38;H331:38;H301:38
45084,N-[4-(aminocarbonyl)phenyl]-4-methoxy-3-nitrobenzamide,298-790-7,93839-20-4,Not Classified,REACH registration C&L,35,Not classified:35
45085,"pentaerythritol, dipentaerythritol, fatty acids, C",426-590-3,187412-41-5,Skin Sens. 1,Harmonised C&L,0,H317:0
45087,fluorotrihexylstannane,243-547-2,20153-50-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H332:0;H400:0;H302:0;H312:0
45088,"2-oxo-1,2-diphenylethyl acrylate",242-730-4,18994-98-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,1,H319:1;H315:1;H411:1;H335:1
45090,"Diethyl 3,3'-[(9,10-dihydro-9,10-dioxoanthracene-1,4-diyl)diimino]bis[triethylpropylammonium] disulphate",267-632-9,67905-14-0,Not Classified,Notified C&L,11,Not classified:11
45093,"Hydrocarbons, C2-4, C3-rich;Petroleum gas",270-689-2,68476-49-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;Not classified:0;H350:0
45098,"Fatty acids, C5-10, mixed esters with dipentaerythritol, 2(or 3)-methylbutanoic acid and pentaerythritol",287-518-2,85536-36-3,Not Classified,Notified C&L,1,Not classified:1
45107,Indium(III) Nitrate Trihydrate,603-841-7,13465-14-0,,Notified C&L,7,H319:7;H315:7;H272:7
45111,2-hydroxy-1-naphthoic acid,218-919-2,2283-08-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
45113,Dilithium tetrachloropalladate(2-),239-567-6,15525-45-8,,Notified C&L,4,H319:4;H315:4;H335:4
45114,4-cyclohexylbenzoic acid,243-472-5,20029-52-1,,Notified C&L,6,H319:6;H315:6;H335:5
45115,"3,3-bis(3,5-dibromo-4-hydroxyphenyl)phthalide",200-974-9,76-62-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,236,H319:236;H315:236
45121,"Resin acids and Rosin acids, ammonium salts",272-037-2,68649-89-8,Not Classified,REACH registration C&L,11,Not classified:11
45122,"Benzeneacetic acid, α-chloro-α-phenyl-, ethyl ester",610-844-7,52460-86-3,Not Classified,Notified C&L,1,Not classified:1
45127,"bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate",411-760-1,116633-52-4,Aquatic Chronic 2,Harmonised C&L,0,H411:0
45132,"N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide",423-990-1,149118-66-1,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H302:0;H318:0
45133,N-acetylhexanelactam,217-565-6,1888-91-1,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,90,H319:90;H302:89;Not classified:39;H315:5;H335:5
45134,Diethyl tartrate,201-783-3,87-91-2,Not Classified,REACH registration C&L,1416,Not classified:1415;H319:1
45142,"1,2,4-Benzenetricarboxylic acid, tri-C9-11-alkyl esters",304-780-6,94279-36-4,Not Classified,REACH registration C&L,4,Not classified:4
45145,3-heptyldihydro-5-methylfuran-2(3H)-one,255-141-2,40923-64-6,Acute Tox. 4,Notified C&L,1373,H302:1286;Not classified:87
45149,Chlortalidone,201-022-5,77-36-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,103,H319:60;H315:59;H335:59;Not classified:41;H360:2;H361:1;H302:1
45155,Rhodinol,229-887-4,6812-78-8,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,1506,H318:1390;H317:1506;H315:1506;H319:116;H411:7
45157,"(4S,4aS,5aS,6S,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide di(4-chlorobenzenesulfonic acid)",925-915-0,,Eye Irrit. 2;Lact.,Notified C&L,1,H362:1;H319:1
45160,"Creosote, wood",232-419-1,8021-39-4,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;Muta. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,1514,H332:1286;H373:1298;H314:1310;H317:1308;H311:1307;H341:1307;H412:1287;H301:1307;H319:194;H302:197;H315:194;H331:21;H411:21;H318:11;Not classified:10;H361:9
45161,Cyclopentadiene,208-835-4,542-92-7,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,266,H332:221;H315:266;H312:232;H335:266;H319:266;H226:265;H301:237;H302:29;H411:27;H311:5;H412:2;Not classified:2;H331:2;H225:1
45171,"1,4:3,6-dianhydro-2,5-di-O-octanoyl-D-glucitol",807-840-4,64896-70-4,Not Classified,Notified C&L,1,Not classified:1
45172,N-ethylmethacrylamine,242-217-5,18328-90-0,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 3;Skin Corr. 1C;Acute Tox. 3;STOT SE 2,REACH registration C&L,44,H318:1;H314:39;H331:1;H311:1;H225:39;H371:1;H300:1;H332:38;H302:38;H312:38;Not classified:5
45175,Pyrrolidin-3-ol,254-944-5,40499-83-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
45178,"Benzamide, 3-bromo-",607-149-6,22726-00-7,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1;H315:1
45179,D-2-oxobornane-10-sulphonyl chloride,244-314-8,21286-54-4,Skin Corr. 1B,Notified C&L,48,H314:48;H318:2;H290:1
45180,"1,2-epoxycyclooctane",206-010-3,286-62-4,Flam. Sol. 1;Aquatic Chronic 3,REACH registration C&L,41,H228:41;H412:2;H319:39;H302:39;H315:39;H332:1;H312:1
45181,(+)-Di-p-anisoyl-D-tartaric Acid,471-150-6,191605-10-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
45187,Methyprylon,204-745-4,125-64-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,39,H315:38;H317:38;H335:38;H302:39;H318:38
45191,3-phenylpropyl isobutyrate,203-125-0,103-58-2,Not Classified,Notified C&L,234,Not classified:234
45192,VSF-X-01,443-140-1,,Not Classified,Notified C&L,1,Not classified:1
45201,Propyltriacetoxysilane,241-816-9,17865-07-5,Skin Corr. 1B,REACH registration C&L,72,H314:33;H319:38;H315:39;H335:38;H302:22;H320:1
45202,Tris[2-(dimethylamino)ethyl]amine,608-885-0,33527-91-2,Skin Corr. 1B,Notified C&L,44,H314:44;H318:1
45203,α-cyanocinnamic acid,213-788-8,1011-92-3,Acute Tox. 3,Notified C&L,44,H301:38;H319:5;H315:5;H335:5;H332:1;H312:1;H302:2
45204,2-nitrophenylacetonitrile,210-231-0,610-66-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H332:42;H315:39;H312:38;H335:38;H302:42;H319:39;H311:4;H301:1
45207,1-(2-fluorophenyl)acetone,220-627-5,2836-82-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;Not classified:1
45211,"Bis(quinolin-8-olato-N1,O8)zinc",237-762-0,13978-85-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H315:43;H335:42;Not classified:1
45214,2-acrylamido-2-methylpropanesulphonic acid,239-268-0,15214-89-8,Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;STOT SE 3,REACH registration C&L,489,H332:183;H302:475;H318:227;H335:356;H319:194;H315:176;H413:79;Not classified:11;H314:7;H312:6;H290:3
45217,Phenethyl valerate,231-246-9,7460-74-4,Not Classified,REACH registration C&L,3,Not classified:3
45222,Disodium [2-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]-5-nitrobenzene-1-sulphonato(3-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-),282-316-0,84145-95-9,Aquatic Chronic 2,REACH registration C&L,38,H411:22;Not classified:16
45223,"[R-(E)]-5-isopropyl-8-methylnona-6,8-dien-2-one",218-907-7,2278-53-7,Not Classified,Notified C&L,88,Not classified:88
45224,Ammonium iodate,236-592-4,13446-09-8,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,42,H319:42;H315:42;H272:42;H335:4
45227,2-Chloro-4-fluoro-5-methylaniline,602-985-8,124185-35-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H332:39;H315:39;H312:39;H335:39;H302:39;H319:39
45228,3-hydroxypropionic acid,207-974-8,503-66-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H318:39;H302:39;H315:40;H335:40;Not classified:3;H319:1
45241,5-iodovanillin,226-617-7,5438-36-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
45245,CREATINE MONOHYDRATE,611-954-8,6020-87-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,146,H319:96;H315:96;H335:95;Not classified:50
45246,"2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-7-oxo-8-oxa-3,5-dithia-4-phosphatetradecanoate 4-oxide",610-601-5,51032-53-2,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,2,H317:2;H315:2;H411:2
45247,"reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'',4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane;1,1,1-tris(phenyl-4'-(6''-diazo-5'',6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane;reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)",422-760-6,,Aquatic Chronic 4,Harmonised C&L,0,Not classified:0;H413:0
45249,Benzyltriethylammonium tetrafluoroborate,278-768-3,77794-93-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
45251,"N-[4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]phenyl]acetamide",267-636-0,67905-17-3,Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,2173,H400:89;H319:89;Not classified:2084
45253,1-(2-ethylbutyl)cyclohexanecarbonyl chloride,619-547-7,211515-46-7,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,2,H317:2;H412:2
45257,2-Heptyn-1-ol,600-040-4,1002-36-4,Resp. Sens. 1,Notified C&L,39,H334:38;H302:1
45262,2-iodothiophene,222-342-1,3437-95-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,45,H315:45;H317:39;H335:39;H302:44;H318:39;H332:5;H312:5;H319:6;H227:1
45264,"Sebacic acid, compound with 2,2'-iminodiethanol",282-256-5,84145-30-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
45266,"2,2'-bipyridyl",206-674-4,366-18-7,Acute Tox. 3;Acute Tox. 3,REACH registration C&L,508,H311:218;H301:473;H312:268;H412:211;H319:95;H302:61;H410:15;H332:21;H315:26;H335:15;Not classified:11;H300:10;H361:1;H331:1
45267,1-(chloromethyl)-2-iodobenzene,261-779-2,59473-45-9,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,39,H314:39;H318:39;H335:39;H317:1;H341:1;H351:1;H413:1
45268,4-diazo-4H-imidazole-5-carboxamide,230-284-3,7008-85-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H335:1
45269,Methyl 5-amino-4-oxovalerate hydrochloride,279-151-1,79416-27-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
45270,Titanium tetraisopropanolate,208-909-6,546-68-9,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1270,H319:760;H226:955;H336:238;H318:452;H331:65;Not classified:58;H315:36;H335:9;H304:4;H372:4;H411:4;H228:1;H332:1
45280,(3-chloro-2-hydroxypropyl)dimethyl[2-[(2-methyl-1-oxoallyl)oxy]ethyl]ammonium chloride,261-329-5,58564-96-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
45282,Bis(diethylamino)dimethylsilane,225-116-0,4669-59-4,Flam. Liq. 3,Notified C&L,39,H226:39;H319:1;H315:1
45288,Tetradecylcyclohexane,217-274-4,1795-18-2,Asp. Tox. 1,Notified C&L,1,H304:1
45291,Pyridinium dichromate,243-478-8,20039-37-6,Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,10,H410:10;H317:8;H400:8;H305:1;H350:10;H314:3;H228:3;H318:1;H272:8;H315:2;H319:2
45292,Isodecyl pivalate,262-108-6,60209-82-7,Aquatic Chronic 1,REACH registration C&L,53,H410:25;Not classified:27;H412:1
45293,Tetrahydro-4H-pyran-4-one,249-967-2,29943-42-8,Flam. Liq. 3,REACH registration C&L,58,H226:55;H319:5;H315:7;H335:5;H225:1;Not classified:1
45294,"(2-formamido-1,3-thiazol-4-yl)(oxo)acetic acid",613-733-1,64987-06-0,Skin Sens. 1,Notified C&L,1,H317:1
45296,Palladium(2+) neodecanoate,269-397-8,68228-02-4,Flam. Sol. 1,Notified C&L,1,H228:1
45297,"Glycerides, C8-21 and C8-21-unsatd. mono- and di-, acetates",307-333-3,97593-30-1,,Notified C&L,35,Not classified:35
45298,bromadiolone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-one,249-205-9,28772-56-7,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H410:0;H310:0;H360:0;H330:0;H372:0;H400:0;H300:0
45299,"Oleic acid, monoester with triglycerol",251-749-7,33940-98-6,Not Classified,Notified C&L,20,Not classified:20
45302,"diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide",278-355-8,75980-60-8,Repr. 2,Harmonised C&L,0,H361:0
45305,Ammonium sulphate,231-984-1,7783-20-2,Not Classified,REACH registration C&L,1491,Not classified:1062;H319:414;H302:181;H315:414;H335:328;H411:44;H336:21;H400:11;H371:1;H331:1;H314:1;H318:1;H412:1
45308,N-[[4-(aminosulphonyl)phenyl]methyl]acetamide,217-942-5,2015-14-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
45309,"Fatty acids, soya, compds. with diethylenetriamine",296-096-9,92257-10-8,Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H317:1;H314:1
45310,Dibismuth tris(sulphate),232-129-5,7787-68-0,Not Classified,Notified C&L,8,Not classified:7;H319:1;H315:1;H335:1
45311,Ethylenebis(oxyethylene) dibenzoate,204-408-1,120-56-9,Not Classified,Notified C&L,157,Not classified:157
45312,"(5α)-4,5-epoxy-3,14-dihydroxymorphinan-6-one",251-561-5,33522-95-1,STOT SE 3,REACH registration C&L,146,H336:7;Not classified:79;H332:58;H317:59;H334:59;H312:41;H301:41;H302:20;H330:1;H300:1;H371:1
45316,Magnesium iodide,233-825-1,10377-58-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,25,H319:25;H315:25
45318,"(1R-cis)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarbonyl chloride",258-886-1,53955-46-7,Acute Tox. 3;Skin Corr. 1B,Notified C&L,1,H314:1;H301:1
45319,trans-dichloroethylene,205-860-2,156-60-5,Flam. Liq. 2;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H332:0;H225:0;H412:0
45320,"α,γ,γ-trimethylcyclohexylpropyl acetate",299-845-8,93917-67-0,Not Classified,Notified C&L,88,Not classified:88
45323,"Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;Methylnaphthalene Oil;[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235°C to 255°C (455°F to 491°F).]",309-972-3,101794-91-6,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
45324,diethyl 2-methylidenebutanedioate,607-321-0,2409-52-1,Eye Irrit. 2,Notified C&L,1,H319:1
45325,"Cyclopropanecarboxylic acid, 1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-ethenyl-, ethyl ester, (1R,2S)-",607-828-7,259217-95-3,,Notified C&L,1,Not classified:1
45328,4-benzyloxybenzyl alcohol,216-931-2,1700-30-7,,Notified C&L,4,H319:4;H315:4;H335:4
45331,disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate,400-350-8,85153-93-1,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
45334,"4,4'-isopropylidenediphenyl dicyanate",214-590-4,1156-51-0,Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,25,H410:12;H400:11;H317:12;Not classified:11;H332:2;H315:2;H312:2;H335:2;H302:2;H319:2
45335,"5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one",212-944-2,885-70-1,Skin Sens. 1;Eye Irrit. 2A,Notified C&L,2,H319:2;H317:2
45340,N-isotridecyl-iso-tridecanamide,435-780-5,,Not Classified,REACH registration C&L,1,Not classified:1
45341,Tetrapentyl orthosilicate,228-977-0,6382-12-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38;H315:38;H335:38
45342,"1,1'-(1,3-phenylene)bis-1H-pyrrole-2,5-dione",221-112-8,3006-93-7,Acute Tox. 4;Skin Sens. 1A;Acute Tox. 2;Aquatic Chronic 2,REACH registration C&L,858,H330:835;H317:107;H302:798;H411:7;H311:723;H312:60;H318:108;H315:42;H412:32;H301:15;Not classified:7;H335:4;H319:4;H331:1;H332:1
45345,2-(2-chloroethoxy)acetonitrile,608-593-3,31250-08-5,Not Classified,REACH registration C&L,1,Not classified:1
45348,1-(2-sulfanylideneimidazolidin-1-yl)ethanone,611-065-5,5391-52-6,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3;Repr. 1B,REACH registration C&L,3,H315:2;H360:2;H317:2;H335:2;H302:3;H319:2
45350,ouabain,211-139-3,630-60-4,Acute Tox. 3;Acute Tox. 3;STOT RE 2,Harmonised C&L,0,H373:0;H331:0;H301:0
45353,"2,6-dibromophenol",210-161-0,608-33-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,48,H332:41;H312:41;H302:46;H319:7;H315:7;H335:6;H301:2;H311:1;H331:1
45355,3-chlorobut-1-ene,209-252-8,563-52-0,Flam. Liq. 2;Skin Sens. 1,Notified C&L,74,H225:41;H317:72;H332:33;H314:33;H412:33;H302:34;H319:2;H315:2;H335:1
45358,2-methyl-3-(1-oxopropoxy)-4H-pyran-4-one,271-440-0,68555-63-5,Not Classified,Notified C&L,89,Not classified:89
45360,2-(diethylamino)-6-methyl-1H-pyrimidin-4-one,255-848-6,42487-72-9,Acute Tox. 4,REACH registration C&L,90,H302:90
45364,3-(2-oxopropyl)-2-pentylcyclopentan-1-one,255-149-6,40942-73-2,Not Classified,Notified C&L,1520,Not classified:1520
45368,"(±)-2-[(p-anisyl)methyl]-1-benzyl-1,2,5,6-tetrahydro-3,4-dimethylpyridinium hydrogen oxalate",302-269-2,94107-36-5,Acute Tox. 4,REACH registration C&L,3,H302:3
45370,Butyl mercaptoacetate,233-156-5,10047-28-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,40,H311:39;H331:39;H301:39;H410:1;H400:1;H317:1;H302:1
45374,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-methoxy-1,3,5-triazin-2-yl]amino]-, sodium salt, compd. with 2-aminoethanesulfonic acid monosodium salt and 2,2'-iminobis[ethanol]",286-151-5,85187-63-9,Not Classified,Notified C&L,1,Not classified:1
45375,2-chlorobenzoic acid,204-285-4,118-91-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,112,H319:78;H315:27;H335:12;H302:34;Not classified:2
45377,"(1-methylethylidene)bis(4,1-phenyleneoxy-2,1-ethanediyl) bismethacrylate",246-263-7,24448-20-2,Not Classified,Notified C&L,351,Not classified:203;H319:71;H317:140;H315:71;H335:71;H334:38;H410:2
45380,Methyl morpholine-4-acetate hydrochloride,266-562-6,67067-94-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H302:3;H315:3;H332:1;H312:1;H335:1
45384,6-methoxypyridazin-3-amine,230-670-1,7252-84-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:4;H315:4;H335:4;H302:1
45388,"2-[(1R,4R,4aS,8aR)-4,7-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-1-yl]acrylic acid",617-040-5,80286-58-4,Not Classified,REACH registration C&L,2,Not classified:2
45389,2-Chloro-N-methyl-N-(4-nitro-phenyl)-acetamide,607-952-1,2653-16-9,Acute Tox. 4,REACH registration C&L,3,H302:3
45390,Lubricating oils;Baseoil - unspecified;[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C,278-012-2,74869-22-0,Carc. 1B,Harmonised C&L,0,H350:0
45392,1-bromobutanone,212-431-3,816-40-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H332:40;H315:40;H312:40;H335:40;H302:40;H319:40;H330:4;H314:4
45394,2-Fluor-4-(trans-4-propylcyclohexyl)-benzoic acid-(4-trifluor methoxyphenylester),608-269-1,288579-86-2,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
45397,"N'-[3-(dimethylamino)propyl]-N,N-dimethylpropane-1,3-diamine",229-761-9,6711-48-4,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,158,H311:102;H314:158;H302:158;H318:89;H312:56;H317:2
45400,"Cryptocarya massoy, ext.",285-357-2,85085-26-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,89,H319:51;H317:54;H412:53;H315:76;Not classified:10
45402,1-vinyl-2-pyrrolidone,201-800-4,88-12-0,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Carc. 2;STOT RE 2,Harmonised C&L,0,H332:0;H335:0;H351:0;H302:0;H312:0;H318:0;H373:0
45403,Methyl 4-(acetylamino)-o-anisate,223-839-6,4093-29-2,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,52,H302:50;H315:11;H319:39;Not classified:1
45404,Tiaprofenic acid,251-329-3,33005-95-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,8,H315:4;H335:3;H361:4;H319:5;H301:7;H332:1;H312:1;H302:1
45413,"9,10-dioxoanthracene-2,6-disulphonic acid",201-534-9,84-50-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H315:38;H335:38;H400:38;H318:38
45414,Chloro(1-methylethyl)magnesium,213-947-1,1068-55-9,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,263,H225:191;H314:263;H318:6;H260:226;H261:4
45416,sulphuryl chloride,232-245-6,7791-25-5,Skin Corr. 1B;STOT SE 3,Harmonised C&L,0,H314:0;H335:0
45418,"isoxathion (ISO);O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate",242-624-8,18854-01-8,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H311:0;H400:0;H410:0;H301:0
45421,O-(4-Nitrophenyl)hydroxylamine,608-888-7,33543-55-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,1,H311:1;H331:1;H411:1;H301:1
45422,"1,3-Propanediamine, N-[3-(C11-14-isoalkyloxy)propyl] derivs., C13-rich, acetates",604-817-9,151789-08-1,Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,22,H410:22;H314:22
45426,2-hydroxy-3-phenoxypropyl methacrylate,240-994-5,16926-87-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,14,H319:14;H315:13;H335:14;H317:1;H412:1;H226:1
45428,"Formaldehyde, reaction products with o-toluidine",270-136-5,68411-63-2,Eye Dam. 1;Aquatic Acute 1,Notified C&L,93,H400:73;H318:73;Not classified:20
45429,Uronium toluene-p-sulphonate,244-608-6,21835-55-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
45431,8-benzyl-8-azabicyclo[3.2.1]octan-3-one,249-329-3,28957-72-4,Skin Corr. 1B,Notified C&L,3,H314:2;H332:1;H312:1;H302:1
45432,"1,3-dimethylbut-3-enyl isobutyrate",279-399-0,80118-06-5,Flam. Liq. 3,REACH registration C&L,1502,H226:1388;Not classified:62;H225:52
45433,"D-Glucopyranose, oligomers, oleyl glycosides",500-527-0,161074-91-5,Not Classified,Notified C&L,1,Not classified:1
45437,Guanidinium nitrate,208-060-1,506-93-4,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,59,H332:6;H302:59;H318:7;H315:52;H335:47;H272:52;H319:52;H412:4
45445,"(3β,4α)-3,23-dihydroxyolean-12-en-28-oic acid",207-369-9,465-99-6,Not Classified,Notified C&L,2,Not classified:2
45446,"Sodium 1-amino-4-[(4-butylphenyl)amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",235-545-5,12269-82-8,Not Classified,Notified C&L,1,Not classified:1
45449,FAT 45'164,414-630-2,,Eye Irrit. 2,Notified C&L,1,H319:1
45450,Trilostane,237-133-0,13647-35-3,Skin Irrit. 2;Eye Irrit. 2;Repr. 2,Notified C&L,44,H361:44;H319:43;H315:43;H332:1;H312:1;H335:1;H302:1
45453,Dipentyl sulphide,212-820-8,872-10-6,,Notified C&L,4,H319:4;H315:4
45454,"Glycerides, rape-oil di-",294-656-7,91744-89-7,Not Classified,Notified C&L,1,Not classified:1
45456,"2,6,6-trimethylbicyclo[3.1.1]heptane-3-thiol",276-598-4,72361-41-2,Not Classified,Notified C&L,96,Not classified:88;H410:8;H400:8;H319:8;H315:8
45457,Ethyl 3-mercaptobutanoate,435-460-5,156472-94-5,Acute Tox. 4,Notified C&L,36,H302:36
45460,Pyrazole,206-017-1,288-13-1,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,270,H315:269;H311:218;H372:218;H302:267;H412:218;H318:218;H319:50;H335:50;H361:4;Not classified:1
45462,A mixture of: a-3-(3-(2Hbenzotriazol- 2-yl)-5-tert-butyl- 4-hydroxyphenyl)propionyl-whydroxypoly( oxyethylene);a-3- (3-(2H-benzotriazo,600-603-4,104810-48-2,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,422,H317:406;H411:405;H373:39;Not classified:16;H361:2;H410:1;H400:1
45468,"N,N'-hexane-1,6-diylbis[3-(3,5-di-tert-butyl-4-hydroxyphenylpropionamide]",245-442-7,23128-74-7,Not Classified,REACH registration C&L,365,Not classified:285;H412:78;H413:18
45471,"Tetrasodium N,N'-ethylenebis[N-(2-carboxylatoethyl)-β-alaninate]",267-473-5,67874-43-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
45472,Napropamide,239-333-3,15299-99-7,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,163,H319:158;H411:158;Not classified:4;H410:1
45475,Hexachloropropene,217-560-9,1888-71-7,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H332:38;H319:45;H315:45;H335:45;H330:7
45478,"2-amino-5-[(3,4,5-trimethoxyphenyl)methyl]-1H-pyrimidin-4-one",296-233-2,92440-76-1,,Notified C&L,1,H302:1
45479,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with 4,4'-isopropylidenediphenol-1-chloro-2,3-epoxypropane co-oligomer and glycidylethers of C12-C14 alcohols",927-322-2,,Not Classified,Notified C&L,9,Not classified:9
45486,Bromopentafluoroethane,206-563-0,354-55-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
45489,1-(methylthio)-3-nitrobenzene,219-761-7,2524-76-7,Acute Tox. 4;Skin Sens. 1,Notified C&L,39,H317:38;H302:39;H332:1;H312:1
45490,"3,9-dichloro-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane",222-870-2,3643-70-7,Not Classified,Notified C&L,1,Not classified:1
45493,"Naphthenic acids, lead salts",263-109-4,61790-14-5,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,48,H410:43;H332:42;H360:43;H400:43;H302:42;H373:42;Not classified:5;H311:1;H331:1;H301:1
45494,Urea sulphate,242-803-0,19082-42-9,Eye Dam. 1,REACH registration C&L,3,H318:2;H319:1;H315:1
45497,Geranyl isobutyrate,219-062-7,2345-26-8,Not Classified,REACH registration C&L,1602,Not classified:1566;H410:36;H400:36;H317:1
45499,"Naphthalene-1,3-diol",205-079-7,132-86-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46;H341:4;H302:3
45500,"Ethanol, 2,2'-iminobis-, N-(hydrogenated tallow alkyl) derivs.",291-276-3,90367-28-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,36,H318:32;H315:34;H400:34;H410:3;H319:2;Not classified:1;H314:1
45503,"Bis(D-gluconato-O1,O2)cobalt",276-206-1,71957-08-9,,Notified C&L,8,H332:8;H317:8;H302:8
45504,Sodium 1H-benzotriazolide,239-269-6,15217-42-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,537,H314:12;H302:477;H318:3;H411:3;H319:465;H315:461;Not classified:60;H290:8;H412:5;H312:1
45506,2-[(2-methyl-1-oxoallyl)oxy]ethyl acetoacetate,244-311-1,21282-97-3,Not Classified,REACH registration C&L,539,Not classified:270;H319:140;H317:185;H315:56;H335:43;H334:39;H412:37
45508,"Reaction mass of hexasodium 2-[{8-amino-7-[(5-{[4-chloro-6-(4-{[2-(sulfonatooxy)ethyl]sulfonyl}anilino)-1,3,5-triazin-2-yl]amino}-2-sulfonatophenyl)diazenyl]-1-yhdroxy-3,6-disulfonato-2-naphthyl}diazenyl]naphthalene-1,5-disulfonate and pentasodiu2-[(8-amino-7-{[5-({4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-yl}amino) -2-sulfonatophenyl]diazenyl}-1-hydroxy-3,6-disulfonato-2-naphthyl)diazenyl]naphthalene-1,5-disulfonate",617-054-1,80315-17-9,Not Classified,REACH registration C&L,4,Not classified:3;H334:1
45511,"Aluminum magnesium hydroxide sulfate (Al5Mg10(OH)31(SO4)2), hydrate",616-176-2,74978-16-8,Not Classified,Notified C&L,77,Not classified:54;H412:23
45514,"2-Propenoic acid, polymer with 1,3-benzenedimethanamine",600-543-9,104242-06-0,Not Classified,Notified C&L,9,Not classified:9
45515,2-fluoro-1-phenylethan-1-one,207-190-6,450-95-3,Skin Corr. 1B,Notified C&L,2,H314:2;H227:1;H335:1
45518,N-ethylcarbazole-3-carbaldehyde,231-471-2,7570-45-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:38;H341:1
45522,"(2,3-epoxyphytyl)menaquinone",247-022-9,25486-55-9,Not Classified,Notified C&L,1,Not classified:1
45526,"1,5-dimethylnaphthalene",209-338-5,571-61-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:39;H315:39;H335:38;Not classified:3
45527,"Fatty acids, C12-14, ethoxylated",608-261-8,288259-63-2,Not Classified,Notified C&L,1,Not classified:1
45528,Dimethyl dicarbonate,224-859-8,4525-33-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2,Notified C&L,100,H330:99;H312:38;H302:99;H314:99;H318:33;H226:25;H301:1
45529,Calcium perchlorate,236-768-0,13477-36-6,Ox. Sol. 1,Notified C&L,38,H271:38
45531,"1-Butene, chlorinated, epoxidized, distn. residues",304-781-1,94279-37-5,Flam. Liq. 3;Met. Corr. 1;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;Muta. 1B;Carc. 1B,Notified C&L,84,H315:84;H317:84;H340:84;H311:84;H330:84;H290:83;H350:84;H319:83;H226:84;H301:84;H320:1
45532,3-methoxycatechol,213-276-4,934-00-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42;H332:1;H312:1;H302:1
45534,"4,4'-bi-o-toluidine",204-358-0,119-93-7,Acute Tox. 4;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H350:0;H302:0;H411:0
45535,Prazepam,220-975-8,2955-38-6,Not Classified,Notified C&L,3,Not classified:2;H362:1;H361:1;H336:1
45537,"2-(((3aR,4S,6R,6aS)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol",468-100-0,,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,5,H317:5;H411:5
45539,1-phenylethyl acetate,202-288-5,93-92-5,Not Classified,REACH registration C&L,1766,Not classified:1766
45542,"Nickel alloy, base, Ni,Al",684-239-1,12635-29-9,,Notified C&L,6,H228:4;H351:6;H317:6;H261:6;H334:2
45546,"Peptones, gelatin",293-431-0,91079-43-5,Not Classified,Notified C&L,7,Not classified:7
45549,"Octanal, 4-ethyl-",611-661-5,58475-04-0,Not Classified,Notified C&L,88,Not classified:88
45550,Titanium nitride,234-354-4,11116-16-8,Flam. Sol. 1,Notified C&L,1,H228:1
45551,"Acetic acid, lead(2+) salt, trihydrate",612-031-2,6080-56-4,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,153,H410:153;H332:96;H360:153;H400:152;H302:96;H373:153;H351:1
45552,"Benz[a]anthracene-7,12-quinone",219-693-8,2498-66-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
45554,N-2-pyridylaniline,229-625-9,6631-37-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H302:39;H318:39
45555,"Fatty acids, linseed-oil, maleated",273-193-4,68953-24-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,4,H319:3;H400:3;H317:3;H315:3;Not classified:1
45556,Dimethyl adipate,211-020-6,627-93-0,Not Classified,REACH registration C&L,1020,Not classified:646;H319:338;H332:26;H312:27;H302:27;H336:20;H335:21;H373:16;H361:7;H315:1
45557,Cinnamyl isobutyrate,203-126-6,103-59-3,Not Classified,Notified C&L,239,Not classified:239
45560,N-[4-[[4-[(4-hydroxyphenyl)azo]-2-methylphenyl]azo]phenyl]acetamide,260-151-5,56395-29-0,Not Classified,Notified C&L,17,Not classified:11;H412:6
45562,4-chloro-2-nitrobenzonitrile,252-133-0,34662-32-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
45564,"Hydrocarbons, C",270-686-6,68476-46-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0;H304:0
45566,"2,5-dimethoxytoluene",246-343-1,24599-58-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:40;H315:44;H335:39
45577,3-methyl-5-phenylmethoxy-2-(4-phenylmethoxyphenyl)-1H-indole,926-072-1,,Not Classified,Notified C&L,1,Not classified:1
45578,"Copper, diammine[5,5'-bi-1H-tetrazolato(2-)-kN1, kN1']",611-056-6,538313-26-7,Expl. 1.3;Flam. Sol. 1;Skin Sens. 1B;Muta. 2,REACH registration C&L,2,H228:2;H341:2;H317:2;H203:2
45580,"tert-butyl (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoate",609-144-4,355806-00-7,,REACH registration C&L,3,H400:3;H360:3;H373:3
45582,"Distillates (petroleum), full-range straight-run middle",272-341-5,68814-87-9,Flam. Liq. 3;Asp. Tox. 1;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,144,H332:144;H304:144;H411:144;H226:72;H373:144
45584,Dibutylbis(palmitoyloxy)stannane,236-360-2,13323-63-2,Muta. 2;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,310,H410:281;H360:274;H400:303;H341:274;H373:227;H372:76;H315:29;H311:22;H302:29;H413:22;H319:29;Not classified:7;H312:7;H317:1;H314:1;H370:1
45586,"2,2,2-trichloroethyl chloroformate",241-363-7,17341-93-4,Skin Corr. 1B;Acute Tox. 3,Notified C&L,51,H314:51;H331:43;H330:7;H302:9;H311:2;H301:2;H310:1;H300:1;H290:2;H318:2;H335:1
45598,"2,3,4-tribromothiophene",221-545-2,3141-25-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
45599,Sebuthylazine,230-710-8,7286-69-3,Not Classified,Notified C&L,3,Not classified:3
45605,5-ethoxy-5H-furan-2-one,428-330-4,2833-30-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;STOT RE 2,Harmonised C&L,0,H317:0;H314:0;H302:0;H312:0;H373:0
45616,"2,3-Dichloro-5-(trifluoromethyl)pyridine",614-913-2,69045-84-7,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,75,H332:73;H317:73;H302:74;H411:71;H318:72;H312:1;H319:2;H315:2;H335:2;H400:1
45618,(o-hydroxyphenoxy)acetic acid,228-684-8,6324-11-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40;H302:2
45635,Fluorotriphenylsilane,206-832-2,379-50-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,40,H314:40;H318:39;H290:1
45639,3-oxo-N-[2-(trifluoromethyl)phenyl]butyramide,279-814-5,81761-28-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
45643,"1',2'-dihydro-4'-methyl-6'-oxido-2'-oxo-1,3'-bipyridinium",271-295-3,68532-86-5,Not Classified,REACH registration C&L,8,Not classified:8
45646,Propionohydrazide,227-390-7,5818-15-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,57,H335:56;H319:56;H315:56;H301:56;Not classified:1
45647,Diethylcyanamide,210-532-7,617-83-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,39,H315:39;H335:38;H311:39;H319:39;H331:39;H301:39
45649,Sodium glycollate,220-624-9,2836-32-0,Not Classified,Notified C&L,407,Not classified:203;H318:156;H315:204;H319:48;H335:48
45650,4-amino-3-nitrophenol,210-236-8,610-81-1,Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2B;Aquatic Chronic 2,REACH registration C&L,107,H319:70;H317:58;H302:65;H411:3;H315:61;H335:44;H332:4;H312:8;H341:2
45656,Menthyl anthranilate,205-129-8,134-09-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,63,H319:38;H315:63;H335:38
45658,Phospholipase A2,232-637-7,9001-84-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:39;H315:39;H335:38;H334:13;H371:4
45659,Sodium [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate,245-528-4,23255-99-4,Acute Tox. 4,REACH registration C&L,1,H302:1
45661,"Cyclohexane, (ethyldimethoxysilyl)-",603-478-4,131390-30-2,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H315:1;H411:1
45662,"(8R,9S,10R,13S,14S,17R)-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione - 2,3,5,6-tetrachlorobenzene-1,4-diol (1:1)",926-987-6,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 4;Repr. 2;STOT RE 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2,H332:2;H315:2;H317:2;H372:2;H401:2;H361:2;H302:2;H411:2;H319:2
45664,"N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride",405-660-7,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
45669,Decahydro-2-naphthyl acetate,234-054-3,10519-11-6,Aquatic Chronic 2,REACH registration C&L,1578,H411:1578
45670,"Methyl 3,4,5-trimethoxyanthranilate",225-728-8,5035-82-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39;H302:1
45671,Trifluoro(isopropylamine)boron,223-230-5,3776-04-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H335:1;H319:1;H315:1;H301:1
45672,4-[(2-methyl-3-furyl)thio]nonan-5-one,262-691-7,61295-50-9,Acute Tox. 4,Notified C&L,1,H302:1
45675,Dimethyl((2-oxocyclohexyl)methyl)ammonium chloride,700-355-8,42036-65-7,Not Classified,REACH registration C&L,44,Not classified:2;H318:40;H315:41;H335:41;H411:1;H301:1;H319:1
45676,2-[4-[3-[2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-1-piperazinyl]ethyl decanoate,250-385-6,30909-51-4,,Notified C&L,6,H302:5;H362:2;H361:2;Not classified:1
45677,Methyl crotonate,210-793-7,623-43-8,Flam. Liq. 2;Eye Irrit. 2,REACH registration C&L,166,H225:165;H319:82;H318:84;H315:55;H335:54;H226:1
45679,Dimethylcyclohex-3-ene-1-carbaldehyde,272-113-5,68737-61-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,347,H319:319;H317:347;H412:305;H315:347;H411:41
45680,Tetrasodium [[(2-hydroxyethyl)imino]bis(methylene)]bisphosphonate,251-029-2,32422-03-0,Met. Corr. 1;Skin Corr. 1B,Notified C&L,1,H290:1;H314:1
45682,"fluroxypyr-meptyl (ISO);methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate",279-752-9,81406-37-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
45685,"4,8-dihydroxyquinoline-2-carboxylic acid",200-410-1,59-00-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
45689,"1,3-Dioxolane-2-pentanoic acid, α-amino-, (αS)-",606-785-1,215054-80-1,,Notified C&L,38,Not classified:38
45692,"α,3-dichlorotoluene",210-629-4,620-20-2,Skin Corr. 1B,Notified C&L,68,H314:67;H318:12;H332:16;H312:16;H302:16;H411:4;Not classified:1;H301:1;H410:2;H317:1
45693,Disperse Blue 124,612-788-9,61951-51-7,Acute Tox. 3;Skin Sens. 1,Notified C&L,38,H317:38;H301:38
45700,Tin dichloride,231-868-0,7772-99-8,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,733,H332:303;H317:236;H314:691;H335:364;H290:171;H302:571;H412:126;H318:355;H373:294;H312:128;H400:282;H319:212;H410:215;H341:61;H361:61;H315:17;Not classified:4;H371:1
45701,"bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride",401-380-4,89066-61-5,Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H411:0
45704,"2-Butenedioic acid (E)-, di-C16-18-alkyl esters",272-944-3,68921-52-8,Not Classified,REACH registration C&L,115,Not classified:115
45706,Magnesium pyrophosphate,236-595-0,13446-24-7,,Notified C&L,7,H315:4;H335:4;Not classified:3
45708,Diethylsilane,208-834-9,542-91-6,Flam. Liq. 2,Notified C&L,67,H225:67;H315:22;H335:22;H302:22;H319:23
45709,fluorotripentylstannane,243-546-7,20153-49-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H332:0;H400:0;H302:0;H312:0
45713,"1-Propanone, 1-[2-(2-propen-1-yloxy)phenyl]-",604-312-3,142819-94-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
45716,Piperonal,204-409-7,120-57-0,Skin Sens. 1B,REACH registration C&L,1951,H317:1570;Not classified:329;H315:51;H319:9;H335:9;H310:1;H312:1
45718,Magnesium di-L-ascorbate,239-442-6,15431-40-0,Not Classified,Notified C&L,3,Not classified:3
45721,"1,6,7-trimethylnaphthalene",218-833-5,2245-38-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H410:38;H400:38;H302:38;Not classified:3
45723,"Amines, N-C14-18-alkyltrimethylenedi-",270-415-1,68439-71-4,Not Classified,Notified C&L,179,Not classified:179
45724,"2H-Pyran-2-one, tetrahydro-5,6-dimethyl-",600-524-5,10413-18-0,Not Classified,Notified C&L,88,Not classified:88
45725,p-[(trimethylsilyl)oxy]benzaldehyde,213-789-3,1012-12-0,,Notified C&L,5,H319:5;H315:5;H335:1
45727,"Citric acid, monoester with propylene glycol",286-541-5,85252-24-0,Not Classified,Notified C&L,36,Not classified:36
45728,"Trilithium 2-[2-(4-nitro-2-sulphonatophenyl)vinyl]-5-[[4-[(4-sulphonatophenyl)azo]phenyl]-O,N,N-azoxy]benzenesulphonate",281-534-3,83968-54-1,Not Classified,Notified C&L,2,Not classified:2
45729,"2,4-dinitro-N-(2-nitrophenyl)aniline",238-406-7,14434-10-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
45730,"Phosphoric acid, C12-18-alkyl esters",286-022-3,85186-38-5,Not Classified,Notified C&L,3,Not classified:2;H314:1
45731,"(2S)-2-(2-AMINO-5-CHLOROPHENYL)-4-CYCLOPROPYL-1,1, 1-TRIFLUOROBUT-3-YN-2-OL METHANESULFONATE (1:1.5)",610-316-6,467426-34-2,Acute Tox. 4,REACH registration C&L,4,H302:4
45740,Tetrahydrofurfuryl methacrylate,219-529-5,2455-24-5,Skin Sens. 1;Repr. 1B;Aquatic Chronic 3,REACH registration C&L,203,H360:25;H317:40;H412:40;H319:178;H315:178;H335:168
45742,C.I. Solvent Yellow 131,615-536-6,71819-82-4,Not Classified,Notified C&L,1,Not classified:1
45744,2-Propylheptyl octanoate,485-390-4,,Not Classified,REACH registration C&L,1,Not classified:1
45745,"N-(2,6-dimethylphenyl)-2-(piperazin-1-yl)acetamide",610-916-8,5294-61-1,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,9,H317:7;H302:7;H318:7;H319:2;H315:2;H335:1
45750,reaction product: bisphenol-A-(epichlorhydrin);epoxy resin (number average molecular weight ≤ 700),500-033-5,25068-38-6,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H319:0;H315:0;H411:0
45751,Potassium 2-methyl-2-[(1-oxoallyl)amino]propanesulphonate,258-205-8,52825-28-2,Not Classified,Notified C&L,1,Not classified:1
45752,"N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-4-[[5-methoxy-2-methyl-4-[(methylamino)sulphonyl]phenyl]azo]naphthalene-2-carboxamide",263-353-1,61951-98-2,Not Classified,Notified C&L,6,Not classified:6
45754,"Methanaminium N,N,N-trimethyl-, salt with 2,2-dimethylpropanoic acid",478-310-4,,Flam. Sol. 1;Acute Tox. 3;Acute Tox. 3,REACH registration C&L,9,H311:9;H228:9;H301:9
45757,Chlorodifluoroacetic acid,200-928-8,76-04-0,Skin Corr. 1A,Notified C&L,46,H314:46;H290:1;H318:1
45758,"Dimethyl 3,3'-thiobispropionate",223-948-9,4131-74-2,Not Classified,Notified C&L,20,Not classified:12;H319:8;H315:8
45762,"3-Chloro-2,4-dimethyl-6-hydroxybenzaldehyde",617-217-7,81322-67-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
45765,"potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;[containing < 0.5 % N,N-dimethylformamide (EC no 200-679-5)];[containing ≥ 0.5 % N,N-dimethylformamide (EC No 200-679-5)]",418-260-2,183196-57-8,,,0,H317:0
45771,"9(or 10)-methoxy-7H-benzimidazo[2,1-a]benz[de]isoquinolin-7-one",269-535-7,68296-59-3,Not Classified,REACH registration C&L,3,Not classified:3
45772,benz[e]acephenanthrylene,205-911-9,205-99-2,Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H350:0;H400:0
45773,"4,4,7,7-tetraethoxy-3,8-dioxa-4,7-disiladecane",240-212-2,16068-37-4,Acute Tox. 3;Acute Tox. 4;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,131,H372:52;H312:51;H412:52;H301:52;H318:78;H315:79;H335:78;H332:1;H302:1;H319:1
45776,Menthyl acetate,240-459-6,16409-45-3,Aquatic Chronic 2,Notified C&L,1549,H411:1548;H317:24;H226:22;Not classified:1
45778,Octadecylbenzene,224-684-7,4445-07-2,Aquatic Chronic 4,REACH registration C&L,38,H413:37;H319:1;H315:1;H335:1
45779,"Anthra[9,1,2-cde]benzo[rst]pentaphene-5,10-dione, amino-, reaction products with 1-amino-9,10-anthracenedione and tetrabromo-8,16-pyranthrenedione",215-520-5,1328-25-2,Not Classified,REACH registration C&L,15,Not classified:15
45781,(3S)-2-{N-[1-ethoxy-1-oxo-4-phenylbutan-2-yl]-substituted}-heteropolycyclic-3-carboxylic acid hydrochloride,919-408-3,,Repr. 2,Notified C&L,1,H361:1
45783,"1,5-diamino-2-(4-ethoxyphenyl)-4,8-dihydroxyanthraquinone",276-034-7,71799-75-2,,Notified C&L,5,Not classified:5
45786,ammonium nonadecafluorodecanoate,221-470-5,3108-42-7,Carc. 2;Lact.;Repr. 1B,Harmonised C&L,0,H362:0;H360:0;H351:0
45788,Triacetin,203-051-9,102-76-1,Not Classified,REACH registration C&L,1943,Not classified:1940;H317:3;H315:3;H226:3
45792,"1-Octanamine, N,N-dimethyl-, N-oxide",607-854-9,2605-78-9,Eye Dam. 1,REACH registration C&L,65,H318:16;H319:44;H315:53;H335:40;H400:11;Not classified:5
45795,"Butanamide, 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-oxo-, N,N'-bis(phenyl and o-tolyl) derivs.",272-732-0,68910-13-4,Not Classified,Notified C&L,83,Not classified:83
45798,3-bromothiophene,212-821-3,872-31-1,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,84,H310:78;H317:40;H335:79;H330:75;H411:83;H319:83;H226:80;H301:83;H315:43;H311:5;H331:3;Not classified:1
45802,5-nonylsalicylaldehyde oxime,256-798-8,50849-47-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,17,H410:14;H315:17;H400:14;H302:15;H319:17;H317:2;H361:2;H411:3
45805,"Chromate(5-), bis[4-hydroxy-3-[(2-hydroxy-3,5-dinitrophenyl)azo]-6-[(sulfomethyl)amino]-2-naphthalenesulfonato(4-)]-, sodium",290-944-1,90294-58-9,Not Classified,Notified C&L,6,Not classified:5;H315:1
45808,Methyl 2-hydroxy-4-methylvalerate,254-883-4,40348-72-9,Not Classified,Notified C&L,88,Not classified:88
45809,calcium cyanamide,205-861-8,156-62-7,Acute Tox. 4;Eye Dam. 1;STOT SE 3,Harmonised C&L,0,H302:0;H318:0;H335:0
45810,"Harpagophytum procumbens, ext.",284-853-6,84988-65-8,Not Classified,Notified C&L,8,Not classified:5;H226:2;H302:1
45814,"2,3,5,6-tetrabromo-p-xylene",245-688-5,23488-38-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:41;H302:1
45815,"2-bromo-2-cyano-N,N-dimethylacetamide",239-441-0,15430-62-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H332:1;H315:1;H312:1;H302:1;H319:1
45817,5-chloro-o-anisic acid,222-343-7,3438-16-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:44;H315:44;H335:43;Not classified:6;H302:1
45820,2-CHLORO-4-FLUOROBENZALDEHYDE,617-548-7,84194-36-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H315:49;H335:48
45821,N-(tert-butoxycarbonyl)-L-aspartic acid,237-294-7,13726-67-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
45826,Mercury(2+) tetrakis(thiocyanato-N)cobaltate(2-),248-602-4,27685-51-4,Acute Tox. 2;Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:42;H315:38;H310:42;H335:38;H330:42;H400:42;H319:38;H300:42;H373:42;H317:4;H334:4
45829,(+)-Bis[(R)-1-phenylethyl]amine,607-220-1,23294-41-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
45831,"Ethylenediamine, propoxylated",500-035-6,25214-63-5,Eye Irrit. 2,REACH registration C&L,354,H319:326;H315:86;Not classified:28;H317:3
45836,Neryl isobutyrate,219-061-1,2345-24-6,Not Classified,Notified C&L,137,Not classified:137
45837,2-oxotrimethylenediammonium dichloride,263-230-2,61798-04-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
45842,"Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polypropylene glycol mono-Bu ether",614-495-1,68440-66-4,Not Classified,Notified C&L,32,Not classified:32
45843,"4,4'-methylenebis[N,N-bis(2,3-epoxypropyl)aniline]",249-204-3,28768-32-3,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,208,H317:208;H411:205;H341:137;H302:104;H312:104;H319:9;H340:2;H412:2;H410:1;H334:1;H315:3
45847,"reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid",413-180-4,187285-15-0,Eye Dam. 1,Harmonised C&L,0,H318:0
45851,"2-(1-(p-Chlorophenyl)-1-phenylethoxy)-N,N-dimethylethylamine",616-456-4,77-38-3,Acute Tox. 4,Notified C&L,38,H302:38
45857,"Glycerides, C8-21 and C8-21-unsatd. mono- and di-",307-332-8,97593-29-8,Not Classified,Notified C&L,111,Not classified:111
45858,"2,6-dichloroaniline",210-160-5,608-31-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,55,H410:52;H301:54;H311:53;H400:51;H331:52;H373:53;H317:38;Not classified:2;H310:1;H330:1;H371:1;H300:1;H341:1;H411:2
45863,"Tallow, reaction products with diethylenetriamine, compds. with di-Et sulfate",273-633-5,68990-93-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
45867,Oxydiethylene dibenzoate,204-407-6,120-55-8,Not Classified,REACH registration C&L,375,Not classified:348;H411:26;H319:1
45874,Magnesium nitrate,233-826-7,10377-60-3,Ox. Sol. 3,REACH registration C&L,2786,H272:2196;Not classified:269;H318:68;H319:1811;H335:526;H315:1042;H270:177;H271:88;H302:5;H350:2
45875,Ammonium glycyrrhizate,258-887-7,53956-04-0,Eye Irrit. 2,REACH registration C&L,107,H319:8;Not classified:97;H302:2;H315:1
45879,"(R)-N,N,α-trimethylbenzylamine",242-976-2,19342-01-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,128,H319:127;H315:127;H335:127;H332:1;H312:1;H302:1
45882,"trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide",417-290-3,147086-81-5,Acute Tox. 4,Harmonised C&L,0,H302:0
45890,"N,N-diethylformamide",210-533-2,617-84-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:41;H226:40;H335:40;Not classified:2
45898,(formylmethyl)triphenylphosphonium chloride,263-767-2,62942-43-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,43,H302:43;H318:43
45899,"(2S)-2-Benzyl-N,N-dimethylaziridine-1-sulfonamide",620-285-0,902146-43-4,Not Classified,Notified C&L,1,Not classified:1
45902,"N-(1,1-dimethylpropyl)formamide",245-776-3,23602-10-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H335:2
45903,3-chloro-2-methylpropene,209-251-2,563-47-3,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H317:0;H314:0;H302:0;H411:0;H225:0
45906,"1-[[2-(2,4-dichlorophenyl)-4-ethyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole",262-107-0,60207-93-4,Aquatic Chronic 2,Notified C&L,159,H411:156;Not classified:3
45916,"3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",240-046-0,15905-32-5,Not Classified,Notified C&L,39,Not classified:37;H302:1;H319:1;H315:1;H335:1
45917,"Aluminium, 4-hydroxy-3-[(4-sulfo-1-naphthalenyl)azo]-1-naphthalenesulfonic acid complex",282-478-2,84238-07-3,Not Classified,Notified C&L,1,Not classified:1
45918,Sodium O-isopentyl dithiocarbonate,926-448-5,,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H302:1;H315:1;H411:1
45922,"Phenol, reaction products with isobutylene, styrene and 2,2,4-trimethylpentene",278-354-2,75975-86-9,Aquatic Chronic 4,Notified C&L,33,H413:33
45924,trans-2-methylcyclopropanecarboxylic acid,228-266-5,6202-94-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H302:2;H315:1;H335:1;H332:1;H312:1
45925,(Z)-non-6-enal,218-900-9,2277-19-2,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,1504,H318:2;H317:2;H315:1339;Not classified:165;H319:49;H335:49
45926,"N,N'-(2,5-dichloro-1,4-phenylene)bis[3-oxobutyramide]",255-847-0,42487-09-2,Not Classified,REACH registration C&L,12,Not classified:12
45927,N-tert-butylglycine hydrochloride (1:1),614-959-3,6939-23-7,Eye Irrit. 2A,REACH registration C&L,6,H319:5;Not classified:1;H315:3;H335:2
45929,"2,4-dichloro-3-nitrotoluene",237-448-3,13790-14-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,33,H332:33;H312:33;H302:33;H411:33
45931,Heptadecafluoro-N-(2-hydroxyethyl)-N-methyloctanesulphonamide,246-262-1,24448-09-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H332:1;H315:1;H312:1;H335:1;H302:1;H319:1
45933,"Fatty acids, C16-18 and C18-unsatd., compds. with ethanolamine",271-687-4,68604-36-4,Not Classified,Notified C&L,19,Not classified:19
45937,N-methylnicotinamide,204-046-4,114-33-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
45940,γ-valerolactone,203-569-5,108-29-2,Not Classified,Notified C&L,1521,Not classified:1425;H319:95;H315:4;H335:3;H312:1;H302:1
45942,"Phosphoric acid, bis(2-chloro-1-methylethyl) 2-chloropropyl ester",616-283-4,76025-08-6,,Notified C&L,33,Not classified:33
45943,"(1S,3R)-3-((Z)-2-Chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarbonyl chloride",604-121-5,139237-90-4,Acute Tox. 4;Skin Corr. 1C;Aquatic Chronic 2,REACH registration C&L,1,H314:1;H302:1;H411:1
45945,"3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt",440-770-9,371921-63-0,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
45947,4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidyl decanoate hydrochloride,281-142-2,83863-76-7,Acute Tox. 4;Repr. 2,Notified C&L,2,H361:2;H302:2
45948,Trichlorotrifluoroethane,206-564-6,354-58-5,,Notified C&L,42,Not classified:41;H059:1
45953,"3,3'-(dodecylazanediyl)dipropanenitrile",605-014-6,1555-62-0,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,37,H412:36;H315:37;H400:1
45954,2-bromo-3-methylthiophene,238-175-2,14282-76-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,45,H302:44;H318:41;H332:5;H315:5;H312:5;H335:5;H319:4;H301:1;H227:1
45955,"2-[[4-(1,1-dimethylethyl)cyclohexyl]methyl]-3-hydroxy-1,4-naphthalenedione",618-162-1,88426-33-9,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:35;H400:35;H319:36;Not classified:2;H315:1;H335:1;H317:1
45956,"Ethanol, 2,2'-[[3-[(2-hydroxyethyl)amino]propyl]imino]bis-, N-tallow alkyl derivs.",291-275-8,90367-27-4,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,107,H400:100;H314:100;H302:107;H318:59;H410:33;H319:7;H315:7;H372:1
45961,"Fatty acids, C12-20 and C12-20-unsatd., C12-15-alkyl esters, oxidized, sulfonated",292-791-6,90990-28-6,Not Classified,Notified C&L,1,Not classified:1
45962,N-[[-2[[[(4-Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alaninethylester p-toluolsulfonat,927-186-4,,Aquatic Chronic 2,REACH registration C&L,3,H411:3
45968,C.I. Reactive Blue 171,616-563-6,77907-32-5,Not Classified,Notified C&L,2,Not classified:2
45969,Acetohydrazide,213-948-7,1068-57-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;Carc. 2,REACH registration C&L,147,H315:58;H341:46;H351:48;H319:58;H301:46;H400:89;H302:98;H331:89;H411:89;H335:7;H332:1;H228:1;Not classified:1
45973,3-phenoxybenzylic alcohol,237-525-1,13826-35-2,Acute Tox. 4;Aquatic Acute 1,REACH registration C&L,193,H400:42;H302:193;H410:1;H319:6;H315:4;H335:4
45981,"4,5,6,7-tetrahydrothieno[3,2-c]pyridine",259-389-2,54903-50-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
45984,"Sodium (±)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulphonate",252-250-7,34850-66-3,Not Classified,Notified C&L,6,Not classified:6
45987,4'-(2-pyridylsulphamoyl)acetanilide,242-802-5,19077-98-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1
45992,"reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr : DTBS = 1.0 : 1.0 to 1.0 : 1.5",430-610-6,226996-19-6,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
45994,5-bromo-4-chloroindol-3-yl-β-D-glucopyranoside,239-603-0,15548-60-4,Not Classified,Notified C&L,2,Not classified:2
45999,"4,5-dibromothenoic acid",228-683-2,6324-10-3,Acute Tox. 4,Notified C&L,43,H302:38;H319:4;H315:4;H335:4;Not classified:1
46000,o-toluic acid,204-284-9,118-90-1,Not Classified,REACH registration C&L,121,Not classified:3;H319:118;H315:117;H335:116;H302:18
46007,Ethyl 3-fluorobenzoate,207-191-1,451-02-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
46008,Ammonium tridecan-1-yl sulphate,252-066-7,34506-45-1,Not Classified,Notified C&L,31,Not classified:31
46009,Dipotassium 1(or 4)-dodecyl 2-sulphonatosuccinate,261-532-9,58977-40-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,15,H302:15;H318:14;H319:1;H315:1
46011,Tetrabutylphosphonium acetate,250-139-8,30345-49-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,17,H319:2;H302:17;H315:2;H311:15;H314:15
46019,cyclopentane,206-016-6,287-92-3,Flam. Liq. 2;Aquatic Chronic 3,Harmonised C&L,0,H225:0;H412:0
46020,EO bis(benztriazolyl)phenylpropionat,600-602-9,104810-47-1,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,489,H317:424;H411:424;Not classified:65;H361:2
46026,"1,3-dibromoacetone",212-430-8,816-39-7,,Notified C&L,6,H317:5;H314:5;H319:1;H315:1;H335:1;H332:1;H302:1
46028,"Cinnamomum aromaticum, ext.",295-158-2,91844-89-2,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H317:1;H412:1
46030,"Chromate(3-), [3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulfonato(3-)][3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-7-nitro-1-naphthalenesulfonato(3-)]-, sodium",284-915-2,84989-26-4,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,198,H317:78;H412:173;H318:90;H319:16;Not classified:10;H411:1;H332:1;H302:1;H315:1
46035,o-nitrocinnamic acid,210-309-4,612-41-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
46036,Tetracycline,200-481-9,60-54-8,Acute Tox. 4;Skin Irrit. 2;Repr. 2;Lact.;Aquatic Chronic 2,REACH registration C&L,49,H362:1;H315:1;H361:1;H302:49;H411:1
46037,"Oxirane, 2-[(C12-13-alkyloxy)methyl] derivs.",601-719-8,120547-52-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,68,H319:67;H317:67;H315:67;H411:22;Not classified:1
46038,Phenacyltriphenylphosphonium bromide,227-945-3,6048-29-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
46040,3-ethyl-o-xylene,213-275-9,933-98-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,64,H319:60;H302:60;H332:22;H315:22;H312:22;H335:22;H226:23;Not classified:3
46041,Methyl α-cyano-1-cyclohexene-1-acetate,279-519-1,80632-53-7,Acute Tox. 4,Notified C&L,38,H302:38
46042,"2,6-dichloro-m-toluidine",264-649-3,64063-37-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
46043,"α,α'-dibromo-o-xylene",202-042-7,91-13-4,Acute Tox. 4;Skin Corr. 1B,Notified C&L,47,H314:47;H302:42;H332:1;H312:1;H318:2;H335:1;H330:1;H290:1
46047,"Hexasodium 2-[8-amino-7-[[5-[[4-chloro-6-[[3-[[2-(sulfato)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl] amino]-2 sulfonatophenyl]azo]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]-naphthalene-1,5-disulfonate",401-310-2,93912-64-2,Not Classified,REACH registration C&L,36,Not classified:21;H371:12;H412:12;H318:14;H334:1;H319:1;H335:1
46051,"Soaps, stocks, rape-oil, acidulated",283-103-5,84540-12-5,Not Classified,Notified C&L,2,Not classified:2
46052,4-morpholinoaniline,219-760-1,2524-67-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:46;H315:46;H335:44;H332:9;H312:8;H302:9
46056,bis(.sc.d.sc.-gluconato-O,276-205-6,71957-07-8,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H410:0;H360:0;H317:0;H372:0;H400:0;H341:0;H334:0;H350:0
46057,"α-D-Glucopyranose, hydrate (1:1)",611-920-2,5996-10-1,Not Classified,Notified C&L,7,Not classified:7
46058,2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium methyl sulphate,235-546-0,12270-13-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,186,H410:88;H314:4;H400:88;H302:115;H318:4;H373:4;H319:170;H315:61;H335:60;H411:14;Not classified:4
46061,"D-Glucopyranose, oligomers, undecenyl glycosides",500-528-6,161074-92-6,Not Classified,Notified C&L,1,Not classified:1
46068,"2-Butenedioic acid (Z)-, di-C10-20-branched and linear alkyl esters, sulfonated, ammonium salts",290-867-3,90268-64-7,Not Classified,Notified C&L,1,Not classified:1
46070,"reaction mass of: 2-methylnonanedioic acid;2,4-dimethyl-4-methoxycarbonylundecanedioic acid;2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid",423-670-1,,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
46072,YELLOW DO 2847,419-510-3,,Not Classified,Notified C&L,37,Not classified:37
46074,"(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid",600-146-0,100986-85-4,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Repr. 2;Lact.,Notified C&L,115,H362:40;H317:108;H361:42;H302:113;H334:110;H332:2;H371:1;H312:1;H320:1;H411:1
46077,"2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide",209-339-0,572-09-8,Not Classified,Notified C&L,19,Not classified:19
46084,"2-methylbenzene-1,4-diyl bis{4-[4-(acryloyloxy)butoxy]benzoate}",700-238-1,132900-75-5,Aquatic Chronic 4,Notified C&L,3,H413:3
46089,Calcium bis(metaphosphate),236-769-6,13477-39-9,Not Classified,REACH registration C&L,4,Not classified:4
46091,N-benzyl-N-ethyl-m-toluidine,204-359-6,119-94-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H311:38;H331:38;H301:38
46092,"2(2-OXO-2,3-DIHYDRO-4-INDOLYL)ETHYLTOLUENESULPHONATE",917-449-1,,Skin Sens. 1,Notified C&L,1,H317:1
46096,"Acetamide, N-[4-[(4S)-2,5-dioxo-4-oxazolidinyl]butyl]-2,2,2-trifluoro-",610-008-1,42267-27-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,41,H318:3;H315:3;H335:3;H319:38
46097,Prometryn,230-711-3,7287-19-6,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,219,H410:159;H400:200;H332:41;H411:16;Not classified:3
46098,"2,3,5-trimethylpyrazine",238-712-0,14667-55-1,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1767,H302:1767;H226:1762;H315:53;H335:51;H319:53
46099,2-chloro-p-toluenesulfochloride,412-890-1,42413-03-6,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H314:0;H412:0
46103,"Resin acids and Rosin acids, fumarated, potassium salts",272-035-1,68649-83-2,Skin Sens. 1,Notified C&L,84,H317:84;H318:1
46104,2-fluorobenzophenone,206-440-1,342-24-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,100,H319:100;H315:100;H335:99
46107,"Estra-1,3,5(10)-triene-3,17β-diol 17-propionate",223-164-7,3758-34-7,Carc. 2,Notified C&L,62,H351:62;H362:24;H360:24
46110,Diethyl dodecylphosphonate,225-429-2,4844-38-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
46114,4-[[5-(anilino)carbonyl-2-methoxyphenyl]azo]-3-hydroxynaphthalene-2-carboxamide,260-152-0,56396-10-2,Aquatic Chronic 4,REACH registration C&L,41,H413:9;Not classified:32
46116,"dimethoate (ISO);O,O-dimethyl methylcarbamoylmethyl phosphorodithioate",200-480-3,60-51-5,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H312:0;H302:0
46119,"Sodium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonamidato(2-)]cobaltate(1-)",252-134-6,34664-47-6,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,69,H319:59;H412:59;H411:8;Not classified:2
46120,"1-chloro-2,2-dimethylpropane",212-040-8,753-89-9,Flam. Liq. 2;Acute Tox. 4;Skin Sens. 1,Notified C&L,46,H225:43;H317:38;H302:38;Not classified:3;H319:1;H315:1
46122,"O,O',O''-(methylsilylidyne)trioxime 2-pentanone",484-460-1,,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,2,H319:2;H302:2;H412:1
46123,7-Chloroquinoline,612-108-0,612-61-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
46124,"N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride",417-950-0,65797-42-4,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
46129,"9(or 10)-sulphooctadecanoic acid, potassium salt",267-966-5,67968-63-2,Eye Dam. 1;Repr. 1B;Aquatic Chronic 3,Notified C&L,166,H360:83;H412:83;H318:166
46131,"Octadecanoic acid, reaction products with tetraethylenepentamine",276-033-1,71799-54-7,Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,85,H410:2;H400:2;H317:2;H318:2;Not classified:83
46133,3-Sulfo-N-succinimidyl 4-(N-Maleimidomethyl)cyclohexane-1-carboxylate Sodium Salt,618-887-3,92921-24-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
46135,benzo[j]fluoranthene,205-910-3,205-82-3,Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H350:0;H400:0
46137,2-pyrrolidin-1-ylethanol,220-976-3,2955-88-6,Flam. Liq. 3;Acute Tox. 4,REACH registration C&L,57,H302:3;H226:57;H319:1;H315:1;H335:1
46139,"Pine, Pinus laricio, ext.",290-799-4,90244-96-5,Not Classified,Notified C&L,184,Not classified:184
46146,3-[(2-methyl-3-furyl)thio]heptan-4-one,262-690-1,61295-41-8,Acute Tox. 4,Notified C&L,1523,H302:1523
46147,Sodium aurothiomalate,235-479-7,12244-57-4,,Notified C&L,5,H332:5;H317:5;H302:5
46156,2-phenoxyethyl isobutyrate,203-127-1,103-60-6,Not Classified,REACH registration C&L,1573,Not classified:1571;H411:2
46158,"N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide",617-367-3,82626-48-0,Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,9,H302:8;H411:8;H336:8;Not classified:1
46160,Potassium bis(trimethylsilyl)amide,609-880-6,40949-94-8,Skin Corr. 1A;Eye Dam. 1,Notified C&L,129,H314:129;H318:85;H332:4;H224:4;H225:1;H335:1;H410:1;H312:1
46162,p-tert-butylacetophenone,213-399-3,943-27-1,Not Classified,Notified C&L,155,Not classified:113;H226:40;H302:1;H225:1
46163,"2,3-Dichloro-5-(trichloromethyl)pyridine",614-912-7,69045-83-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
46165,"3,4-dibromothiophene",221-546-8,3141-26-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:46;H315:46;H335:41;H332:2;H312:2;H302:2
46167,Magnesium diniobate,235-310-7,12163-26-7,Not Classified,REACH registration C&L,4,Not classified:4
46168,Methyl phenothiazin-2-yl ketone,229-626-4,6631-94-3,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,42,H412:39;H302:39;H319:2;H315:2;H335:2;Not classified:1
46169,(propan-2-olato)tris(stearate-O)titanium,270-532-8,68443-53-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H335:1
46175,"6-chloro-1,3,5-triazine-2,4(1H,3H)-dione, sodium salt",251-327-2,32998-00-8,Not Classified,Notified C&L,1,Not classified:1
46176,"Hydrocarbons, C",270-687-1,68476-47-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0;H304:0
46178,"Fatty acids, C18-unsatd., dimers, reaction products with diethylenetriamine",614-451-1,68410-22-0,Not Classified,Notified C&L,106,Not classified:83;H319:23;H315:23
46182,2-(phosphonooxy)ethyl methacrylate,246-342-6,24599-21-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,203,H318:84;H315:157;H319:73;H314:40;H335:15;Not classified:6;H317:2;H226:1
46184,1-chlorodecane,213-691-0,1002-69-3,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,41,H410:41;H400:41;H315:2;H351:38
46187,CASSIFFIX,604-149-8,139539-71-2,Flam. Liq. 3,Notified C&L,10,H226:10
46188,(3-pyridylmethyl)urea,252-928-2,36226-32-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
46189,Manganese dichloride,231-869-6,7773-01-5,Acute Tox. 3;Eye Dam. 1;STOT RE 2,REACH registration C&L,180,H373:60;H318:54;H301:67;H302:110;H411:96;H334:4;Not classified:4;H412:3;H315:1;H360:1;H340:1;H335:1;H319:1
46191,3-perhydroazepin-1-ylpropiononitrile,213-330-7,937-51-9,Acute Tox. 3,Notified C&L,39,H301:39;H332:1;H315:1;H312:1;H335:1;H319:1
46192,(E)-hex-2-enyl formate,258-512-7,53398-78-0,Flam. Liq. 3,Notified C&L,89,H226:89
46193,Chromium (III) chloride hexahydrate,629-714-6,10060-12-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,113,H319:60;H315:60;H335:60;H302:48;Not classified:6;H317:5;H314:4;H334:4;H332:1;H312:1;H290:1;H411:1
46196,Ammonium hydrogen phosphonate,236-594-5,13446-12-3,Acute Tox. 4;Eye Irrit. 2;STOT SE 3,Notified C&L,17,H319:15;H302:14;H335:14;Not classified:2;H315:1
46200,4-methyl-3-decen-5-ol,279-815-0,81782-77-6,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1733,H400:1540;H411:18;Not classified:191;H319:22
46202,"(3E)-4-ethoxy-1,1,1-trifluorobut-3-en-2-one",858-371-7,59938-06-6,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Acute Tox. 4;Carc. 2;STOT RE 1;Aquatic Chronic 3,Notified C&L,1,H332:1;H315:1;H317:1;H372:1;H351:1;H302:1;H412:1;H319:1;H226:1
46203,Cycloaliphatic Epoxy Resin,607-386-5,244772-00-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,14,H319:14;H302:14;H315:14
46204,1-Ethyl-3-methylimidazolium methyl carbonate,607-553-2,251102-25-7,Not Classified,Notified C&L,122,Not classified:83;H319:39;H315:39;H335:39;H311:1;H370:1;H225:1;H331:1;H301:1
46205,S-[1-methyl-1-(4-methyl-2-oxocyclohexyl)ethyl] (1Rtrans)ethanethioate,260-546-2,57074-34-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,113,H319:113;H315:113
46210,Transaldolase,232-759-0,9014-46-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
46211,Semicarbazide,200-339-6,57-56-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,71,H335:38;H319:38;H315:38;H301:71
46225,"1,6-hexanediyl dioleate",244-283-0,21224-03-3,Not Classified,Notified C&L,1,Not classified:1
46226,"Tris(2,2,6,6-tetramethylheptane-3,5-dionato-O,O')europium",239-565-5,15522-71-1,,Notified C&L,4,H319:4;H315:4;H335:4
46232,"Thiodiethylene bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]",255-392-8,41484-35-9,Not Classified,REACH registration C&L,1017,Not classified:251;H412:488;H413:225;H411:53
46233,Methyl butyrate,210-792-1,623-42-7,Flam. Liq. 2,Notified C&L,1687,H225:1660;H315:33;H319:7;H335:6;Not classified:2
46242,TCA (ISO);trichloroacetic acid,200-927-2,76-03-9,Skin Corr. 1A;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H314:0
46245,Methyl 2-methyl-3-mercaptopropionate,223-949-4,4131-76-4,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H332:1;H315:1;H335:1;H227:1;H302:1;H319:1
46252,"Magnesiumsodium N,N'-1,2-cyclohexanediylbis[N-(carboxymethyl)]glycinate (1:2:1)",264-195-6,63451-33-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
46257,"Distearic acid, diester with glycerol",215-359-0,1323-83-7,Not Classified,Notified C&L,178,Not classified:178
46258,"1,1'-(tetradecylimino)dipropan-2-ol",260-495-6,56975-11-2,,Notified C&L,34,Not classified:33;H314:1;H411:1
46263,N-(2-phenoxyphenyl)methanesulphonamide,257-399-1,51765-51-6,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,7,H412:4;H302:6;Not classified:1
46265,Ethyl thiocyanate,208-833-3,542-90-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H332:41;H315:39;H312:41;H335:38;H302:41;H319:39;H226:42;H310:1;H330:1;H300:1
46269,"2-Butenedioic acid (E)-, di-C12-18-alkyl esters",272-943-8,68921-51-7,Not Classified,REACH registration C&L,145,Not classified:145
46273,Di-p-tolyl ether,216-423-0,1579-40-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,73,H410:39;H315:40;H335:39;H400:39;H319:39;Not classified:33
46275,C.I. Reactive Red 111,618-130-7,88232-20-6,Not Classified,Notified C&L,15,Not classified:15
46276,4-chloro-2-methylanisole,221-860-5,3260-85-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
46277,"Amines, N-(C14-18 and C16-18-unsatd. alkyl)trimethylenedi-",270-416-7,68439-73-6,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,35,H400:28;H314:34;H302:33;H317:5;H318:5;H319:1
46281,Isodecyl salicylate,286-542-0,85252-25-1,Not Classified,Notified C&L,1,Not classified:1
46282,"(3R,6R)-3,6-dimethyl-1,4-dioxane-2,5-dione",603-436-5,13076-17-0,Eye Irrit. 2,REACH registration C&L,4,H319:4
46283,Ethyl 2-acetylpent-4-enoate,210-237-3,610-89-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H335:38
46285,Cyclopropanecarboxamide,228-332-3,6228-73-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,41,H319:41;H302:39;H315:2;H335:2
46288,Sodium p-(2-bromoethyl)benzenesulphonate,265-318-6,65036-65-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
46290,"Acetamide,2-[2-[4-[(S)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-",618-689-7,909779-47-1,Acute Tox. 4,Notified C&L,1,H302:1
46292,"1,3-Cyclohexanediol, 6-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-,1R,3R,6R)-rel-, phosphate, hydrate",930-916-4,,Acute Tox. 4,Notified C&L,1,H302:1
46296,"4,4'-bis(chloromethyl)-1,1'-biphenyl",216-784-4,1667-10-3,Skin Sens. 1,REACH registration C&L,43,H317:1;H314:42;H318:1
46297,Diethyl (iodomethyl)phosphonate,233-895-3,10419-77-9,,Notified C&L,4,H319:4;H315:4
46300,"2,2,6,6-tetrachlorocyclohexan-1-one",223-231-0,3776-30-5,Acute Tox. 4,Notified C&L,38,H302:38
46302,"1,1,1,4,4,4-hexafluorobut-2-yne",211-732-7,692-50-2,Press. Gas (Comp.);Acute Tox. 3,Notified C&L,38,H280:38;H331:38
46303,Decahydro-2-naphthyl formate,234-055-9,10519-12-7,Not Classified,Notified C&L,115,Not classified:114;H315:1
46304,"reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol;2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol",429-590-1,,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H317:0
46307,4-aminobenzamidine dihydrochloride,219-692-2,2498-50-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:50;H315:50;H335:49;H302:4;H317:2
46308,"Formaldehyde, oligomeric reaction products with toluene",500-034-0,25155-81-1,Not Classified,Notified C&L,28,Not classified:28
46310,"Reaction mass of (2E,5Z)-5,6,7-trimethylocta-2,5-dien-4-one and (2E,5E)-5,6,7-trimethylocta-2,5-dien-4-one",451-330-0,,Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,1287,H319:1;H317:1287;H315:1287;H318:1286;H411:1286
46321,"(1,3-dioxolan-2-ylmethyl)triphenylphosphonium bromide",257-977-3,52509-14-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H332:40;H315:44;H312:40;H335:43;H302:41;H319:44;H412:1;H318:1;H373:1
46322,α-chloro-m-xylene,210-628-9,620-19-9,Skin Corr. 1B;STOT SE 3,Notified C&L,72,H314:46;H335:65;H319:26;H302:27;H315:26;H290:2;H318:2;H332:2;H312:2
46323,"Phosphoric acid, potassium salt",240-213-8,16068-46-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,24,H319:20;H315:20;Not classified:4
46327,"3,7-dimethylocta-2,6-dienyl acetate",240-458-0,16409-44-2,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,140,H317:19;H412:19;H315:19;H411:95;Not classified:26
46332,"Lawsonia inermis, ext.",284-854-1,84988-66-9,Eye Irrit. 2B,REACH registration C&L,7,H319:4;H226:3;H371:1;H317:1
46334,"2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride",235-399-2,12217-48-0,Eye Irrit. 2;STOT SE 3,Notified C&L,71,H319:52;H335:52;Not classified:19
46335,"Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides",263-090-2,61789-80-8,Eye Dam. 1;Aquatic Chronic 1,Notified C&L,918,H410:796;H318:811;H400:240;Not classified:75;H411:30;H226:18;H315:7;H361:1;H314:1
46341,"3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane",435-790-1,297730-93-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
46342,"2,9-bis(2-phenylethyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone",266-564-7,67075-37-0,Not Classified,REACH registration C&L,93,Not classified:92;H319:1;H315:1;H335:1
46344,"1,6-Octadiene, 7-methyl-3-methylene-, acid-hydrated, citronellol fractions",296-654-1,92908-26-4,Skin Irrit. 2;Skin Sens. 1,Notified C&L,233,H317:233;H315:233;H319:52
46346,"Adenosine 5'-(tetrahydrogen triphosphate), disodium salt",213-579-1,987-65-5,Self-heat. 2,REACH registration C&L,5,H252:1;Not classified:4
46347,Perfluoropalmitic acid,267-638-1,67905-19-5,,Notified C&L,6,H314:6
46350,"Sodium 3-[[4-amino-9,10-dihydro-3-[2-(2-methoxyethoxy)ethoxy]-9,10-dioxo-1-anthryl]amino]-2,4,6-trimethylbenzenesulphonate",274-366-7,70179-77-0,Acute Tox. 4,REACH registration C&L,2089,H302:14;Not classified:2075
46354,"1-(tert-butyl) hydrogen (S)-pyrrolidine-1,2-dicarboxylate",239-848-3,15761-39-4,Not Classified,Notified C&L,8,Not classified:6;H319:2;H315:2;H335:2
46357,2-(diphenylphosphino)benzonitrile,609-030-4,34825-99-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H332:1;H315:1;H312:1;H302:1;H319:1
46358,3-amino-p-cresol,220-622-8,2836-00-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,92,H319:92;H315:92;H335:91
46360,"2,4-dimethylphenylacetaldehyde",268-404-1,68083-55-6,Not Classified,Notified C&L,88,Not classified:88
46361,"reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol",412-020-0,,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0
46362,Fluorophenylacetic acid,216-420-4,1578-63-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,45,H311:45;H331:41;H301:45;H315:6;H335:6;H330:4;H319:6
46366,"2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole",600-587-9,104617-49-4,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,39,H319:39;H412:1;H317:1;H302:1;H315:38;H335:38
46375,Acetalization products between glucose and C12/18(even numbered)alcohol,923-908-7,,Not Classified,Notified C&L,1,Not classified:1
46376,"Cyclohex-1,4-ylenebis(methylamine)",219-840-6,2549-93-1,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B,Notified C&L,73,H311:65;H314:73;H302:65;H312:8;H318:9
46377,Dimethyl isobutylmalonate,254-490-8,39520-24-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
46378,"8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid",261-777-1,59468-44-9,Not Classified,REACH registration C&L,4,Not classified:4
46379,Triethylstibine,210-534-8,617-85-6,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,61,H332:61;H302:61;H411:61;H261:22;H314:23;H250:23;H260:1;H318:1
46385,4-Cyano-4'-hydroxybiphenyl,427-840-4,19812-93-2,,Notified C&L,2,H317:1;H335:1;H319:2;H302:2;H312:1;H331:1;H315:1
46387,"Juniper, Juniperus mexicana, ext., isomerized, acetylated",293-297-3,91053-33-7,Asp. Tox. 1;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H411:1;H304:1
46388,"4-(1-Phenylethyl)-benzene-1,3-diol",480-070-0,85-27-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2,H314:1;H302:1;H318:1;H411:1;H319:1;H315:1
46390,"Fatty acids, C16 and C18-22-unsatd., C16-18 and C18-unsatd. alkyl esters",292-792-1,90990-29-7,Not Classified,REACH registration C&L,4,Not classified:4
46392,Aminoguanidinium sulphate,213-945-0,1068-42-4,,Notified C&L,4,H319:4;H315:4;H335:4
46393,"Cyclohexane, oxidized, aq. ext., Me esters, C5-6 ester fraction, distn. residues, Me hydroxyhexanoate fraction, distn. residues",610-910-5,528857-23-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,83,H318:83;H315:83
46398,Bismuth triiodide,232-127-4,7787-64-6,Skin Corr. 1B,Notified C&L,62,H314:62;H318:1
46400,"2-Propenal, 3-[3-(trifluoromethyl)phenyl]-",617-975-9,871543-59-8,Not Classified,Notified C&L,1,Not classified:1
46401,"2,3-dihydroxypropyl (9Z,12Z)-octadeca-9,12-dienoate",218-901-4,2277-28-3,Not Classified,Notified C&L,2,Not classified:2
46405,"1,4-bis[2-(vinyloxy)ethoxy]benzene",406-900-3,84563-49-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
46406,"2,6-bis(p-tolyl)pyridine",238-409-3,14435-88-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
46410,"Glycerides, C8-21 and C8-21-unsatd. mono- and di-, citrates, sodium salts",307-335-4,97593-32-3,Not Classified,Notified C&L,1,Not classified:1
46413,m-anisohydrazide,227-310-0,5785-06-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:1
46414,"3,4-dihydro-5-methyl-2H-pyrrole",212-822-9,872-32-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H225:43;H319:39;H315:39;H335:39;H314:4
46415,Bis(cyclopent-2-enyl) ether,239-195-4,15131-55-2,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H335:38;H311:38;H302:38;H319:38
46418,"Bis(2,4,4-trimethylpentyl)phosphinic acid",280-445-7,83411-71-6,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,39,H319:39;H411:39;H315:1
46422,"Benzenesulfonic acid, mono-C10-16-alkyl derivs., ammonium salts",272-733-6,68910-31-6,,Notified C&L,61,H318:61;H302:61;H315:41;H314:20;H335:20;H412:20
46424,5-methyl-2-pyrrolidinone,203-566-9,108-27-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:39
46425,"Perboric acid (HBO(O2)), sodium salt, tetrahydrate",600-611-8,10486-00-7,Ox. Sol. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Repr. 1B,Notified C&L,371,H360:287;H331:83;H335:307;H272:204;H318:307;H332:103;H302:239;H319:59;H315:59;H361:59;Not classified:5
46428,Zinc succinate,228-331-8,6228-53-1,Not Classified,Notified C&L,1,Not classified:1
46431,2-methoxynaphthalen-1-amine,218-835-6,2246-42-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
46433,Octadecylammonium acetate,218-583-7,2190-04-7,Not Classified,Notified C&L,59,Not classified:58;H302:1
46437,Ammonium isodecyl sulphate,288-854-2,85909-50-8,Not Classified,Notified C&L,38,Not classified:37;H412:1;H318:1;H302:1;H315:1
46439,Prop-2-ynylamine hydrochloride,239-440-5,15430-52-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H319:45;H315:45;H301:44;H311:5;H330:4;H332:1;H312:1;H302:1;H331:1
46440,3-ethyltoluene,210-626-8,620-14-4,Flam. Liq. 3,Notified C&L,80,H226:79;H411:26;H336:8;H304:12;H319:1;H315:1;H335:1;Not classified:1
46442,dodine (ISO);dodecylguanidinium acetate,219-459-5,2439-10-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H400:0;H302:0;H319:0
46444,"Anthra[2,1,9-mna]naphth[2,3-h]acridine-5,10,15(16H)-trione",603-679-7,1328-45-6,Aquatic Chronic 3,Notified C&L,3,H412:2;Not classified:1
46447,"Amines, N-vegetable-oil alkyltrimethylenedi-",294-733-5,91745-61-8,Not Classified,Notified C&L,1,Not classified:1
46448,"Formaldehyde, oligomeric reaction products with aniline",500-036-1,25214-70-4,Skin Sens. 1;Muta. 2;Carc. 1B;STOT SE 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,149,H410:149;H317:149;H341:149;H400:145;H370:149;H350:149;H373:149;H301:2
46451,"Orthoboric acid, potassium salt",244-038-8,20786-60-1,Not Classified,Notified C&L,36,Not classified:29;H413:6;H360:1
46453,Stearohydrazide,223-946-8,4130-54-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
46456,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with α-hydro-ω-hydroxypoly[oxy(methyl-1,2-ethanediyl)] and polyethoxylated and polypropoxylated glycerol",500-159-0,64298-75-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,27,H334:27;H317:27;H319:2
46457,(2-carboxylatophenyl)phenyliodonium,216-070-2,1488-42-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
46458,Vanitiolide,241-690-5,17692-71-6,Eye Irrit. 2,Notified C&L,38,H319:38
46460,"α-chloro-3,5-dinitrotoluene",277-841-7,74367-78-5,Skin Corr. 1B;STOT SE 3,Notified C&L,38,H314:38;H335:38
46463,Cyclohexylphenylacetonitrile,223-442-8,3893-23-0,Acute Tox. 3;Eye Dam. 1,Notified C&L,42,H318:38;H301:38;H332:4;H312:4;H302:4
46472,2-hydroxypropiophenone,227-091-1,5650-40-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
46480,"bis(4-fluorophenyl)methyl(4H-1,2,4-triazol-4yl-methyl)silane",600-198-4,101377-47-3,Aquatic Chronic 2,Notified C&L,13,H411:13
46483,"Dehydrogenase, d-lactate",232-829-0,9028-36-8,Resp. Sens. 1,Notified C&L,52,H334:52
46485,"1,2,3,4-tetrahydro-2-naphthylamine",220-973-7,2954-50-9,,Notified C&L,4,H319:4;H315:4;H335:4;H302:1
46486,"2-Butene, chlorinated, epoxidized, distn. residues",304-783-2,94279-39-7,Flam. Liq. 3;Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Carc. 2,Notified C&L,84,H332:84;H315:84;H317:84;H319:83;H290:83;H302:84;H351:84;H312:84;H226:84;H320:1;H334:1
46487,"Citrus medica, ext.",285-359-3,85085-28-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1376,H410:1376;H315:1376;H317:1376;H400:1340;H226:1376;H304:1376
46489,Hexaammineruthenium trichloride,238-176-8,14282-91-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:44;H335:44;H302:4;H311:1;H301:1
46490,3-hydroxypyridine-2-carboxamide,213-274-3,933-90-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
46491,"2,6-dimethoxyphenol",202-041-1,91-10-1,Acute Tox. 4;Acute Tox. 5;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1701,H315:139;H317:2;H313:2;H335:137;H302:1700;H319:139;H332:26;Not classified:1
46495,Bisisobutyryl peroxide,222-340-0,3437-84-1,Org. Perox. B;Asp. Tox. 1;Skin Corr. 1B;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,5,H241:5;H317:1;H314:5;H319:1;H304:1
46498,"3-Decen-5-one, 4-methyl-, (3E)-",477-870-7,811412-48-3,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,37,H410:37;H400:1;H317:37;H315:36
46500,"Aluminum, 2-butanol iso-Pr alc. complexes",302-192-4,94094-90-3,Not Classified,Notified C&L,3,Not classified:3
46505,"(E)-7,11-dimethyl-3-methylenedodeca-1,6,10-triene",242-582-0,18794-84-8,Asp. Tox. 1;Skin Mild Irrit. 3,REACH registration C&L,1712,H316:16;H304:1674;H317:399;H315:437;H413:89;H332:10;H411:10
46508,Dichlorine oxide,232-243-5,7791-21-1,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,33,H314:33;H400:33;H290:33;H411:33;H318:33
46513,N-phenyl-N-[(trichloromethyl)thio]benzenesulphonamide,218-915-0,2280-49-1,Skin Sens. 1A,REACH registration C&L,9,H317:6;Not classified:3
46514,"1-Dodecanaminium N,N-didodecyl-n-methyl-, chloride (1:1)",615-335-3,7173-54-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:39;H335:38;H410:1;H400:1;H318:1;H301:1
46515,2-(2-ethoxyphenoxy)ethanamine methanesulfonate,610-786-2,521300-98-1,Not Classified,REACH registration C&L,2,Not classified:2
46516,Boc-D-phenylalanine,606-177-6,18942-49-9,,Notified C&L,5,Not classified:3;H319:2
46518,Isopropyl isocyanate,217-276-5,1795-48-8,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,169,H315:166;H317:43;H335:165;H330:161;H302:85;H334:50;H225:169;H319:166;H260:83;H301:36
46526,"6-ethyl-1,2,3,4-tetrahydroanthraquinone",239-600-4,15547-17-8,Not Classified,Notified C&L,2,Not classified:2
46528,"D-Glucopyranose, oligomers, 2-ethylhexyl glycosides",500-529-1,161074-93-7,Not Classified,Notified C&L,18,Not classified:9;H319:8;H318:1
46531,Triethyl arsenite,221-543-1,3141-12-6,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:42;H400:38;H331:42;H226:38;H301:42;H373:4
46532,"Ethanaminium, N,N,N-triethyl-, (2Z)-2-butenedioate (1:1)",601-117-5,111754-37-1,,Notified C&L,1,Not classified:1
46533,Trilithium orthophosphate,233-823-0,10377-52-3,Acute Tox. 4,REACH registration C&L,165,H302:165;H319:128;H315:46;H335:41;H314:1;H318:1
46534,4-dipropylaminobutyronitrile,274-539-7,70288-99-2,Acute Tox. 4,Notified C&L,38,H302:38
46536,"Benzeneacetic acid, α-hydroxy-, (αS)-(γS)-compd. with N-methyl-γ-(2-methylphenoxy)benzenepropanamine (1:1)",617-995-8,872996-05-9,Acute Tox. 3;Eye Dam. 1;Acute Tox. 2;Aquatic Chronic 2,REACH registration C&L,1,H330:1;H318:1;H411:1;H301:1
46537,"cyclanilide (ISO);1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid",419-150-7,113136-77-9,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
46539,"Fatty acids, C8-18 and C18-unsatd., compds. with diethanolamine",271-686-9,68604-35-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,9,H318:6;H315:7;H319:3;H373:1
46540,"fatty acids, C",283-972-0,84776-45-4,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H410:0;H360:0;H317:0;H372:0;H400:0;H341:0;H334:0;H350:0
46541,"poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)",403-430-0,138360-92-6,Eye Dam. 1,Harmonised C&L,0,H318:0
46542,Thietane,206-015-0,287-27-4,Flam. Liq. 2;Acute Tox. 4,Notified C&L,40,H225:40;H302:40
46546,"Propane-1,3-diylbis[triphenylphosphonium] dibromide",230-835-8,7333-67-7,,Notified C&L,4,H319:4;H315:4;H335:4
46549,"2,4-Diamino-6-chloropyrimidine-3-oxide",609-076-5,35139-67-4,Unst. Expl.;Flam. Sol. 1,REACH registration C&L,47,H200:4;H228:4;H319:38;H315:38;H335:38;Not classified:2;H302:3
46555,Didodecylamine,221-114-9,3007-31-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39,H319:39;H315:39
46562,"Soaps, stocks, tallow, acidulated",283-104-0,84540-13-6,Not Classified,Notified C&L,1,Not classified:1
46563,"Adenosine 5'-(trihydrogen diphosphate), monoanhydride with phosphorothioic acid, tetralithium salt",298-862-8,93839-89-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
46564,"Fatty acids, tall-oil, reaction products with tetraethylenepentamine",273-201-6,68953-36-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,1026,H319:588;H317:642;H315:589;H335:553;Not classified:281;H318:116;H411:117;H334:20;H410:15;H400:15;H314:8;H290:4;H302:1;H312:1
46572,2-methylbut-1-ene,209-250-7,563-46-2,Flam. Liq. 2;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Muta. 2;Carc. 2;Aquatic Chronic 2,Notified C&L,126,H304:104;H315:69;H341:47;H351:47;H302:78;H411:56;H225:47;H336:47;H224:79;H332:22;H335:22;H319:22
46579,"Disodium 2,2'-(azodi-p-phenylene)bis[6-methylbenzothiazolesulphonate]",275-151-0,71033-21-1,Not Classified,Notified C&L,2084,Not classified:2084
46580,N-(methoxymethyl)methacrylamide,222-872-3,3644-12-0,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,36,H319:36;H302:35;H315:1
46584,2-ethoxy-5-fluoro-1H-pyrimidin-4-one,260-029-1,56177-80-1,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,4,H412:1;H302:4
46585,"Formaldehyde, polymer with 1,3-benzenedimethanamine, 4-(1,1-dimethylethyl)phenol, nonylphenol and C,C,C-trimethyl-1,6-hexanediamine",600-544-4,104242-08-2,Not Classified,Notified C&L,93,Not classified:93
46592,AMINOINDOLE,618-221-1,88919-22-6,,Notified C&L,2,H302:1;H335:1;H319:1;H315:1;H301:1
46597,"(3aR-cis)3a,12c-dihydro-8-hydroxy-6-methoxy-7H-furo[3',2':4,5]furo[2,3-c]xanthen-7-one",233-158-6,10048-13-2,Acute Tox. 3;Carc. 2,Notified C&L,197,H351:197;H301:197
46600,"Tallow, reaction products with 2-[(2-aminoethyl)amino]ethanol",273-630-9,68990-91-0,Not Classified,Notified C&L,1,Not classified:1
46601,Magnesium 2-oxopyrrolidine-5-carboxylate,227-392-8,5819-47-6,Not Classified,REACH registration C&L,2,Not classified:2
46604,Propyl cyclohexaneacetate,259-891-1,55910-09-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B,Notified C&L,38,H315:38;H335:38;H311:38;H350:38;H319:38;H301:38
46605,"Cyclopentaneacetic acid, 3-oxo-2-pentyl-, propyl ester",605-149-0,158474-72-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1;H315:1;H335:1
46607,3-thenoic acid,201-802-5,88-13-1,,Notified C&L,9,H319:9;H315:9;H335:8
46609,"2,5-dibromobenzoic acid",210-234-7,610-71-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H315:49;H335:48
46616,Cinnamyl butyrate,203-128-7,103-61-7,Not Classified,REACH registration C&L,278,Not classified:240;H332:38;H315:38;H312:38;H335:38;H302:38;H319:38
46619,C.I. Direct Yellow 137,615-571-7,71838-47-6,Not Classified,Notified C&L,2,Not classified:2
46620,"3,5-bis(trifluoromethyl)benzophenone",244-282-5,21221-93-2,,Notified C&L,6,H319:6;H315:6;H335:5
46624,"1-Piperazinecarboximidamide, sulfate (2:1)",607-004-7,22365-47-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H332:1;H315:1;H312:1;H335:1;H302:1;H319:1
46626,"(±)-2,3-diaminopropionic acid hydrochloride",259-387-1,54897-59-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
46631,"cyanazine (ISO);2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile",244-544-9,21725-46-2,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H302:0
46635,"1,4-Naphthalenedione, 2-chloro-3-[[4-(1,1-dimethylethyl)cyclohexyl]methyl]-, trans-",617-921-4,86790-14-9,,Notified C&L,1,H319:1;H315:1;H335:1
46642,Magnesium 2-methylpropan-2-olate,250-931-3,32149-57-8,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,69,H332:26;H315:26;H335:26;H228:69;H319:26;H314:43
46644,(E)-hex-2-enyl propionate,258-513-2,53398-80-4,Not Classified,Notified C&L,137,Not classified:137
46647,"(1α,2β,5α)-2-methyl-5-(1-methylvinyl)cyclohexan-1-ol",253-755-5,38049-26-2,Not Classified,Notified C&L,114,Not classified:114
46649,4-Undecyloxybenzoic Acid,605-157-4,15872-44-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
46650,Apramycin sulphate,265-890-7,65710-07-8,Repr. 1B,Notified C&L,43,H360:40;H319:2;H315:3;Not classified:1;H410:1;H332:1;H312:1;H302:1
46651,Disodium dihydrogen (dichloromethylene)diphosphonate,245-078-9,22560-50-5,STOT RE 2;Aquatic Chronic 2,Notified C&L,27,H411:27;H373:26
46658,"Disodium hydrogen [N,N-bis[2-[bis(carboxymethyl)amino]ethyl]glycinato(5-)]magnesate(3-)",268-353-5,68081-73-2,Not Classified,Notified C&L,1,Not classified:1
46662,"2,5-dichloro-3,6-dihydroxybenzoquinone",201-780-7,87-88-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H319:53;H315:53;H335:52
46668,Methyl 2-chloro-4-nitrobenzoate,236-362-3,13324-11-3,Acute Tox. 4,Notified C&L,44,H302:38;H319:6;H315:6;H335:5
46669,"Tar, coal;Coal tar;[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.]",232-361-7,8007-45-2,Carc. 1A,Harmonised C&L,0,H350:0
46670,"1-Propanaminium, N-(3-aminopropyl)-2-hydroxy-N,N-dimethyl-3-sulfo-, N-C12-14 acyl derivs., hydroxides, inner salts",293-878-1,91648-19-0,Eye Dam. 1;Aquatic Acute 2;Aquatic Chronic 3,REACH registration C&L,2,H401:2;H412:2;H318:2
46676,"Dodecylbenzenesulphonic acid, compound with 2-(dimethylamino)ethanol (1:1)",303-042-0,94139-26-1,,Notified C&L,2,Not classified:2
46679,"2-[4-(2,3-epoxypropoxy)phenyl]acetamide",249-452-2,29122-69-8,,Notified C&L,1,H302:1
46680,"4-(5-propyl-1,3-dioxan-2-yl)benzonitrile",279-441-8,80285-16-1,,Notified C&L,4,H302:4
46681,"1,3,5-Triazine-2,4,6-triamine, deammoniated",272-034-6,68649-66-1,Not Classified,REACH registration C&L,3,Not classified:3
46683,"Bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate",258-207-9,52829-07-9,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1387,H410:83;H400:132;H318:365;H411:1198;H319:890;H315:153;Not classified:107;H331:35;H335:26;H330:4
46685,α-[(ethylamino)methyl]-m-hydroxybenzyl alcohol hydrochloride,213-398-8,943-17-9,Acute Tox. 3;Eye Irrit. 2,Notified C&L,42,H319:39;H301:41;H302:1;H361:1;H412:1
46687,2-hydroxyethyldimethyl-3-stearamidopropylammonium phosphate,223-165-2,3758-54-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,14,H410:14;H319:14;H315:14
46688,Cobalt distearate,213-694-7,1002-88-6,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,2,H317:2;H411:1;H315:1;H351:1;H334:1;H319:1
46689,2-ethyl-3-methylpyrazine,239-799-8,15707-23-0,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,1684,H314:16;H302:1684;H318:16;H226:1626;H224:52;H315:46;H335:45;H319:46;H332:1;H312:1
46692,"10-[4-(2-chloroethyl)piperazin-1-yl]-2-thia-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,9,12,14-heptaene",609-095-9,352232-17-8,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,2,H319:2;H317:2
46693,"Sulfonic acids, petroleum, calcium salts",263-093-9,61789-86-4,Skin Sens. 1B,REACH registration C&L,1320,H317:637;Not classified:532;H319:119;H411:30;H413:44;H315:32;H335:15;H334:15;H336:15
46696,"(2R)-2-amino-3,3-dimethylbutanoic acid",607-998-2,26782-71-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
46697,"1-Naphthalenecarboxylic acid, 1,2,3,4-tetrahydro-, (1S)-",617-787-7,85977-52-2,,Notified C&L,4,H319:4;H315:4;H335:4
46699,Tetraammonium [μ12-[orthosilicato(4-)-O:O:O:O':O':O':O'':O'':O'':O''':O''':O''']]tetracosa-μ-oxododecaoxododecawolframate(4-),278-805-3,77981-80-7,Not Classified,Notified C&L,1,Not classified:1
46701,"Fatty acids, sunflower-oil, conjugated",273-195-5,68953-27-5,Not Classified,REACH registration C&L,5,Not classified:5
46709,Sodium pentafluoropropionate,206-830-1,378-77-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
46710,Dinonylphenol,215-356-4,1323-65-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,74,H318:60;H315:47;H411:45;Not classified:14;H410:13;H314:13;H361:13;H400:13;H302:13
46711,"9,11-Octadecadienoic acid, calcium salt (2:1)",607-164-8,228243-35-4,Not Classified,Notified C&L,1,Not classified:1
46712,DRIMAREN BRILLANTGRUN X-VT 4260,402-830-2,,Not Classified,Notified C&L,37,Not classified:37
46714,"Methyl 4-hydroxy-2H-thieno[2,3- e][1,2]thiazine-3-carboxylate 1,1- dioxide",619-376-8,98827-44-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H332:1;H315:1;H335:1;H302:1;H319:1
46716,Disodium tartrate,212-773-3,868-18-8,Not Classified,REACH registration C&L,184,Not classified:82;H302:102
46718,(1-methylpropylidene)bis[tert-butyl] peroxide,237-136-7,13653-62-8,Flam. Liq. 3;Org. Perox. D;Asp. Tox. 1;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H410:2;H315:3;H242:3;H400:2;H226:2;H304:2;H319:1;H302:1
46720,"allethrin;(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;bioallethrin;(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate",209-542-4,584-79-2,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H332:0;H400:0;H302:0
46721,"(2,4-difluorophenyl)boronic acid",604-390-9,144025-03-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
46729,"Iron manganese oxide ((Fe,Mn)2O3)",616-275-0,75864-23-2,,Notified C&L,24,H373:22;H319:2;H315:2;H335:2
46733,"Quaternary ammonium compounds, C16-18-alkyltrimethyl, Me sulfates",296-099-5,92257-12-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:2;H302:2;H315:2
46735,"Sodium 5-(2,4-diamino-5-(2-hydroxy-5-nitrophenylazo)phenylazo)naphthalene-1-sulphonate",222-640-1,3564-15-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;Not classified:1
46737,3-chloro-o-cresol,221-861-0,3260-87-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,40,H319:40;H302:38;H411:38;H315:2;H335:2
46743,Tributyl[(2-ethylhexanoyl)oxy]stannane,225-726-7,5035-67-6,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H315:38;H312:38;H372:38;H400:38;H319:38;H301:38
46746,2-Amino-3-cyanothiophene,610-308-2,4651-82-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,41,H318:38;H302:40;H315:41;H335:40;H319:3;H332:2;H312:1
46749,Stanozolol,233-894-8,10418-03-8,Repr. 2,Notified C&L,41,H361:40;H332:1;H312:1;H302:1;H373:1
46758,Cyclohexylguanidine monohydrochloride,219-691-7,2498-47-7,Acute Tox. 4,Notified C&L,38,H302:38
46760,Silver azide,237-606-1,13863-88-2,Unst. Expl.,Notified C&L,3,H200:3;H410:1;H310:1;H330:1;H400:1;H300:1
46762,"Benzene, mono-C10-14-alkyl derivs., fractionation bottoms",285-591-5,85117-41-5,Not Classified,Notified C&L,202,Not classified:202
46763,3-ethylphenol,210-627-3,620-17-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,197,H332:113;H315:70;H312:118;H335:70;H302:118;H319:70;H311:78;H314:124;H301:78;H318:37
46767,Diethylstilbestrol dipropionate,204-995-4,130-80-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 1B;Repr. 1B,Notified C&L,38,H332:38;H360:38;H302:38;H350:38;H312:38
46768,"Cymbopogon citratus, ext.",289-752-0,89998-14-1,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1510,H318:1436;H317:1510;H315:1510;H411:1507;H319:72;H304:4;H412:3;H341:1;H312:1
46777,Phenethyl pivalate,266-841-2,67662-96-8,Not Classified,REACH registration C&L,1555,Not classified:1555
46778,Diethylgallium chloride,250-387-7,30914-08-0,Pyr. Liq. 1,Notified C&L,38,H250:38
46779,4-ethylmorpholinium 4-methylbenzene-1-sulphonate,272-115-6,68738-85-2,,Notified C&L,1,Not classified:1
46780,PM 14978,416-290-0,,Not Classified,Notified C&L,1,Not classified:1
46781,Tridodecylphosphine,229-110-9,6411-24-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H318:38
46786,bis(chloromethyl) ether;oxybis(chloromethane),208-832-8,542-88-1,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Acute Tox. 2;Carc. 1A,Harmonised C&L,0,H311:0;H330:0;H302:0;H350:0;H225:0
46787,"8-ethylidene-tetracyclo[4.4.0.1(2,5).1(7,10)]dodeca-3-ene",823-945-8,38233-76-0,Acute Tox. 4,Notified C&L,1,H302:1
46789,1-amino-4-[[4-[(dimethylamino)methyl]phenyl]amino]anthraquinone,235-398-7,12217-43-5,Eye Irrit. 2,Notified C&L,38,H319:38
46792,1-(methylamino)-4-[(3-methylphenyl)amino]anthraquinone,229-059-2,6408-50-0,Skin Sens. 1A;Aquatic Chronic 4,REACH registration C&L,23,H317:6;H413:6;Not classified:15;H319:2;H315:2;H335:2
46793,Didodecyl hydrogen phosphate,230-341-2,7057-92-3,Eye Irrit. 2,Notified C&L,81,H319:39;H314:42
46794,"Gases (petroleum), platformer products separator off;Refinery gas;[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]",272-343-6,68814-90-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;Not classified:0;H350:0
46795,"[(5-(4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-3-methyl-2,4-pentadienyl](triphenyl)phosphonium bromide",617-589-0,84592-32-5,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,84,H317:84;H412:84;H302:84;H402:1;H318:84
46796,Decamethyltetrasiloxane,205-491-7,141-62-8,Flam. Liq. 3,REACH registration C&L,206,H226:58;Not classified:123;H413:38
46798,"Ethanediol, reaction products with [1,2-ethanediylbis(oxy)]bis[methanol] and formaldehyde",288-739-7,85895-66-5,,Notified C&L,1,H302:1
46801,"Disodium 3,3'-carbonylbis[4-hydroxy-6-methoxybenzenesulphonate]",278-520-4,76656-36-5,Not Classified,Notified C&L,89,Not classified:89
46803,2-Fluoro-5-methoxybenzaldehyde,600-676-2,105728-90-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:45;H302:1
46804,Yttrium(3+) acetate,245-612-0,23363-14-6,Not Classified,REACH registration C&L,6,Not classified:5;H319:1;H315:1;H335:1
46809,4-(diethylamino)but-2-yn-1-yl acetate,607-061-8,22396-77-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,45,H319:45;H315:45;H335:45
46811,"3-nitro[1,1'-biphenyl]-4-ol",212-946-3,885-82-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,44,H318:39;H302:39;H315:44;H335:43;H319:5
46817,"Trisodium 5-[(3-carboxylato-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidene)(2,6-dichloro-3-sulphonatophenyl)methyl]-2-hydroxy-3-methylbenzoate",216-787-0,1667-99-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:41;H315:41;H335:40;Not classified:1
46818,bupirimate (ISO);5-butyl-2-ethylamino-6-methylpyrimidin-4-yl dimethylsulphamate,255-391-2,41483-43-6,Skin Sens. 1B;Carc. 2;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H351:0
46820,2-[p-(dimethylamino)styryl]-1-methylpyridinium iodide,218-460-8,2156-29-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
46822,[No public or meaningful name is available],682-366-7,70433-85-1,Acute Tox. 3;Eye Dam. 1,Notified C&L,1,H318:1;H301:1
46823,"2,4,6-Trimethylphenylacetyl chloride",462-070-2,,Skin Corr. 1A;Resp. Sens. 1;Aquatic Chronic 3,REACH registration C&L,2,H317:2;H412:2;H314:2;H334:2
46825,Zirconium propionate,281-897-8,84057-80-7,Not Classified,REACH registration C&L,59,Not classified:44;H315:8;H319:7
46826,"Borate(1-), tris(acetato-.kappa.O)hydro-, sodium, (T-4)-",611-401-0,56553-60-7,Water-react. 1;Skin Irrit. 2;Eye Dam. 1;Repr. 1B,Notified C&L,198,H318:117;H360:95;H315:160;H260:126;H228:89;H261:72;H335:60;H314:26;H302:6;Not classified:1
46828,Ethyl 8-hydroxyoctanoate,299-486-7,93892-06-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
46832,"3,3',5,5'-tetra-tert-butyl-4,4'-dibenzoquinone",219-527-4,2455-14-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
46835,"(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyly-2,2-dimethyl butanoate",616-751-8,79902-63-9,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,188,H315:106;H411:170;H317:48;H361:54;H351:50;H302:50;H373:48;H372:35;H362:22;H360:20;H410:8;H400:3;Not classified:2;H319:3;H335:2;H412:1
46836,"(+)-13-ethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione",418-490-3,,Carc. 2;Repr. 1B;Lact.,Notified C&L,6,H362:6;H360:6;H351:6
46837,"(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one",444-830-5,124379-29-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
46842,"Propane-1,3-diyl dioctanoate",700-003-3,56519-71-2,Not Classified,Notified C&L,1,Not classified:1
46847,γ-thiobutyrolactone,213-700-8,1003-10-7,Acute Tox. 4,Notified C&L,40,H302:40;H332:1;H315:1;H312:1;H335:1;H319:1
46849,"Cyclohexanol, 2-amino-, (1R,2R)-rel-",620-194-6,6982-39-4,Skin Corr. 1B,Notified C&L,85,H314:84;H319:1;H302:1;H315:1;H335:1
46851,Tall-oil pitch,232-414-4,8016-81-7,Not Classified,REACH registration C&L,80,Not classified:79;H317:1
46857,Meglutol,207-971-1,503-49-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
46861,"Dipotassium [2,2'-biquinoline]-4,4'-dicarboxylate",264-196-1,63451-34-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
46864,"(2-hydroxy-1,1-dimethylethyl)ammonium toluene-4-sulphonate",269-537-8,68298-05-5,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,181,H302:4;H318:4;Not classified:177;H315:1;H335:1;H226:1;H336:1
46867,p-cumenesulphonic acid,240-210-1,16066-35-6,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,29,H290:4;H318:4;H314:29
46870,"Phosphoric acid, isononyl ester",284-851-5,84988-61-4,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,20,H314:20;H318:19
46872,Sodium dichloroacetate,218-461-3,2156-56-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,86,H351:39;H319:51;H315:51;H335:50;Not classified:34;H341:4;H361:1
46873,Tetradecyl myristate,221-787-9,3234-85-3,Not Classified,REACH registration C&L,129,Not classified:129
46874,Imidazole-2-thiol,212-823-4,872-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:45
46876,"Fatty acids, C14-18 and C16-18-unsatd., ammonium salts",271-685-3,68604-33-1,,Notified C&L,40,H319:39;H412:1
46883,"2,2',2''-[methylidynetris(oxy)]trispropane",224-688-9,4447-60-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H226:47;H335:44
46884,"6,15-dihydroanthrazine-5,9,14,18-tetrone",201-375-5,81-77-6,Not Classified,REACH registration C&L,279,Not classified:209;H413:36;H412:33;H302:1
46885,Ammonium tetraformate,274-367-2,70179-79-2,Skin Corr. 1B,Notified C&L,1,H314:1
46886,N-[2-[(2-hydroxyethyl)amino]ethyl]dodecanamide,203-360-9,106-09-2,Not Classified,REACH registration C&L,85,Not classified:84;H360:1
46887,Lead tetraacetate,208-908-0,546-67-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,71,H410:70;H332:67;H360:70;H400:70;H302:67;H373:69;H315:1;H272:1;H341:1;H361:1;H350:1
46888,"Benzenesulfonic acid, mono-C10-16-alkyl derivs., compds. with ethanolamine",272-734-1,68910-32-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,131,H318:103;H302:90;H315:111;H319:28;H314:20;H335:20;H412:20
46889,"(6S)-6-(propylamino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrobromide (1:1)",605-420-3,165950-84-5,Acute Tox. 4,REACH registration C&L,4,H302:3;Not classified:1;H319:1;H315:1
46890,"9-fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 21-acetate",213-578-6,987-24-6,Carc. 2,Notified C&L,90,H351:40;H330:36;H360:48;H372:37;H410:37;H317:10;H331:10;H373:12;H361:2;H362:1;H332:1
46891,3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane,433-050-0,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
46894,"Ethanol, 2,2'-[[3-[(2-hydroxyethyl)amino]propyl]imino]bis-, N-(hydrogenated tallow alkyl) derivs.",291-273-7,90367-25-2,Acute Tox. 4;Skin Corr. 1C;Aquatic Acute 1,Notified C&L,1,H400:1;H314:1;H302:1
46898,N2-[(tert-butoxy)carbonyl]-L-glutamine,237-296-8,13726-85-7,Not Classified,Notified C&L,4,Not classified:3;H319:1;H315:1;H335:1
46900,octhilinone (ISO);octhilinone (ISO); 2-octyl-2H-isothiazol-3-one; [OIT],247-761-7,26530-20-1,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1;Eye Dam. 1;Skin Sens. 1A;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H314:0;H317:0;H311:0;H330:0;H400:0;H318:0;H301:0
46904,Ethyl 3-[[bis(1-methylethoxy)phosphinothioyl]thio]propionate,275-965-6,71735-74-5,Aquatic Chronic 2,REACH registration C&L,151,H411:136;H412:15
46905,"2,4-Dichloro-5-nitrobenzotrifluoride",609-778-1,400-70-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43;H302:5;H341:1;H332:1;H312:1
46909,Potassium zinc phosphate,237-527-2,13826-55-6,Not Classified,Notified C&L,1,Not classified:1
46910,"5,6,7,8-Tetrahydro-3-(trifluoromethyl)[1,2,4]triazolo[4,3-a]pyrazine",610-429-0,486460-21-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
46911,1-mercaptopropan-2-ol,213-946-6,1068-47-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39;H302:1
46914,"Formaldehyde, oligomeric reaction products with 3-aminomethyl-3,5,5-trimethylcyclohexylamine and phenol",500-037-7,25265-17-2,Not Classified,Notified C&L,24,Not classified:24
46915,"3-(1H-tetrazol-5-yl)-9H-thioxanthen-9-one 10,10-dioxide",257-397-0,51762-95-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
46916,Hydroxyprogesterone caproate,211-138-8,630-56-8,Repr. 1B,Notified C&L,43,H360:40;H332:1;H315:1;H312:1;H335:1;H302:1;H319:1;H361:2;H351:4;H413:2;H362:1
46919,"Phenol, 4,4'-(1-methylethylidene)bis-, oligomer with (chloromethyl)oxirane and ethylenediamine, reaction products with carbon disulphide, potassium salts",600-775-0,1067676-04-3,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H302:1;H411:1;H318:1;H226:1
46921,"Tallow, reaction products with 2-[(2-aminoethyl)amino]ethanol, compds. with di-Et sulfate",273-631-4,68990-92-1,,Notified C&L,35,Not classified:35
46930,"Fatty acids, soya, stearyl esters",307-173-4,97553-18-9,Not Classified,Notified C&L,1,Not classified:1
46935,"Glycerides, C8-21 and C8-21-unsatd. mono- and di-, citrates",307-334-9,97593-31-2,Not Classified,Notified C&L,131,Not classified:131
46938,Sodium 6-amino-4-hydroxynaphthalene-2-sulphonate,240-829-7,16781-08-1,Not Classified,Notified C&L,1,Not classified:1
46939,sulphur dichloride,234-129-0,10545-99-0,Skin Corr. 1B;STOT SE 3;Aquatic Acute 1,Harmonised C&L,0,H400:0;H314:0;H335:0
46943,"Benzenamine, N-phenyl-, reaction products with styrene and 2,4,4-trimethylpentene",272-940-1,68921-45-9,Not Classified,Notified C&L,108,Not classified:78;H412:17;H411:13
46945,[2H9]-tert-butyl chloride,213-041-6,918-20-7,Flam. Liq. 2,Notified C&L,38,H225:38
46951,"2,2-bis[(allyloxy)methyl]butyl hydrogen maleate",258-673-3,53632-09-0,,Notified C&L,2,H319:1;H315:1;Not classified:1
46952,3-chloro-2-methylanisole,221-862-6,3260-88-6,Flam. Liq. 3,Notified C&L,62,H226:62;H332:1;H312:1;H302:1
46954,Triethylsilane,210-535-3,617-86-7,Flam. Liq. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,130,H410:24;H225:129;H400:24;H412:63;H315:38;H335:37;H319:38;H226:4;H332:1;H312:1;H302:1;H413:1;Not classified:1
46959,α-bromo-m-xylene,210-625-2,620-13-3,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,46,H332:40;H314:46;H302:40;H330:5;H312:1;H290:1;H318:1;H311:1;H331:1;H301:1
46962,"Dipropyl pyridine-2,5-dicarboxylate",205-245-9,136-45-8,Aquatic Acute 1,Notified C&L,46,H400:38;Not classified:8
46966,Octylbenzene,218-582-1,2189-60-8,Not Classified,Notified C&L,4,Not classified:4
46968,Benzyltriethoxysilane,219-841-1,2549-99-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
46969,Triphenylpropylphosphonium bromide,228-330-2,6228-47-3,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,48,H312:41;H302:41;H319:6;H315:6;H335:6;H411:1;H301:1;H332:1;Not classified:1
46970,(4-ethylphenyl)acetaldehyde,268-403-6,68083-54-5,Not Classified,Notified C&L,88,Not classified:88
46974,"(2S)-(-)-3,3,3-Trifluoro-1,2-propenoxide",603-381-7,130025-34-2,Flam. Liq. 1,Notified C&L,42,H224:41;H332:3;H315:1;H340:1;H312:3;H335:1;H302:3;H350:1;H319:1;H225:1
46976,"3,5-dichlorobenzylic alcohol",262-109-1,60211-57-6,,Notified C&L,6,H319:6;H315:6;H335:6
46977,"(6RS,7RS)3,5,5,6,7,8,8-heptamethyl-5,6,7,8-tetrahydronaphthalene-2-carbaldehyde",482-190-9,,Skin Sens. 1B,Notified C&L,25,H317:25
46980,"Sodium 2,5-dichloro-4-[4-[[2-[(ethylphenylamino)sulphonyl]phenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",235-397-1,12217-38-8,Eye Irrit. 2,REACH registration C&L,21,H319:6;H412:10;Not classified:4;H334:1
46982,"4,4'-bis[[4-[bis(2-hydroxyethyl)amino]-6-methoxy-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonic acid, sodium salt, compound with 2,2'-iminodiethanol",286-152-0,85187-64-0,Not Classified,Notified C&L,1,Not classified:1
46984,"isodrin;(1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene",207-366-2,465-73-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H310:0;H330:0;H400:0;H300:0
46986,"1,1'-(ethane-1,2-diyl)bis[pentabromobenzene]",284-366-9,84852-53-9,Not Classified,REACH registration C&L,616,Not classified:615;H413:1
46989,Disilver tetraborate,235-548-1,12271-95-3,Aquatic Acute 1,Notified C&L,1,H410:1;H400:1
46990,2-Bromo-4-methylaniline hydrochloride,603-537-4,13194-71-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H315:38;H335:38
46991,"Diaminotoluene, propoxylated",500-158-5,63641-63-4,Eye Irrit. 2,Notified C&L,65,H319:65
46994,"4,9-diazadodecamethylenediamine bis(phosphate)",223-441-2,3891-79-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
46996,"Bis(2,4-dimethoxybenzyl)amine",244-037-2,20781-23-1,,Notified C&L,1,H319:1;H315:1;H335:1
47003,"3,6,9,12-tetraoxatetradecan-1-ol",227-090-6,5650-20-4,Eye Irrit. 2,Notified C&L,49,H319:49
47007,"Glycerides, rape-oil mono-, di- and tri-",294-657-2,91744-90-0,Not Classified,Notified C&L,1,Not classified:1
47009,2-(2-chloroethyl)-1-methylpiperidine,256-796-7,50846-01-0,Acute Tox. 3;Aquatic Chronic 4,REACH registration C&L,2,H413:2;H301:2
47011,[No public or meaningful name is available],619-670-6,95032-84-1,Eye Irrit. 2,Notified C&L,1,H319:1
47012,"1,2-dibromo-1-chloro-1,2,2-trifluoroethane",206-562-5,354-51-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
47018,Actinoquinol,239-334-9,15301-40-3,,Notified C&L,5,H319:5;H315:5;H335:5
47020,"Hydrocarbons, C4-6, C5-rich",270-684-5,68476-43-7,Flam. Liq. 1;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3;Muta. 2;Carc. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,91,H332:3;H315:36;H224:76;H335:36;H341:9;H351:3;H302:30;H361:24;H400:12;H411:91;H319:36;H336:91;H304:36;H340:82;H350:88;H312:27;H225:15;H301:6;H311:6;H372:6;H331:6;H373:58
47021,Isopropyllithium,217-561-4,1888-75-1,Skin Corr. 1B,Notified C&L,63,H314:63;H250:25;H260:25
47022,polyhexamethylene biguanide hydrochloride;PHMB,608-723-9,32289-58-0,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1B;Acute Tox. 2;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H330:0;H372:0;H400:0;H351:0;H302:0;H318:0
47024,2-Amino-6-nitrobenzoic acid,610-543-0,50573-74-5,Eye Dam. 1,Notified C&L,159,H318:156;H319:3;H315:3;H335:1
47026,Tetraamminecopper sulphate,238-177-3,14283-05-7,Acute Tox. 2;Aquatic Chronic 1,Notified C&L,1,H412:1;H302:1
47027,Isohexadecene,288-853-7,85909-49-5,Aquatic Chronic 4,Notified C&L,84,H413:84
47033,Isoquinolin-6-ol,231-612-8,7651-82-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
47035,"Paraffin waxes and Hydrocarbon waxes, oxidized, lithium salts",272-032-5,68649-48-9,Not Classified,REACH registration C&L,3,Not classified:3
47038,Isopropoxybenzene,220-370-9,2741-16-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2;H227:1
47041,"Fatty acids, tallow, hydrogenated, barium salts",273-202-1,68953-38-8,Not Classified,Notified C&L,1,Not classified:1
47042,Seleninyl dichloride,232-244-0,7791-23-3,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:42;H314:38;H301:42;H400:42;H331:42;H373:42
47044,D-glucose,218-914-5,2280-44-6,Not Classified,Notified C&L,1,Not classified:1
47045,N-(methoxymethyl)acrylamide,222-871-8,3644-11-9,Acute Tox. 3;Eye Irrit. 2,REACH registration C&L,2,H319:2;H301:2
47054,Flurprimidol,611-386-0,56425-91-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,74,H319:38;H302:74;H315:38;H332:2;H312:1;H413:1
47057,Tris(nitrato-O)nitrosylruthenium,252-068-8,34513-98-9,Ox. Sol. 1;Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,10,H271:3;H314:6;H290:6;H411:3;H318:4;H335:4;H319:4;H315:4;H272:5
47058,4-aminotoluene-2-sulphonic acid,204-282-8,118-88-7,Skin Irrit. 2,REACH registration C&L,8,H315:1;H314:6;Not classified:1
47061,"Decahydro-2,8,8-trimethylnaphthalene-2,4a-carbolactone",244-310-6,21280-29-5,Acute Tox. 4,Notified C&L,1564,H302:1564
47063,Methyl DL-leucinate hydrochloride,228-681-1,6322-53-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
47064,"Heracleum sphondylium, ext.",289-930-8,90045-67-3,Flam. Liq. 3,Notified C&L,1,H226:1
47067,"carbofuran (ISO);2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate",216-353-0,1563-66-2,Acute Tox. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H330:0;H410:0;H400:0;H300:0
47068,"Gases (petroleum), crude distn. and catalytic cracking;Refinery gas;[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",273-563-5,68989-88-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;Not classified:0;H350:0
47070,"2,3,5-tribromothiophene",221-544-7,3141-24-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H332:44;H315:46;H312:45;H335:42;H302:45;H319:46
47072,"Disodium [disulphamoyl-29H,31H-phthalocyaninedisulphonato(4-)-N29,N30,N31,N32]cuprate(2-)",267-963-9,67968-25-6,Not Classified,Notified C&L,1,Not classified:1
47073,Cyclobutane,206-014-5,287-23-0,Flam. Gas 1;Press. Gas (Liq.),Notified C&L,71,H220:71;H280:71
47076,"Hexasodium 2,2'-[vinylenebis[(3-sulfonato-4,1-phenylene)imino[6-[bis (2-hydroxypropyl)amino]-1,3,5-triazine-4,2-diyl]imino]]bis(benzene-1,4-disulfonate)",609-336-8,371756-75-1,Not Classified,REACH registration C&L,2,Not classified:2
47083,"Distillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling;[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135°C to 210°C (275°F to 410°F). May also include unsaturated hydrocarbons such as indene and coumarone.]",309-971-8,101794-90-5,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
47086,1-chloro-3-(dibromomethyl)benzene,274-538-1,70288-97-0,Skin Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H335:38
47088,Magnesium phosphinate,233-824-6,10377-57-8,Not Classified,Notified C&L,2,Not classified:1;H302:1
47089,o-toluoyl chloride,213-273-8,933-88-0,Skin Corr. 1B;STOT SE 3,Notified C&L,45,H314:45;H335:38;H290:1;H318:1
47091,o-(3-pentenyl)toluene,227-943-2,6047-69-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
47096,"5,6-dichlorobenzothiazol-2-amine",246-006-9,24072-75-1,Acute Tox. 4,Notified C&L,9,H302:9
47100,2-ethylhexyl 2-(4-chloro-2-methylphenoxy)propionate,275-596-0,71526-69-7,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H410:3;H400:3;H317:3;H302:3
47101,Cyclohexyltriphenylphosphonium bromide,230-834-2,7333-51-9,,Notified C&L,4,H319:4;H315:4;H335:4
47102,Lubricating greases;Grease;[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C,278-011-7,74869-21-9,Carc. 1B,Harmonised C&L,0,H350:0
47105,4-chloro-o-toluidine hydrochloride,221-627-8,3165-93-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H311:0;H341:0;H400:0;H350:0;H331:0;H301:0
47110,2-ethylanthraquinone,201-535-4,84-51-5,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,128,H410:104;H400:113;H373:113;H350:34;Not classified:14;H413:1
47111,"[R-(R*,S*)]-α-(1-aminoethyl)benzyl alcohol hydrochloride",221-702-5,3198-15-0,Acute Tox. 4,Notified C&L,1,H302:1
47113,"Benzenesulfonic acid, 4-amino-, diazotized, coupled with Dyer’s mulberry (Chlorophora tinctoria) extract",276-203-5,71949-32-1,Not Classified,Notified C&L,71,Not classified:69;H319:2
47116,"(4aR,4bS,6aS,7S,7aS,8aS,8bR,8cR)-7-[2-(1,3-dioxolan-2-yl)ethyl]-2-methoxy-4a,6a-dimethyl-3,4,4a,4b,5,6,6a,7,7a,8,8a,8b,8c,9-tetradecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-7-ol",618-226-9,889652-22-6,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2,H315:2;H317:2;H401:2;H411:2;H373:2
47118,DL-lysine mono(o-acetoxybenzoate),263-769-3,62952-06-1,Acute Tox. 4,Notified C&L,2,H302:1;Not classified:1
47124,3-Bromo-4-methoxybenzonitrile,601-486-2,117572-79-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H332:42;H315:43;H312:42;H335:42;H302:42;H319:43;H301:1
47132,"3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)propyl(dimethyl)ammonium chloride",228-264-4,6202-23-9,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,55,H332:43;H312:43;H301:49;H317:7;H302:5;H315:2;H335:2;H311:2;H330:2;H361:2;H334:2;H319:2;Not classified:1;H370:1
47134,HPLL,472-170-8,,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 4,REACH registration C&L,4,H318:4;H413:4;H315:4;H301:4
47137,Pinaverium bromide,258-450-0,53251-94-8,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,47,H410:44;H302:46;H400:1;H411:1;Not classified:1;H332:1;H315:1;H312:1;H335:1;H319:1
47138,4'-(Trifluoromethyl)-2-biphenylcarboxylic acid,617-563-9,84392-17-6,,Notified C&L,7,H319:7;H315:7;H335:6
47141,Diphenyl phosphoramidate,217-945-1,2015-56-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
47142,Phenylsulfonylacetic Acid Methyl Ester,608-946-1,34097-60-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H332:1;H315:2;H312:1;H335:1;H302:1;H319:2
47144,(2-methylallyloxy)benzene,227-393-3,5820-22-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H317:43;H315:39;H335:39;H334:5
47145,2-furoic acid,201-803-0,88-14-2,Not Classified,REACH registration C&L,150,Not classified:90;H319:54;H315:60;H335:58;H318:5;H302:6;H332:1;H312:1
47150,(±)-α-methylbenzyl alcohol,236-361-8,13323-81-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,2,H318:2;H302:2;H315:2;H335:2
47152,"2,4-Bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-n-octyloxyphenyl)-1,3,5-triazine",412-440-4,2725-22-6,Not Classified,REACH registration C&L,54,Not classified:25;H411:28;H412:1
47155,"Fatty acids, tall-oil, propoxylated",614-379-0,68213-45-6,Not Classified,Notified C&L,28,Not classified:28
47157,Diethyl[2-[2-(1-naphthylmethyl)-3-(tetrahydro-2-furyl)propionyloxy]ethyl]ammonium hydrogen oxalate,221-703-0,3200-06-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H312:40;H302:42;H319:1;H332:2
47159,Resorcinol-formaldehyde resin,607-469-6,24969-11-7,Eye Irrit. 2,Notified C&L,34,H319:34
47162,"Fatty acids, tall-oil, compds. with diisopropanolamine",273-196-0,68953-28-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
47166,3-carboxy-1-methyl-1H-pyrrole-2-acetic acid,281-140-1,83863-74-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;Not classified:1
47179,"Agathosma crenulata, ext.",296-166-9,92346-82-2,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,23,H317:23;H315:22;H411:23;H302:1;H304:1
47182,Morpholine-4-carboxamidinium acetate,609-809-9,402726-73-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H332:1;H315:1;H312:1;H335:1;H302:1;H319:1
47183,"N,N-bis(carboxymethyl)-L-glutamic acid",261-530-8,58976-65-1,Eye Irrit. 2,REACH registration C&L,3,H319:2;Not classified:1
47185,"Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-hydroxy-, C9-11-isoalkyl ethers, C10-rich, ammonium salts",616-611-6,78330-26-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,446,H318:446;H412:446;H315:446
47186,"N,N'-naphthalene-1,5-diylbis[4-[(2,3-dichlorophenyl)azo]-3-hydroxynaphthalene-2-carboxamide]",271-178-7,68516-75-6,Not Classified,REACH registration C&L,40,Not classified:40
47187,"1,6-Hexanediamine, N,N'-bis(2,2,6,6-tetramethyl-4-piperidinyl)-, polymer with 2,4-dichloro-6-(4-morpholinyl)-1,3,5-triazine",617-335-9,82451-48-7,Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,185,H332:99;H318:137;H411:93;Not classified:48;H410:6;H400:6
47193,"2-amino-2-methylpropane-1,3-diol",204-100-7,115-69-5,Eye Dam. 1,REACH registration C&L,235,H318:35;H319:200;H315:232;H335:127;H412:32
47195,"Potassium 1,2,3,6-tetrahydro-5-nitro-2,6-dioxopyrimidine-4-carboxylate",265-891-2,65717-13-7,Not Classified,Notified C&L,1,Not classified:1
47199,"Methyl 2-cyano-3-(2,3-dihydro-2-methyl-1H-indol-1-yl)acrylate",245-079-4,22560-84-5,,Notified C&L,33,Not classified:33
47200,"Trisodium [N,N-bis[2-[bis(carboxymethyl)amino]ethyl]glycinato(5-)]magnesate(3-)",268-354-0,68081-74-3,Not Classified,Notified C&L,2,Not classified:2
47204,"5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid",605-303-7,162758-35-2,Acute Tox. 4,Notified C&L,157,H302:156;H319:1;H315:1;H335:1
47208,"Tricarbonyl[(1,2,3,4,5,6-η)-N-methylaniline]chromium",235-477-6,12241-41-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H332:38;H315:38;H312:38;H335:38;H302:38;H319:38
47211,"7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-benzo-1,4-diazepin-2-one 4-oxide",220-974-2,2955-37-5,Repr. 2;Lact.,REACH registration C&L,8,H362:4;H361:5;Not classified:3
47212,"Addition product of maleic anhydride, tall oil fatty acids, linseed oil and methanol",926-195-0,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,73,H317:2;H315:2;H413:2;Not classified:71
47214,"Sorbitan, (Z)-9-octadecenoate (2:3)",232-360-1,8007-43-0,Not Classified,REACH registration C&L,338,Not classified:338
47218,Atenolol,249-451-7,29122-68-7,Acute Tox. 4;Eye Irrit. 2;Carc. 2;Lact.,Notified C&L,87,H362:65;H319:58;H302:69;H351:56;H332:5;H312:4;H360:6;H411:4;H361:5;H317:5;Not classified:3;H373:3;H315:4;H335:4;H412:1;H413:1
47223,"4-methylmorpholine 4-oxide, monohydrate",231-391-8,7529-22-8,Flam. Sol. 1;Ox. Sol. 2,REACH registration C&L,81,H228:8;H272:8;H361:2;H319:64;H315:64;H335:63;Not classified:9
47226,Iron molybdenum oxide,234-353-9,11115-97-2,Not Classified,Notified C&L,32,Not classified:32
47227,Petrolatum,617-134-6,8063-27-2,Not Classified,Notified C&L,1,Not classified:1
47228,Ethyl 4-hydroxy-3-methoxyphenylacetate,262-298-0,60563-13-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,63,H319:63;H315:63;H335:63
47230,2-nitro-p-cymene,213-397-2,943-15-7,Acute Tox. 4,Notified C&L,39,H302:38;H319:1
47234,Molybdenum phosphide,235-312-8,12163-69-8,,Notified C&L,4,H319:4;H335:4
47236,"2H-Pyran, 2-[trans-4-[difluoro(3,4,5-trifluorophenoxy)methyl]cyclohexyl]tetrahydro-5-propyl-, (2R,5S)-rel-",615-059-3,700863-35-0,Not Classified,Notified C&L,1,Not classified:1
47237,"Cymbopogon nardus, ext.",289-753-6,89998-15-2,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Muta. 2;Carc. 2;Aquatic Chronic 2,Notified C&L,1508,H315:1391;H317:1336;H341:1371;H351:1321;H411:1443;H318:1446;H226:1294;H304:1376;Not classified:61;H335:2;H360:1;H400:1;H302:1
47242,Pentadecanoic acid,213-693-1,1002-84-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,134,H319:133;H315:133;H335:132;H413:1;Not classified:1
47243,Butyl 2-methylbutyrate,239-798-2,15706-73-7,Flam. Liq. 3,Notified C&L,1447,H226:1366;Not classified:53;H411:66;H319:30;H315:30;H335:30
47244,Bismuth 12-HS,472-560-8,,Not Classified,Notified C&L,2,Not classified:2
47249,"Lithium tetrafluoroborate, anhydrous",238-178-9,14283-07-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Muta. 2,REACH registration C&L,196,H341:9;H319:25;H302:191;H315:25;H314:170;H318:88;H332:51;H312:54;H360:2;H335:1;H372:1;H304:1;Not classified:1
47252,"Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.]",272-342-0,68814-89-1,Carc. 1B,Harmonised C&L,0,H350:0
47257,(Z)-4-decenol,260-548-3,57074-37-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
47258,"Hydrocarbons, C5-10 arom. conc., ethylene-manuf.-by-product",270-685-0,68476-45-9,Not Classified,Notified C&L,11,Not classified:11
47261,Bis[2-(2-methoxyethoxy)ethyl]amine,227-239-5,5732-47-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
47266,"Sulfonic acids, petroleum",263-092-3,61789-85-3,Not Classified,REACH registration C&L,36,Not classified:1;H317:1;H314:33;H319:1
47269,(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride,406-090-1,81880-96-8,Acute Tox. 3;Skin Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H372:0;H400:0;H341:0;H301:0
47272,"3-Chloro-1,2-benzisothiazole",616-440-7,7716-66-7,,Notified C&L,7,H319:7;H315:7;H335:6
47273,Oxybispropanediol,261-605-5,59113-36-9,Not Classified,REACH registration C&L,107,Not classified:68;H319:38;H315:38;H335:38;H317:1;H318:1
47275,"Trisodium hydrogen 3,3'-(3H-2,1-benzoxathiol-3-ylidene)bis[6-oxido-5-methylbenzoate S,S-dioxide",222-641-7,3564-18-9,Not Classified,Notified C&L,2082,Not classified:2042;H319:40;H315:40;H335:38
47279,"Benzenamine, 4-bromo-2-methyl-, hydrochloride (1:1)",603-536-9,13194-70-2,,Notified C&L,4,H315:4;H335:4;H311:4;H319:4;H301:4
47280,"2,2'-[1,4-phenylenebis(oxy)]bisacetic acid",218-834-0,2245-53-6,,Notified C&L,4,H319:4;H315:4;H335:4
47281,"8-chloro-1-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione",244-909-2,22316-55-8,STOT SE 3,REACH registration C&L,44,H336:6;H317:38
47285,"5,6,7,8-tetrahydroisoquinoline",253-098-4,36556-06-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
47289,"Pine, Pinus pumila, ext.",307-681-6,97676-05-6,Not Classified,Notified C&L,185,Not classified:185
47291,3-O-ethylmorphine,200-970-7,76-58-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,40,H318:2;H302:40;H315:2
47293,"Tris(2,2,6,6-tetramethylheptane-3,5-dionato-O,O')dysprosium",239-563-4,15522-69-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
47295,"1,1-dibutoxyhexane",299-487-2,93892-07-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H315:1;H335:1;H302:1;H318:1;H336:1
47300,"1-Decene, sulfurized",276-428-9,72162-15-3,Not Classified,Notified C&L,457,Not classified:457
47307,Diammonium hydrogenorthophosphate,231-987-8,7783-28-0,Not Classified,REACH registration C&L,626,Not classified:444;H332:61;H315:173;H312:60;H335:154;H319:174;H412:1;H317:1;H320:1;H316:1;H402:1;H311:1
47310,AAA reaction product,452-110-7,,Not Classified,REACH registration C&L,2,Not classified:2
47312,"2,3-dihydrotoluene",216-071-8,1489-56-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H225:1;H319:1;H315:1;H335:1
47314,Sodium 2-butoxyethyl sulphate,266-840-7,67656-24-0,Eye Dam. 1,REACH registration C&L,34,H318:1;H319:26;Not classified:7;H315:1
47316,trifluoroacetic acid . . . %,200-929-3,76-05-1,Skin Corr. 1A;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H332:0;H314:0;H412:0
47318,"Tris(2,2,6,6-tetramethyl-3,5-heptanedionato)lanthanum (III)",604-336-4,14319-13-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,27,H319:27;H315:27;H335:27
47319,Hexan-3-ol,210-790-0,623-37-0,Flam. Liq. 3,Notified C&L,159,H226:159;H302:3
47325,2-(morpholinothio)benzothiazole,203-052-4,102-77-2,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H319:0;H315:0;H411:0
47328,2'-methylbenzanilide,209-541-9,584-70-3,Acute Tox. 4,Notified C&L,38,H302:38
47329,Ethyl isothiocyanate,208-831-2,542-85-8,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,55,H318:4;H314:53;H311:49;H331:47;H226:52;H301:55;H400:52;H334:49;H330:7;H410:2;H310:3;H317:6;H335:3;H315:2;H319:1
47330,"2-ethylhexanoic acid, compound with 2,2'-iminodiethanol (1:1)",271-294-8,68528-01-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6,H319:6;H315:6
47336,"5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;etem",251-684-4,33813-20-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H302:0
47337,"Trisodium 3-hydroxy-4-[(2-hydroxy-4-sulphonato-1-naphthyl)azo]naphthalene-2,7-disulphonate",264-197-7,63451-35-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H315:39;H335:39;H341:1;H351:1
47340,"1,3-diphenylpropane-1,2,3-trione 2-[O-(ethoxycarbonyl)oxime]",419-200-8,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H317:1;H411:1
47347,"1-(2,5,5-trimethylcycloheptyl)ethan-1-one",245-611-5,23361-88-8,Not Classified,Notified C&L,88,Not classified:88
47348,"Butanedioic acid, 2-oxo-3-phenyl-, 1,4-diethyl ester",615-295-7,7147-33-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
47350,"2,5-dimethylbenzoic acid",210-235-2,610-72-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H302:1
47354,"N,N-dimethylbenzene-1,3-diamine",220-623-3,2836-04-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0,H311:0;H331:0;H301:0
47355,"Amines, C12-16-alkyldimethyl",270-414-6,68439-70-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,252,H410:85;H400:117;H314:118;H302:117;Not classified:134;H318:53;H335:20;H411:20
47357,1-(2-benzoylethyl)piperidinium chloride,212-947-9,886-06-6,Acute Tox. 4,REACH registration C&L,41,H302:41;H318:38;H315:38;H335:38
47366,methyl neodecanamide,414-460-9,105726-67-8,Acute Tox. 4,Harmonised C&L,0,H302:0
47372,Ethylguanidine hydrochloride,242-974-1,19341-54-9,,Notified C&L,4,H319:4;H315:4;H335:4
47374,4-chlorobutyramide,219-526-9,2455-04-1,Acute Tox. 3,Notified C&L,38,H301:38
47376,4-(chloromethyl)biphenyl,216-786-5,1667-11-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
47380,Chlorotriethoxysilane,225-112-9,4667-99-6,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,61,H314:61;H226:61;H290:1;H318:1
47381,Tert-butyl 3-Cyano-4-oxo-pyrrolidine-1-carboxylate,700-004-9,175463-32-8,,Notified C&L,7,H319:7;H302:7;H315:7;H335:6;H332:2;H312:2
47387,5-chloro-2-methyl-2H-isothiazol-3-one hydrochloride,247-760-1,26530-03-0,Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,13,H317:13;H400:13;H314:13;H410:13
47389,"Cyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxylic acid, 2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxo-, (2R,3aR,10Z,11aS,12aR,14aR)-",618-844-9,923604-58-4,Acute Tox. 4,REACH registration C&L,1,H302:1
47394,"β-D-Glucopyranose, 1-thio-, 1-[N-(sulfooxy)benzeneethanimidate], monopotassium salt",610-625-6,5115-71-9,Not Classified,Notified C&L,1,Not classified:1
47395,"1,3,3-trimethylcyclohexene",207-970-6,503-47-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
47396,"Tetrasodium [μ-[[3,3'-[azoxybis[(2-hydroxy-p-phenylene)azo]]bis[4-hydroxy-6-(3-sulphoanilino)naphthalene-2-sulphonato]](8-)]]dicuprate(4-)",250-792-9,31765-95-4,Skin Sens. 1B,REACH registration C&L,28,H317:2;Not classified:26;H412:13
47397,2-bromo-6-chlorotoluene,263-520-9,62356-27-8,,Notified C&L,7,H319:6;H315:6;H335:1;H332:1;H312:1;H302:1
47399,Dimanganese diphosphate,236-596-6,13446-44-1,Not Classified,Notified C&L,1,Not classified:1
47400,"Ethanol, 2-methoxy-, manufacture of, by-products from, esters with boric acid",310-290-3,161907-80-8,Not Classified,Notified C&L,25,Not classified:25
47403,"Reaction products of disodium 3,5-diamino-2-[(2-sulfonatophenyl)diazenyl]benzoate and  diazotised sodium 2-[(4-aminophenyl)sulfonyl]ethyl sulfate",448-170-9,,Eye Dam. 1,Notified C&L,4,H318:4
47404,(3-chloro-1-methoxypropyl)benzene,224-687-3,4446-91-7,Acute Tox. 4,Notified C&L,38,H302:38
47410,"2,4,4-trimethylpentane-2-thiol",205-490-1,141-59-3,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 4;Acute Tox. 1,Notified C&L,442,H330:442;H312:442;H226:442;H301:441;H302:1
47412,Dipropyl peroxydicarbonate,240-211-7,16066-38-9,Org. Perox. C;Acute Tox. 5;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,6,H303:2;H410:2;H315:6;H242:6;H400:2;H411:2;H319:6;H318:2
47416,2-ethylhexyl 12-(acetoxy)octadecanoate,263-233-9,61800-40-6,Not Classified,REACH registration C&L,2,Not classified:2
47418,Cobalt titanium trioxide,234-615-2,12017-01-5,,Notified C&L,4,H315:4;H317:4;H335:4;H334:4;H319:4
47419,"Fatty acids, C12-18, compds. with N,N-bis(hydroxyethyl)coco amides and diethanolamine",267-061-5,67785-13-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H318:8;H315:8
47420,(+)-(R)-2-Methyl-1-butanol,612-181-9,616-16-0,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4,Notified C&L,39,H332:39;H318:38;H315:39;H226:39;H335:1;H319:1
47421,diisopentylphthalate,210-088-4,605-50-5,Aquatic Acute 1;Repr. 1B,Harmonised C&L,0,H400:0;H360:0
47422,"Formaldehyde, polymer with isobutylenated phenol",614-660-8,68610-07-1,Eye Irrit. 2,Notified C&L,473,H319:472;H315:31;H413:31;Not classified:1
47427,1-decyl-1H-imidazole,251-565-7,33529-02-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
47431,Disodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulphonato(3-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-),280-886-5,83803-66-1,Eye Irrit. 2,Notified C&L,2,H319:2
47433,"3,3,4,4-tetrafluoro-1,2-oxathietane 2,2-dioxide",211-805-3,697-18-7,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Acute Tox. 2,Notified C&L,3,H311:1;H330:1;H314:2;H301:1;H332:1;H312:1;H302:1;Not classified:1
47440,"Hexane-2,5-diol",220-910-3,2935-44-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H302:44;H315:44;H335:43
47441,"2,6-dimethylquinoline",212-891-5,877-43-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
47442,2-({4-[[](E)-2-(4-aminophenyl)diazen-1-yl]-3-methylphenyl}(2-hydroxyethyl)amino)ethan-1-ol,600-539-7,104226-21-3,Acute Tox. 4;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1;H302:1;H335:1
47443,Dibutyl chloromethylphosphonate,221-350-2,3074-81-5,Acute Tox. 3,Notified C&L,38,H301:38
47445,"myclobutanil (ISO);2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile",618-198-8,88671-89-0,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H361:0;H319:0;H302:0;H411:0
47447,Hexanamide,211-024-8,628-02-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:44;H335:43;Not classified:1
47452,Thallium acetate,209-257-5,563-68-8,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,43,H330:43;H300:43;H411:43;H373:43
47454,Octadecane-1-thiol,220-744-1,2885-00-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,89,H319:87;H315:89;H335:84;H413:3;H317:1
47460,1-nitro-2-phenylsulfanylbenzene,609-953-2,4171-83-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,44,H319:40;H302:6;H315:43;H335:40;H332:2;H312:2
47461,Diethyl pyrocarbonate,216-542-8,1609-47-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,60,H319:54;H302:55;H315:53;H335:54;H332:6;H301:4;Not classified:1;H311:1;H330:1
47467,"3,4-dihydrocoumarin",204-354-9,119-84-6,Acute Tox. 4;Skin Sens. 1,REACH registration C&L,1778,H317:1733;H302:1778;H319:46;H315:46;H335:44;H412:49
47468,2'-nitroacetanilide,209-009-6,552-32-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
47469,Chromium lanthanum trioxide,234-629-9,12017-94-6,,Notified C&L,174,H332:174;H315:174;H335:174;H302:174;H319:174
47474,"Sodium 9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",205-009-5,131-08-8,Not Classified,REACH registration C&L,114,Not classified:6;H319:108;H315:108;H335:107
47478,Dimethyl trisulphide,222-910-9,3658-80-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1504,H319:1493;H302:1332;H315:1493;H335:1492;H226:165;H224:52
47481,4-BROMO-2-METHOXYBENZOIC ACID,615-721-1,72135-36-5,Acute Tox. 3,Notified C&L,41,H301:40;H319:2;H315:2;H335:2
47482,"Asphalt, oxidized",265-196-4,64742-93-4,Not Classified,REACH registration C&L,195,Not classified:190;H319:5;H315:5
47487,Ethyl phenylacetate,202-993-8,101-97-3,Not Classified,REACH registration C&L,1710,Not classified:1621;H319:6;H315:89;H335:85
47489,"1',2'-dihydro-6'-hydroxy-3,4'-dimethyl-2'-oxo-1,3'-bipyridinium chloride",279-301-6,79817-70-2,Not Classified,REACH registration C&L,43,Not classified:43
47493,"(3β,16α)-3-(β-D-glucopyranosyloxy)-16-hydroxyolean-12-en-28-oic acid",278-887-0,78285-90-2,Not Classified,Notified C&L,2,Not classified:2
47494,"Protein hydrolyzates, soybean meal",296-537-5,92731-35-6,Not Classified,Notified C&L,2,Not classified:2
47497,3-(bromoacetyl)pyridinium bromide,241-692-6,17694-68-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H302:40;H315:46;H335:45
47502,beryllium,231-150-7,7440-41-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 2;STOT SE 3;STOT RE 1;Carc. 1B,Harmonised C&L,0,H315:0;H317:0;H335:0;H330:0;H372:0;H350:0;H319:0;H301:0
47505,"{(E)-1,2-Diazenediylbis[4,1-phenylene(6-methyl-1,3-benzothiazole-2,5-diyl)methylenesulfanediyl]}bis[(dimethylamino)-N,N-dimethylmethaniminium]",612-904-8,61968-76-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1A,Notified C&L,1,H360:1;H319:1;H315:1;H335:1
47509,Sodium 4-propoxycarbonylphenoxide,252-488-1,35285-69-9,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,399,H412:6;H318:368;Not classified:22;H319:8;H332:1;H314:1;H312:1
47510,(E)-N- (3-Chloroallyl)-n-Methyl-N-9Naphtalin-1-YL-methyl-amine,449-170-1,,Acute Tox. 4;Aquatic Chronic 1,REACH registration C&L,3,H410:3;H302:3;H400:1;H312:1
47512,Alkyl polyethylene glycol derivative,614-849-5,68954-91-6,Skin Irrit. 2,Notified C&L,169,H315:139;H318:30
47513,"2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride",228-799-3,6359-45-1,Acute Tox. 2;Eye Irrit. 2;Acute Tox. 2,Notified C&L,22,H330:11;H319:18;H300:10;H301:9;H410:3;H400:2;H318:2;Not classified:2;H302:1
47514,"Alkenes, C8-14 α-, δ-ω-perfluoro",307-452-0,97659-47-7,Not Classified,Notified C&L,37,Not classified:37
47519,"5-tert-butyl 1-(2,5-dioxopyrrolidin-1-yl) (S)-2-[[(phenylmethoxy)carbonyl]amino]glutarate",225-111-3,4666-16-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
47520,(phenylthio)acetonitrile,226-013-3,5219-61-4,Acute Tox. 4,Notified C&L,44,H302:43;H332:1;H315:2;H312:1;H319:2;H335:1;H311:1;H330:1;H301:1
47525,Diethyl hydrogen phosphate,209-912-5,598-02-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,76,H319:43;H315:43;H335:39;Not classified:33
47526,Phenyl hydrogen phosphonate,218-998-3,2310-89-6,Not Classified,Notified C&L,1,Not classified:1
47530,"1,3,4,5-tetrahydro-2H-1,5-methano-3-benzazepin-2-one",609-171-1,357426-13-2,Not Classified,REACH registration C&L,4,Not classified:4
47531,Disodium Cis-endo-bicyclo(2.2.1)alkane-2-3-dicarboxylate,441-430-2,,Not Classified,Notified C&L,1,Not classified:1
47533,"2,5-di-tert-butyl-4-methoxyphenol",217-873-0,1991-52-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
47536,Copper chlorophthalocyanine,235-476-0,12239-87-1,Not Classified,REACH registration C&L,382,Not classified:357;H302:25
47538,Mianserin hydrochloride,244-426-7,21535-47-7,Acute Tox. 4,Notified C&L,276,H302:276;H361:51;H370:51;H304:26;H332:2;H312:2
47540,"Potassium 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoate",280-373-6,83310-58-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H332:38;H315:38;H312:38;H335:38;H302:38;H319:38
47544,Tris(4-chlorophenyl)sulfonium 5-benzoyl-4-hydroxy- 2-methoxybenzenesulfonate,457-900-5,,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H317:1;H411:1
47547,"Bis(ethyl acetoacetato-O1',O3)bis(propan-2-olato)titanium",248-697-2,27858-32-8,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,REACH registration C&L,170,H319:92;H226:170;H336:77;H315:8;H335:2
47548,"Tail gas (petroleum), gas recovery plant;Petroleum gas;[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",269-624-0,68308-04-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;Not classified:0;H350:0
47551,"Sulfuric acid, mono-C8-14-alkyl esters, ammonium salts, compds. with triethanolamine",306-271-4,96690-74-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,105,H412:83;H318:105;H302:83;H315:105
47552,"3-β-acetoxy-14-hydroxy-5-β,14-β-card-20(22)-enolide",212-363-4,808-19-5,Acute Tox. 2,Notified C&L,38,H300:38
47553,Diprenorphine,238-325-7,14357-78-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H332:39;H315:38;H312:38;H335:38;H302:39;H319:38
47557,Dienochlor,218-763-5,2227-17-0,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H400:38;H319:38;H302:38
47559,Methyl 4-acetamido-2-ethoxybenzoate,200-414-3,59-06-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,46,H319:40;H302:44;Not classified:1;H412:1
47560,"Chromate(2-), (2,4-dihydro-4-((2-hydroxy-4-nitrophenyl)azo)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-))(2,4-dihydro-4-((2-hydroxy-4-nitrophenyl)azo)-5-methyl-2-(4-sulfophenyl)-3H-pyrazol-3-onato(2-))-, dihydrogen",615-806-3,72812-27-2,Not Classified,Notified C&L,1,Not classified:1
47562,"3-(2,2,2-trimethylhydrazinium)methylpropionate bromide",920-257-0,,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H335:2;H319:2;H315:2;H301:2
47563,Diisopropylbenzenesulphonic acid,248-928-7,28261-72-5,Skin Corr. 1B,Notified C&L,8,H314:8
47565,"(10R,11R,13S,17R)-11-Hydroxy-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione",606-276-4,192569-17-8,Carc. 2;Aquatic Chronic 2,Notified C&L,3,H351:3;H411:3
47567,"Urea, reaction products with formaldehyde",271-898-1,68611-64-3,Not Classified,Notified C&L,279,Not classified:269;H332:6;H317:8;H351:6;H302:6;H312:6;H412:2
47572,"Sodium 2-[[4-[[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]amino]-6-methoxy-1,3,5-triazin-2-yl]methylamino]ethanesulphonate",267-598-5,67892-96-0,Not Classified,Notified C&L,9,Not classified:9
47573,"Lubricating oils (petroleum), C",276-738-4,72623-87-1,Carc. 1B,Harmonised C&L,0,H350:0
47574,"2H-Pyrido[3,2-b]-1,4-oxazin-3 (4H)-one, 6-[(2-chloro-5-fluoro-4-pyrimidinyl)amino]-2,2-dimethyl-",611-556-4,575484-83-2,Aquatic Chronic 3,Notified C&L,1,H412:1
47575,"Octanoic acid, cerium salt",231-083-3,7435-02-1,Skin Irrit. 2,Notified C&L,79,H315:78;H319:5;Not classified:1
47576,4-hydroxy-3-methoxyphenylacetonitrile,224-739-5,4468-59-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H332:40;H315:40;H312:40;H335:40;H302:40;H319:40
47583,Platinum dibromide,236-648-8,13455-12-4,,Notified C&L,5,H319:5;H315:5;H335:5
47584,"D-Glucitol, 1,3:2,4-bis-O-((4-methylphenyl)methylene)-",617-241-8,81541-12-0,Not Classified,Notified C&L,17,Not classified:17
47589,"N,N',N''-tricyclohexyl-1-methylsilanetriamine",240-040-8,15901-40-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,115,H312:115;H302:115;H318:2;H314:115;H335:66
47590,"Glycerides, tallow mono- and di-, hydrogenated",287-835-6,85586-31-8,Not Classified,Notified C&L,7,Not classified:7
47592,"Sodium 2,5-difluorobenzoate",610-815-9,522651-42-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
47595,2-fluorocinnamic acid,207-195-3,451-69-4,,Notified C&L,8,H319:8;H315:8;H335:7
47596,Quinoxaline,202-047-4,91-19-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
47599,"7-amino-8-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2-sulphonic acid, sodium salt",303-164-4,94158-90-4,Not Classified,Notified C&L,2,Not classified:2
47601,Clobazam,244-908-7,22316-47-8,Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,95,H412:92;H302:92;H336:93;Not classified:2;H362:1;H361:1
47602,p-tolualdehyde,203-246-9,104-87-0,Acute Tox. 4,REACH registration C&L,1787,H302:1783;H319:1645;H315:46;H335:42;Not classified:2;H312:1
47604,N-[4-[[(4-chloro-3-nitrophenyl)sulphonyl]amino]phenyl]acetamide,279-279-8,79817-49-5,Not Classified,REACH registration C&L,39,Not classified:39
47608,"Distillates (coal tar), pitch, pyrene fraction;Heavy Anthracene Oil Redistillate;[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 °C to 410 °C (716 to 770 °F). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.];[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 °C to 410 °C (7160 to 770 °F). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.]",295-313-4,91995-52-7,Carc. 1B,Harmonised C&L,0,H350:0
47611,Imidazoletrione,204-434-3,120-89-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
47620,"Slags, steelmaking, vanadium",273-734-4,69012-34-6,Not Classified,REACH registration C&L,1,Not classified:1
47621,"5-α-androstane-3-β,17-β-diol",209-334-3,571-20-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H315:38
47622,Dimethylcyanamide,215-991-7,1467-79-4,Acute Tox. 3;Acute Tox. 3,Notified C&L,40,H331:39;H301:40;H310:1;H332:1;H226:1
47625,1-(dichloromethyl)-3-fluorobenzene,206-952-5,402-64-2,,Notified C&L,5,H314:5;H319:1
47627,lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate,411-140-0,125328-86-1,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H318:0;H411:0
47632,2-[2-(piperidyl)ethyl]pyridine,226-696-8,5452-83-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
47633,(ethylbenzyl)dimethyltetradecylammonium chloride,248-487-0,27479-29-4,Not Classified,Notified C&L,5,Not classified:5
47639,"3-(2,4-dihydroxyphenylazo)-4-hydroxybenzenesulphonic acid",220-855-5,2918-80-1,Not Classified,Notified C&L,1,Not classified:1
47640,"Moringa oleifera, ext.",296-941-1,93165-54-9,Not Classified,Notified C&L,53,Not classified:53
47644,"Amides, C12-18 and C18-unsatd., N-(hydroxyethyl)",292-481-0,90622-77-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,135,H318:135;H315:135;H411:129;H319:6
47647,Palladium monosulphide,235-190-6,12125-22-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
47649,"N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide",402-510-2,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
47653,"4-((4-Butyl-2,6-difluorphenyl)-ethinyl)-4'-propylbiphenyl",606-941-9,221526-79-0,Aquatic Chronic 4,Notified C&L,2,Not classified:1;H413:2
47654,manganese sulphate,232-089-9,7785-87-7,STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H373:0
47655,"dibenz[a,h]anthracene",200-181-8,53-70-3,Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H350:0;H400:0
47656,Azadirachtin,601-089-4,11141-17-6,Not Classified,Notified C&L,5,Not classified:3;H410:1;H400:1;H317:2
47661,"5,6-dimethoxy-1H-indole",238-402-5,14430-23-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
47662,Tetraammonium disodium vanadate,235-012-7,12055-09-3,,Notified C&L,1,H334:1;H370:1;H302:1;H315:1
47663,N-[5-[[(3-amino-3-iminopropyl)amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]-4-[[[4-(formylamino)-1-methyl-1H-pyrrol-2-yl]carbonyl]amino]-1-methyl-1H-pyrrole-2-carboxamide monohydrochloride,229-505-6,6576-51-8,Skin Sens. 1,Notified C&L,38,H317:38
47667,"L-threo-hexo-2,3-diulosono-1,4-lactone",207-720-6,490-83-5,Acute Tox. 4,Notified C&L,60,H302:60
47670,"2,2'-methylenebis(6-bromo-4-chlorophenol)",239-446-8,15435-29-7,Not Classified,Notified C&L,5,Not classified:3;H319:2;H315:2
47673,3-(Ethylsulfonyl)pyridine-2-sulfonamide,412-810-5,,Not Classified,REACH registration C&L,2,Not classified:2
47675,Chromium (III) propionate,919-722-0,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2,H319:2;H317:2;H315:2;H411:2
47676,"1,5-dinitroanthraquinone",201-414-6,82-35-9,Eye Irrit. 2,Notified C&L,39,H319:39
47679,"Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-",605-168-4,158966-92-8,Not Classified,Notified C&L,2,Not classified:1;H332:1;H312:1;H302:1
47680,Bismuth pentafluoride,232-125-3,7787-62-4,Ox. Sol. 2;Skin Corr. 1B,Notified C&L,39,H314:39;H272:38;H311:1;H301:1
47681,Tetraheptylammonium iodide,222-570-1,3535-83-9,,Notified C&L,4,H319:4;H315:4;H335:4
47683,"1,3,4-thiadiazole-2(3H)-thione",242-504-5,18686-82-3,,Notified C&L,41,H319:41;H315:41;H335:40
47685,"Paraffin waxes and Hydrocarbon waxes, chloro",264-150-0,63449-39-8,Not Classified,REACH registration C&L,695,Not classified:649;H319:22;H362:14;H400:17;H410:5;H332:2;H351:3;H373:2;H315:1;H335:1;H372:1;H225:1;H336:1
47688,Salicylaldehyde hydrazone,221-953-0,3291-00-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,160,H319:160;H315:160;H335:160
47690,Fluoro(2H5)benzene,215-831-6,1423-10-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H225:38;H319:38;H315:38;H335:38
47693,nickel(II) octanoate,225-656-7,4995-91-9,Skin Corr. 1A;Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H410:0;H360:0;H317:0;H314:0;H372:0;H341:0;H400:0;H334:0;H350:0
47694,reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine;3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine,411-880-4,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
47695,S-2-aminoethylthiouronium bromide hydrobromide,200-257-0,56-10-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:38;H302:43;H315:38;H335:38
47703,Ditridecyl sebacate,220-373-5,2741-62-0,Not Classified,Notified C&L,18,Not classified:18
47706,"2-ethylhexanoic acid, lead salt",241-076-7,16996-40-0,Not Classified,Notified C&L,9,Not classified:5;H410:4;H332:4;H373:4;H360:4;H400:4;H302:4;H226:4;H304:4
47707,"(±)-(R*, S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran",616-687-0,793669-26-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H319:1;H315:1;H411:1;H335:1
47712,(S)-3-hydroxybutyric acid,228-209-4,6168-83-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
47713,Dodecyl(ethylbenzyl)dimethylammonium chloride,248-486-5,27479-28-3,Not Classified,Notified C&L,6,Not classified:6
47715,Dodec-3-en-1-al,268-406-2,68083-57-8,Skin Irrit. 2,Notified C&L,115,H315:115;H410:25;H317:36;H400:35;H319:36;H413:1
47717,"(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate",616-212-7,75330-75-5,Skin Sens. 1;Carc. 2;Repr. 2,REACH registration C&L,143,H361:96;H317:2;H351:2;H302:44;H372:35;H319:6;H315:4;H335:4;H373:1;H350:1;Not classified:1;H412:1;H360:1
47718,2-nitro-N-(4-nitrophenyl)aniline,210-306-8,612-36-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
47720,"Butane-1,2,4-triyl trinitrate",229-697-1,6659-60-5,Unst. Expl.;Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,2,H310:1;H330:1;H411:1;H200:1;H300:1;H373:1;Not classified:1
47727,Harmine hydrochloride,206-443-8,343-27-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,39,H332:38;H312:38;H302:38;H351:38;H311:1;H370:1;H331:1;H301:1
47731,Ethyl L-prolinate hydrochloride,251-449-6,33305-75-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2;H332:1;H302:1
47733,"2,3-dichloropropan-1-ol",210-470-0,616-23-9,Acute Tox. 3;Acute Tox. 2;Eye Dam. 1;Acute Tox. 4,Notified C&L,67,H310:66;H332:38;H318:43;H301:67;H319:24;H315:28;H335:4;H341:5;H311:1;Not classified:1
47735,2-(p-tolyloxy)ethyl acetate,229-881-1,6807-11-0,Not Classified,Notified C&L,88,Not classified:88
47744,Undecanoyl chloride,241-741-1,17746-05-3,Skin Corr. 1B,REACH registration C&L,42,H314:42;H290:1;H318:1
47745,(Z)-hex-3-enyl isovalerate,252-404-3,35154-45-1,Not Classified,Notified C&L,237,Not classified:196;H226:41
47749,"2,4-dimethoxybenzylamine hydrochloride",244-036-7,20781-21-9,,Notified C&L,1,H319:1;H315:1;H335:1
47750,4-chlorobenzylamine,203-245-3,104-86-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,50,H312:43;H302:43;H314:49;H319:1;H315:1;H335:1;H332:2;H318:2
47751,[2-hydroxy-3-(tridecyloxy)propyl]trimethylammonium chloride,269-834-2,68334-55-4,Eye Dam. 1,Notified C&L,20,H318:20
47753,"reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid;cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid",418-170-3,116193-72-7,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
47757,"6,10,14-Trimethyl-5-Pentadecen-2-on",609-306-4,3689-69-8,Aquatic Chronic 4,REACH registration C&L,85,H413:85
47758,"trans,trans-nona-2,4-dienal",227-629-5,5910-87-2,Skin Sens. 1,Notified C&L,1435,H317:1434;H315:19;H413:1
47759,"1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane",429-280-6,151900-44-6,Aquatic Chronic 4,Harmonised C&L,0,H413:0
47760,"(3,4-dichlorophenoxy)acetic acid",209-612-4,588-22-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:40;H317:38;H315:40;H335:40;H332:5;H312:5;H302:5
47762,Aminomalononitrile p-toluenesulphonate,225-817-1,5098-14-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45,H332:43;H312:43;H302:43;H315:5;H335:4;H319:5;H311:2;H331:2;H301:2
47763,Chlorite-group minerals,215-285-9,1318-59-8,Not Classified,Notified C&L,624,Not classified:604;H319:20
47766,DIMETHYL METHYLHYDROGEN SILOXANE,614-223-1,68037-59-2,Not Classified,Notified C&L,267,Not classified:101;H226:80;H319:108;H315:109;H335:83;H332:3;H411:1;H312:1;H318:1
47767,C.I. Acid Brown 349,615-816-8,72827-73-7,Not Classified,Notified C&L,7,Not classified:7
47771,Valpromide,219-394-2,2430-27-5,Acute Tox. 4,Notified C&L,45,H302:45;H360:1
47775,"N,N-bis(2-hydroxyethyl)-3-[(C16-18)alkoxy]-1-propanamine",930-859-5,,Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1,H400:1;H314:1;H318:1;H411:1
47776,"2,4-dihydro-4-[(2-methoxyphenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-one",225-074-3,4645-07-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,157,H319:130;H315:130;H335:38;H400:38;H302:38;Not classified:27
47779,"3,3,5-trimethylcyclohexylamine",240-041-3,15901-42-5,Skin Corr. 1B,Notified C&L,7,H314:7;H318:1;H226:1
47783,3-(β-Hydroxyethyl sulfonyl sulfate)-N-ethyl-aniline,617-476-6,83574-63-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H314:39;H318:39
47784,2-hydroxy-3-methylbutyric acid,223-697-5,4026-18-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
47788,propoxur (ISO);2-isopropyloxyphenyl N-methylcarbamate;2-isopropoxyphenyl methylcarbamate,204-043-8,114-26-1,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H301:0
47789,"2, 4-Dichloro-7H-pyrrolo [2,3-d] pyrimidine",618-507-6,90213-66-4,Not Classified,REACH registration C&L,5,Not classified:1;H319:4;H315:4;H335:3;H302:2;H301:1
47790,"2-(benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate",259-932-3,55985-32-5,Acute Tox. 4,Notified C&L,2,H302:2
47792,2-nitro-p-xylene,201-920-7,89-58-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H310:1;H330:1;H300:1
47794,Ethyl 1-benzylpiperidine-4-carboxylate,246-094-9,24228-40-8,Acute Tox. 3,Notified C&L,40,H301:38;H319:2;H315:2;H335:2
47796,"Fatty acids, C7-11, esters with trimethylolpropane",275-736-0,71630-99-4,Not Classified,Notified C&L,441,Not classified:441
47798,Thionyl dibromide,208-064-3,507-16-4,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,42,H332:38;H312:38;H314:42
47799,(maleato)trioxotetralead,235-549-7,12275-07-9,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,33,H410:33;H332:33;H360:33;H400:33;H302:33;H373:33
47800,dodecyldiphenyl phosphate,431-760-5,27460-02-2,Skin Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H315:0
47801,"3,7-dihydro-1H-purine-2,6-dione, sodium salt",272-117-7,68738-87-4,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
47802,o-phenylenediarsonic acid,217-154-1,1758-48-1,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38;H331:38;H301:38
47804,1-octanesulphonyl chloride,232-249-8,7795-95-1,Skin Corr. 1B,Notified C&L,43,H314:43;H290:1;H318:1
47805,Dihydro-4-methyl-5-pentylfuran-2(3H)-one,251-629-4,33673-62-0,Not Classified,Notified C&L,145,Not classified:145
47806,(bromomethyl)chlorodimethylsilane,240-601-7,16532-02-8,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,40,H314:40;H226:40;H290:1;H318:2
47809,Tetrakis(2-ethylhexyl) orthosilicate,204-109-6,115-82-2,Not Classified,Notified C&L,7,Not classified:6;H319:1
47810,"Magnesium, [3,7,11,15-tetramethyl-2-hexadecenyl 9-ethenyl-14-ethyl-13-formyl-21-(methoxycarbonyl)-4,8,18-trimethyl-20-oxo-3-phorbinepropanoato(2-)-N23,N24,N25,N26]-, [SP-4-2-[3S-[3α(2E,7S*,11S*),4β,21β]]]-",208-272-4,519-62-0,Not Classified,Notified C&L,1,Not classified:1
47818,"β-D-Glucopyranoside, octyl 1-thio-",617-729-0,85618-21-9,Not Classified,Notified C&L,2,Not classified:2
47821,Samarium trihydroxide,243-787-8,20403-06-9,,Notified C&L,6,H314:4;Not classified:2
47831,Furfurylamine,210-536-9,617-89-0,Not Classified,REACH registration C&L,89,Not classified:5;H312:43;H302:54;H226:85;H314:85;H332:28;H310:26;H301:30;H311:14;H318:4
47835,"[1R-(1α,2β,5α)]-2-isopropyl-5-methylcyclohexyl 5-oxo-L-prolinate",264-935-8,64519-44-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2,H319:1;H412:1;H315:1;Not classified:1
47836,Triethoxypropylsilane,219-842-7,2550-02-9,Flam. Liq. 3;Skin Irrit. 2,REACH registration C&L,283,H315:283;H226:283;H319:74;H335:73
47838,"Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C",269-783-6,68333-27-7,Carc. 1B,Harmonised C&L,0,H350:0
47844,2-chloro-6-methoxybenzoic acid,221-863-1,3260-89-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
47848,Perfluoroperhydrophenanthrene,400-470-0,,Not Classified,REACH registration C&L,1,Not classified:1
47849,6-amino-m-cresol,220-620-7,2835-98-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,108,H319:98;H315:98;H335:97;H317:45;H302:67;H332:4;H312:3;H311:1;H411:1;H301:1
47852,Trimethylsilyl N-trimethylsilylacetamidate,233-892-7,10416-59-8,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,90,H314:88;H302:87;H226:88;H225:1;H319:3;H315:2;H335:1;H318:2
47855,"Poly(oxy-1,2-ethanediyl",608-068-9,27252-80-8,Acute Tox. 4,Notified C&L,232,H302:144;H319:55;H315:55;Not classified:32;H314:1;H318:1
47856,"5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide hydrochloride (1:1)",619-728-0,635702-64-6,Repr. 2,Notified C&L,4,H361:3;H372:3;H411:3;H400:2;H360:1;H351:1
47860,Ammonium sulphamate,237-372-0,13765-36-1,Not Classified,Notified C&L,2,Not classified:2
47861,Bis[ethyl(4-hydroxy-o-tolyl)ammonium] sulphate,269-473-0,68239-79-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H332:1;H315:1;H317:1;H335:1;H302:1;H319:1
47862,Dinitrogen trioxide,234-128-5,10544-73-7,Ox. Gas 1;Press. Gas (Comp.);Acute Tox. 2;Skin Corr. 1B;Acute Tox. 2,Notified C&L,38,H310:38;H314:38;H280:38;H330:38;H270:38
47868,Dodecyldimethylammonium acetate,217-646-6,1920-05-4,Acute Tox. 4,Notified C&L,48,H302:48
47869,"1,6-diiodoperfluorohexane",206-794-7,375-80-4,Repr. 2;STOT RE 1,REACH registration C&L,52,H372:1;H361:1;Not classified:47;H319:3;H315:3;H335:2;H332:1;H312:1;H302:1;H413:1
47870,Chromium (III) hydroxynitrate,601-791-0,12158-37-1,Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,13,H317:11;H314:13;H318:11;H411:10
47873,"4-chloro-2,6-dinitroaniline",226-381-5,5388-62-5,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,38,H310:38;H330:38;H411:38;H300:38;H373:38
47874,Tetrabutylammonium tetraphenylborate,239-562-9,15522-59-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
47878,1-ethynyl-3-nitrobenzene,221-232-0,3034-94-4,,Notified C&L,2,H315:2;H335:1;H311:1;H319:2;H331:1;H301:1
47879,"Gases (petroleum), deisobutanizer tower overheads;Petroleum gas;[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]",270-769-7,68477-87-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;Not classified:0;H350:0
47882,6-chloro-1H-indole,241-449-4,17422-33-2,,Notified C&L,10,H319:10;H315:10;H335:9;H332:1;H312:1;H302:1
47889,Ethylsuccinic acid,211-259-6,636-48-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
47891,Magnesium diformate,209-173-9,557-39-1,Not Classified,Notified C&L,49,Not classified:48;H319:1
47894,"1,1,1-trichloropropan-2-ol",200-924-6,76-00-6,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,38,H319:38;H411:38
47896,Oestriol,200-022-2,50-27-1,Carc. 2;Repr. 1A;Lact.,Notified C&L,169,H362:76;H360:167;H351:115;H372:52;H350:52;H410:51;H400:1;H332:1;H302:1;H312:1;H361:1
47897,potassium dichromate,231-906-6,7778-50-9,Ox. Sol. 2;Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1;Muta. 1B;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H410:0;H360:0;H317:0;H314:0;H340:0;H272:0;H330:0;H372:0;H400:0;H334:0;H350:0;H312:0;H301:0
47901,"reaction mass of 1-(1-Methyl-2-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yloxy)ethoxy)-propan-2-ol and 1-(2-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yloxy)propoxy)propan-2-ol and 2-(2-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yloxy]propoxy)-propan-1-ol and 2-(1-Methyl-2-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yloxy)ethoxy)propan-1-ol",470-680-5,958872-63-4,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1
47902,"(,E)-3,7-dimethyl-2,6-octadienyl 2-butenoate",260-027-0,56172-46-4,Not Classified,Notified C&L,1375,Not classified:1375
47905,Sulfiram,202-387-3,95-05-6,,Notified C&L,3,H312:2;H302:3
47906,"1,3-diphenylpropane",214-101-4,1081-75-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
47908,"reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-)",405-665-4,118685-33-9,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H317:0
47911,"Benzoic acid, 2,4-dihydroxy-6-methyl-",610-404-4,480-64-8,,Notified C&L,4,H319:4;H315:4;H335:4
47914,"3,4-dihydro-2H-pyrrole",227-230-6,5724-81-2,Not Classified,Notified C&L,88,Not classified:88
47915,disulphur dichloride;sulfur monochloride,233-036-2,10025-67-9,Acute Tox. 3;Skin Corr. 1A;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H332:0;H400:0;H314:0;H301:0
47916,"1,3-dihydro-2H-purine-2-thione",248-855-0,28128-19-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H318:38
47917,"N,N-bis(2-ethylhexyl)-5-methyl-1H-benzotriazole-1-methylamine",279-514-4,80595-74-0,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1112,H317:1111;H315:1073;H411:1085;H319:38;H412:25;H312:6;Not classified:1
47923,p-ethylphenyl isocyanate,245-446-9,23138-50-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H332:39;H315:44;H312:39;H335:44;H302:39;H319:44;H330:4;H334:5;H301:5;H331:1
47926,Benzyl bromoacetate,226-611-4,5437-45-6,,REACH registration C&L,50,H319:50;H315:50;H335:48;H332:1;H312:1;H302:2
47929,"1,1'-(1,3-phenylenedicarbonyl)bis[2-methylaziridine]",231-617-5,7652-64-4,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Muta. 2,REACH registration C&L,9,H341:5;H314:8;H302:8;H318:5;H319:1;H315:1;H335:1
47938,6-benzylaminopurine,224-298-9,4294-16-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
47942,Hexaglycerol,253-154-8,36675-34-0,Not Classified,Notified C&L,11,Not classified:11
47944,Tetraethylammonium thiocyanate,224-972-2,4587-19-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H312:38;H302:38
47945,Ethyl N-(3-methoxy-2-methyl-3-oxopropyl)-N-(phenylmethyl)-β-alaninate,279-031-9,78987-79-8,Acute Tox. 4,Notified C&L,38,H302:38
47946,Iron hydroxide succinate,231-240-6,7459-88-3,Not Classified,Notified C&L,1,Not classified:1
47947,Methoxydimethyloctadecylsilane,276-039-4,71808-65-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
47952,Cobalt disilicide,234-616-8,12017-12-8,,Notified C&L,174,H315:174;H317:174;H335:174;H334:174;H319:174
47955,"Amides, C18 and C18-unsatd., N-[2-[2-(C17 and C17-unsatd. alkyl)-4,5-dihydro-1H-imidazol-1-yl]ethyl]",276-037-3,71808-32-7,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1,Notified C&L,22,H400:22;H314:22;H302:22;H318:22
47956,"N,N',N'',N'''-(1,5-pentanediylidene)tetrakismethacrylamide",309-978-6,101810-92-8,,Notified C&L,1,H319:1;H315:1;H335:1
47957,"(2S,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]oct-2-yl)methanol",606-607-2,207129-35-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H302:1;H335:1
47958,"2'-[2,4-dichloro-5-(1-methylethoxy)phenyl]-2,2-dimethylpropionohydrazide",257-027-8,51167-18-1,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H410:2;H400:1;H301:2;Not classified:1
47960,"Benzyl (S)-(-)-1,2,3,4-tetrahydroiso-quinolinecarboxylate p-toluenesulfonic acid salt",616-464-8,77497-97-3,Aquatic Chronic 2,Notified C&L,38,H411:38
47965,4-Chloropiperidine,611-055-0,5382-18-3,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H318:1;H226:1
47966,"Residues (petroleum), dewaxed heavy paraffinic, vacuum",302-656-6,94114-22-4,,Notified C&L,1,Not classified:1
47972,"1,3,5-trioxan;trioxymethylene",203-812-5,110-88-3,Flam. Sol. 1;STOT SE 3;Repr. 2,Harmonised C&L,0,H228:0;H361:0;H335:0
47973,"Tetramethyl 2,2'-[1,4-phenylenebis[imino(1-acetyl-2-oxoethane-1,2-diyl)azo]]bisterephthalate",271-176-6,68516-73-4,Not Classified,REACH registration C&L,327,Not classified:326;H412:1
47976,α-oxofuran-2-acetic acid,215-990-1,1467-70-5,Skin Corr. 1B,Notified C&L,38,H314:38
47977,"2,3,5-trimethylphenol",211-806-9,697-82-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,150,H319:93;H315:93;H335:89;H314:57;H311:6;H411:6;H301:6;H412:2;Not classified:1;H318:1
47978,Ambazone,208-713-0,539-21-9,Not Classified,Notified C&L,2,Not classified:1;H302:1
47980,Mercury diiodate,231-989-9,7783-32-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H310:38;H330:38;H400:38;H300:38;H373:38
47981,Thioacetazone,203-170-6,104-06-3,Acute Tox. 4,Notified C&L,39,H302:39
47982,"8-azaspiro[4.5]decane-7,9-dione",427-770-4,1075-89-4,Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H301:0
47983,"Dimethyl pyridine-2,6-carboxylate",226-697-3,5453-67-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H318:39;H315:39;H335:39;H319:4
47987,Trisodium trimetaphosphate,232-088-3,7785-84-4,Not Classified,REACH registration C&L,125,Not classified:125
47988,Nonylbenzene,214-103-5,1081-77-2,Not Classified,Notified C&L,3,Not classified:3
47990,1-nitropentane,211-025-3,628-05-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
47991,"Chromium, acetylacetone 6-methyl-2,4-heptanedione complexes",290-948-3,90294-62-5,Not Classified,REACH registration C&L,2,Not classified:2
47992,"2,2-diphenyl-2-(2-ethylbutoxy)essigsäure 2-(dimethylamino)ethylester hydrochlorid",608-845-2,3321-06-0,Skin Sens. 1,Notified C&L,1,H317:1;H332:1;H312:1
47993,Vinylene carbonate,212-825-5,872-36-6,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,211,H315:175;H317:171;H311:161;H302:176;H411:170;H318:203;H373:161;H332:4;H335:4;H319:6;Not classified:2
47994,N-phenyl-N-piperidin-4-ylpropionamide,216-543-3,1609-66-1,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,47,H412:1;H317:1;H302:42;H318:2;H319:43;H315:43;H335:5;H314:2
47995,"tert-butyl [(2S,3R)-3-hydroxy-4-(isobutylamino)-1-phenylbutan-2-yl]carbamate",605-203-3,160232-08-6,Acute Tox. 4;Eye Dam. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H410:4;H361:4;H400:4;H302:4;H318:4;Not classified:1
47998,2-(tert-butyl)anthracene,242-588-3,18801-00-8,Not Classified,Notified C&L,3,Not classified:3
47999,"4-Bromo-2,6-difluorobenzonitrile",602-957-5,123843-67-4,,Notified C&L,29,H332:25;H312:20;H301:22;H315:10;H311:10;H302:7;H319:10;H335:4;H331:4
48004,"Naphtha (petroleum), light steam-cracked, hydrogenated;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C",296-942-7,93165-55-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0;H304:0
48007,"2-[(3S)-2,6-dioxooxan-3-yl]isoindole-1,3-dione",607-813-5,25830-77-7,Eye Dam. 1,REACH registration C&L,1,H318:1
48008,2-chloropyridin-4-amine,238-403-0,14432-12-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:51;H315:51;H335:50;H332:8;H312:8;H302:8;H311:1;H331:1;H301:1
48009,Colistimethate sodium,232-516-9,8068-28-8,Repr. 2;Lact.,Notified C&L,10,H362:9;H361:9;Not classified:1
48011,"3,3'-dimethoxybenzidine;o-dianisidine",204-355-4,119-90-4,Acute Tox. 4;Carc. 1B,Harmonised C&L,0,H350:0;H302:0
48012,"3,4-difluorobenzylamine",276-503-6,72235-53-1,Skin Corr. 1B,Notified C&L,47,H314:47;H318:1;H319:1;H335:1
48016,"3-[(dimethylsilyl)oxy]-1,1,3,5,5-pentamethyltrisiloxane",241-136-2,17082-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
48022,Ammonium nitrite,236-598-7,13446-48-5,Not Classified,Notified C&L,1,Not classified:1
48024,"Buckwheat, ext.",289-631-2,89958-09-8,Not Classified,Notified C&L,1,Not classified:1
48030,Promethazine teoclate,241-691-0,17693-51-5,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Repr. 2;Aquatic Chronic 2,Notified C&L,2,H332:2;H317:2;H361:2;H302:2;H411:2;H312:2;H318:2
48031,"N,N'-di-sec-butyl-p-phenylenediamine",202-992-2,101-96-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1A;Eye Irrit. 2;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1105,H410:1036;H373:91;H314:1060;H317:1094;H311:178;H400:1094;H319:70;H331:92;H301:1094;H318:968;H315:40;Not classified:5;H302:5
48034,1-amino-4-(cyclohexylamino)anthraquinone,229-058-7,6408-45-3,Aquatic Chronic 3,Notified C&L,31,H412:31
48038,"Tris[[]3-bromo-2,2-bis(bromomethyl)propyl] phosphate",413-060-1,19186-97-1,Not Classified,REACH registration C&L,4,Not classified:4
48040,2-Bromo-6-fluoroaniline,613-850-8,65896-11-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H315:42;H335:38;H332:4;H312:4;H302:4;H311:1;H331:1;H301:1
48041,Boron,231-151-2,7440-42-8,Not Classified,REACH registration C&L,333,Not classified:121;H302:205;H413:21;H301:4;H319:3;H315:3;H228:3;H332:2;H312:1;H250:1
48042,Ammonium stearate,213-695-2,1002-89-7,Eye Irrit. 2,Notified C&L,560,H319:479;Not classified:81;H315:38;H335:38
48043,"3,5-bis(trifluoromethyl)benzoic acid",211-970-1,725-89-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,136,H319:136;H315:136;H335:135
48045,Methyl cyclopropanecarboxylate,220-690-9,2868-37-3,Flam. Liq. 2;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 3,REACH registration C&L,91,H225:48;H319:57;H302:58;H331:13;H311:41;Not classified:33;H226:10;H312:1
48047,DL-tryptophan,200-194-9,54-12-6,Not Classified,Notified C&L,8,Not classified:7;H319:1;H315:1;H335:1
48049,"ACETIC ACID, MERCAPTO-, CALCIUM SALT (1:1), TRIHYDRATE",613-757-2,65208-41-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,80,H319:76;H302:80;H315:75;H335:76;H317:2;H290:1
48055,"Fatty acids, C12-20 and C12-20-unsatd., compds. with diethanolamine",292-796-3,90990-33-3,Not Classified,Notified C&L,1,Not classified:1
48061,2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid,609-571-6,38677-85-9,Acute Tox. 3,Notified C&L,43,H301:40;H302:3
48062,": (-)-trans-4-(4-fluorophenyl)-3-(3,4-methylendioxiphenoxymethyl)-1-phenoxycarboxy-piperidine",607-713-1,253768-88-6,Repr. 2,REACH registration C&L,1,H361:1
48068,"Zirconium, dipropylene glycol iso-Bu alc. neodecanoate propionate cobalt complexes",273-514-8,68988-10-3,Not Classified,Notified C&L,5,Not classified:5
48071,Zinc trifluoromethanesulphonate,258-922-6,54010-75-2,Skin Corr. 1B,Notified C&L,51,H314:50;H318:5;H400:1;H411:1
48074,"Fatty acids, tallow, hydrogenated, iron salts",294-344-0,91697-82-4,Not Classified,Notified C&L,7,Not classified:7
48076,"10,12-Pentacosadiynoic Acid",614-006-1,66990-32-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,86,H319:86;H315:86;H335:85
48083,Calcium carbonate,207-439-9,471-34-1,Not Classified,REACH registration C&L,3259,Not classified:2925;H319:144;H315:318;H318:185;H335:132;H372:1;H336:1;H332:1;H312:1;H302:1
48084,"7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-benzo-1,4-diazepin-2-one 4-oxide",231-084-9,7435-12-3,Repr. 2;Lact.,REACH registration C&L,2,H362:2;H361:2
48085,3-methylbenzofuran,244-427-2,21535-97-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,41,H302:39;H318:38;H319:3;H315:3;H335:3;H227:1
48086,Allyltriethoxysilane,219-843-2,2550-04-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H225:45;H319:45;H315:45;H335:44
48087,Dipropylmalonic acid,216-664-1,1636-27-7,,Notified C&L,6,H319:6;H315:6;H335:5
48089,"2,2'-[[5-acetamide-4-[(2-bromo-4,6-dinitrophenyl)azo]-2-ethoxyphenyl]imino]diethyl diacetate",235-475-5,12239-34-8,Not Classified,Notified C&L,46,Not classified:46
48090,3-methylpyridin-4-amine,217-872-5,1990-90-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:1;H312:1;H302:3;H319:2;H315:2
48091,"2,4,6-trinitrotoluene;TNT",204-289-6,118-96-7,Expl. 1.1;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H201:0;H301:0;H311:0;H411:0;H331:0;H373:0
48092,"Benzoic acid, 4-(methylsulfonyl)-2-nitro-",601-017-1,110964-79-9,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,194,H319:194;H317:33;H314:1;H315:161;H335:159
48093,Dibenzoyl disulphide,211-413-2,644-32-6,Aquatic Acute 1,Notified C&L,38,H400:38
48094,2-methylcyclohexanecarboxylic acid,260-272-3,56586-13-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H302:39;H318:39
48098,"Tail gas (petroleum), gas recovery plant deethanizer;Petroleum gas;[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",269-625-6,68308-05-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;Not classified:0;H350:0
48099,Tetrabromo(tetrabromophenyl)benzene,248-696-7,27858-07-7,Not Classified,Notified C&L,1,Not classified:1
48100,"Distillates (coal tar), pitch, heavy oils;Heavy Anthracene Oil;[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 °C to 470 °C (572 °F to 878 °F). The product may also contain heteroatoms.]",295-312-9,91995-51-6,Carc. 1B,Harmonised C&L,0,H350:0
48105,"1,1-dichloro-2-methoxyethane",252-254-9,34862-07-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H332:38;H351:38;H302:38;H312:38;H226:38
48110,"1,3,5-trinitro-2-[2-(2,4,6-trinitrophenyl)ethyl]benzene",610-734-9,5180-53-0,Expl. 1.1,Notified C&L,1,H201:1
48118,3-(azidopropyl)triethoxysilane,280-374-1,83315-69-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,REACH registration C&L,17,H311:3;H331:2;H301:2;H312:14;H302:15;H315:15
48121,1-[(2-hydroxyethyl)thio]propan-2-ol,229-765-0,6713-03-7,Eye Irrit. 2,REACH registration C&L,2,H319:1;Not classified:1
48124,2-bromo-1-(3-nitrophenyl)ethan-1-one,218-764-0,2227-64-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,47,H314:47;H318:40;H290:1
48125,Minoxidil,253-874-2,38304-91-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,75,H319:42;H302:74;H315:42;H335:42;H361:31;H351:30;H301:1
48137,"Propanamide, 2-amino-3-mercapto-, hydrochloride (1:1), (2R)-",605-332-5,16359-98-1,Not Classified,Notified C&L,1,Not classified:1
48140,"Tris[8-[2-(octa-2,5-dien-1-yl)oxiranyl]octanoato-O1](propan-2-olato)titanium",272-278-3,68784-86-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H335:1
48142,"Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, mono-C11-14-isoalkyl ethers, C13-rich, phosphates",616-610-0,78330-24-2,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,121,H318:109;H412:89;H315:109;Not classified:12;H411:1
48143,"2-methylpyrimidine-4,6-diol",601-611-0,1194-22-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
48148,N-[2-(2-oxoimidazolidin-1-yl)ethyl]methacrylamide,221-426-5,3089-19-8,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Carc. 1B,Notified C&L,38,H315:38;H317:38;H335:38;H350:38;H318:38
48151,4-chlorobenzaldehyde,203-247-4,104-88-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,252,H315:251;H317:200;H302:252;H411:211;H319:251;H335:38;H410:1;H413:1;H371:1
48152,"(9Z,12Z)-octadeca-9,12-dienoic acid, diester with glycerol",250-259-0,30606-27-0,Not Classified,Notified C&L,1,Not classified:1
48153,"Glycerides, rape-oil mono-",287-834-0,85586-30-7,Not Classified,Notified C&L,1,Not classified:1
48157,"Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 6'-(diethylamino)-2'-[(2,4-dimethylphenyl)amino]-3'-methyl-",609-245-3,36431-22-8,Not Classified,Notified C&L,1,Not classified:1
48158,Ethyl 3-[(5-chloro-2-nitrophenyl)phenylamino]-3-oxopropionate,244-907-1,22316-45-6,Not Classified,REACH registration C&L,4,Not classified:4
48159,2-fluorophenylacetic acid,207-196-9,451-82-1,Skin Irrit. 2,Notified C&L,48,H315:47;H319:10;H335:8
48161,"3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indenyl propionate",272-805-7,68912-13-0,Aquatic Chronic 2,REACH registration C&L,366,H411:366
48162,"Trisodium 5,8-bis[[4-(1,1-dimethylethyl)-2-sulphonatophenyl]amino]-9,10-dihydro-1,4-dihydroxy-9,10-dioxoanthracene-2-sulphonate",280-118-9,83006-69-3,Not Classified,Notified C&L,2040,Not classified:2040
48166,4-aminobutyric acid,200-258-6,56-12-2,Not Classified,REACH registration C&L,367,Not classified:193;H319:174;H315:174;H335:174
48167,propoxycarbazone-sodium,605-920-1,181274-15-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
48168,"Slags, silicomanganese-manufg.",273-733-9,69012-33-5,Repr. 2,REACH registration C&L,14,H361:8;Not classified:6
48169,"2,7-dihydroxy-9H-fluoren-9-one",610-035-9,42523-29-5,Not Classified,REACH registration C&L,6,Not classified:2;H332:2;H312:2;H301:1;H302:1;H319:2;H315:2;H335:1
48178,"Tetrasodium 4,4'-[carbonylbis[imino(5-methoxy-2-methyl-4,1-phenylene)azo]]bis[5-hydroxynaphthalene-2,7-disulphonate]",217-708-2,1937-34-4,Not Classified,REACH registration C&L,24,Not classified:17;H319:3;H412:2;H413:2
48181,DL-2-aminopropan-1-ol,228-207-3,6168-72-5,Not Classified,Notified C&L,584,Not classified:441;H314:143;H318:85;H290:13
48183,"Extracts (petroleum), residual oil solvent",265-110-5,64742-10-5,Not Classified,REACH registration C&L,189,Not classified:111;H351:78
48184,Methotrexate,200-413-8,59-05-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Repr. 1B,Notified C&L,188,H360:184;H319:185;H315:184;H301:188;H340:41;H335:4;H351:3;H361:2;H341:5;H311:1;H331:1
48185,"3,7-dimethylocta-1,6-dien-3-ol;2-(4-methylcyclohex-3-en-1-yl)propan-2-ol;1-methyl-4-propan-2-ylbenzene;4-methyl-1-propan-2-ylbicyclo[3.1.0]hexan-4-ol;5-methyl-2-propan-2-ylphenol",616-910-1,8007-46-3,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,Notified C&L,192,H317:129;H315:111;H226:167;H413:111;H314:56;Not classified:25;H302:17;H411:18;H304:17;H318:4;H361:1
48189,Tetraethylammonium trifluoromethanesulphonate,252-781-4,35895-69-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
48190,N-benzyl-N-ethylaniline,202-169-8,92-59-1,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,46,H412:2;H302:44;H312:42;H311:1;H301:1;H315:1
48196,3-decen-2-one,234-059-0,10519-33-2,Not Classified,Notified C&L,127,Not classified:88;H319:39;H330:1;H315:1
48200,Cobalt dimolybdate,271-952-4,68647-47-2,Not Classified,Notified C&L,39,Not classified:32;H410:7;H317:7;H335:7;H400:7;H319:7;H373:7
48206,"1,1-diethoxyhexane",222-911-4,3658-93-3,Flam. Liq. 3,Notified C&L,1403,H226:1403
48209,Isopropyl anthranilate,242-074-9,18189-02-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
48214,"1,4-diamino-5-nitroanthraquinone",201-412-5,82-33-7,Not Classified,Notified C&L,2,Not classified:2
48215,Benzimidazol-5-ylamine,213-279-0,934-22-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,44,H319:43;H302:41;H315:5;H317:2;H335:4;Not classified:1
48217,5-bromo-4-chloro-3-indolyl hydrogen phosphate - p-toluidine (1:1),229-506-1,6578-06-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,23,H332:12;H312:13;H302:12;H319:9;H315:8;H335:8;H371:2;H317:1;H311:2;H400:1;H351:2;H331:2;H301:2
48218,Decahydronaphthalene,202-046-9,91-17-8,Flam. Liq. 3;Asp. Tox. 1;Skin Corr. 1C;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,272,H410:138;H314:267;H400:138;H331:232;H226:232;H304:204;H318:106;H411:112;H332:40;H413:22;H315:5;H335:5;H319:5;H371:1
48219,"Amides, C6-12, N,N-bis(hydroxyethyl)",270-412-5,68439-61-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:3;H315:3
48224,"ALCOHOLS, C12-14, ETHOXYLATED, PROPOXYLATED",614-484-1,68439-51-0,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1103,H410:619;H400:729;H319:575;H412:171;Not classified:101;H304:90;H411:50;H318:80;H315:24;H302:7
48225,3-pyridyl acetate,241-742-7,17747-43-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
48227,1-nitroanthraquinone,201-413-0,82-34-8,Acute Tox. 4,Notified C&L,1,H302:1
48232,Urapidil,252-130-4,34661-75-1,Acute Tox. 4,Notified C&L,126,H302:125;H319:38;H315:38;H335:38;Not classified:1
48239,cyclopentanone,204-435-9,120-92-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0,H319:0;H315:0;H226:0
48240,N-methyldidocosylamine,262-740-2,61372-91-6,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,33,H412:33;H314:33;H302:33
48241,(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin,430-730-9,,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H318:0
48242,p-anisohydrazide,221-952-5,3290-99-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
48243,2-(4-aminophenyl)-1H-benzimidazol-2-amine,231-538-6,7621-86-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,36,H332:33;H312:33;H302:33;H341:1;H319:1;H315:1;H372:1;H360:1;H317:1;H412:1;Not classified:1
48244,(R)-(-)-2-Methylpyrrolidine,609-954-8,41720-98-3,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B,Notified C&L,39,H225:39;H314:39;H302:39
48247,"Citric acid, potassium salt",231-905-0,7778-49-6,Not Classified,Notified C&L,14,Not classified:14
48248,2-bromo-4-fluorotoluene,215-830-0,1422-53-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46;H332:1;H312:1;H302:1
48249,3-(hydroxymethyl)octan-2-one,261-652-1,59191-78-5,Not Classified,Notified C&L,88,Not classified:88
48254,3-[2-(dimethylamino)ethoxy]propylamine,265-825-2,65573-13-9,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,8,H314:8;H311:8;H302:8;H411:8;H318:8
48255,"2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium oxalate",282-165-0,84100-86-7,Not Classified,Notified C&L,2,Not classified:2
48256,"oxamyl (ISO);N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate",245-445-3,23135-22-0,Acute Tox. 2;Acute Tox. 4;Acute Tox. 2;Aquatic Chronic 2,Harmonised C&L,0,H330:0;H312:0;H300:0;H411:0
48258,Crotetamide,228-208-9,6168-76-9,Not Classified,Notified C&L,1,Not classified:1
48262,"Tetrasodium 3-[[4-[[4,6-bis-[(3-sulfonatoprop-1-yl)thio]-1,3,5-triazin-2-yl]amino]-2-methyl-5-methoxy-phenyl]azonaphthalene-1,5-disulfonate",421-950-6,,Not Classified,Notified C&L,2038,Not classified:2038
48266,Tin tetrahydroxide,235-011-1,12054-72-7,Not Classified,Notified C&L,1,Not classified:1
48271,4-chloro-2-nitrotoluene,201-921-2,89-59-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:44;H315:44;H335:38;H332:5;H312:5;H302:7;H411:5;H373:7;H311:3;H330:3;H301:3
48276,"Sodium [2S-(2α,5α,6β)]-6-[[[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",206-444-3,343-55-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,2,H334:2;H317:2;H315:1;H335:1;H319:1
48290,"2,2,3,3,4,4,5-heptafluorotetrahydro-5-(nonafluorobutyl)furan",206-389-5,335-36-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;H413:1
48291,(2S)-2-(benzyloxy)-1-(pyrrolidin-1-yl)propan-1-one,601-832-2,122151-32-0,Acute Tox. 3,Notified C&L,1,H301:1
48294,"5-iodo-1H-indole-2,3-dione",244-035-1,20780-76-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H317:38;H335:40;H302:40;H319:41;H332:2;H312:2
48298,"methabenzthiazuron (ISO);1-(1,3-benzothiazol-2-yl)1,3-dimethylurea",242-505-0,18691-97-9,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
48299,"L-Histidine, 1-(triphenylmethyl)-",609-078-6,35146-32-8,Not Classified,Notified C&L,1,Not classified:1
48301,"3,4-dichloro-N-(4-chlorophenyl)benzenesulphonamide",211-365-2,640-59-5,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H332:1;H319:1;H302:1;H335:1
48302,Tantalum phosphide,234-860-5,12037-63-7,,Notified C&L,4,H319:4;H315:4;H335:4
48303,2-Mercaptothiazole,611-429-3,5685-05-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H302:38;H315:38;H335:38
48306,"quaternary ammonium compounds, benzyl-C",264-151-6,63449-41-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Harmonised C&L,0,H400:0;H312:0;H302:0;H314:0
48311,5-amino-1H-imidazole-4-carbonitrile,225-816-6,5098-11-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H302:38;H318:38;H315:1;H311:1;H319:1;H331:1;H301:1
48312,"4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenylacetic acid",200-649-1,67-30-1,Acute Tox. 2,Notified C&L,40,H300:40
48313,"pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate",423-790-2,,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0;H318:0
48314,2-(4-tert-butylphenyl)ethanol,410-020-5,5406-86-0,Eye Dam. 1;STOT RE 2;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H361:0;H318:0;H411:0;H373:0
48318,"3-(1,5-Disulfo-naphthalene-2-ylazo)-5-[4-(3-ethenesulfonyl-phenylamino)-6-fluoro-[1,3,5]triazin-2-ylamino]-4-hydroxy-naphthalene-2,7-disulfonic acid as sodium salt",461-680-6,1443224-69-8,Skin Sens. 1B;Eye Dam. 1,Notified C&L,1,H317:1;H318:1
48319,"2,3-dimethyl-4-nitroso-1-phenyl-3-pyrazolin-5-one",212-941-6,885-11-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
48325,"Dihydrogen bis[P-butyl P-octyl diphosphato(2-)-O'',O''''][hydroxyacetato(2-)-O1,O2]titanate(2-), branched and linear, compound with dioctyl phosphonate, branched and linear",271-567-1,68585-60-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H226:1;H335:1
48328,Chloro(methyl)silane,213-600-4,993-00-0,Flam. Gas 1;Water-react. 3;Press. Gas (Comp.);Skin Corr. 1A,REACH registration C&L,50,H220:50;H314:50;H280:50;H261:50
48329,"Phosphorodithioic acid, mixed O,O-bis(iso-Bu and pentyl) esters, zinc salts",270-608-0,68457-79-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,922,H318:891;H315:922;H411:916;H319:31;H400:1
48330,2-furonitrile,210-537-4,617-90-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,Notified C&L,43,H332:43;H302:43;H312:39;H318:38;H226:43;H311:4;H315:1;H319:1
48331,5-benzyl-3-furylmethanol,243-802-8,20416-09-5,Not Classified,Notified C&L,1,Not classified:1
48341,"1-Propanamine, 3-[methylbis[(trimethylsilyl)oxy]silyl]-",610-012-3,42292-18-2,,Notified C&L,1,H314:1
48343,"Benzenamine, 2-(2,2-dimethoxyethyl)-",604-752-6,150760-45-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,33,H319:33;H302:33
48344,red phosphorus,918-594-3,,Flam. Sol. 1;Aquatic Chronic 3,REACH registration C&L,42,H228:41;H412:41;Not classified:1
48346,"dalapon;2,2-dichloropropionic acid",200-923-0,75-99-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H412:0;H315:0
48348,"Poly(oxy-1,2-ethanediyl), α,α'-[(methyloctadecyliminio)di-2,1-ethanediyl]bis[ω-hydroxy-, methyl sulfate (1:1)",609-519-2,38096-68-3,Eye Dam. 1;Acute Tox. 3,Notified C&L,49,H318:48;H331:47;H315:1;H411:2;H319:1
48349,"2-(3-hydroxy-2-quinolyl)-1H-indene-1,3(2H)-dione",231-474-9,7576-65-0,Not Classified,Notified C&L,2251,Not classified:2137;H317:90;H411:20;H413:3;H319:2;H315:1;H341:1;H351:1
48351,"Ashes (residues), rice husk",275-735-5,71630-92-7,STOT RE 2,REACH registration C&L,61,H373:21;Not classified:21;H372:19
48352,Diallyl ether,209-174-4,557-40-4,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H332:38;H315:39;H335:38;H311:39;H302:39;H225:39;H319:39
48360,2'-hydroxyacetophenone,204-288-0,118-93-4,Not Classified,REACH registration C&L,227,Not classified:155;H319:48;H315:48;H335:47;H302:25
48361,methyl 5-chloro-2-hydroxy-1-oxo-indane-2-carboxylate,604-399-8,144172-24-7,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1,Notified C&L,122,H400:122;H302:122;H318:122
48366,Boehmite (Al(OH)O),215-284-3,1318-23-6,Not Classified,REACH registration C&L,294,Not classified:293;H332:1;H302:1
48372,Bis(2-hydroxyethyl)ammonium acetate,245-524-2,23251-72-1,Not Classified,REACH registration C&L,66,Not classified:65;H319:1;H317:1;H315:1
48373,"2,3,4-trimethoxybenzylamine",255-268-3,41219-16-3,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H314:1;H302:1;H335:1
48374,3-methylhexan-3-ol,209-910-4,597-96-6,Acute Tox. 4,Notified C&L,42,H302:42;H226:4
48375,MEXORYL SAJ,439-720-9,,Skin Sens. 1,Notified C&L,1,H317:1
48376,"Dihydro-3-(tetradecenyl)furan-2,5-dione",251-682-3,33806-58-5,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,34,Not classified:33;H318:33;H317:33;H315:34;H319:1
48378,1-hydroxy-4-[[4-[(methylsulphonyl)oxy]phenyl]amino]anthraquinone,216-475-4,1594-08-7,Skin Sens. 1B,REACH registration C&L,100,H317:17;Not classified:83;H410:2;H400:2
48379,"(1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol",930-010-9,461432-25-7,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H400:2
48381,"α-[1-(tert-butylamino)ethyl]-2,5-dimethoxybenzyl alcohol hydrochloride",227-169-5,5696-15-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
48382,"Di-tert-butyl 1,1,4,4-tetramethylbut-2-yn-1,4-ylene diperoxide",213-944-5,1068-27-5,Org. Perox. C;Aquatic Chronic 2,REACH registration C&L,47,H242:5;H411:5;H319:38;H315:38;H241:42;H413:4
48397,Distilled acetalization product between glucose and C12-18(even numbered)alcohol,922-178-7,,Not Classified,Notified C&L,1,Not classified:1
48398,"4-tert-butyl-3-methoxy-2,6-dinitrotoluene",201-493-7,83-66-9,Acute Tox. 4,Notified C&L,134,H302:134;H315:39;H319:1;H317:1
48400,"(S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione",444-280-6,7689-03-4,Acute Tox. 3,Notified C&L,3,H301:2;H362:1;H340:2;H372:1;H361:1;H413:1;H350:1;H300:1;H315:1;H335:1;H319:1
48401,Quinine hydrogen sulphate,208-970-9,549-56-4,Acute Tox. 4;Skin Sens. 1A,REACH registration C&L,129,H317:127;H302:3;H315:127;H335:127;H334:88;H319:127;H332:1;H312:1
48402,2-nitro-m-toluic acid,226-610-9,5437-38-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
48407,tert-butyl 2-oxopyrrolidine-1-carboxylate,617-776-7,85909-08-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,45,H319:45;H315:45;H335:45
48408,"Distillates (petroleum), hydrodesulfurized heavy catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C",269-784-1,68333-28-8,Carc. 1B,Harmonised C&L,0,H350:0
48415,Sodium pyridine-3-sulphonate,239-561-3,15521-77-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
48416,Dipotassium tetraoxomolybdate,236-599-2,13446-49-6,Not Classified,REACH registration C&L,639,Not classified:119;H319:520;H315:520;H335:520
48417,Tetraammonium pyrophosphate,237-371-5,13765-35-0,Not Classified,Notified C&L,2,Not classified:2
48420,N-(4-hydroxyphenyl)nonan-1-amide,202-991-7,101-95-1,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,38,H302:38;H411:38
48423,5-amino-6-methyluracil,228-452-6,6270-46-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H302:38;H315:38;H335:38
48426,"Gases (petroleum), deethanizer overheads;Petroleum gas;[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]",270-768-1,68477-86-1,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;Not classified:0;H350:0
48430,Bismuth iodide oxide,232-126-9,7787-63-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H332:40;H315:40;H312:40;H335:40;H302:40;H319:40
48433,1-benzyl-4-(cyclohexylamino)piperidine-4-carboxamide,213-869-8,1042-35-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H315:38;H335:38
48434,"(3S)-3-{[(2S)-4-amino-2-{[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino}-4-oxobutanoyl]amino}-4-{[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(1R)-2-carboxy-1-methylethyl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontan-30-yl]amino}-4-oxobutanoic acid",600-389-2,103060-53-3,STOT RE 2,Notified C&L,40,H373:35;H317:1;H319:2;H315:2;H311:1;H302:1;Not classified:1
48436,"1,1,1,3-tetrachloroacetone",241-075-1,16995-35-0,Acute Tox. 3;Acute Tox. 2,Notified C&L,1,H310:1;H301:1
48437,Thioacetic acid,208-063-8,507-09-5,Flam. Liq. 2;Acute Tox. 3;Skin Sens. 1A;Eye Dam. 1,REACH registration C&L,172,H225:172;H317:115;H318:45;H301:56;H314:163;H302:104;H331:7;H330:4;H351:4;H332:2
48441,Estradiol,200-023-8,50-28-2,Carc. 2;Repr. 1A;Lact.;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,154,H362:48;H410:53;H360:144;H400:46;H351:89;H372:53;H350:61;Not classified:3;H373:3;H361:1;H411:2;H413:1
48449,"Cyclohexanol, 4-methylene-3-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexenyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1S,3Z)-",606-742-7,21343-40-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2;STOT RE 1,Notified C&L,38,H311:38;H372:38;H330:38;H301:38
48450,"Octanoic acid, compound with 2,2'-iminodiethanol (1:1)",240-600-1,16530-72-6,Not Classified,Notified C&L,26,Not classified:25;H319:1;H315:1
48451,Insulin (ox),234-291-2,11070-73-8,Resp. Sens. 1,Notified C&L,16,H334:16
48453,"D-fructose 1,6-bis(dihydrogen phosphate)",207-683-6,488-69-7,Not Classified,Notified C&L,1,Not classified:1
48456,Diethyl isobutylmalonate,233-504-6,10203-58-4,Acute Tox. 4,Notified C&L,39,H302:38;Not classified:1
48461,4'-nitroacetophenone,202-827-4,100-19-6,,Notified C&L,8,H302:8;H319:2;H315:1;H335:1
48472,"3,6-Bis-biphenyl-4-yl-2,5-dihydro-pyrrolo[3,4-c]-pyrrole-1,4-dione",413-920-6,,Not Classified,Notified C&L,115,Not classified:115
48474,o-benzylbenzoic acid,210-305-2,612-35-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
48475,4-amino-m-cresol,220-621-2,2835-99-6,Acute Tox. 4;Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,127,H410:51;H400:73;H317:74;H302:126;H319:109;H315:101;H335:94;H411:9;H332:4;H312:4;Not classified:1
48481,"4-ethyl-2-methyl-4,5-dihydrothiazole",224-297-3,4293-61-2,Flam. Liq. 3,Notified C&L,1,H226:1
48482,"Quaternary ammonium compounds, C12-18-alkylbis(hydroxyethyl)methyl, chlorides",276-038-9,71808-53-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1,H410:1;H314:1;H400:1;H302:1;H411:1;H318:1
48485,α1-39-Corticotropin (pig),232-946-7,9061-27-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,39,H332:39;H312:39;H302:39;H351:39
48488,Ivermectin,274-536-0,70288-86-7,Acute Tox. 2;Acute Tox. 3;Repr. 2;STOT RE 2;Aquatic Acute 1,Notified C&L,334,H311:276;H400:282;H361:170;H300:329;H373:160;H410:42;H372:37;H370:37;Not classified:3;H312:4;H301:2;H360:2;H319:1;H362:2
48493,4-phenoxyaniline,205-367-2,139-59-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:41;H317:46;H335:41;H302:47;H319:46;H410:7;H341:8;H400:7;H412:1
48495,3-(2-ammonioethyl)-5-hydroxy-1H-indolium oxalate,221-233-6,3036-16-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H302:38
48502,Escin,229-880-6,6805-41-0,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,126,H332:99;H335:59;H302:125;H411:59;H319:60;Not classified:1;H315:1
48504,isopropyl formate,210-901-2,625-55-8,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Harmonised C&L,0,H225:0;H319:0;H336:0;H335:0
48506,4-amino-5-chloro-2-methoxybenzoic acid,230-582-3,7206-70-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H315:45;H335:44;H302:1
48509,"Benzenemethanol, α-[(1S)-2-(dimethylamino)-1-methylethyl]-α-ethyl-3-methoxy-, (αR)-",617-182-8,809282-20-0,Not Classified,Notified C&L,3,Not classified:2;H302:1;H318:1
48517,"Hexahydro-1,4,10,10-tetramethyl-1H,4H-3a,8a-epoxy-4,7-methanoazulene",266-961-5,67710-71-8,Not Classified,Notified C&L,88,Not classified:88
48518,"Sodium [2S-(2α,5α,6β)]-6-[[(2-ethoxy-1-naphthyl)carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",213-574-4,985-16-0,Skin Sens. 1;Resp. Sens. 1,Notified C&L,41,H334:39;H317:39;H341:1;H302:1;H319:1;H315:1;H335:1
48520,Diethyl octylphosphonate,213-941-9,1068-07-1,,Notified C&L,5,H319:4;H315:4;Not classified:1
48524,"reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate",419-450-8,,Skin Sens. 1,Harmonised C&L,0,H317:0
48525,"(R*,R*)-(±)-1,4-dimercaptobutane-2,3-diol",248-531-9,27565-41-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,92,H319:84;H302:90;H315:84;H335:83;H332:8;H312:8
48526,"[1,1'-bicyclopentyl]-2-yl 2-butenoate",268-280-9,68039-73-6,Not Classified,Notified C&L,261,Not classified:207;H411:43;H410:11;H400:11;H315:11
48527,"Ferrocene, 1,1',2,2',3,3',4,4',5,5'-decamethyl-",601-765-9,12126-50-0,,Notified C&L,6,H319:6;H315:6;H335:6
48528,Bis[bis(2-hydroxyethyl)ammonium hydrogen phosphate,250-935-5,32154-53-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,25,H319:25;H315:25
48532,"5-chloro-2,4,6-trifluoropyrimidine",211-807-4,697-83-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
48536,p-tolylacetaldehyde,203-173-2,104-09-6,Skin Sens. 1,Notified C&L,353,H317:315;H318:38
48538,Di-p-tolylcarbodiimide,211-971-7,726-42-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H332:38;H315:38;H312:38;H335:38;H302:38;H319:38
48543,2-Methyltetrahydrofuran-3-thiol acetate,619-647-0,252736-41-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,11,H319:10;H302:10;H315:10;H335:10;Not classified:1
48545,piperidine,203-813-0,110-89-4,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Harmonised C&L,0,H311:0;H225:0;H314:0;H331:0
48546,"1,2,4-Thiadiazole-3-ethanethioic acid, 5-amino-alpha-[(triphenylmethoxy)imino]-, S-2-benzothiazolyl ester, (alphaZ)-",447-420-4,,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H410:1;H400:1
48547,Lithium Citrate Tetrahydrate,612-032-8,6080-58-6,Acute Tox. 4,REACH registration C&L,65,H302:27;H319:38;H315:38;H335:38
48549,SILCARE 1M75,435-930-1,,Not Classified,Notified C&L,33,Not classified:33
48551,"α-d-Glucopyranoside, β-d-fructofuranosyl, hexadecanoate",254-410-1,39300-95-3,Not Classified,Notified C&L,31,Not classified:31
48555,"D-Glucose, 6-(dihydrogen phosphate), monosodium salt",258-921-0,54010-71-8,Not Classified,Notified C&L,1,Not classified:1
48560,"[1R(1α,4aβ,4bα,10aα)]-1,2,3,4,4a,4b,5,6,10,10a-decahydro-7-isopropyl-1,4a-dimethylphenanthren-1-carbonyl chloride",260-024-4,56151-64-5,Skin Corr. 1B,Notified C&L,1,H314:1
48566,"[1,3-dihydro-5,6-bis[[(2-hydroxy-1-naphthyl)methylene]amino]-2H-benzimidazol-2-onato(2-)-N5,N6,O5,O6]nickel",255-965-2,42844-93-9,Not Classified,REACH registration C&L,74,Not classified:74
48567,"Solvent naphtha (petroleum), heavy arom.; Kerosine - unspecified;[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",265-198-5,64742-94-5,Asp. Tox. 1,Harmonised C&L,0,H304:0
48568,Trichloro(3-chloropropyl)silane,219-844-8,2550-06-3,Acute Tox. 4;Skin Corr. 1A,REACH registration C&L,38,H314:38;H302:30;H290:1;H318:1
48575,"1,2,4-trimethyl-5-nitrobenzene",210-238-9,610-91-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H332:42;H315:43;H312:43;H335:43;H302:43;H319:43
48578,"2,3:4,5-Di-O-isopropylidene-beta -D-fructopyranose",606-663-8,20880-92-6,,Notified C&L,2,H319:1;H315:1;H335:1;Not classified:1
48581,"2,4-difluorobenzylamine",276-502-0,72235-52-0,Skin Corr. 1B,Notified C&L,48,H314:48;H318:1;H319:1;H335:1
48587,"Reaction mass of 4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 3-aminomethyl-3,5,5-trimethylcyclohexylamine and 4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with trimethylhexane-1,6-diamine",919-956-3,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,46,H317:46;H302:46;H411:46
48591,"2,4'-dimethylpropiophenone",256-572-9,50390-51-7,Acute Tox. 4,Notified C&L,63,H302:38;H317:25
48593,Ethyl phenylcarbamate,202-995-9,101-99-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
48594,Tobramycin sulphate,256-499-2,49842-07-1,Acute Tox. 4;Acute Tox. 4;Repr. 1B,Notified C&L,91,H332:90;H360:90;H312:90;H361:1
48597,"4-[(4-aminophenyl)azo]-N,N-dimethylaniline",208-712-5,539-17-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
48601,2-[2-(2-{2-[2-(11-methyl-dodecyloxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethanol,616-609-5,78330-21-9,Eye Dam. 1,Notified C&L,1408,H318:1051;H302:335;H400:373;H315:392;H412:234;H319:134;H317:55;Not classified:45;H410:15;H411:24;H314:1
48603,Dihydrothiophen-3(2H)-one,213-698-9,1003-04-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1547,H319:1387;H302:1447;H315:1387;H335:1386
48604,Trisodium hydrogendicarbonate,208-580-9,533-96-0,Eye Irrit. 2,REACH registration C&L,246,H319:221;H315:39;H335:38;Not classified:24
48605,Trichloroacetyl chloride,200-926-7,76-02-8,Not Classified,REACH registration C&L,55,Not classified:3;H330:49;H314:53;H302:54;H290:4;H318:6;H315:1;H335:1;H319:1
48609,Bicyclo[2.2.1]hept-5-ene-2-carbaldehyde,226-698-9,5453-80-5,Flam. Liq. 3,Notified C&L,47,H226:47;H319:1;H315:1;H335:1
48610,"2,5-dimethyl-3-furoic acid",211-257-5,636-44-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
48618,Residue product of formaldehyde and propionaldehyde condensation and hydrogen peroxide oxidation followed by filtration and concentration.,922-433-2,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
48619,Tridecyl laurate,253-152-7,36665-67-5,Not Classified,Notified C&L,2,Not classified:2
48620,"Fatty acids, tallow, hydrogenated, reaction products with diethanolamine",294-347-7,91697-85-7,Not Classified,Notified C&L,485,Not classified:479;H319:6;H315:6
48621,"3,4-dimethylbenzenethiol",242-587-8,18800-53-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H332:4;H312:4;H302:4;H227:1
48623,Potassium 4-chloro-o-tolyloxyacetate,226-015-4,5221-16-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,229,H410:146;H332:229;H400:146;H302:229;H312:229;H361:55
48624,"2,3-dihydro-1-methyl-1H-phosphole 1-oxide",212-826-0,872-45-7,Not Classified,Notified C&L,33,Not classified:33
48626,"Fatty acids, coco, esters with 3,3'-oxybis[1,2-propanediol]",285-089-6,85029-63-6,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,34,H317:1;H412:1;Not classified:33
48628,"(1R,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene",232-087-8,7785-70-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1429,H410:1281;H315:1196;H400:1275;H226:1424;H304:1345;H317:1381;H319:81;H335:38;H332:38;H302:51;H411:42;H312:38;Not classified:5;H318:1
48636,2-chloro-4-nitropyridine 1-oxide,238-404-6,14432-16-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,43,H315:43;H335:42;H311:39;H319:43;H331:39;H301:39
48640,Sodium antimonate,239-444-7,15432-85-6,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,145,H332:131;H302:131;H411:131;Not classified:13;H412:1
48644,o-tolylacetic acid,211-416-9,644-36-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,103,H319:103;H315:103;H335:102
48648,"Fatty acids, tall-oil, iso-Pr esters",267-063-6,67785-17-5,Not Classified,Notified C&L,3,Not classified:3
48654,"1,3-dimethyl-1,1,3,3-tetraphenyldisiloxane",212-361-3,807-28-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,65,H319:41;H315:41;H335:41;Not classified:22;H413:4
48656,Diisopropyl phthalate,210-086-3,605-45-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,40,H351:38;H319:39;H315:39;H335:38;Not classified:1
48659,"Fatty acids, C18-unsatd., dimers, reaction products with polyethylenepolyamines",614-452-7,68410-23-1,Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1097,H318:578;H317:106;H315:979;H411:97;H319:487;H410:82;H400:39;H335:4;H334:2;Not classified:1;H314:2;H312:2
48661,α-tocopherol,200-412-2,59-02-9,Not Classified,REACH registration C&L,281,Not classified:262;H317:19;H413:18
48663,Carbazamidine monohydrochloride,217-707-7,1937-19-5,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,76,H317:34;H411:1;H319:75;H315:75;H335:74;H360:33
48664,"Licorice, Glycyrrhiza lepidota, ext., calcium salts",308-973-6,99328-55-9,Not Classified,Notified C&L,1,Not classified:1
48665,"2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethoxy]triethylammonium decyl sulphate",242-502-4,18684-60-1,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H318:1;H315:1;H411:1
48666,"chlorobenzilate (ISO);ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate;ethyl 4,4'-dichlorobenzilate",208-110-2,510-15-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H302:0
48669,"Lubricating oils (petroleum), C",276-736-3,72623-85-9,Carc. 1B,Harmonised C&L,0,H350:0
48672,N-(2-benzoyl-4-chlorophenyl)-2-bromoacetamide,251-107-6,32580-26-0,Not Classified,REACH registration C&L,4,Not classified:2;H410:1;H400:1;H332:1;H315:1;H312:1;H335:1;H302:1;H319:1
48674,"Benzenesulfonic acid, 2-[2-[5-(aminocarbonyl)-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl]diazenyl]-4-[[4-chloro-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2)",605-067-5,156653-67-7,Not Classified,Notified C&L,1,Not classified:1
48675,2-methylhept-2-ene,211-022-7,627-97-4,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,38,H225:38;H304:38
48676,C.I. Acid Blue 350,604-057-8,138067-74-0,Not Classified,Notified C&L,4,Not classified:2;H411:2
48677,"4,5-dimethoxyanthranilic acid",227-095-3,5653-40-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
48682,"Ethane-1,2-diylbis(oxyethane-2,1-diyl) bisheptanoate",231-081-2,7434-40-4,Not Classified,Notified C&L,2,Not classified:2
48684,"(3-carboxy-1,1'-(1,2-dicyanovinylenebis(nitrilomethylidyne)-2,2'-dinaphtholato)nickel(II)",403-550-3,205057-15-4,Not Classified,Notified C&L,2041,Not classified:2041
48687,"7 beta-Hydroxy-3 beta,15 alpha-dipivaloyloxy-5-androsten-17-one",617-708-6,85390-94-9,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H410:3;H400:3
48688,"Methyl 2,4-Difluorobenzoate",600-756-7,106614-28-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H318:40;H302:40;H315:42;H335:40;H319:2
48690,C.I. Acid Brown 50,600-997-8,11075-38-0,Not Classified,Notified C&L,1,Not classified:1
48693,GDS 2000,448-320-3,,Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4,Notified C&L,1,H332:1;H317:1;H314:1;H290:1;H302:1;H312:1;H318:1
48695,1-chlorobutan-2-one,210-473-7,616-27-3,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H410:1;H315:2;H310:1;H335:2;H330:1;H400:2;H319:2;H226:2;H301:2;H311:1;H331:1
48696,Veratrole,202-045-3,91-16-7,Acute Tox. 4,REACH registration C&L,1691,H302:1691;Not classified:1
48699,Tetrahydrofurfuryl bromide,214-750-3,1192-30-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H302:38;H315:45;H335:43;H227:1
48701,Deoxybenzoin,207-193-2,451-40-1,Not Classified,REACH registration C&L,2,Not classified:2
48702,ethyl propoxy aluminium chloride,421-790-7,13014-29-4,Water-react. 1;Skin Corr. 1A,Harmonised C&L,0,H314:0;H260:0
48707,"4,4-(1-Methylethyliden)-bis-[2,6-bis-(dimethylaminomethyl)-phenol]",605-281-9,16224-36-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,25,H319:25;H302:25;H315:25
48709,(diphenylmethyl)triphenylphosphonium chloride,216-229-6,1530-43-4,,Notified C&L,4,H319:4;H315:4;H335:4
48710,"2,4,4,7-tetramethylnona-6,8-dien-3-one",279-816-6,81782-89-0,Aquatic Chronic 3,Notified C&L,1374,H412:1286;Not classified:88
48711,"Tetrasodium [2-[[α-[[3-[[4-fluoro-6-(3-sulphoanilino)-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulphophenyl]azo]benzyl]azo]-4-sulphobenzoato(6-)]cuprate(4-)",272-804-1,68912-12-9,Not Classified,Notified C&L,1,Not classified:1
48713,"Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;Low boiling point cat-cracked naphtha.;[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.]",295-311-3,91995-50-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0;H304:0
48718,"Bulnesia sarmienti, ext.",289-632-8,89958-10-1,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1511,H317:68;H315:44;H411:44;H226:1286;Not classified:157
48723,"L-Ascorbic acid, mono(dihydrogen phosphate), magnesium salt (1:1)",601-295-4,114040-31-2,Not Classified,Notified C&L,2,Not classified:2
48724,nicotine (ISO); 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine,200-193-3,54-11-5,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Aquatic Chronic 2,Harmonised C&L,0,H310:0;H330:0;H300:0;H411:0
48725,2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate,426-400-9,170222-39-6,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
48726,"Benzoic acid, C9-11 , C10-rich, branched alkyl esters",421-090-1,131298-44-7,Not Classified,Notified C&L,15,Not classified:14;H332:1
48727,Magnesium dodecylbenzenesulphonate,248-489-1,27479-45-4,Not Classified,Notified C&L,6,Not classified:5;H319:1;H302:1;H315:1
48728,"1-(N,N-bis(2-hydroxyethyl)amino)propan-2-ol",229-764-5,6712-98-7,Not Classified,REACH registration C&L,223,Not classified:166;H319:57;H361:55;H315:1
48729,"1,5-Naphthalenedisulfonic acid, 2-[[1-hydroxy-6-(methylamino)-3-sulfo-2-naphthalenyl]azo]-, sodium salt",604-470-3,145417-43-2,Not Classified,REACH registration C&L,2,Not classified:2
48731,BB 331,468-980-6,,Aquatic Chronic 4,Notified C&L,1,H413:1
48733,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with 2-(chloromethyl)oxirane and 2-methyl-1,5-pentanediamine",618-210-1,887325-96-4,Not Classified,Notified C&L,22,Not classified:22
48735,3-fluoro-α-methylbenzyl alcohol,206-950-4,402-63-1,,Notified C&L,6,H319:6;H315:6;H335:6
48736,"Naphthalene-1,4-diol",209-336-4,571-60-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,39,H315:39;H335:38;H412:38;H302:39;H318:39
48742,9-ethylcarbazole,201-660-4,86-28-2,Aquatic Chronic 2,REACH registration C&L,81,H411:3;H319:45;H315:45;H335:43;Not classified:33
48744,"phosalone (ISO);S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate",218-996-2,2310-17-0,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H332:0;H317:0;H400:0;H312:0;H301:0
48746,2-ethylhexyl diphenyl phosphate,214-987-2,1241-94-7,Not Classified,REACH registration C&L,870,Not classified:232;H410:572;H400:612;H411:66;H332:36
48748,2-tert-butylanthraquinone,201-531-2,84-47-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1
48752,4-Cyano-3-fluorophenyl 4-Pentylbenzoate,617-920-9,86786-89-2,Aquatic Chronic 4,Notified C&L,2,Not classified:1;H413:1;H332:1;H315:1;H312:1;H302:1;H319:1
48753,(nonylphenyl) hydrogen phosphonate,301-777-1,94060-69-2,Not Classified,Notified C&L,1,Not classified:1
48757,1-Oxaspiro[4.5]decan-2-one,478-240-4,699-61-6,Acute Tox. 4,Notified C&L,25,H302:25
48758,guanidinium benzoate,429-820-0,26739-54-8,Acute Tox. 4,Harmonised C&L,0,H302:0
48761,2-(Methacryloyloxyethyl)-2'-((trimethylammonium)ethyl)phosphate,417-560-0,67881-98-5,Skin Sens. 1,Notified C&L,2,H317:2
48766,Bismuth trichloride,232-123-2,7787-60-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,104,H319:100;H315:100;H314:4;Not classified:1;H335:1
48767,"1,2-diaminoanthraquinone",217-156-2,1758-68-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:38
48770,"Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",269-626-1,68308-06-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;Not classified:0;H350:0
48772,"Quaternary ammonium compounds, [2-[[2-[(2-carboxyethyl)(2-hydroxyethyl)amino]ethyl]amino]-2-oxoethyl]coco alkyldimethyl, hydroxides, inner salts",309-206-8,100085-64-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,7,H400:7;H319:7;H315:7
48777,1-[4-chloro-3-(trifluoromethyl)phenyl]piperazine,255-267-8,41213-04-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H319:91;H315:91;H335:91
48779,"9-Octadecenoic acid, 12-hydroxy-, [R-(Z)]-, ester with 1,2,3-propanetriol",261-327-4,58561-47-0,Not Classified,Notified C&L,1,Not classified:1
48780,"dodemorph (ISO);4-cyclododecyl-2,6-dimethylmorpholine",216-474-9,1593-77-7,Skin Corr. 1C;Skin Sens. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H410:0;H317:0;H314:0;H400:0;H361:0;H373:0
48783,"Amides, vegetable-oil, N-[3-(diethylamino)propyl]",277-721-4,74113-67-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:2;H315:2
48786,Holmium tribromide,237-524-6,13825-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:44
48789,"2-PROPENOIC ACID, 2-METHYL-, 2-(DIMETHYLAMINO)ETHYL ESTER, POLYMER WITH 1-ETHENYL-2-PYRROLIDINONE",611-022-0,53633-54-8,Aquatic Chronic 2,Notified C&L,236,H411:171;H412:30;H410:35;H400:13
48790,4-chlorobut-1-ene,213-160-3,927-73-1,Flam. Liq. 2;Acute Tox. 4,Notified C&L,2,H225:2;H302:2;H319:1;H315:1
48794,Decyl anthranilate,242-077-5,18189-07-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,534,H319:446;H315:446;H413:446;Not classified:88
48796,2-(2-carboxyvinyl)benzoic acid,210-308-9,612-40-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
48799,"cis-2-(acryloyloxy)ethyl hydrogen cyhexane-1,2-dicarboxylate",478-080-5,,Skin Corr. 1C;Skin Sens. 1;Resp. Sens. 1A;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,2,H317:2;H314:2;H412:2;H402:2;H334:2
48804,N-(carboxymethyl)-N-(phosphonomethyl)glycine,227-824-5,5994-61-6,Eye Dam. 1;STOT SE 3,REACH registration C&L,42,H318:3;H335:3;H314:39
48807,Bis[(3-hydroxyphenyl)ammonium] sulphate,269-475-1,68239-81-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,23,H332:21;H315:10;H302:21;H411:18;H319:10;H312:3;Not classified:2
48809,ι-Carrageenan,232-949-3,9062-07-1,,Notified C&L,42,Not classified:42
48811,"9,10-Deepithio-9,10-didehydroacanthifolicin",616-589-8,78111-17-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Acute Tox. 3,Notified C&L,41,H311:40;H315:40;H331:40;H301:41
48815,"2,4'-difluorobenzophenone",206-441-7,342-25-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,46,H319:46;H315:46;H411:2;H335:40
48821,"1,2,3-propanetriyl tris(12-hydroxyoctadecanoate)",205-364-6,139-44-6,Not Classified,Notified C&L,39,Not classified:39
48823,dinitrogen tetraoxide,234-126-4,10544-72-6,Press. Gas;Ox. Gas 1;Skin Corr. 1B;Acute Tox. 2,Harmonised C&L,0,H330:0;H270:0;H314:0;Not classified:0
48824,Methyl 3-aminocrotonate,238-056-5,14205-39-1,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,81,H317:36;H302:67;H318:24;H402:1;H330:40;H319:16;H315:3;H335:1;H314:1
48829,"1,3-diethoxy-1,1,3,3-tetramethyldisiloxane",242-298-7,18420-09-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H226:39;H335:39
48830,"Resin acids and Rosin acids, cobalt salts",273-321-9,68956-82-1,Self-heat. 2;Skin Sens. 1A;Resp. Sens. 1B;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,29,H317:29;H252:29;H372:4;H412:15;H334:29;H411:14;H302:1
48833,"3,7-dimethyl-1-octyl acetate",244-034-6,20780-49-8,Not Classified,REACH registration C&L,137,Not classified:87;H410:38;H400:38;H315:50;H317:10;H411:10;H319:1
48835,"(2,5-dihydroxyphenyl)acetic acid",207-192-7,451-13-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
48836,2-(4-Cyanophenylamino)acetic acid,459-560-3,42288-26-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,2,H332:2;H315:1;H312:2;H302:1;H319:1
48838,diethyleneglycyl bis (chloroacetate),619-642-3,106-78-5,Acute Tox. 2;Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H410:2;H312:2;H400:2;H319:3;H300:2;H301:1
48845,"Fatty acids, C14-22, 2-ethylhexyl esters, epoxidized",305-962-8,95370-96-0,Not Classified,REACH registration C&L,61,Not classified:61
48846,Pent-1-en-3-ol,210-472-1,616-25-1,Flam. Liq. 3,Notified C&L,1497,H226:1487;Not classified:10;H319:2;H315:2;H335:2
48847,"(2-hydroxyethyl)ammonium (o,p-dichlorophenoxy)acetate",222-752-0,3599-58-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Carc. 2;Aquatic Chronic 2,Notified C&L,38,H315:38;H317:38;H351:38;H302:38;H411:38;H318:38
48849,"Coal, anthracite, calcined",269-111-1,68187-59-7,Not Classified,Notified C&L,3,Not classified:3
48853,reaction mass of: tri-p-tolyltin hydroxide;hexa-p-tolyl-distannoxane,432-230-6,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H317:0;H372:0;H400:0;H302:0;H318:0
48859,tetrahydromethylphthalic anhydride,234-290-7,11070-44-3,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H334:0;H317:0;H318:0
48862,Sodium 4-[(4-hydroxy-1-naphthyl)azo]benzenesulphonate,208-346-6,523-44-4,Not Classified,Notified C&L,1,Not classified:1
48864,3'-chloroacetanilide,209-610-3,588-07-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
48866,Chromium trichloride,233-038-3,10025-73-7,Met. Corr. 1;Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,139,H317:10;H290:4;H302:131;H411:76;H315:60;H330:64;H319:60;H312:12;H314:21;H412:6;Not classified:8;H334:6;H318:3;H413:1;H332:2;H373:1;H301:1
48868,"Hepta-2,4-dienal",227-627-4,5910-85-0,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,258,H311:258;H319:258;H302:258;H315:258
48870,2-imidazolidone,204-436-4,120-93-4,Eye Irrit. 2;STOT RE 2,REACH registration C&L,802,H319:801;H373:153;H361:111;H315:41;H335:40;Not classified:1
48872,"2,2'-ethylenedioxydiethyl bis(2-ethylbutyrate)",202-389-4,95-08-9,Not Classified,Notified C&L,1,Not classified:1
48874,1-propyl-4-piperidone,245-444-8,23133-37-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:44
48875,"2-[4-(dimethylamino)phenyl]-3,6-dimethylbenzothiazolium chloride",219-228-9,2390-54-7,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,8,H410:4;H317:4;H400:4;H318:4;H301:5;Not classified:2;H319:1;H411:1
48879,"Pentasodium trihydrogen [ethane-1,2-diylbis[nitrilobis(methylene)]]tetrakisphosphonate",231-615-4,7651-99-2,Not Classified,Notified C&L,44,Not classified:44
48880,"Acacia mearnsi, ext., bisulfited",296-235-3,92456-58-1,Not Classified,Notified C&L,2,Not classified:2
48882,"4-hydroxy-2,2,6,6-tetramethylpiperidinoxyl",218-760-9,2226-96-2,Acute Tox. 4;Eye Dam. 1;STOT RE 2;STOT RE 2,REACH registration C&L,367,H302:333;H318:199;H373:55;H319:133;H315:102;H335:99;H412:38;Not classified:30;H317:8;H413:4;H332:3;H312:3
48883,Potassium tetrabromoaurate,238-268-8,14323-32-1,,Notified C&L,4,H319:4;H315:4;H335:4
48884,"4,11-dichloro-5,12-dihydroquino[2,3-b]acridine-7,14-dione",221-423-9,3089-16-5,Not Classified,REACH registration C&L,109,Not classified:109
48886,o-(trifluoromethyl)phenethyl alcohol,301-591-0,94022-96-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
48891,1-[(2-hydroxyethyl)amino]propan-2-ol,229-507-7,6579-55-1,Acute Tox. 4;Skin Corr. 1B,Notified C&L,39,H314:38;H302:38;H319:1;H315:1
48895,"Disodium 2,2'-[(9,10-dihydro-5,8-dihydroxy-9,10-dioxo-1,4-anthrylene)diimino]bis[5-tert-butylbenzenesulphonate]",280-116-8,83006-67-1,Not Classified,REACH registration C&L,2041,Not classified:2041
48897,4-chloro-3-nitrotoluene,201-922-8,89-60-1,Acute Tox. 4,Notified C&L,48,H302:44;H332:5;H315:5;H312:5;H411:4;H319:5;H373:7;H311:4;H330:3;H301:4;H331:1
48899,Hexanophenone,213-394-6,942-92-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:39;H335:39
48900,"2-[2-(2,3-dihydro-2-methyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium dihydrogen phosphate",261-897-4,59737-18-7,Acute Tox. 3;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H410:2;H400:2;H319:2;H301:2
48901,(2-ethylphenyl)urea,204-045-9,114-32-9,Acute Tox. 4,Notified C&L,38,H302:38
48902,"3,5-dibromo-L-tyrosine",206-091-5,300-38-9,Not Classified,Notified C&L,157,Not classified:157
48906,2-nitropyridin-3-ol,239-191-2,15128-82-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H319:55;H315:55;H335:54
48909,"Phenol, 4-isocyanato-, 1,1',1''-phosphorothioate, reaction p roducts with 3-(trimethoxysilyl)-N-(3-(trimethoxysilyl)propy l)-1-propanamine",480-190-3,,Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 4,Notified C&L,1,H334:1;H317:1;H413:1
48911,"1-[4-(phenylazo)phenyl]-1H-pyrrole-2,5-dione",240-330-4,16201-96-0,,Notified C&L,4,H319:4;H315:4;H335:4
48912,Propyl isobutyrate,211-417-4,644-49-5,Flam. Liq. 3,Notified C&L,155,H226:155
48913,"Octahydro-8,8-dimethylnaphthalene-2-carbaldehyde",272-119-8,68738-94-3,Not Classified,Notified C&L,1520,Not classified:1510;H317:10;H411:10
48914,Acetyl iodide,208-062-2,507-02-8,Flam. Liq. 2;Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H225:1;H290:1;H318:1;H314:1
48915,Nickel iron chromite black spinel,275-738-1,71631-15-7,Not Classified,REACH registration C&L,29,Not classified:29
48918,"Chromium, 3-[(8-hydroxy-5-quinolinyl)azo]benzenesulfonic acid complex",229-055-0,6408-33-9,Not Classified,REACH registration C&L,154,Not classified:120;H318:34
48926,"Amines, tri-C8-10-alkyl",272-347-8,68814-95-9,Skin Irrit. 2;Eye Irrit. 2;Repr. 1B;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,240,H315:202;H360:145;H372:145;H411:200;H319:201;H400:39;H314:38
48927,Allo-L-threonine,249-327-2,28954-12-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,19,H319:19;H302:18;H315:19;H335:19
48932,Methyl 3-(dimethylamino)-2-methylpropionate,233-505-1,10205-34-2,,Notified C&L,4,H319:4;H315:4;H335:4
48933,"Acetylcoenzyme A, trilithium salt",278-233-4,75520-41-1,Not Classified,Notified C&L,3,Not classified:3
48935,"2,4-dinitroresorcinol",208-270-3,519-44-8,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H201:1;H302:1;H312:1
48937,"Amines, N-C8-22-alkyltrimethylenedi-, acrylated, sodium salts",307-455-7,97659-50-2,Eye Irrit. 2,Notified C&L,41,H319:35;Not classified:6
48938,ethene; (5E)-5-ethylidenebicyclo[[]2.2.1]hept-2-ene; prop-1-ene,607-505-0,25038-36-2,,Notified C&L,48,Not classified:45;H412:3
48941,"2-(6-methoxybenzofuran-2-yl)-1,3-dimethyl-5-(methylsulphonyl)1H-benzimidazolium acetate",278-014-3,74878-48-1,Eye Irrit. 2B;Aquatic Chronic 3,REACH registration C&L,50,H319:4;H412:4;Not classified:46
48942,p-methylphenethylamine,221-865-2,3261-62-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:41;H315:41;H335:41;H314:2;H318:1;H301:2
48943,"Peptones, milk",296-534-9,92731-33-4,Eye Dam. 1,Notified C&L,2,H318:1;Not classified:1
48946,"Citrus, ext.",304-454-3,94266-47-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2290,H410:1469;H315:2010;H317:1561;H400:1492;H226:1564;H304:1497;H319:450;Not classified:279;H413:64;H412:5;H411:1;H335:1
48947,2-bromothiophene,213-699-4,1003-09-4,Flam. Liq. 3;Acute Tox. 2;Eye Dam. 1,REACH registration C&L,72,H318:48;H300:51;H226:71;H315:24;H310:21;H330:19;H319:24;H301:20;H411:2;H332:1;H335:1;H311:2;H302:1;H331:1
48949,3-(p-cumenyl)-2-methylpropionaldehyde,229-695-0,6658-48-6,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,1511,H317:1510;H315:53;H361:1360;H226:1
48950,Quizalofop-P,618-997-1,94051-08-8,Acute Tox. 3,Notified C&L,38,H301:38
48951,Tetrabenzylthiuram disulfide,600-699-8,10591-85-2,Aquatic Chronic 4,Notified C&L,113,H413:113
48953,"(2R,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]oct-2-yl)methanol",606-608-8,207129-36-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H302:1;H335:1
48961,EUCALYPTUS EXT,616-775-9,8000-48-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,314,H315:276;H317:218;H411:216;H226:258;H304:215;H319:31;H336:6;Not classified:5;H332:1;H302:2;H312:1;H410:2;H335:1
48963,"reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene",412-140-3,32144-25-5,Org. Perox. D;Aquatic Chronic 4,Harmonised C&L,0,H242:0;H413:0
48965,"Buta-1,3-dienyl methyl ether",221-234-1,3036-66-6,Flam. Liq. 2;Acute Tox. 4,Notified C&L,38,H225:38;H302:38
48966,Cerium dioxide,215-150-4,1306-38-3,Not Classified,REACH registration C&L,588,Not classified:516;H373:23;H413:19;H302:19;H319:6;H315:6;H335:6;H331:5;H330:1
48967,2-hydroxypalmitic acid,212-129-1,764-67-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
48969,Iopanoic acid,202-539-9,96-83-3,Acute Tox. 4,Notified C&L,40,H302:40
48970,"1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulphonyl fluoride",206-792-6,375-72-4,STOT SE 1,REACH registration C&L,101,H370:8;H311:4;H314:97;H302:4;H335:2;H413:2;H290:1;H318:1
48971,"Hepta-1,6-dien-4-ol",220-742-0,2883-45-6,Flam. Liq. 3,Notified C&L,40,H226:40;H302:1;H319:1;H315:1;H335:1
48972,Pent-4-yn-1-ol,226-383-6,5390-04-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58,H319:58;H315:58;H335:56;H332:1;H312:1;H302:1
48973,Nickel bis(dimethyldithiocarbamate),239-560-8,15521-65-0,Not Classified,Notified C&L,35,Not classified:35
48974,QAVR,414-310-2,,Not Classified,REACH registration C&L,85,Not classified:85
48977,5-[4'-(Bromomethyl)biphenyl-2-yl]-1-trityl-1H-tetrazole,603-010-9,124750-51-2,Acute Tox. 3;Skin Irrit. 2;STOT SE 3,Notified C&L,45,H335:43;H315:44;H301:44;H319:6;Not classified:1;H317:1;H411:1
48978,4-(5-Propyl-tetrahydropyran-2-yl)-cyclohexanone,926-360-7,,Not Classified,Notified C&L,1,Not classified:1
48979,"Thiobis[2-(1,1-dimethylethyl)-5-methyl-4,1-phenylene] bis[3-(dodecylthio)propionate]",266-393-8,66534-05-2,Not Classified,Notified C&L,1,Not classified:1
48986,Hydrocortisone,200-020-1,50-23-7,Repr. 2,Notified C&L,254,H361:237;H373:67;H360:12;Not classified:3;H400:1;H362:1;H332:2;H315:1;H312:2;H335:1;H302:2;H319:1;H412:1
48987,Anthranilic acid,204-287-5,118-92-3,Eye Dam. 1,REACH registration C&L,319,H318:133;H319:185;H335:2;Not classified:2;H315:1;H412:1
48989,Sodium [N-[2-[bis(carboxylatomethyl)amino]ethyl]-N-(2-hydroxyethyl)glycinato(3-)]zincate(1-),275-554-1,71501-24-1,Aquatic Chronic 3,REACH registration C&L,1,H412:1
48992,ammonium 2-cocoyloxyethanesulfonate,441-050-7,,Skin Irrit. 2;Eye Dam. 1,Harmonised C&L,0,H318:0;H315:0
48996,1-Butyl-1-methylpyrrolidinium bromide,618-948-4,93457-69-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H319:39;H302:38;H315:1;H335:1;Not classified:1
48997,Endo-bicyclo[2.2.1]heptan-2-amine hydrochloride,265-790-3,65481-69-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
48999,"5-Azoniaspiro[[]4.4]nonane, tetrafluoroborate(1-) (1:1)",603-322-5,129211-47-8,Not Classified,Notified C&L,3,Not classified:2;H314:1;H302:1;H318:1
49000,C.I. Reactive Red 58,602-420-5,12226-27-6,Not Classified,Notified C&L,1,Not classified:1
49001,Silver acetate,209-254-9,563-63-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,54,H400:51;H319:48;H315:54;H335:50;H290:1;H318:4;Not classified:2;H410:4
49003,"Iron, complexes with chloroacetic acid-formaldehyde-resorcinol reaction products coupled with 2-hydroxy-3,5-dinitrobenzenediazonium hydroxide inner salt and 4-sulfobenzenediazonium hydroxide inner salt, ammonium sodium salts",286-273-9,85203-82-3,Aquatic Chronic 3,REACH registration C&L,21,H412:9;Not classified:8;H315:4
49005,Monopotassium phosphite,604-162-9,13977-65-6,Eye Irrit. 2,REACH registration C&L,43,H319:39;Not classified:4;H315:3
49007,"4,4'-[1,4-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]bis[5-hydroxy-6-[(2-sulphophenyl)azo]naphthalene-2,7-disulphonic acid",263-351-0,61951-82-4,Not Classified,Notified C&L,172,Not classified:103;H334:42;H317:43;H319:26
49009,"2,3,3-trimethyl-3H-indole-5-carboxylic acid",282-162-4,84100-84-5,Not Classified,REACH registration C&L,6,Not classified:4;H319:2;H302:2;H315:2;H335:2
49011,calcium hypochlorite,231-908-7,7778-54-3,Ox. Sol. 2;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Harmonised C&L,0,H400:0;H314:0;H302:0;H272:0
49012,Niobium hydride,237-769-9,13981-86-7,Not Classified,REACH registration C&L,6,Not classified:2;H228:4;H319:4;H260:4;H335:4
49014,"Cuprate(3-), [3-[[2,4-dihydroxy-3-[[2-hydroxy-5-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]phenyl]azo]-1,5-naphthalenedisulfonato(5-)]-, sodium",289-119-9,86014-72-4,Not Classified,Notified C&L,18,Not classified:10;H334:8
49016,"Soybean oil, hydrogenated",232-410-2,8016-70-4,Not Classified,Notified C&L,149,Not classified:149
49018,3-[3-(Trifluoromethyl)phenyl]-1-propanol,616-635-7,78573-45-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,4,H319:3;H315:3;Not classified:1;H335:1
49020,Delmadinone acetate,237-219-8,13698-49-2,Carc. 2;Repr. 2,Notified C&L,1,H361:1;H351:1
49021,Dodecyl oleate,252-862-4,36078-10-1,Not Classified,REACH registration C&L,6,Not classified:6
49022,Methyl p-hydroxycinnamate,223-531-1,3943-97-3,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,6,H317:5;H412:5;H319:1;H315:1;H335:1
49023,Dysprosium trifluoride,236-992-9,13569-80-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,217,H319:215;H315:215;H335:215;Not classified:1;H312:2;H302:2;H331:1;H314:1;H332:1;H413:1
49025,5-amino-2-hydroxybenzoic acid hydrochloride,613-105-7,6291-36-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H315:2;H335:2
49028,Theobromine,201-494-2,83-67-0,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,172,H319:28;H302:168;H351:79;H301:4;H373:2;H361:1
49029,"1,4-dihydroanthraquinone",212-942-1,885-19-8,Acute Tox. 3;Aquatic Chronic 2,Notified C&L,38,H411:38;H301:38
49035,"Hydrocarbons, C",309-974-4,101794-97-2,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0;H304:0
49037,KOUMALACTONE,429-980-1,,Not Classified,Notified C&L,24,Not classified:24
49038,Disodium hydrogenphosphate dihydrate,600-275-2,10213-10-2,Acute Tox. 4,Notified C&L,81,H302:81;H319:7;H315:1;H335:1
49039,ethyl 1-(2-mesitylacetoxy)cyclopentanecarboxylate,609-205-5,361366-15-6,Aquatic Chronic 2,Notified C&L,1,H411:1
49042,2-chloroethyldimethylammonium chloride,224-970-1,4584-46-7,Acute Tox. 4;Muta. 2;STOT RE 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,76,H341:20;H302:21;H411:21;H373:15;H315:56;H335:53;H311:60;H319:56;H301:56;Not classified:2;H330:5;H371:2
49045,Tributyl(stearoyloxy)stannane,223-699-6,4027-13-8,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H315:38;H312:38;H372:38;H400:38;H319:38;H301:38
49046,2-(hydroxyimino)-N-(2-methylphenyl)acetamide,214-472-2,1132-03-2,Acute Tox. 3,Notified C&L,38,H301:38
49050,"2,4,6-triphenyl-s-triazine",217-644-5,1919-48-8,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38
49051,(tetrapropenyl)succinic acid,248-698-8,27859-58-1,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,952,H318:538;H315:260;H412:490;Not classified:236;H319:165;H413:72;H302:2;H335:2
49055,"Naphtha (petroleum), sweetened light;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",309-976-5,101795-01-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0;H304:0
49056,"Di[1,3,5-triazine-2,4,6-triamine] phosphate",260-493-5,56974-60-8,,Notified C&L,16,Not classified:16
49057,"Adenosine 5'-(trihydrogen diphosphate), monopotassium salt",274-533-4,70285-70-0,Not Classified,Notified C&L,1,Not classified:1
49058,Ethyl isopropyl ether,210-900-7,625-54-7,Flam. Liq. 2,Notified C&L,1,H225:1
49059,"Ammonium O,O-diethyl dithiophosphate",213-942-4,1068-22-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H312:38;H302:38
49061,Dicobalt titanium tetraoxide,234-618-9,12017-38-8,,Notified C&L,1,H315:1;H317:1;H335:1;H334:1;H319:1
49063,5-mesyl-o-anisic acid,256-573-4,50390-76-6,,Notified C&L,3,H302:2;H319:2;H315:2;H335:2
49065,(4-chlorobenzyl)triphenylphosphonium chloride,216-228-0,1530-39-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43;H302:4
49067,Diisobutyldimethoxysilane,605-870-0,17980-32-4,Aquatic Chronic 2,Notified C&L,5,H411:3;H319:2;H315:2;Not classified:1
49069,"2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester",448-050-6,444065-11-6,Aquatic Chronic 4,Harmonised C&L,0,H413:0
49083,N-ethylheptadecafluoro-N-(2-hydroxyethyl)octanesulphonamide,216-887-4,1691-99-2,Not Classified,Notified C&L,1,Not classified:1
49085,Ethyl cyclopentanecarboxylate,226-699-4,5453-85-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H226:1;H335:1
49088,Tramazoline,214-105-6,1082-57-1,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
49089,"Rosin, maleated",232-480-4,8050-28-0,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,692,H317:179;H318:79;H411:17;Not classified:512;H319:82;H315:81;H335:81;H412:5;H332:1;H320:1;H228:1;H316:1
49097,"Nepeta cataria, ext.",284-520-5,84929-35-1,Not Classified,Notified C&L,195,Not classified:186;H412:7;H304:5;H317:6;H318:2;H315:2;H411:1
49104,5-chloro-1-methyl-1H-imidazole,212-827-6,872-49-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H319:46;H302:2;H315:46;H335:45
49105,3-aminocyclohex-2-en-1-one,226-014-9,5220-49-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
49106,Butyl 2-methylcrotonate,232-086-2,7785-66-2,Not Classified,Notified C&L,1,Not classified:1
49107,"1,1,1,2,3,3,3-heptafluoropropane",207-079-2,431-89-0,Press. Gas (Liq.),REACH registration C&L,144,H280:120;Not classified:24;H319:1;H315:1;H335:1
49111,"N,N-dimethyldecan-1-amide",238-405-1,14433-76-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,542,H319:541;H412:402;H315:542;H335:431;H411:38;H318:1;H361:1;H302:1
49114,"7,8,9,10,11,12,20,21,22,23,24,25-dodecahydrodibenzo[i,t][1,4,7,12,15,18]hexaazacyclodocosine-5,13,18,26(6H,19H)-tetrone",268-115-0,68003-28-1,Not Classified,Notified C&L,22,Not classified:22
49118,"Trisodium 5,5'-[(2-sulphonato-1,4-phenylene)bis(azo)]bis(salicylate)",276-501-5,72230-95-6,Not Classified,Notified C&L,1313,Not classified:1313
49119,"3,3-diphenylpropyl 4-methylbenzenesulfonate",607-274-6,23808-47-1,Acute Tox. 4,Notified C&L,1,H302:1
49121,Cellobiose oxidase,613-938-6,66458-10-4,Resp. Sens. 1,Notified C&L,1,H334:1
49124,"4-[[2-[[2,5-dimethoxy-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-1,3-dioxobutyl]amino]-5-methoxy-2-methylbenzenesulphonic acid, sodium salt",303-161-8,94158-87-9,Skin Sens. 1B,REACH registration C&L,26,H317:5;H319:9;H320:7;H335:9;Not classified:5
49130,2-(benzylmethylamino)ethanol,202-994-3,101-98-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 2,REACH registration C&L,45,H319:44;H315:45;H335:45;H318:1;H350:1
49131,"Carbamic acid, N-(aminosulfonyl)-, 1,1-dimethylethyl ester",604-619-2,148017-28-1,Not Classified,Notified C&L,1,Not classified:1
49132,"Amines, N-tallow alkyltrimethylenedi-, reaction products with oleic acid",272-346-2,68814-93-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
49134,Sodium thiosulphate,231-867-5,7772-98-7,Not Classified,REACH registration C&L,2910,Not classified:2584;H319:280;H315:280;H335:293;H332:24;H302:2
49144,HE Carum carvi,607-245-8,235433-20-2,Flam. Liq. 3;Asp. Tox. 1;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,2,H315:1;H317:1;H411:1;H312:1;H226:1;H304:1;Not classified:1
49146,"Benzoic acid, 2,2'-[[2,4(or 4,6)-dihydroxy-1,3-phenylene]bis(2,1-diazenediyl)]bis-, mixed C11-14-branched and linear alkyl and 2-ethylhexyl diesters",601-356-5,115340-73-3,Not Classified,Notified C&L,2,Not classified:2
49149,4-hydroxyisophthalic acid,211-258-0,636-46-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:42;H315:42;H335:41;H302:2;H318:1
49150,4-oxo-4-[[3-(triethoxysilyl)propyl]amino]-2-butenoic acid,251-564-1,33525-68-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,16,H319:16;H315:16;H335:16
49154,"1-ethyl-2-[7-(1-ethyl-2(1H)-quinolylidene)hepta-1,3,5-trienyl]quinolinium iodide",241-693-1,17695-32-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H332:38;H315:38;H312:38;H335:38;H302:38;H319:38
49155,"1-Octadecanamine, N,N-dimethyl-, reaction products with 1,2-oxathiolane 2,2-dioxide",291-690-4,90459-46-4,Acute Tox. 3;Skin Corr. 1C;Aquatic Chronic 1,Notified C&L,1,H410:1;H314:1;H301:1
49157,Cyclopentylamine,213-697-3,1003-03-8,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,130,H318:123;H314:91;H317:45;H331:85;H311:1;H225:129;H300:128;H412:84;H332:39;H315:39;Not classified:1
49164,"6,6'-dithiodinicotinic acid",239-729-6,15658-35-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
49165,4-O-β-D-galactopyranosyl-D-gluconic acid,202-538-3,96-82-2,Not Classified,Notified C&L,24,Not classified:22;H318:1;H315:2;H335:1;H319:1
49170,(E)-3-(4-hydroxyphenyl)prop-2-enoic acid,610-511-6,501-98-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H361:4
49176,2-propylphenol,211-415-3,644-35-9,Acute Tox. 4,Notified C&L,305,H302:305;H332:48;H315:48;H312:66;H335:48;H319:48;H318:19;H314:23
49178,"4-[(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)azo]-2,5-dichlorobenzenesulphonic acid",235-473-4,12239-15-5,Eye Irrit. 2,REACH registration C&L,124,H319:90;H302:38;Not classified:32;H412:2
49179,"4,7-dimethyloct-6-en-3-one",219-845-3,2550-11-0,Eye Irrit. 2,REACH registration C&L,1503,H319:1467;Not classified:36
49185,(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole,430-560-5,180637-89-2,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 2,Harmonised C&L,0,H317:0;H302:0;H318:0;H373:0
49186,"N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide",406-390-2,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
49189,2-isopropyl-5-methyl-p-benzoquinone,207-721-1,490-91-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H302:44;H315:43;H335:42;H332:1;H312:1
49190,"3 beta,7 beta,15 alpha-Trihydroxy-5-androsten-17-one",617-707-0,85390-93-8,Repr. 1B;Lact.,Notified C&L,2,H362:2;H360:2
49194,1-imidazol-1-yl-octadecan-2-ol,434-120-3,,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
49195,"Naphthalenesulfonic acid, polymer with formaldehyde and 4,4' -sulfonylbis(phenol), sodium salt",615-041-5,69961-73-5,Aquatic Chronic 2,Notified C&L,36,H411:36
49199,D-(+)-tryptophan,205-819-9,153-94-6,Not Classified,Notified C&L,8,Not classified:7;H319:1;H315:1;H335:1
49201,Sodium 5-formylfuran-2-sulphonate,250-810-5,31795-44-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
49202,formic acid … %,200-579-1,64-18-6,Skin Corr. 1A,Harmonised C&L,0,H314:0
49203,"9,10-dichloroanthracene",210-087-9,605-48-1,Eye Irrit. 2,Notified C&L,46,H319:46;H315:5;H335:4
49204,Lithium 12-hydroxystearate,231-536-5,7620-77-1,Not Classified,REACH registration C&L,1242,Not classified:1234;H319:8;H315:8;H335:8
49206,"Thiomorpholine, 1-oxide, hydrochloride (1:1)",616-300-5,76176-87-9,Eye Irrit. 2A,Notified C&L,1,H319:1
49210,"2,6-difluorobenzophenone",261-650-0,59189-51-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
49211,Diethylmalonic acid,208-111-8,510-20-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
49219,"Licorice, Glycyrrhiza uralensis, ext., calcium salts",308-974-1,99328-56-0,Not Classified,Notified C&L,1,Not classified:1
49222,"2,12-dibromocyclododecanone",246-268-4,24459-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
49227,5-methylhexan-1-ol,211-023-2,627-98-5,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2,Notified C&L,38,H302:38;H315:38;H226:38
49228,Nitrofurantoin,200-646-5,67-20-9,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,91,H334:54;H317:53;H302:85;H341:6;H351:8;H361:10;H301:6;H373:2;H412:2;H340:2;H332:1;H312:1
49230,"1,4-dichloro-2-nitrobenzene",201-923-3,89-61-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Aquatic Chronic 3,REACH registration C&L,89,H315:4;H317:3;H341:6;H302:55;H412:2;H319:51;H411:82;H335:1;H410:1;H372:1;H361:1;H400:1;H370:1;Not classified:1
49232,"Lubricating oils (petroleum), C",276-737-9,72623-86-0,Carc. 1B,Harmonised C&L,0,H350:0
49239,"Amides, C16-20 and C16-20-unsatd., N-[2-[2-(C15-19 and C15-19-unsatd. alkyl)-4,5-dihydro-1H-imidazol-1-yl]ethyl]",292-480-5,90622-76-7,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,3,H317:3;H314:3;H410:3
49240,sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate,412-320-1,31361-99-6,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
49243,1-(2-bromoethyl)-2-(trifluoromethyl)benzene,301-590-5,94022-95-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H319:39;H302:40;H332:2;H312:2;H315:1;H335:1;H412:1
49244,"2,2'-biquinolyl",204-357-5,119-91-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:47;H315:47;H335:46;Not classified:3
49245,"Octadecanoic acid, ester with 1,2,3-propanetriol hexadecanoate",232-514-8,8067-32-1,Not Classified,Notified C&L,1,Not classified:1
49247,5-ethyl-2-methylpiperidine,203-249-5,104-89-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H302:38;H315:38;H335:38
49249,Bis(4-bromophenyl)ethanedione,252-628-1,35578-47-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
49250,Piperidinium piperidine-1-carbodithioate,202-698-4,98-77-1,Not Classified,Notified C&L,52,Not classified:35;H301:17
49253,Sodium hydrogen 4-aminophenylarsonate,204-869-9,127-85-5,Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1;H350:1;H331:1;H301:1
49254,Hafnium dioxide,235-013-2,12055-23-1,Not Classified,REACH registration C&L,298,Not classified:291;H319:6;H315:6;H335:2;H413:1
49257,Ethyl 4-fluorobenzoate,207-194-8,451-46-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
49259,"2,9-dichloro-5,12-dihydroquino[2,3-b]acridine-7,14-dione",221-424-4,3089-17-6,Not Classified,REACH registration C&L,333,Not classified:331;H413:2
49261,"N-[4-chloro-3-[[4,5-dihydro-5-oxo-1-(2,4,6-trichlorophenyl)-1H-pyrazol-3-yl]amino]phenyl]myristamide",259-266-3,54636-84-9,Not Classified,Notified C&L,2,Not classified:2
49264,4-(trifluoromethyl)anilinium chloride,292-679-7,90774-69-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H332:38;H315:44;H312:38;H335:43;H302:39;H319:44;H410:4;H301:5;H400:4;H373:5;H311:1;H331:1
49267,Ethaverine hydrochloride,213-573-9,985-13-7,Not Classified,Notified C&L,2,Not classified:2
49268,"2,4,4,7-tetramethylnona-6,8-dien-3-one oxime",279-817-1,81783-01-9,Not Classified,Notified C&L,1406,Not classified:1406
49273,Phosphinate1030,609-080-7,35160-38-4,Not Classified,REACH registration C&L,32,Not classified:32
49275,Ethyl 3-(dimethylamino)-2-butenoate,238-058-6,14205-42-6,Eye Irrit. 2,Notified C&L,38,H319:38
49279,2-(trifluoromethyl)benzophenone,211-972-2,727-99-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,133,H319:133;H315:133;H335:133
49285,"(+)-(S,R)-6-fluoro-3,4-dihydro-2-(2-oxiranyl)-2H-1-benzopyran",606-374-7,197706-51-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Muta. 2;Aquatic Chronic 2,REACH registration C&L,2,H315:1;H317:1;H341:1;H302:1;H411:2;H319:1
49288,p-(methylamino)phenol sulphate,217-706-1,1936-57-8,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Chronic 1,Notified C&L,1,H410:1;H317:1;H302:1;H373:1
49293,Cobalt lithium manganese nickel oxide,695-690-9,182442-95-1,Acute Tox. 2;Carc. 1B;STOT RE 1;Aquatic Chronic 3,Notified C&L,95,H330:91;H350:91;H372:92;H412:92;H334:3;H317:3
49294,2-amino-3-chloroanthraquinone,201-530-7,84-46-8,Acute Tox. 5;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H303:1;H319:1;H315:1;H335:1
49299,calcium octadecylxylenesulphonate,402-040-8,,Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H314:0;H411:0
49303,Isobutyl 2-ethylhexanoate,231-082-8,7434-89-1,Not Classified,Notified C&L,37,Not classified:37
49309,"2-[4-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)phenyl]butyric acid",303-995-2,94232-67-4,Aquatic Chronic 3,REACH registration C&L,1,H412:1
49310,"spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)]",415-460-1,154171-76-3,Aquatic Chronic 2,Harmonised C&L,0,H411:0
49311,Hexahydro-1H-azepine-1-carbaldehyde,246-630-1,25114-81-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H332:38;H315:38;H312:38;H335:38;H302:38;H319:38
49312,"1,1-diethoxybutane",222-913-5,3658-95-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,182,H225:118;H319:156;H315:156;H226:59;H317:20;Not classified:5
49315,Trimethylamine--borane (1:1),200-850-4,75-22-9,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H228:55;H319:54;H315:54;H335:53;H332:1;H302:1;H312:1;H310:1;H314:1;H300:1;H372:1;H370:1;H318:1
49316,Pentaerythritol tetrakis(3-mercaptopropionate),231-472-8,7575-23-7,Acute Tox. 4;Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,264,H410:236;H400:236;H317:249;H302:249;H335:45;H371:34;H319:15;H315:15;H332:9
49317,Peptones,615-895-9,73049-73-7,,Notified C&L,73,Not classified:73
49318,"Fatty acids, C16-18, 1,2-ethanediylbis(oxy-2,1-ethanediyl) esters",292-947-3,91031-45-7,Eye Irrit. 2,REACH registration C&L,87,H319:4;Not classified:83
49319,5-chloro-2-nitrobenzonitrile,252-132-5,34662-31-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H332:39;H315:39;H312:39;H335:38;H302:39;H319:39
49324,"Benzene, 1,4-dichloro-, polymer with sodium sulfide (Na2S)",607-869-0,26125-40-6,Not Classified,Notified C&L,1,Not classified:1
49325,Norfloxacin,274-614-4,70458-96-7,Eye Irrit. 2,Notified C&L,110,H319:64;H318:35;H361:12;Not classified:5;H335:1;H302:1;H332:1;H315:1;H412:1
49326,4-oxo-1-phenylcyclohexanenitrile,246-631-7,25115-74-6,,Notified C&L,7,H302:7;H332:3;H315:3;H312:3;H335:2;H319:3
49327,Zinc diformate,209-176-5,557-41-5,,Notified C&L,2,Not classified:2
49332,"Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",269-627-7,68308-07-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;Not classified:0;H350:0
49337,"Butanedioic acid, polyisobutenyl derivatives",614-666-0,68610-89-9,Eye Irrit. 2,Notified C&L,838,H319:838
49340,"1H-benzotriazole, compound with morpholine(1:1)",283-357-7,84604-74-0,Not Classified,Notified C&L,1,Not classified:1
49341,Kaolinite,215-286-4,1318-74-7,Not Classified,Notified C&L,309,Not classified:308;H372:1
49342,"1-(2-chloroethyl)pyrrolidine-2,5-dione",255-266-2,41212-96-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
49343,"3,4,5-trimethoxybenzohydrazide",221-954-6,3291-03-0,Eye Irrit. 2,Notified C&L,38,H319:38
49344,Titanium oxide sulphate,237-523-0,13825-74-6,Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,92,H290:15;H318:15;H314:92
49345,"Distillates (coal tar), naphthalene oil crystn. mother liquor;Naphthalene Oil Redistillate;[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200°C to 230°C (392°F to 446°F). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.]",295-310-8,91995-49-2,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
49349,N-(tert-Butyldimethylsilyl)-N-methyltrifluoroacetamide,616-455-9,77377-52-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H226:44;H335:43
49351,"1,4-bis(dibromomethyl)benzene",216-473-3,1592-31-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 4,Notified C&L,1,H332:1;H314:1;H302:1;H312:1;H318:1
49353,4-cyclopentylpiperazin-1-amine,262-742-3,61379-64-4,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,3,H314:3;H302:3
49359,Ethyl 4-oxopiperidine-3-carboxylate,225-073-8,4644-61-5,,Notified C&L,6,H319:6;H315:6;H335:6
49360,But-3-yn-1-ol,213-161-9,927-74-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,103,H319:103;H315:103;H226:103;H335:99;H312:3;H302:3
49361,"pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate",400-120-7,,Eye Irrit. 2,Harmonised C&L,0,H319:0
49364,"Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester",603-088-4,1257-08-5,Not Classified,Notified C&L,3,Not classified:2;H319:1;H315:1;H335:1
49365,"(-)-[R-(R*,R*)]-6-fluoro-3,4-dihydro-2-(2-oxiranyl)-2H-1-benzopyran",606-373-1,197706-50-6,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,3,H317:3;H411:3;H315:1;H341:1;H319:1
49366,Tetrasul,218-761-4,2227-13-6,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,41,H312:41;H412:38
49368,sodium hydrogensulphite … %;sodium bisulphite … %,231-548-0,7631-90-5,Acute Tox. 4,Harmonised C&L,0,H302:0
49369,2-Hexynoic Acid,616-334-0,764-33-0,Acute Tox. 4;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,44,H334:38;H319:38;H302:38;H314:6;H290:1;H318:1
49370,"Disodium 5-[[4'-[(2-amino-8-hydroxy-6-sulphonato-1-naphthyl)azo][1,1'-biphenyl]-4-yl]azo]salicylate",219-393-7,2429-84-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H315:38;H335:38;H400:38;H302:38;H350:38;H319:38
49372,"2,3,4-trimethoxybenzyl alcohol",276-270-0,71989-96-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
49373,2-[2-(nonylphenoxy)ethoxy]ethyl oleate,301-507-2,94022-13-6,Not Classified,Notified C&L,1,Not classified:1
49375,"Ethyl 2,5-dihydroxybenzoate",223-530-6,3943-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
49378,1-tert-butyl-3-nitrobenzene,245-443-2,23132-52-7,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H315:1;H335:1
49380,"3,5-dimethoxybenzoic acid",214-473-8,1132-21-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
49383,"3,5-diiodo-L-tyrosine",206-092-0,300-39-0,Not Classified,REACH registration C&L,12,Not classified:2;H319:10;H315:10;H335:10
49385,6-methyl-2-nitropyridin-3-ol,239-192-8,15128-90-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
49387,2-amino-5-[(2-chloro-6-cyano-4-nitrophenyl)azo]-6-[[3-(4-hydroxybutoxy)propyl]amino]-4-methylnicotinonitrile,272-567-4,68877-62-3,Not Classified,Notified C&L,2,Not classified:2
49391,"Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 4-piperidinyl ester",605-615-3,171722-92-2,,Notified C&L,34,Not classified:33;H332:1;H312:1;H302:1
49394,Titanium phosphide,234-862-6,12037-65-9,Not Classified,Notified C&L,1,Not classified:1
49399,Acetyl bromide,208-061-7,506-96-7,Flam. Liq. 3;Skin Corr. 1B;Aquatic Chronic 3,REACH registration C&L,49,H314:49;H412:3;H226:2;H290:2;H302:1;H318:2;H315:1;H402:1
49400,Aminoiminomethanesulphinic acid,217-157-8,1758-73-2,Self-heat. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;STOT RE 2;Self-react. G,REACH registration C&L,187,H332:23;H315:181;H252:43;H335:112;H302:182;Not classified:19;H318:25;H373:25;H251:94;H319:157;H330:35
49402,"Fatty acids, C14-22-conjugated unsatd., tetraesters with pentaerythritol",305-961-2,95370-95-9,Not Classified,Notified C&L,1,Not classified:1
49403,Methyl 4-fluorobenzoylacetate,263-889-6,63131-29-3,,Notified C&L,2,Not classified:2
49404,"3,7-dimethyloctan-3-yl acetate",244-033-0,20780-48-7,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1652,H410:25;H400:25;H319:77;H315:1627;H411:1627;Not classified:1;H317:1
49406,Manganese oxalate,211-367-3,640-67-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,34,H312:34;H302:34
49407,4-nitrobenzenesulphonyl chloride,202-697-9,98-74-8,Skin Sens. 1A;Eye Dam. 1;Muta. 2;Repr. 2,REACH registration C&L,65,H317:13;H314:63;H361:1;H341:1;H318:4;H412:6;H315:1;Not classified:1;H290:1
49409,Bismuth trifluoride,232-124-8,7787-61-3,Not Classified,Notified C&L,95,Not classified:52;H314:39;H319:4;H315:4
49410,1-ethylpropylamine,210-471-6,616-24-0,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,48,H225:47;H314:48;H332:5;H302:5;H312:5;H318:2;H226:1
49412,"[3R-(3α,3aβ,7β,8aα)]-1-(2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5-yl)ethan-1-one",251-020-3,32388-55-9,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1840,H410:1805;H400:1696;H317:1677;Not classified:34;H411:1
49414,"Sodium 2-[7-[3,3-dimethyl-1-(4-sulfonatobutyl)benz[e]indolin-2-ylidene]hepta-1,3,5-trien-1-yl]-3,3-dimethyl-1-(4-sulfonatobutyl)benz[e]indolinium",222-751-5,3599-32-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
49418,"Bis[3-[[4-[benzylmethylamino]phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium] tetrachlorozincate(2-)",281-650-4,84000-94-2,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,4,H302:4;H318:4;H411:4
49422,DL-2-amino-4-(ethylthio)butyric acid,200-647-0,67-21-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,132,H319:127;H315:127;H335:127;H351:5;H361:1;H341:1
49423,"Pitch, petroleum, arom.",269-110-6,68187-58-6,Not Classified,REACH registration C&L,17,Not classified:8;H360:9;H317:9;H340:9;H413:9;H350:9
49426,"4,5-dimethoxy-2-nitrobenzoic acid",225-657-2,4998-07-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
49430,2-amino-6-hydroxy-1H-pyrimidin-4-one,200-256-5,56-09-7,Not Classified,Notified C&L,4,Not classified:1;H332:1;H315:3;H312:1;H335:2;H302:2;H319:3
49431,Ribitol,207-685-7,488-81-3,Not Classified,Notified C&L,4,Not classified:4
49432,Selenium chloride,233-037-8,10025-68-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H410:43;H314:39;H301:42;H311:38;H400:42;H331:42;H373:42;H332:1;H302:1;H312:1
49433,Phthalonitrile,202-044-8,91-15-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,168,H311:123;H412:122;H331:123;H301:123;H300:45;H312:4;H370:1
49434,[No public or meaningful name is available],674-129-1,7505-81-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
49436,"1,3-dimethyl-3-phenylbutyl acetate",268-407-8,68083-58-9,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1563,H412:11;H315:17;Not classified:1546
49437,C-4000,682-594-7,926010-02-8,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,55,H410:55;H400:55;H312:55;H302:55
49438,3-amino-7-(dimethylamino)-5-phenylphenazinium chloride,219-229-4,2390-56-9,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1;H317:1;H318:1
49439,2-phenylpropan-2-ol,210-539-5,617-94-7,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1782,H319:1743;H227:4;H302:1758;H315:1758;H335:40;Not classified:24;H312:2;H332:1
49447,Diamminedichloropalladium,238-269-3,14323-43-4,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,84,H410:6;H400:6;H302:80;H318:7;H332:69;H319:4;H315:4;H335:4;H413:5;H317:1
49450,C.I. Acid Brown 348,615-815-2,72827-72-6,Not Classified,Notified C&L,16,Not classified:16
49452,Methanesulphonyl cyanide,246-093-3,24225-08-9,Flam. Liq. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H335:1;H227:1;H319:1;H301:1
49454,Ethyl crotonate,234-125-9,10544-63-5,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1550,H319:1549;H226:1546;H225:3;H411:1
49459,[(phenylthioxomethyl)thio]acetic acid,213-393-0,942-91-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H319:53;H315:53;H335:52
49466,"tert-butyl 2-{(2S,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyl}-2-[4-(pyridin-2-yl)benzyl]hydrazinecarboxylate",606-396-7,198904-86-8,Not Classified,REACH registration C&L,4,Not classified:3;H319:1;H373:1
49467,(Z)-tetradec-9-enol,252-401-7,35153-15-2,Not Classified,REACH registration C&L,42,Not classified:4;H319:38;H315:38;H335:38
49469,pentachloroethane,200-925-1,76-01-7,Carc. 2;STOT RE 1;Aquatic Chronic 2,Harmonised C&L,0,H372:0;H351:0;H411:0
49477,"N,N-dimethylmethyleneammonium iodide",251-680-2,33797-51-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
49479,Bubet,457-470-9,,Not Classified,REACH registration C&L,1,Not classified:1
49480,"2-Pyrrolidinone, 1-coco alkyl derivs.",273-511-1,68988-02-3,Skin Corr. 1A;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H400:1;H314:1;H410:1
49484,"Hexanoic acid, 2-ethyl-, zinc salt, basic",286-272-3,85203-81-2,Eye Irrit. 2;Repr. 2;Repr. 2;Aquatic Chronic 3,REACH registration C&L,308,H361:122;H319:123;H412:106;H315:221;H411:185;H400:17;H336:16;H373:16;Not classified:1
49486,Tripropyltin chloride,218-910-3,2279-76-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,8,H410:8;H311:8;H400:8;H331:8;H301:8
49488,Didecyl hydrogen phosphate,232-248-2,7795-87-1,,Notified C&L,1,Not classified:1
49491,"sulfallate (ISO);2-chloroallyl N,N-dimethyldithiocarbamate",202-388-9,95-06-7,Acute Tox. 4;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H350:0;H302:0;H400:0
49492,Ethyl 3-oxocyclohexanecarboxylate,251-626-8,33668-25-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2;H302:1
49495,Tripotassium orthophosphate,231-907-1,7778-53-2,Eye Dam. 1;STOT SE 3,REACH registration C&L,1843,H318:187;H335:1504;H319:1535;H315:1594;Not classified:66;H314:82;H302:11;H331:10
49496,"3-[[4-[(5,6-dichlorobenzothiazol-2-yl)azo]phenyl]methylamino]propiononitrile",255-334-1,41362-82-7,Not Classified,Notified C&L,17,Not classified:17
49497,"5H-Tetrazole-5-thione, 1-ethyl-1,2-dihydro-, compd. with cyclohexanamine (1:1)",618-082-7,878629-97-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
49498,2-bromoethyl p-bromophenyl ether,242-585-7,18800-30-1,Acute Tox. 4,Notified C&L,194,H302:194
49503,Dibenzoyl-L-tartaric acid monohydrate,220-374-0,2743-38-6,Eye Irrit. 2,REACH registration C&L,214,H319:157;H317:54;H318:54;Not classified:2;H315:3;H335:1;H302:1
49514,3-(dodecylthio)butyronitrile,299-966-6,93918-85-5,Flam. Liq. 3;Aquatic Chronic 2,REACH registration C&L,2,H411:1;H226:2
49516,chlormethyl methyl ether;chlorodimethyl ether,203-480-1,107-30-2,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 1A,Harmonised C&L,0,H332:0;H302:0;H350:0;H225:0;H312:0
49517,"Pine, ext.",304-455-9,94266-48-5,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2172,H410:1470;H315:2071;H317:1525;H400:1434;H319:1900;H304:1606;H412:136;H226:82;H411:3
49523,"ethyl 1-[2-(2,4-dichlorophenyl)acetoxy]cyclohexanecarboxylate",609-206-0,361366-16-7,,Notified C&L,1,H360:1
49525,"Octadecanoic acid, reaction products with triethanolamine, di-Me sulfate-quaternized",286-970-8,85408-12-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6,H319:6;H315:6
49527,"1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulphonic acid",206-793-1,375-73-5,Met. Corr. 1;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,43,H290:2;H302:42;H318:3;H314:43
49529,Octan-2-yl cyanoacetate,610-886-6,52688-08-1,Not Classified,Notified C&L,16,Not classified:13;H302:3;H319:1;H315:1;H335:1
49530,3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxylic acid,481-150-8,500011-86-9,Aquatic Chronic 3,REACH registration C&L,93,H412:91;H319:1;H317:2;H318:1
49532,"(E)-1,2,4-trimethoxy-5-prop-1-enylbenzene",220-743-6,2883-98-9,Acute Tox. 4,Notified C&L,128,H302:118;H410:10;H400:10;H351:10
49533,Carbonic acid calcium salt (1:1),615-782-4,72608-12-9,Not Classified,Notified C&L,12,Not classified:12
49536,"4-(2,3-epoxypropyl)morpholine",228-450-5,6270-19-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H332:1;H315:2;H312:1;H335:2;H302:2;H319:1;H318:1
49537,Tris(pentafluorophenyl) borane,601-014-5,1109-15-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:47;H315:47;H335:46;H410:4;H400:4;H301:5;H311:1;H331:1
49538,"Azelaic acid, compound with 2,2'-iminodiethanol",272-412-0,68833-69-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
49540,"Bis[[2,2',2''-nitrilotris[ethanolato]](1-)-N,O]bis(propan-2-olato)titanium",253-153-2,36673-16-2,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,127,H225:4;H319:117;H336:29;H315:79;H226:27;H317:44;H335:51;H318:8;H224:1
49542,"2,5-Dihydro-1H-pyrrole, N-BOC protected",615-949-1,73286-70-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
49543,4-Chlorobutyraldehyde Diethyl Acetal,612-144-7,6139-83-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H226:1;H335:1
49546,Prednisolone,200-021-7,50-24-8,Repr. 1B,REACH registration C&L,204,H360:85;H332:70;H312:54;H302:116;H372:35;H361:55;H411:35;H373:27;H341:2;H350:2;Not classified:2;H315:1;H335:1;H319:1;H400:1
49550,"3-(2-(1,3-DIOXOLAN-2-YL)ETHYL)-7,8-DIMETHOXY-1H-BENZO[d]AZEPIN-2-ONE",617-898-0,866462-52-4,Acute Tox. 3;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1,H400:1;H317:1;H411:1;H301:1
49551,"D-Glucitol, 1,4:3,6-dianhydro-, 2-(4-methoxybenzoate) 5-[4-[(1-oxo-2-propen-1-yl)oxy]benzoate], polymer with 1,4:3,6-dianhydro-D-glucitol 5-(4-methoxybenzoate) 2-[4-[(1-oxo-2-propen-1-yl)oxy]benzoate] and 1,1'-(1,4-phenylene) bis[4-[4-[(1-oxo-2-propen-1-yl)oxy]butoxy]benzoate]",607-177-9,228863-31-8,Not Classified,Notified C&L,2,Not classified:2
49555,"Concentrates of lead and zinc compounds with sulfur resulting from hydrometallurgy (hot acid leaching, super-hot acid leaching and flotation)",936-276-2,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Carc. 2;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H332:2;H315:2;H360:2;H372:2;H400:2;H351:2;H302:2;H318:2
49557,"3,3'-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]imino]bis[propiononitrile]",223-765-4,4058-30-4,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,24,H317:17;H411:17;Not classified:7
49560,Ginsenoside-Re from Panax quinquefolium (American ginseng) root,610-685-3,51542-56-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H312:38;H302:38
49562,Terephthaloyl dichloride,202-829-5,100-20-9,Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3;STOT SE 3;STOT SE 3,REACH registration C&L,2177,H314:137;H318:81;H331:134;H335:19;Not classified:2039;H290:1;H315:1;H317:1;H319:1
49565,"1,1-dichloropropene",209-253-3,563-58-6,Flam. Liq. 2;Acute Tox. 3;Aquatic Chronic 3,Harmonised C&L,0,H225:0;H412:0;H301:0
49566,3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoic Acid,605-288-7,162401-62-9,Aquatic Chronic 4,Notified C&L,2,H413:1;H315:1;H335:1;H302:1;H411:1;H319:1
49571,3-Aminooctan-4-ol,482-070-6,1001354-72-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,466,H314:466;H302:466;H318:465
49572,"4-trans-Pentyl-4'-trans-vinyl-[1,1'-bicyclohexyl]",685-447-5,129738-34-7,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
49575,"Sodium 2,4-dinitrobenzenesulphonate",212-943-7,885-62-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42;H228:1
49578,morpholine,203-815-1,110-91-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Harmonised C&L,0,H332:0;H314:0;H302:0;H312:0;H226:0
49581,"Amides, tallow, N,N'-(iminodi-2,1-ethanediyl)bis-",269-902-1,68390-49-8,Not Classified,Notified C&L,1,Not classified:1
49586,"2,5-dihydroxyterephthalic acid",210-239-4,610-92-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
49590,Glycerol tripropionate,205-365-1,139-45-7,Not Classified,Notified C&L,89,Not classified:89
49597,"2-hydroxy-3,3-dimethylbutyric acid",223-698-0,4026-20-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
49601,o-[N-(5-nitrothiazol-2-yl)carbamoyl]phenyl acetate,259-931-8,55981-09-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:43;H302:43;H315:43;H335:42;Not classified:2
49607,6-bromo-3-(o-hydroxyphenylaminocarbonyl)-2-naphthyl phosphate,217-645-0,1919-91-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
49608,5-chloroindole,241-448-9,17422-32-1,,Notified C&L,12,H319:12;H315:12;H335:11;H332:2;H312:2;H302:2
49609,2-chloropropyldimethylammonium chloride,224-971-7,4584-49-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,71,H410:10;H315:67;H335:55;H400:10;H319:67;H301:11;H302:59;H332:2;H312:2;H311:1
49613,4-(methylsulphonyl)phenylhydrazine,212-895-7,877-66-7,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H315:1;H335:1
49615,Ambroxol,242-500-3,18683-91-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,3,H319:2;H302:2;H315:2;H335:2;Not classified:1
49616,"Disodium 7-hydroxy-8-phenylazonaphthalene-1,3-disulphonate",217-705-6,1936-15-8,Not Classified,Notified C&L,2146,Not classified:2143;H319:2;H315:1;H335:1;H412:1
49617,"4-bromo-2,6-dichloroaniline",211-809-5,697-88-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H302:44;H315:44;H335:39;H332:6;H312:6
49620,1-Chloro-4 Trifluromethyl Bisphenol A Epoxy Resin,607-537-5,25085-99-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,987,H319:901;H317:966;H315:902;H411:842;Not classified:5
49623,Nitroxinil,216-884-8,1689-89-0,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,95,H315:93;H317:94;H335:93;H400:93;H319:95;H301:95;H311:1;H310:1;H330:1;H412:1
49625,Butyl 4-nitrobenzoate,204-400-8,120-48-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
49631,Metopimazine,237-818-4,14008-44-7,Acute Tox. 4,Notified C&L,14,H302:12;Not classified:1;H360:1
49637,"(Z,Z)-1,1'-[ethylidenebis(oxy)]di(hex-3-ene)",264-154-2,63449-64-9,Not Classified,Notified C&L,88,Not classified:88
49639,"1,3-Dichloro-2-(2,4-difluoro-phenyl-propan-2-ol",617-842-5,86386-74-5,Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4;STOT RE 2;Aquatic Acute 2,REACH registration C&L,2,H332:2;H317:2;H401:2;H302:2;H373:2
49640,ethyl nitrate,210-903-3,625-58-1,Unst. Expl.,Harmonised C&L,0,H200:0
49641,Phenethyl decanoate,263-237-0,61810-55-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1399,H319:1399;H302:1399;H315:1399
49649,Disodium bis[4-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]benzenesulphonamidato(2-)]cobaltate(2-),275-157-3,71060-75-8,Aquatic Chronic 3,Notified C&L,47,H412:34;Not classified:13
49650,bromo(prop-1-en-2-yl)magnesium,603-688-6,13291-18-4,Flam. Liq. 2;Water-react. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,74,H260:73;H314:74;H302:8;H225:33;H318:9;H335:4;H351:4;H228:40
49651,"3-aminopropane-1,2-diol",210-475-8,616-30-8,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,76,H314:65;H318:5;H319:11;H315:11
49652,Bismuth bromide oxide,232-120-6,7787-57-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H332:1;H315:1;H312:1;H335:1;H302:1;H319:1
49655,"Cobalt, compound with samarium (5:1)",234-625-7,12017-68-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H332:38;H315:38;H312:38;H335:38;H302:38;H319:38;H334:5;H317:5;H226:4;H228:1
49656,"1,4-diaminobutan-2-one dihydrochloride",222-914-0,3660-09-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
49661,"2,3-dimethoxybenzonitrile",227-097-4,5653-62-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H332:42;H315:42;H312:42;H335:42;H302:42;H319:42
49664,Arsenic acid,231-901-9,7778-39-4,Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Chronic 1,REACH registration C&L,14,H410:14;H400:10;H350:14;H331:14;H301:14;H318:4;H314:4;H361:4;H312:4
49668,3-(2-furyl)acrylic acid,208-718-8,539-47-9,,Notified C&L,5,H319:5;H315:5;H335:4
49669,"1-(4-acetylphenyl)-1H-pyrrole-2,5-dione",214-106-1,1082-85-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H318:38;H302:38;H315:42;H335:42;H319:4
49670,"7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one",220-748-3,2886-65-9,Not Classified,REACH registration C&L,5,Not classified:3;H302:1;H319:1;H315:1;H335:1
49672,2-ethoxyethyl isobutyrate,259-146-0,54396-97-3,Flam. Liq. 3,Notified C&L,1,H226:1
49679,"N-(3,5-dimethyl-1-adamantyl)acetamide",606-412-2,19982-07-1,Acute Tox. 4,REACH registration C&L,5,H302:5;H332:1;H315:1;H312:1;H335:1;H319:1
49680,"Dimethyl 2,5-pyridine dicarboxylate",629-154-2,881-86-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:38;H335:38
49682,2-(chloromethyl)-2-methyloxirane,209-916-7,598-09-4,,Notified C&L,4,Not classified:1;H314:3;H318:1;H226:3;H332:1;H302:1;H312:1
49683,"D-(-)-2,5-diaminopentanoic acid",240-729-3,16682-12-5,Not Classified,Notified C&L,2,Not classified:2
49685,D-valine,211-368-9,640-68-6,Not Classified,REACH registration C&L,7,Not classified:7
49686,"1,1,2,2,3,3,4,5,5,6-decafluoro-4,6-bis(trifluoromethyl)cyclohexane",206-386-9,335-27-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H315:40;H335:39;Not classified:1
49688,"4-tert-butyl-2,5-xylenol",241-696-8,17696-37-6,Not Classified,Notified C&L,28,Not classified:27;H319:1;H302:1;H315:1;H335:1
49690,(E)-4-ethyl-oct-2-enoic acid,262-156-8,60308-76-1,Not Classified,Notified C&L,10,Not classified:10
49691,"Siloxanes and Silicones, di-Me, polymers with Me silsesquioxanes, hydroxy-terminated",614-608-4,68554-67-6,Not Classified,Notified C&L,16,Not classified:16
49692,(2S)-2-(carbamoylamino)pentanedioic acid,601-569-3,1188-38-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H302:40;H315:40;H335:40
49695,"4-Ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl) benzenesulfonic acid",610-141-5,437717-43-6,Skin Sens. 1,Notified C&L,2,H317:2
49698,(trichloromethyl)phosphonic acid,227-821-9,5994-41-2,Acute Tox. 3,Notified C&L,38,H301:38
49700,"2,5-dichlorotoluene",243-032-2,19398-61-9,Acute Tox. 4,Notified C&L,76,H332:38;Not classified:34;H411:4
49701,Molybdenum zinc tetraoxide,237-377-8,13767-32-3,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,65,H319:63;H411:6;H315:59;H335:59;H400:2
49703,Methyl 2-chloro-5-iodobenzoate,612-940-4,620621-48-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;H410:1;H400:1;H318:1;H301:1
49704,Butanediyl bis(3-aminobut-2-enoate),238-059-1,14205-47-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:39;H315:39;H335:38;Not classified:12
49705,2'-benzonaphthone,211-410-6,644-13-3,,Notified C&L,4,H319:4;H315:4;H335:4
49711,Azidotrimethylsilane,225-078-5,4648-54-8,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,47,H410:8;H311:47;H400:8;H225:47;H331:43;H301:47;H330:4
49712,3-Fluor-1-[trans-4-(trans-4-propylcyclohexyl)-cyclohexyl)-benzen,617-389-3,82832-46-0,Not Classified,REACH registration C&L,2,Not classified:2
49714,C.I. Solvent Red 68,612-423-3,61813-90-9,Not Classified,Notified C&L,25,Not classified:25
49717,Didodecylnaphthalenesulphonic acid,254-771-5,40038-00-4,,Notified C&L,1,Not classified:1
49719,"(4S)-4-Benzyl-1,3-oxazolidin-2-one",618-632-6,90719-32-7,Acute Tox. 4;STOT RE 2,Notified C&L,88,H302:83;H373:83;H319:5;H315:4;H335:4
49720,Boron monophosphide,243-593-3,20205-91-8,,Notified C&L,4,H260:4;H301:4
49721,Dioctadecyl malate,302-495-1,94109-53-2,Not Classified,Notified C&L,1,Not classified:1
49722,2-nitro-p-toluidine,201-924-9,89-62-3,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,166,H332:4;H317:4;H302:4;H411:164;H312:4;H373:164;H301:161;H311:161;H331:161;Not classified:1;H412:1
49723,"Dimethyl 2,5-dichloroterephthalate",221-958-8,3293-89-8,Eye Irrit. 2,Notified C&L,38,H319:38
49725,"Fatty acids, tall-oil, reaction products with diethylenetriamine and triethylenetetramine",294-341-4,91697-79-9,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,3,H317:2;H314:2;H302:1;H411:1;H319:1;H315:1
49726,"Ocimum gratissimum, ext.",294-822-9,91770-38-6,,Notified C&L,2,H319:2;H317:2;H304:2
49727,chlorfenapyr (ISO);4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile,602-782-4,122453-73-0,Acute Tox. 4;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H302:0;H331:0
49728,"Coconut oil, reaction products with diethanolamine",232-483-0,8051-30-7,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,503,H318:361;H315:336;H411:157;Not classified:84;H314:61;H319:25;H335:20
49729,(chlorosulphonyl)acetyl chloride,223-693-3,4025-77-8,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,38,H314:38;H318:38;H335:38
49730,"3,3'-dinitro[1,1'-biphenyl]-4,4'-diamine",228-457-3,6271-79-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
49731,Tetramethyluric acid,218-994-1,2309-49-1,,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
49732,Methyl trifluoroacetate,207-074-5,431-47-0,Flam. Liq. 2,REACH registration C&L,96,H225:94;H317:34;H318:35;H411:1;H314:57;H332:1;H302:1;H312:1;H226:1;H371:1
49733,Diphenylacetonitrile,201-662-5,86-29-3,Acute Tox. 3,REACH registration C&L,112,H301:60;H319:52;H315:51;H335:50;H412:1;H302:1;H303:1
49734,"Antimonate(2-), bis(mu-(2,3-di(hydroxy-kappaO)butanedioato(4-)-kappaO1:kappaO4))di-, dipotassium, trihydrate, stereoisomer",608-190-2,28300-74-5,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,113,H332:113;H302:99;H411:113;H301:14;Not classified:1
49735,Aminopeptidase,232-874-6,9031-94-1,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,72,H334:72;H319:40;H315:40;H335:40
49739,"4-[[4,6-bis[[4-(2-ethylhexoxy-oxomethyl)phenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid 2-ethylhexyl ester",618-112-9,88122-99-0,Aquatic Chronic 4,Notified C&L,108,H413:108
49740,3-bromooctan-2-one,257-002-1,51134-60-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,10,H319:10;H302:10;H315:10;H335:10
49742,N-tridecyltridecan-1-amine,227-624-8,5910-75-8,Skin Corr. 1B,Notified C&L,64,H314:39;Not classified:25
49744,"Fatty acids, vegetable-oil, compds. with 2-amino-2-methyl-1-propanol",284-977-0,85005-43-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
49745,Tetraiodomethane,208-068-5,507-25-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42;H332:4;H312:4;H302:4
49748,thiobencarb (ISO);S-4-chlorobenzyl diethylthiocarbamate,248-924-5,28249-77-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H302:0
49751,N-acetyl-4-piperidone,250-937-6,32161-06-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
49753,"Fatty acids, tall-oil, compds. with 4,5-dihydro-2-nortall-oil alkyl-1H-imidazole-1-ethanamine",269-906-3,68390-59-0,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,3,H317:3;H314:3;H410:3
49754,"Hydrocarbons, C6-30",274-000-6,69430-33-7,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,30,H302:25;H315:25;H336:25;H335:25;Not classified:5
49759,"2,4-bis(1-phenylethyl)phenol",220-460-8,2769-94-0,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1;H335:1
49763,2-Hydroxypropyl cellulose,618-388-0,9004-64-2,Not Classified,Notified C&L,2293,Not classified:2292;H332:1;H315:1;H335:1;H302:1;H319:1
49764,"2-phosphonobutane-1,2,4-tricarboxylic acid, potassium salt",299-311-4,93858-78-7,,Notified C&L,84,Not classified:81;H319:3;H315:2;H290:1
49766,"chlorphonium chloride (ISO);tributyl (2,4-dichlorobenzyl) phosphonium chloride",204-105-4,115-78-6,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0,H319:0;H312:0;H315:0;H301:0
49768,"Tail gas (petroleum), cracked distillate hydrotreater stripper;Petroleum gas;[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",269-620-9,68308-01-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;Not classified:0;H350:0
49769,ethanol;ethyl alcohol,200-578-6,64-17-5,Flam. Liq. 2,Harmonised C&L,0,H225:0
49772,6-ethoxybenzothiazole-2-sulphonamide,207-199-5,452-35-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
49779,Methylenecyclohexane,214-752-4,1192-37-6,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,41,H225:41;H304:39
49781,3-methylhexan-2-one,219-846-9,2550-21-2,Flam. Liq. 3,Notified C&L,2,H226:2;H319:1;H315:1;H335:1
49782,Toluene-2-sulphonamide,201-808-8,88-19-7,Acute Tox. 4,REACH registration C&L,95,H302:41;Not classified:8;H319:45;H351:45;H315:5;H335:5;H332:1;H312:1;H350:1
49786,"6-fluoro-1,2,3,4-tetrahydro-2-methylquinoline",255-963-1,42835-89-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
49787,Perfluorovaleryl fluoride,206-790-5,375-62-2,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H290:1;H318:1;H314:1
49788,"Steroids, soya hydroxy, ethoxylated (25EO)",614-690-1,68648-64-6,Aquatic Chronic 3,Notified C&L,22,H412:22
49789,"(±)-3-(hexadecyloxy)propane-1,2-diol",228-149-9,6145-69-3,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38
49790,"ε-Caprolactone, oligomers, esters with acrylic acid and 2,2,2',2'-tetrakis (hydroxymethyl)-3,3'-oxydipropan-1-ol",500-276-7,89800-10-2,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,2,H317:2;H412:2
49791,N-acetylvaline,202-537-8,96-81-1,Not Classified,Notified C&L,1,Not classified:1
49797,"N-[5-[bis(2-hydroxyethyl)amino]-2-[(5-nitro-2,1-benzisothiazol-3-yl)azo]phenyl]acetamide",251-101-3,32569-24-7,Not Classified,Notified C&L,3,Not classified:3
49799,Carboxypeptidase A,234-297-5,11075-17-5,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H334:38;H319:38;H315:38;H335:38
49802,"N,N'-bis(tert-butyl)ethylenediamine",223-769-6,4062-60-6,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,46,H314:46;H318:2;H302:2;H226:2;H341:1
49803,"Arctium lappa, ext.",281-658-8,84012-13-5,Not Classified,REACH registration C&L,10,Not classified:8;H226:2
49810,"N-[2-[(2-cyano-4,6-dinitrophenyl)azo]-5-[ethyl(phenylmethyl)amino]phenyl]acetamide",256-866-7,50963-62-7,Not Classified,Notified C&L,1,Not classified:1
49812,MDT,422-020-2,,,Notified C&L,1,H317:1;H318:1
49819,"N,N-dimethylicosylamine",256-216-2,45275-74-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,38,H400:38;H314:38;H302:38;H318:38
49821,Methyl 4-fluorobenzoate,206-956-7,403-33-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:38;H302:38;H315:45;H335:44;H319:7
49822,"sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate",410-770-3,146177-84-6,Skin Sens. 1,Harmonised C&L,0,H317:0
49825,2-(methylsulphonyl)ethanol,239-261-2,15205-66-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H315:2;H335:2;Not classified:1
49826,(2-methylbenzyl)triphenylphosphonium bromide,216-227-5,1530-36-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H312:1;H335:1;H302:1;H319:1
49836,"2,2,3,3,4,4,4-heptafluorobutyl methacrylate",237-217-7,13695-31-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H332:38;H312:38;H335:43;H302:38;H319:44;H226:41;H315:6
49837,(2S)-2-{[(1E)-(5-chloro-2-hydroxyphenyl)(phenyl)methylene]amino}-3-methylbutanoic acid,609-516-6,38075-43-3,Not Classified,REACH registration C&L,1,Not classified:1
49839,(3-NITROPHENYL)UREA,603-484-7,13142-61-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H317:38;H302:38
49841,"Quaternary ammonium compounds, (C12-16-branched and linear alkyl)trimethyl, Me sulfates",296-491-6,92704-57-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,4,H318:4;H302:4;H315:4;H400:4
49842,"1,1'-(1,1,2,2-tetramethylethylene)dibenzene",217-568-2,1889-67-4,Skin Sens. 1B,REACH registration C&L,79,H317:11;Not classified:66;H335:2
49843,"Phenol, nonyl derivs.",268-359-8,68081-86-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,444,H319:441;H315:441;H410:3;H314:3;H361:3;H400:3;H302:3
49845,"Acetamide, N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-4-methyl-6-oxo-1,4-cyclohexadien-1-yl]-",417-490-0,105296-07-9,Skin Sens. 1,Notified C&L,8,H317:8
49847,"Phosphonium, tetrabutyl-, salt with 1H-benzotriazole (1:1)",600-912-4,109348-55-2,Skin Irrit. 2,Notified C&L,15,H315:13;H332:2;H312:2;H302:2
49848,Dibenzyl carbonate,222-401-1,3459-92-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H312:39;H302:39
49849,N-dodecyl-4-methoxybenzamide,442-340-6,1854-15-5,Aquatic Chronic 4,Harmonised C&L,0,H413:0
49851,"Imidazolium compounds, 1(or 3)-(carboxymethyl)-4,5-dihydro-1-(hydroxyethyl)-2-norcoco alkyl, hydroxides, monosodium salts",271-957-1,68647-53-0,Eye Dam. 1,Notified C&L,2,H318:2
49852,Neodymium trichloride,233-031-5,10024-93-8,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,158,H412:7;H318:91;H410:83;H315:151;H400:83;H319:67;H335:67;H317:1;H290:1;H370:1;H411:1
49853,"N-[4-[[(1-methylethyl)amino]acetyl]phenyl]-, monohydrochloride",611-314-8,5576-49-8,Not Classified,REACH registration C&L,5,Not classified:4;H302:1
49856,nickel(II) neoundecanoate,300-093-0,93920-09-3,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H410:0;H360:0;H317:0;H372:0;H400:0;H341:0;H334:0;H350:0
49861,N-methyl-2-pyrrolidone;1-methyl-2-pyrrolidone,212-828-1,872-50-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Harmonised C&L,0,H360:0;H319:0;H315:0;H335:0
49862,"7-chloro-3-(1H-imidazol-1-yl)-1,2,4-benzotriazine 1-oxide",276-668-4,72459-58-6,Acute Tox. 3;Acute Tox. 3,Notified C&L,128,H331:128;H301:128;H410:1;H400:1;H373:1
49863,"Tris(2-hydroxyethyl)-1,3,5-triazinetrione",212-660-9,839-90-7,Not Classified,REACH registration C&L,453,Not classified:266;H319:187;H315:187;H335:186
49866,"4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]benzenesulphonamide",220-378-2,2744-49-2,Not Classified,REACH registration C&L,72,Not classified:72
49867,Oxirane-2-carboxamide,227-163-2,5694-00-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Carc. 1B,Notified C&L,38,H315:38;H317:38;H335:38;H302:38;H350:38;H319:38
49873,"Fatty acids, tall-oil, esters with triethanolamine",271-958-7,68647-55-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,32,H319:32;H312:31;H315:32
49875,Zinc dipalmitate,225-652-5,4991-47-3,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H410:38;H400:38;H319:38;Not classified:2
49880,Tricyclohexylphosphine,220-069-2,2622-14-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,63,H319:63;H315:63;H335:62;H251:14;H411:15;H302:7;H413:1;H361:1;H225:1;H336:1;H304:1;H410:1;H400:1;H301:2;H412:1
49885,ethyl 8-bromooctanoate,608-417-5,29823-21-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H315:2;H335:2
49886,"4,6-dichloropyrimidin-2-ylamine",200-253-9,56-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:51;H315:51;H335:50;H302:1
49897,"Fatty acids, C16-18, esters with triethylene glycol",292-944-7,91031-42-4,Not Classified,Notified C&L,4,Not classified:4
49903,4-chlorobenzylmethylamine,203-175-3,104-11-0,Skin Corr. 1C;Eye Dam. 1,Notified C&L,3,H314:2;H318:2;H302:1;H315:1;H335:1
49904,Opium,232-368-5,8008-60-4,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,84,H334:44;H317:44;H302:45;H336:44;H310:38;H330:38;H300:38;Not classified:1;H311:1;H331:1;H301:1
49910,Bis(lactato)oxotitanium,252-183-3,34747-99-4,Met. Corr. 1;Skin Corr. 1A,Notified C&L,6,H290:6;H314:6
49912,1-bromo-3-ethoxytoluene,268-982-5,68155-69-1,Acute Tox. 3,Notified C&L,38,H301:38
49913,Methyl syringate,618-163-7,884-35-5,Eye Irrit. 2,Notified C&L,42,H319:42;H315:4;H335:4
49917,GERANIUM E.O,616-774-3,8000-46-2,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,169,H315:155;H317:88;H411:80;H318:84;H304:97;H319:43;H412:7;Not classified:1
49918,Hex-5-enal,212-127-0,764-59-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H225:1;H319:1;H315:1;H335:1
49924,"1,6-dioxacyclododecane-7,12-dione",212-291-3,777-95-7,Acute Tox. 5;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H303:1;H319:1;H315:1;H335:1
49927,Trihexyl borate,226-262-8,5337-36-0,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,39,H319:39;H413:38
49929,barium chlorate,236-760-7,13477-00-4,Ox. Sol. 1;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H302:0;H271:0;H411:0
49930,5-chloro-2-nitroaniline,216-661-5,1635-61-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,55,H310:54;H330:54;H411:55;H300:54;H373:54;Not classified:2;H315:1;H311:1;H361:1;H319:1;H331:1;H301:1
49932,"3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one",200-488-7,60-82-2,Not Classified,Notified C&L,162,Not classified:107;H319:55;H315:55;H335:54
49936,"3,4,5-trimethoxybenzoyl chloride",224-851-4,4521-61-3,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,REACH registration C&L,47,H314:47;H302:2;H335:42;H290:1;H318:1
49937,"N,N-bis(2-hydroxyethyl)stearamide",202-280-1,93-82-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,185,H319:95;H315:128;Not classified:47;H318:43;H412:11;H335:1
49938,"7-anilino-3-[[4-[(2,4-dimethyl-6-sulphophenyl)azo]-2-methoxy-5-methylphenyl]azo]-4-hydroxynaphthalene-2-sulphonic acid, compound with 2,2'-iminodiethanol (1:2)",302-819-1,94134-50-6,Not Classified,Notified C&L,1,Not classified:1
49941,2-nitrobenzyl alcohol,210-302-6,612-25-9,,Notified C&L,6,H319:5;H315:5;H335:5;H332:2;H312:2;H302:2
49942,Formamide oxime,210-865-8,624-82-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,39,H332:39;H312:39;H302:39;H351:39;H315:1;H335:1;H319:1
49946,"4-trans-Propyl-[1,1-bicyclohexyl]-4-trans-carbonic acid-(2-fluor-4-pentylphenylester)",603-996-0,137019-96-6,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
49950,3-chlorophenoxyacetic acid,209-616-6,588-32-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,44,H302:44;H318:39;H319:4;H315:5;H335:5
49954,"Amines, C10-14-branched and linear alkyl, bis[2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-)",285-082-8,85029-57-8,Skin Sens. 1B;Aquatic Chronic 3,Notified C&L,195,H317:83;H412:83;H302:86;H411:54;H413:32;H410:26;H400:26
49955,"Bisbenzimidazo[2,1-b:1',2'-j]benzo[lmn][3,8]phenanthroline-6,9-dione",224-152-4,4216-02-8,Not Classified,REACH registration C&L,68,Not classified:67;H412:1
49957,"Boric acid, compd. with 2,2',2''-nitrilotris[ethanol]",270-252-6,68413-80-9,Eye Irrit. 2,Notified C&L,2,H319:1;Not classified:1
49958,α-chloro-p-xylene,203-241-1,104-82-5,Acute Tox. 4;Skin Corr. 1B,Notified C&L,61,H314:60;H302:60;H318:2;H335:2;H319:1;H315:1;H226:1;H290:1
49965,Cerium,231-154-9,7440-45-1,Flam. Sol. 1,REACH registration C&L,293,H228:277;H332:39;H315:39;H312:39;H335:39;H302:39;H319:39;Not classified:11;H260:4;H250:4;H413:3;H318:2;H272:2;H261:3
49968,Diethyl trisulphide,222-754-1,3600-24-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,89,H319:89;H315:89;H335:89
49971,2-hydroxyoctacosyl 12-hydroxyoctadecanoate,298-937-5,93840-71-2,Not Classified,Notified C&L,1,Not classified:1
49975,"2,2-dimethylpropiophenone",213-338-0,938-16-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73,H319:39;H315:39;H335:39;Not classified:34
49979,"Benzene, ethenyl-, polymer with 1,3-butadiene, hydrogenated",613-880-1,66070-58-4,Not Classified,Notified C&L,668,Not classified:589;H413:40;H332:37;H228:1;H412:1
49981,5-[[4-(aminosulphonyl)-2-nitrophenyl]amino]-2-[[4-[[4-(aminosulphonyl)-2-nitrophenyl]amino]phenyl]amino]benzenesulphonic acid,235-472-9,12239-00-8,Not Classified,Notified C&L,2,Not classified:2
49985,Iron tris(2-ethylhexanoate),230-794-6,7321-53-1,Not Classified,REACH registration C&L,17,Not classified:10;H361:6;H226:5;H304:5;H319:1;H315:1
49986,"2-hydroxy-1,4-naphthoquinone",201-496-3,83-72-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H315:40;H335:38;H341:5;H302:7;H411:1
49987,"Ammonium [trisulphamoyl-29H,31H-phthalocyaninesulphonato(3-)-N29,N30,N31,N32]cuprate(1-)",305-403-8,94534-99-3,Aquatic Chronic 3,REACH registration C&L,120,H412:84;H413:1;H302:36;H411:36;H373:36
49992,1-Benzyl-4-(hydroxymethyl)piperidine,614-102-3,67686-01-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
49993,"Tetrasodium 5-[[4'-[[2,6-diamino-3-[[8-hydroxy-3,6-disulphonato-7-[(4-sulphonato-1-naphthyl)azo]-2-naphthyl]azo]-5-tolyl]azo][1,1'-biphenyl]-4-yl]azo]salicylate",219-390-0,2429-81-4,Acute Tox. 4;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H350:38;H302:38;H400:38
49997,(R)-2-aminobutan-1-ol,227-476-4,5856-63-3,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,107,H314:107;H318:61;H410:55;H400:56;H302:102;H332:1;H312:1
49999,1-isopropoxypropan-2-ol,223-533-2,3944-36-3,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,2,H319:1;H226:2
50006,Benzylbis(2-hydroxyethyl)methylammonium hydroxide,251-625-2,33667-49-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
50007,Calcium distearate,216-472-8,1592-23-0,Not Classified,REACH registration C&L,3750,Not classified:3196;H319:538;H335:551;H332:51;H315:51;H312:51;H302:51;H314:2;H318:2;H203:1
50009,4-hydroxy-DL-tryptophan,240-605-9,16533-77-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
50011,"pentane-1,3-diol",608-665-4,3174-67-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H226:1;H335:1
50016,"Ocotea cymbarum, ext.",294-823-4,91770-39-7,Acute Tox. 4;Muta. 2;Carc. 1B,Notified C&L,1,H341:1;H302:1;H350:1
50017,"Guanidine, N,N'''-1,3-propanediylbis-, N-coco alkyl derivs.",308-757-1,98246-84-5,Acute Tox. 4;Skin Corr. 1C;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,51,H410:2;H400:51;H314:51;H302:51
50029,2-ethyl-p-xylene,217-158-3,1758-88-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,43,H302:38;H318:38;H226:5
50031,1-Ethyl-3-methylimidazolium ethylsulfate,460-100-9,,Not Classified,REACH registration C&L,87,Not classified:87
50032,"1,3,4,6-tetraacetyltetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione",234-124-3,10543-60-9,Acute Tox. 2,Notified C&L,38,H300:38
50036,1-(2-benzylphenoxy)propan-2-ol,225-720-4,5029-76-5,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H400:38;H319:38
50037,"1,3-bis{}{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}}propane lithium-, sodium salt",415-100-3,149850-29-3,Skin Sens. 1,Harmonised C&L,0,H317:0
50038,Dicerium trisulphate,236-644-6,13454-94-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:44
50043,(S)-2-amino-N-(4-methoxy-2-naphthyl)-4-methylvaleramide monohydrochloride,224-735-3,4467-68-9,Carc. 2,Notified C&L,39,H351:38;H350:1
50045,Magnesium molybdate,237-376-2,13767-03-8,Not Classified,Notified C&L,37,Not classified:33;H319:4;H315:4;H335:4
50046,Sodium 4-[(octadecylamino)carbonyl]benzoate,227-822-4,5994-45-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,52,H319:31;H315:31;Not classified:21
50047,"2-nitrobenzene-1,4-diammonium sulphate",269-477-2,68239-83-8,Skin Sens. 1,Notified C&L,1,H317:1
50050,"Hydrogen [4-[4-(4-ethoxyanilino)-4'-[ethyl[3(or 4)-sulphonatobenzyl]amino]benzhydrylidene]cyclohexa-2,5-dien-1-ylidene](ethyl)[3(or 4)-sulphonatobenzyl]ammonium, sodium salt",299-907-4,93918-26-4,Not Classified,Notified C&L,2,Not classified:2
50051,Bismuth triacetate,244-904-5,22306-37-2,Not Classified,Notified C&L,1,Not classified:1
50052,"Phosphoric acid, triethyl ester, polymer with oxirane and phosphorus oxide (P2O5)",606-033-2,184538-58-7,Not Classified,Notified C&L,1,Not classified:1
50055,N-[tert-butoxycarbonyl]-L-serine,221-867-3,3262-72-4,Not Classified,Notified C&L,5,Not classified:2;H319:3;H315:3;H335:3
50056,2-ethyl-m-xylene,220-696-1,2870-04-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:38;H302:38;H225:4
50060,"Rutile, antimony chromium manganese brown",274-248-5,69991-68-0,Not Classified,Notified C&L,5,Not classified:5
50065,Folic acid,200-419-0,59-30-3,Not Classified,REACH registration C&L,182,Not classified:83;H319:94;H315:94;H335:6;H362:5;H341:5;H361:5;H373:5
50067,1-methylpyrrolidine,204-438-5,120-94-5,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,297,H332:96;H314:297;H411:89;H225:297;H318:86;H301:100;H302:197;H331:1
50070,Rifapentine,262-743-9,61379-65-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H315:39;H335:39;H302:1;H361:1
50072,Methyl 2-isothiocyanatobenzoate,240-164-2,16024-82-1,,Notified C&L,6,H312:4;H302:5;H331:4;H314:4;H319:2;H315:2;H335:2;H332:1
50075,D-arabinitol,207-686-2,488-82-4,Not Classified,Notified C&L,1,Not classified:1
50077,Methyl carbazate,228-560-3,6294-89-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,83,H320:4;H319:83;H315:83;H301:44;H335:44;Not classified:1;H311:1;H331:1
50081,"(1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxamide",600-115-1,1006376-62-0,Not Classified,Notified C&L,1,Not classified:1
50082,3-aminopropyldibutylamine,203-059-2,102-83-0,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B,Notified C&L,67,H311:67;H314:67;H302:67;H318:1
50083,Disodium hydrogenarsenate,231-902-4,7778-43-0,Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H410:3;H400:3;H350:3;H331:3;H301:3
50085,Thiophene-2-carbonitrile,213-706-0,1003-31-2,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,49,H315:49;H335:44;H302:43;H318:43;H226:45;H332:6;H312:6;H319:6;H301:5
50086,"3,4,5 Trihydrobenzoic acid, monohydrate",611-919-7,5995-86-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,102,H319:99;H315:99;H335:99;Not classified:3
50090,Sodium 3-(benzothiazol-2-ylthio)propanesulphonate,256-401-8,49625-94-7,Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,44,H317:2;H315:44;H319:42;H335:39;H312:2;H302:3
50092,"6α,9-difluoro-11β,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-valerate",261-655-8,59198-70-8,Repr. 1A;STOT RE 1,Notified C&L,29,H372:26;H360:26;H361:1;H332:1;H312:1;H302:3;H373:1;H362:1;H412:1
50094,"1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione",414-540-3,484-33-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
50095,"disodium 9,10-anthracenedioxide",426-030-8,46492-07-3,Skin Corr. 1A,Harmonised C&L,0,H314:0
50102,"Diphosphoric acid, compd. with piperazine",613-872-8,66034-17-1,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,447,H319:447;H412:446;H335:1
50106,"3,3-dimethylbutanone",200-920-4,75-97-8,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,160,H332:66;H225:121;H302:154;H335:58;H412:48;H319:33;H315:34;Not classified:5;H224:1;H301:1
50107,3-ethoxybenzonitrile,246-632-2,25117-75-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H332:42;H312:42;H302:42;H315:4;H335:4;H319:4
50110,2-Methoxy-4-methylpyridine,600-136-6,100848-70-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H226:39;H335:38
50111,"Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, potassium salt",214-985-1,1240-04-6,Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,38,H361:38;H319:38;H335:38
50112,"Extract residues (coal), brown;Coal Tar Extract;[The residue from extraction of dried coal.]",294-285-0,91697-23-3,Carc. 1B,Harmonised C&L,0,H350:0
50114,4-phenylmorpholine,202-164-0,92-53-5,Acute Tox. 4;Acute Tox. 3,Notified C&L,40,H311:40;H302:40;H319:2;H315:2
50116,"Sodium 2-[2-[2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]ethoxy]ethoxy]ethanesulphonate",220-851-3,2917-94-4,Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,174,H410:72;H319:162;H412:93;Not classified:9
50119,Hexylcyclohexane,224-294-7,4292-75-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,41,H319:38;H302:38;H413:38;Not classified:3
50122,"N,α-dimethylphenethylamine hydrochloride",206-093-6,300-42-5,Acute Tox. 2;Acute Tox. 3;Acute Tox. 1;Repr. 2,Notified C&L,38,H311:38;H361:38;H330:38;H300:38
50125,Tetrahydro-2-methoxy-2H-pyran,229-509-8,6581-66-4,Flam. Liq. 3,Notified C&L,38,H226:38
50128,"4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide)",418-320-8,133467-41-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H302:0
50130,"4-(2,2-dichlorocyclopropyl)phenyl acetate",924-945-1,144900-34-5,Aquatic Chronic 2,REACH registration C&L,1,H411:1
50132,"Distillates (petroleum), acid-treated light;Gasoil - unspecified;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-114-7,64742-14-9,Carc. 1B,Harmonised C&L,0,H350:0
50134,"1,1'-(octadecylimino)dipropan-2-ol",248-859-2,28137-64-6,Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,1,H314:1;H411:1
50138,"Phenol, reaction products with divinylbenzene",297-029-6,93281-16-4,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 3,Notified C&L,1,H317:1;H412:1;H315:1
50141,Heptanal,203-898-4,111-71-7,Flam. Liq. 3;Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1711,H412:29;H315:1708;H226:1711;H319:1552;H335:4;H280:1;H330:1;H400:1
50142,p-phenylenebis(methylamine),208-719-3,539-48-0,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,46,H317:1;H314:46;H412:1;H302:1;H318:2;Not classified:1
50143,4'-methoxyacetoacetanilide,226-615-6,5437-98-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,139,H332:36;H312:36;H302:55;Not classified:83;H317:1
50146,Germanium diiodide,236-998-1,13573-08-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42,H314:42;H318:38
50147,Isovaleric anhydride,215-994-3,1468-39-9,Acute Tox. 3;Skin Corr. 1B,Notified C&L,43,H311:38;H314:43;H290:1;H318:1
50150,p-tolylhydrazine,208-717-2,539-44-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1;H301:1
50151,4-tert-butylbenzyl alcohol,212-894-1,877-65-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
50152,"Disodium 2-(11-oxido-3-oxo-3H-dibenzo[c,h]xanthen-7-yl)benzoate",228-794-6,6359-10-0,Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,116,H314:2;H318:85;H411:2;H317:83;Not classified:31
50156,Methyl 4-chloro-4-oxobutyrate,216-077-0,1490-25-1,Skin Corr. 1B,REACH registration C&L,47,H314:47;H318:3;H332:1;H290:2;H227:1
50157,"bromoxynil octanoate (ISO);2,6-dibromo-4-cyanophenyl octanoate",216-885-3,1689-99-2,Acute Tox. 4;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H410:0;H317:0;H400:0;H361:0;H302:0;H331:0
50160,"Dimethyl heptane-1,7-diimidate dihydrochloride",261-320-6,58537-94-3,Skin Irrit. 2,Notified C&L,155,H315:155;H319:1
50161,Malonamic acid,219-069-5,2345-56-4,Eye Irrit. 2,Notified C&L,39,H319:39;H315:1;H335:1
50163,2-hydroxyanthraquinone,210-085-8,605-32-3,Aquatic Chronic 2,Notified C&L,48,H411:38;H319:10;H317:9;H315:1
50167,"Glycine, N-acetyl-N-[3-(trifluoromethyl)phenyl]valyl-, ethyl ester",609-496-9,379685-94-6,Not Classified,REACH registration C&L,2,Not classified:2
50168,1-ethoxyethylideneammonium chloride,218-631-7,2208-07-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:44
50169,Chloromethyl acetate,210-902-8,625-56-9,Acute Tox. 3;Eye Dam. 1,Notified C&L,41,H318:39;H301:40;H314:2;H226:2;H335:1
50177,"[1α(E),2β]-1-(2,6,6-trimethylcyclohex-3-en-1-yl)but-2-en-1-one",275-156-8,71048-82-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,168,H410:167;H315:107;H317:168;H400:93;H302:107
50180,2-furfuryl isothiocyanate,225-079-0,4650-60-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4,Notified C&L,44,H332:43;H317:39;H314:43;H302:43;H312:43;H319:1;H315:1;H335:1;H334:1
50181,Zinc bis(4-hydroxybenzenesulphonate),204-867-8,127-82-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,76,H319:39;H302:40;H315:39;H335:39;Not classified:36
50182,N-tert-Butylethylamine,619-627-1,4432-77-3,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H225:1;H314:1;H318:1
50185,"2,6-dimethyl-1,4-benzoquinone 4,4'-[O,O'-[methylenebis(p-phenyleneiminocarbonyl)]dioxime]",281-772-8,84030-01-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,2,H319:1;H312:1;H317:1
50187,Bismuth tribromide,232-121-1,7787-58-8,Skin Corr. 1B,Notified C&L,64,H314:64;Not classified:1;H335:1;H318:1
50190,"2-ethyl-2-nitropropane-1,3-diol",209-893-3,597-09-1,,Notified C&L,42,Not classified:38;H319:4;H315:4;H335:4
50191,Atraton,216-547-5,1610-17-9,Acute Tox. 4,Notified C&L,41,H302:40;Not classified:1
50192,p-[[4-(phenylazo)-1-naphthyl]azo]phenol,228-381-0,6253-10-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
50193,2'-hydroxybutyrophenone,220-749-9,2887-61-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H302:2;H315:2;H335:2
50196,4-chloro-2-nitroaniline,201-925-4,89-63-4,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,170,H310:169;H330:169;H411:170;H300:169;H373:169;H311:1;H331:1;H301:1
50198,"Butyl 3,4,5-trihydroxybenzoate",214-107-7,1083-41-6,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,39,H319:38;H317:38;H302:39
50199,"Resin acids and Rosin acids, esters with glycerol",232-482-5,8050-31-5,Not Classified,REACH registration C&L,272,Not classified:267;H319:4;H332:1;H312:1;H302:1
50200,Cyclopentanecarbaldehyde,212-829-7,872-53-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42;H226:4
50204,"α,2,6,6-tetramethylcyclohexene-1-propan-1-ol",221-957-2,3293-47-8,Not Classified,Notified C&L,1373,Not classified:1373
50205,4-benzylpiperidin-4-ol,257-003-7,51135-96-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:42;H302:38;H315:4;H335:4
50207,Calcium sulfate,231-900-3,7778-18-9,Not Classified,REACH registration C&L,1907,Not classified:1786;H318:68;H315:70;H319:46;H334:5;H350:5;H317:5;H412:5;H335:3;H312:1;H302:1
50208,"2,5-dimethylresorcinol",207-688-3,488-87-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,40,H332:40;H312:40;H302:40;H314:40;H318:1
50210,"17-α,21-dihydroxypregn-4-ene-3,20-dione 21-acetate",211-369-4,640-87-9,Repr. 2;Aquatic Chronic 2,Notified C&L,1,H361:1;H411:1
50215,Bis(4-chloro-3-nitrophenyl) sulphone,217-159-9,1759-05-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H335:38
50216,"Polyphosphoric acids, ammonium salts",269-789-9,68333-79-9,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,487,H319:15;H302:15;Not classified:472
50218,Sodium xylenesulphonate,215-090-9,1300-72-7,Eye Irrit. 2,Notified C&L,1733,H319:1176;Not classified:557;H315:222;H335:155;H320:1;H400:1
50219,"reaction mass of (1S,1'R)-2-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy]-2-methylpropyl propanoate, (1R,1'R)-2-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy]-2-methylpropyl propanoate and 2-methyl-2-{[(1R,2R)-2,6,6-trimethylcycloheptyl]oxy}propyl propanoate",604-250-7,141773-73-1,Aquatic Chronic 2,Notified C&L,143,H411:118;H315:25
50220,"Polysiloxan (di-Me), Polymer mit Methylsilsesquioxan, ethoxy-terminiert",614-607-9,68554-66-5,Flam. Liq. 3,Notified C&L,1,H226:1
50221,Dimesna,240-337-2,16208-51-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;H332:1;H312:1;H302:1
50222,4-methyl-2-oxo-2H-1-benzopyran-7-yl palmitate,241-695-2,17695-48-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
50226,Trimethyl(octadecyl)ammonium methyl sulphate,242-501-9,18684-11-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,94,H400:61;H314:61;H302:61;H318:61;H315:33
50227,Tridecylamine,220-694-0,2869-34-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,481,H319:441;H412:441;H315:441;H400:40;H314:40;H302:40;H410:1;H318:1
50228,"Estra-1,3,5,7,9-pentaen-17-one, 3-(sulfooxy)-, sodium salt",240-728-8,16680-48-1,Skin Irrit. 2;Eye Irrit. 2;Carc. 1B;Repr. 1A;Lact.;STOT RE 2,Notified C&L,1,H362:1;H315:1;H360:1;H350:1;H319:1;H373:1
50229,2-fluoro-5-nitroaniline,206-720-3,369-36-8,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H228:39;H319:46;H315:46;H335:45;H332:7;H312:7;H302:7;H311:1;H331:1;H301:1
50230,"N,N-diphenylacetamide",208-277-1,519-87-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
50232,Benzimidazol-2-ylmethylamine dihydrochloride hydrate,227-820-3,5993-91-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
50235,"7-methyl-2H-benzo-1,5-dioxepin-3(4H)-one",249-320-4,28940-11-6,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,1828,H314:62;H318:62;H336:62;H302:1763;Not classified:5
50236,2-naphthyl anthranilate,264-155-8,63449-68-3,Eye Irrit. 2,Notified C&L,88,H319:88
50238,Ethylamine--boron trifluoride,200-852-5,75-23-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,230,H319:5;H302:10;H315:7;H335:121;H314:182;H332:33;H301:7;H318:4;H372:1;H290:1;H371:1
50239,"Fatty acids, C14-18 and C16-18-unsatd., esters with triethanolamine",285-536-5,85116-83-2,Not Classified,Notified C&L,32,Not classified:32
50241,(1S)-1-(4-methoxyphenyl)ethanamine,609-962-1,41851-59-6,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,132,H317:85;H314:131;H302:90;H402:2;H412:85;H318:86;H319:1;H315:1;H335:1
50243,4-phenylbutan-2-one,219-847-4,2550-26-7,Not Classified,REACH registration C&L,1616,Not classified:1569;H315:47;H319:6;H302:1
50248,"4,4'-bis[[6-anilino-4-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonic acid, compound with 2-aminoethanol (1:2)",243-594-9,20206-64-8,Not Classified,Notified C&L,2,Not classified:2
50249,trans-dec-5-ene,231-080-7,7433-56-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H315:38;H226:42;H335:38
50250,"1,3-dihydro-4-methyl-2H-imidazol-2-one",214-751-9,1192-34-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
50251,"1,3-diaminopropan-2-ol",210-474-2,616-29-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:44;H315:44;H335:44;Not classified:5;H314:2;H318:1;H317:1;H302:1
50252,N-[2-[(2-bromo-6-cyano-4-nitrophenyl)azo]-5-(diethylamino)phenyl]propionamide,218-995-7,2309-94-6,Not Classified,Notified C&L,54,Not classified:33;H317:12;H319:8;H315:8;H350:1
50254,"(5-ethyl-2-methyl-1,3,2-dioxaphosphorinan-5-yl)methyl dimethyl phosphonate P-oxide",255-263-6,41203-81-0,Not Classified,Notified C&L,91,Not classified:91
50258,Saponite,215-289-0,1319-41-1,Not Classified,Notified C&L,1,Not classified:1
50260,3-(chlorosulphonyl)benzoic acid,223-692-8,4025-64-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,46,H314:46;H318:39;H290:1
50265,"N,N'-ethylenebis[N-acetylacetamide]",234-123-8,10543-57-4,Not Classified,REACH registration C&L,324,Not classified:324
50266,Dibenzyl phthalate,208-344-5,523-31-9,,Notified C&L,37,Not classified:37
50267,Perfluorophenyl isocyanate,216-470-7,1591-95-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H332:38;H315:38;H312:38;H335:38;H302:38;H334:38;H319:38
50268,Peptidase,232-875-1,9031-96-3,Resp. Sens. 1,Notified C&L,1324,H334:1324;H319:38;H315:38;H335:38
50269,"N,N-ditridecyltridecan-1-amine",227-625-3,5910-77-0,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,441,H314:441;H412:441;H318:441
50270,N-(2-nitrophenyl)phosphoric triamide,477-690-9,,Repr. 1B;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,4,H360:4;H412:4;H373:3
50271,Chlorophosphonitrile,217-390-5,1832-07-1,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,Notified C&L,2,H317:1;H314:2;H318:2;H300:1;H335:1;H411:1
50274,Sodium dibutylnaphthalene-2-sulphonate,297-971-8,93776-42-2,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H332:1;H335:1;H412:1;H302:1;H319:1
50277,"2,3-dihydro-1H-imidazo[1,2-b]pyrazole",229-769-2,6714-29-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
50280,"fluroxypyr-butometyl (ISO);2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate",604-959-1,154486-27-8,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
50281,"[3R-(3α,3aβ,6α,7β,8aα)]-octahydro-6-methoxy-3,6,8,8-tetramethyl-1H-3a,7-methanoazulene",267-510-5,67874-81-1,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,64,H410:30;H400:30;H317:30;H332:33;H319:33;H315:33;Not classified:1
50283,2-bromo-1-(4-fluorophenyl)ethan-1-one,206-955-1,403-29-2,Skin Corr. 1B,Notified C&L,46,H314:42;H319:4;H315:4;H335:4;H290:1;H318:2
50284,Dihydrofolic acid,609-824-0,4033-27-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;H334:1;H317:1
50286,"1,1',1''-[methylidynetris(oxy)]tributane",209-618-7,588-43-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;Not classified:1
50287,(4-methylbenzyl)triphenylphosphonium bromide,219-159-4,2378-86-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
50289,2'-deoxycytidine,213-454-1,951-77-9,Not Classified,Notified C&L,12,Not classified:12
50291,Zinc di(acetate),209-170-2,557-34-6,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,589,H302:166;H318:69;H411:87;Not classified:366;H410:113;H400:125;H319:81;H301:20;H315:22;H314:6;H332:5;H312:5;H335:4;H413:1;H316:1
50292,"Fatty acids, tall-oil, 1-methyl-1,2-ethanediyl esters",269-905-8,68390-58-9,Not Classified,REACH registration C&L,1,Not classified:1
50293,"6α,9-difluoro-11β,17,21-trihydroxypregna-1,4-diene-3,20-dione",212-360-8,806-29-1,Not Classified,Notified C&L,1,Not classified:1
50296,"2,4-dibromopentane",243-031-7,19398-53-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
50299,1-hydroxy-2-(3-pyridinyl)ethylidene-bisphosphonic acid,600-654-2,105462-24-6,Met. Corr. 1;Skin Corr. 1B;STOT SE 3;STOT SE 3,Notified C&L,5,H290:3;H335:3;H314:3;H361:2;H319:2;H302:1;H315:2;H362:1;H373:1
50305,"Fatty acids, butter, Et esters",276-276-3,71990-22-2,Not Classified,Notified C&L,89,Not classified:79;H226:10
50309,"Distillates (petroleum), solvent-refined light naphthenic, hydrotreated;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C",295-316-0,91995-54-9,Carc. 1B,Harmonised C&L,0,H350:0
50312,Sodium N-[(4-aminophenyl)sulphonyl]benzamidate,230-678-5,7257-44-5,Not Classified,Notified C&L,1,Not classified:1
50314,(ethylsulphonyl)ethylene,217-567-7,1889-59-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:38;H315:38;H335:38;H311:2;H330:1;H301:1;H302:1;H318:1
50317,Toluene-2-sulphonic acid,201-809-3,88-20-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:40;H315:40;H335:42;H314:2
50318,organic nitrogen-phosphorous compound,485-300-3,,Not Classified,REACH registration C&L,1,Not classified:1
50319,"Fatty acids, tall-oil, reaction products with benzyl alc., iso-Bu alc. and styrene, epoxidized",287-830-9,85586-27-2,Not Classified,Notified C&L,1,Not classified:1
50320,Diiodohydroxyquinoline,201-497-9,83-73-8,Not Classified,REACH registration C&L,66,Not classified:1;H302:64;H318:38;H332:24;H315:25;H312:24;H335:24;H319:25;H301:1
50322,6-chloronicotinamide,228-456-8,6271-78-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
50324,17β-hydroxy-1α-methyl-5-αandrostan-3-one acetate,223-768-0,4062-46-8,Carc. 2;Repr. 1A;Lact.;Aquatic Chronic 4,Notified C&L,1,H362:1;H360:1;H351:1;H413:1
50326,Tungsten oxide,254-413-8,39318-18-8,Not Classified,REACH registration C&L,28,Not classified:21;H319:7;H351:7;H335:7
50329,Flumequine,255-962-6,42835-25-6,,Notified C&L,25,H334:18;H317:18;H315:16;Not classified:5;H411:1;H373:1;H302:1
50330,(3R)-3-ethoxy-2-methylnonane,616-607-4,78330-20-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,718,H302:463;H318:610;Not classified:106;H315:84;H400:83;H412:20;H411:33;H410:15;H319:2;H317:1
50331,"Linseed oil, polymer with glycerol and phthalic anhydride",613-881-7,66070-59-5,Not Classified,Notified C&L,5,Not classified:5
50333,DS-1112A-E-1,428-950-5,,Not Classified,Notified C&L,84,Not classified:84
50345,"Fatty acids, linseed-oil, reaction products with 2-amino-2-(hydroxymethyl)-1,3-propanediol and formaldehyde",279-510-2,80584-99-2,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,21,H317:2;H412:2;Not classified:19
50352,"1,4-dihydroxy-2-naphthoic acid",250-674-7,31519-22-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
50353,1-ethyl-2-methylquinolinium iodide,210-120-7,606-55-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;H332:1;H312:1;H302:1
